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DIRECTOR'S REPORT
The fascination that the DNA molecule holds for so
many has never, until recently, held the connotation of
flirting with disaster. I, for one, have never given a
moment's thought to whether my passion about the
nature of the gene might be misplaced, much less a
major danger to others or even to the future of mankind
itself. Yet hardly a day now passes that I do not see the
term "recombinant DNA" in some news article, and I
am constantly being asked questions about the possible
dangers of DNA research when I am in the company of
students or even with our nonscientific friends in the
Cold Spring Harbor community. Answers to such ques-
tions are never simple, and now even less so. The vision
of the hysterics has so peopled biological laboratories
with monsters and super bugs that I often feel the
discussion has descended to the realm of a surrealistic
nightmare from which we will most surely soon awak-
en
I am afraid, however, that it is not a nightmare from
which we suffer, but a massive miscalculation in which
we cried wolf without having seen or even heard one.
Although from childhood we have been told that this is a
silly way to proceed, we thought we were acting wisely
because it was not an ordinary wolf, which we could
fight away with a club, that we feared, but a creature so
formidable that it could eat us up before we could even
cry for help. The "super wolf" in this case is, of course,
the new types of DNA molecules ("recombinant DNA")
that can now be made in test tubes. The tool that has
made such creatures possible is a newly discovered
class of ordinary enzymes (the restriction enzymes)
which make specific cuts in DNA molecules in a way
that allows their genetic information to be specially
rearranged. For example, the end product might be a
new DNA molecule consisting of sections derived from
both bacterial and human cells. Even more important,
the means now exist to put these hybrid molecules back
into bacteria, thereby creating new forms of bacteria
capable of synthesizing human proteins together with
their normal bacterial products.
Hall goes as we now suspect it will, we should be able
to produce, for example, human insulin in virtually
inexhaustible quantities, as well as scores of other med-
ically useful human proteins that are now in short
supply. Naturally, many first-rate scientists have begun
to do research in this area, for not only can we foresee a
variety of important applied benefits, but, in addition,
the recombinant DNA technology provides a simple
means to work out the detailed structure of the chromo-
somes of higher organisms, thereby opening up for the
first time the possibility of, for example, detailed
molecular characterization of the genes involved in the
immunological response. This is a practical break-
through of vast importance, and we can anticipate that
in the next several years there will be a rash of dis-
coveries which without "recombinant DNA" might not
have been achieved within this century.
Simultaneously, however, with the arrival of this new
technology, some of us began to wonder whether it
might also have unexpectedly bad consequences, such
as through the creation of new types of organisms never
yet subjected to the pressures of evolution and which
might have disease-causing potentials that we do not
now have to face. In particular, we worried about the
creation of bacteria selectively tailored to be resistant to
all known antibiotics or the insertion of the genes of
tumor viruses into bacteria known to multiply in
humans. Such discussions, first initiated at the 1973
Gordon Conference on Nucleic Acids, were followed in
April 1974 by the proposal by a number of molecular
biologists, of which I was one, that there be a formal
moratorium on these two types of experimentation until
an international meeting could be held to discuss
whether such experimentation did, in fact, pose any
plausible public health danger. It is important to stress
that in making this proposal we did not urge any restric-
tions on most other forms of recombinant DNA re-
search, as we believed these other forms of research
would be just as safe as experiments we now conduct
routinely with many forms of viruses and bacteria.
Because those of us who signed the moratorium
proposal were respected scientists, not known for envi-
ronmental or political kookism, we were taken seri-
ously, and eleven months later some one hundred and
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fifty people came together at the Asilomar Conference
Center in California to make further proposals. This
course of action, however, was far from what I had
anticipated when we gathered together at MIT to urge
the limited moratorium. Instead of coming together to
discuss whether the moratorium should be continued,
the debate focused on how widely it should be ex-
tended. Committees had already been at work drafting
regulations under which recombinant DNA research
could be done. Much to my dismay, the category of
experiments thought to need regulations had become
greatly expanded, with the general operational rule
being that while your own experimental system was
safe, there was no reason to assume your neighbor's
was. From the start I felt most out of tune, and almost no
one took seriously my opening argument that since
there was no effective way to regulate experimentation
with the known pathogenic bacteria and viruses, how
could we come up with any logical rules for assuring
protection from dangers that we could quantitate even
less well.
As we know all too well today, the result of the
meeting was a near unanimous consensus that we must
act as if virtually all forms of recombinant DNA tech-
nology were potentially dangerous and work to
minimize the possibility of bad consequences by
employing a variety of devices for the physical
containment of the new bacteria. There was also
agreement that the specific bacteria (E. coli strain K12)
to be used for such experiments should be especially
tailored genetically so that even if they did escape into
the outside world, they would have no chance to
colonize the human digestive tract. All in all, most
everyone, including the press, thought the affair was a
smashing success, and the world of molecular genetics
would gain infinite kudos for the deliberate self-restraint
with which it had moved ahead. To be sure, there were
mimeographed sheets in the back of the hall that spit out
nonsense about recombinant DNA leading to the
enslavement of the masses by genetic engineering, but
this was regarded as scientifically absurd and surely
never to be taken seriously by any sensible person.
I, however, left Asilomar feeling very uneasy. My
view that the whole affair was a hasty rush into unjus-
tified bureaucratic roadblocks that would set back the
course of legitimate science was considered by some to
be eccentric irresponsibility. Yet I did not then, nor do I
now, believe all recombinant DNA research is
necessarily totally safe. The future automatically entails
uncertainty, and the days of all of us are marked by
unexpected occurrences that might suddenly do us in.
Obviously, no sane person rushes in directions where
he anticipates harm to himself or others, and we would
be deluding ourselves if we were to proceed as if in a
risk-free world. Instead, our sanity demands that we try
to find means to order actions in terms of the magnitude
6
of their potential risk. In particular, when no quantita-
tion is possible because we have never faced a particu-
lar situation before, we must not assume the worst. If we
did, we would quickly be suffocated by the inaction of
unlimited prudent behavior. There are just too many
awful scenarios about living that can be written if we let
our imaginations loose, and anyone who would attempt
to warn his neighbors of all the awful things that might
happen tomorrow would soon be without an audience.
This is most surely the case for those scientists who
work with viruses that multiply in humans. Every day
new mutations occur that may convey to progeny vi-
ruses unexpected new properties, and so we can never
say that the apparent safety of yesterday will extend into
the future. On the other hand, we do know from past
experience that when most viruses and bacteria are
adapted to grow under laboratory conditions, they lose
any pathogenicity for humans, and that, for example, al
there is no reason to assume a scientist who works with P'
laboratory strains of polio or one of the adenoviruses ith
faces greater occupational hazards than say a truck re
driver or plumber. In the last analysis, the only way to
evaluate the need for regulatory controls is to look at the hu
past and see whether a particular occupation poses c3'
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unusual risks.
With most forms of recombinant DNA research,
however, there is no laboratory past to guide us. And
when we had some facts to ponder over, I fear we did
not use them well. Much too late, I have come to believe
that the two types of experiments that we urged a halt to
under the original moratorium pose no real threat to the
general public. Much too superficially, we came to the
conclusion that it would be foolhardy, to say the least, to
make bacteria which are resistant to many classes of
antibiotics or are capable of synthesizing a deadly
poison that they normally do not make. Instead, we
should have focused upon the more important fact that
most, if not all, bacterial species are not clean entities
which never exchange DNA with each other in nature.
Instead, they are continually subject to injection of
foreign bacterial DNA as a result of infection by bac-
teriophages or plasmids whose host ranges frequently 13111
encompass more than one bacterial genera (e.g., Vibrio
and Escherichia). Thus, if through recombinant DNA all
technology we were to make an E. co/i strain that, say, 1'g
makes the cholera toxin, we would very likely be repeat- 81
ing what nature has done many times in the past. Of latr
course, it might be a lethal bug for any host it might 'at
infect, but since as far as we know it doesn't presently II
exist in nature, there is every reason to believe that even :gu
if it did escape from the laboratory it would not have any 'tat
positive selective advantage and so would not pose any V
major public health threat. To be sure, you can argue 'ast,
that such novel killers would be just the thing for CIA or °rc''s
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Even less convincing, especially in retrospect, were
the arguments against putting the genes of tumor viruses
into laboratory strains of bacteria. The argument here
was that such cancer-gene-bearing bacteria might acci-
dently colonize parts of the human body, opening up
the chance that they might release cancer-causing DNA
that might pass into our cells and initiate a cancer.
Already by the time of Asilomar, however, we realized
that many, if not all, of the so-called DNA tumor viruses
were in fact ordinary animal viruses that routinely infect
most of us early in life. By still unknown means, they
remain latent in our bodies for the remainder of our
lives, usually only expressing themselves as disease-
causing agents under various forms of physical stress
(e.g., herpesvirus-induced cold sores).
As a case in point, within our first five years of life
almost all of us are infected with BK virus, a human
papovavirus that can make cells cancerous. Yet despite
the fact that this virus resides within us for most of our
remaining years, it doesn't routinely lead to a mul-
tiplicity of tumors, and whether it is connected with any
human cancer is completely open to conjecture. In any
case, the danger we face from our intestinal bacteria
acquiring a little oncogenic virus DNA must be negligi-
ble compared to that which we face every time we are
infected with any of the innumerable DNA-containing
viruses.
This leads to the question of why did many first-rate
scientists become upset at the thought that Paul Berg
and his students wanted to place the SV40 genome
within a strain of E. coli (K12) known not to effectively
colonize the human gut. Yet I and many others, includ-
ing finally Paul himself, took the matter seriously
enough to initiate the chain of events that inexorably led
to the regulatory mood at Asilomar. The best answer that
I can give for our intellectual sloppiness was suggested
to me in Sacramento by Governor Jerry Brown, who,
after listening to me talk about recombinant DNA, asked
; me whether we had gotten into this mess because of
10 "liberal guilt." When I repeated this most perceptive
comment to my Harvard molecular biologist friend Matt
Meselson, he misunderstood me to say "left-wing
guilt," trying to be generous to the motivation of our
long-time acquaintances on the Boston left.
But the heart of our trouble comes not from the silly
diatribes of "Science for the People," but from the fact
that at Asilomar the molecular genetics establishment
put the weight of their collective authority behind a set
of guidelines that implied that we could honestly predict
that one form of recombinant DNA experimentation
might carry more potential danger than another. In con-
trast, I, for one, saw no way to decide whether work on
Drosophila DNA, or yeast DNA, or mouse DNA should
be more or less restricted, if at all, and so found the
Asilomar experience an exercise in the theater of the
.11C,
absurd. Particularly misguided was the placing of work
with human DNA in the highest potential risk category,
thereby restricting it to biological-warfare-like facilities
and insuring that almost no one in pure research could
work with it. Yet this is a DNA to which our ordinary E.
coli intestinal flora must be exposed constantly, for it is
very hard to imagine that none of the human DNA
released from the normal sloughing off of dead epithe-
lial cells does not occasionally enter neighboring
bacterial cells and become integrated into their DNA.
Nor should we assume the lack of any genetic conse-
quences from those "abnormal" transfers of human
DNA that now can be so explicitly displayed in the
many multicolored magazines of our sexually permis-
sive era.
There was, however, no discussion at Asilomar of
these hard, if not perennial, facts of life. Instead, the
almost unanimous final consensus appeared to hinge
solely on the oft-repeated speculation that human DNA
might carry the genomes of the so-called RNA tumor
viruses; and given no real understanding of why so
many cells harbor such potential sources of trouble, the
general paranoia which affects almost all of us about
cancer carried the day. No enlightened liberal would
want responsibility for a decision that had the slightest
chance of increasing human cancer incidence. More to
the point would have been the acceptance of the
counter argument that as all vertebrate cells most likely
carry many such genomes as normal genetic compo-
nents, their real function must not be to cause cancer,
and we should not panic about potential exposure to
DNA sequences which we already possess.
Fortunately, there are now second thoughts about the
matter, and there are efforts within NIH to downgrade
the hysteria over test-tube-transferred human DNA.
Given the total softness of the reasons for initially fearing
it, however, it will not be easy to convince others that
anything has really changed, and the whole effort to
rehabilitate human DNA must be seen by many as an
attempt to place personal ambition ahead of the public
good.
So, to say the least, we are in a rotten mess. Not only
do we face the prospect that the miserable set of
guidelines will be enacted into formal laws, but by their
very coming into existence it will be generally accepted
as fact that such research carries a profound threat to
human existence. It is as if we were to pass a law saying
that purple witches carry much more potential danger
than green witches. Then it would be hard to tell anyone
that all you meant was that an imaginary purple witch
might be more scary to your three-year-old than an
imaginary green witch. No sensible nation would go to
such trouble for witches that did not exist. Thus when
any reputable person says that the guidelines should be
given the force of law, he is in fact saying to the public
that he is scared of DNA. It does not help for our "best
7
and brightest" to say to each other that they now know
that Asilomar was a tactical mistake, and then to pop off
to Washington to flatter our legislators into thinking they
are acting most wisely in giving recombinant DNA more
attention than they ever paid to the Pearl Harbor fiasco.
Instead of going back to the question which should
have dominated the Asilomar gathering -Is there a rea-
son for formal guidelines?-our congressmen are being
asked to decide between twosilly alternatives: either (1)
to formalize the Asilomar nonsense at the level of the
now current NIH guidelines, and in so doing create
another regulatory bureaucracy that will not only cost
piles of money but will legitimize a control over the
direction of science not seen since the Middle Ages, or
(2) to effectively stop all recombinant DNA research by
taking seriously the doomsday scenarios of an odd co-
alition that ranges from environmental kooks, who want
to save the world by banning not only all man-made
additives but also evolution; through the Cavalieri-
Chargaff monopole of disgruntled biochemists who
have never been happy with many key triumphs of
molecular biology and who now seem to suggest that
we should all stop in our tracks; to a group of Boston
pseudoleftists whose greatest triumph over the past dec-
ade was to announce how bright they were to isolate a
pure gene for ((3-galactosidase) and then to denounce
themselves as wicked capitalistic geneticists in a farci-
cal press conference that almost might have occurred
during the Stalinist 1930s.
Then there is also Bob Sinsheimer, the Caltech
molecular biologist, who has never been connected
with even a trace of eccentricity, just the opposite! And
if he is publicly scared about using E. coli in
recombinant DNA research, must not we take him seri-
ously and take an intermediate position. We should, of
course, listen, but only in the context that good scientists
are no different from good bankers and brokers, and that
when they speak about the future they inherently have a
slippery base. Only at the risk of great peril can it be
assumed that when experts disagree, the truth must be
somewhere in between. We shall always find some
"expert" fraction who, all too overwhelmed by the
already awful complexity of everyday life, will want to
call a halt to anything new, arguing that we are already
too close to doom to take any more chances with the
future.
The trouble here is that almost everyone has his own
pet list of irresponsible assaults on the human condition,
and that unless there is some solid hint that real harm
will emerge, we had best go along with the more r op-
timistic alternative. Even if Sinsheimer's morbid fear
becomes reality and research with recombinant DNA
does in fact produce a potentially pathogenic E. coli
strain, the worldwide consequences would very likely
be minimal. Not only is E. coli remarkably uninfectious,
but there are antibiotics presently available that should
8
control the mean new variants. In fact, I do not know of
any authority on infectious disease who takes the
recombinant DNA doomsday scenario seriously.
So you might expect that our Congressmen would he
deluged by angry molecular biologists who do not at all
like the idea of being singled out as perpetrators of
potential crime without the slightest trace of evidence
and being tainted thereafter by perpetual suspicions of
guilt. Instead, the dominant establishment comment
these days is that the matter is already so out of control 1,
that our only concern should be to contain our Frank-
enstein before it hovers over all of biological research,
and, for example, we have to obtain a "memorandum of
understanding" every time we want to work with a new
human cell line. This most defeatist mood assumes that
some federal law restricting recombinant DNA research
is bound to come, and we should focus our efforts on
seeing to it that it takes precedence over local laws anc
so keep the youthful burghers of Berkeley from outper.
forming the mad antics of the Cambridge mayor. \NE ,"
should remember, however, that even a "reasonable'
law that talks only about recombinant DNA is a perfect
setup for a new round of local initiatives, say, for exam-
ple, to protect New Haven from unregulated work at.
Yale with potential human tumor viruses. And if that,
happens, as with the recombinant DNA story, we are mm
likely to find that our opposition is for the most part led..14
not by individuals with any deep knowledge of or ever7kr
fear of our work, but by persons who, for a myriad
reasons, do not like the fruits of science, if not of th
intellect, and see us as the most vulnerable foe.
I thus believe that the ostrich-like approach of mos ,
molecular biologists to the events of the past two year
can only lead to much more restrictive action agains
our freedom, not only to do good science, but to find th
facts that may be necessary for the survival of our 1).!..
now inherently advanced societies. In privatO\
conversations with the vast majority of molecul
biologists, I find almost universal agreement that tK,1,
guidelines are a total farce but no one who feels equal
the task of telling the Senior Senator from Massachusetl
that the Emperor has no clothes. Equally bad, the crecl,\,,
bility of so many top figures within our national scie
tific and health bureaucracy has been tied to a defens
of the safety, and hence reasonableness, of the guid
lines that, as with our Vietnam fiasco, no official
importance can be expected to admit that he has been
naive fool. So it is not surprising that they are alrea
being propelled by the momentum of their past no
sense to adopt their own form of the Cambodian escalliku
tion by trying to have the American guidelines enforce%
throughout the world by a series of international agre(
ments that will make the Swiss have more examiners
DNA research than they will ever have for their banks
So by this stage I realize how much the rest of th2,?1) ury
world misses the almost automatic rejection by Chad(
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The main house, to be named Robertson House, will
01:.''serve as a residence for visitors attending either one of
ifiloOthe major conferences held at the Laboratory itself or
lefce one of the special small meetings which we intend to
.0acIlhold on the Robertson property. Toward the latter goal,
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De Gaulle of any Anglo-American initiative. If he were
still with us, the whole story could still have a happy
ending. We could look forward to spending part of each
year in France, not only eating the food we want to eat
but also doing the science that we so associate with the
best of our free societies.
Highlights of the year
Gift of Robertson House and creation of the Banbury
Educational Center
Of immense importance to the future of this Laboratory
was the gift last June by Mr. Charles S. Robertson of his
marvelous Georgian-style house on Banbury Lane, in
Lloyd Harbor, with its some forty-five acres of land.
Most of this acreage is covered by an easement to the
Nature Conservancy, which insures that it will remain in
its current undeveloped state. Built in 1936 to serve as
the home of Mr. Robertson and his wife, the late Marie
H. Robertson, this most attractive house was designed
by the noted architect Mott B. Schmidt and located on
land that had belonged to the family of Mr. Robertson's
mother, the Sammises, for most of the 300 years that
have passed since the original settling of Huntington
township in the middle of the 17th century. Along with
the main house are two smaller dwellings, as well as a
splendid garage, also the design of Mr. Schmidt, a
swimming pool that looks out onto Cooper's Bluff, and a
we are in the process of converting the garage into a
modern conference building, which will contain not
only a large conference room with a capacity of approx-
imately thirty-five, but also a library, reception rooms,
and office space for the staff that will be appointed to run
the meetings held at the Banbury Lane property. For the
design of the Conference Center, which we intend to
call the Banbury Conference Center, we have again
enlisted the services of the noted architects Moore,
Grover & Harper of Essex, Connecticut. Their plans are
now being executed by Mr. Jack Richards, our excep-
tionally talented contractor-in-residence, and we an-
ticipate its first use in June 1977 for a lecture course on
the synapse. Possession of this marvelous facility, with
its well-defined size and limited dining facilities, will
allow us to hold, throughout the year, tightly organized
conferences of between twenty-five and thirty-five par-
ticipants, a perfect complement to the usual one-
hundred- to three-hundred-and-fifty-person gatherings
that characterize our summer sessions. In theory, we
should be overjoyed by the very large number of partic-
ipants who come to our major meetings, but there are
times when we wistfully remember the tiny phage meet-
ings of the late '40s and early '50s and look forward to
occasions when we shall not have to face the prospect
of feeling ill at ease because we can't remember some of
the names and faces from the previous summer.
Five-year renewal of Cancer Center Grant
The spirited pace at which we have been able to probe
how viruses may make cells cancerous and our ability to
explore seriously the biochemistry and molecular struc-
ture of the cancer cell reflect not only the excellence of
E
TO: Banbury Conference Center under construction
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our scientific staff but also their most efficient funding,
largely through the vehicle of a single, very large,
program-project type grant administered through the
Cancer Center Program of the National Cancer Institute.
This grant covers the salaries of virtually all our key
scientists who work on cancer and provides most of the
funds needed for both supplies and equipment. As it is
most assuredly at the heart of our high-level functioning,
the fact that our current five-year grant would end on
December 13, 1976 necessarily made us apprehensive
about the way in which our renewal application would
be received by the Site Visit Committee, the Cancer
Center Study Section, and finally by the National
Cancer Advisory Board. Naturally, much effort, skill-
fully coordinated by Joe Sambrook, went into the prep-
aration of the almost three-hundred-page grant pro-
posal. By the time the Site Visit Committee arrived, we
began to relax. We felt reassured by our ability to report
several incisive new facts not known when the formal
grant proposal was prepared several months before.
Happily, the final verdict was a reassuring vote of
approval, with the National Cancer Advisory Board
awarding us this past September direct costs of
$1,590,000 for 1977, a substantial increase over the
1976 sum of $1,100,00. By the end of the year, how-
ever, the National Cancer Institute found that it had so
overcommitted itself that it had to reduce by $100,000
the sum committed to us. Of course, we are still most
pleased by the final increment, as it will allow us to
bring the expenses of our present programs approxi set
mately in line with the level of our monetary intake anc no
will give us the capability of markedly expanding ou th
cell biology efforts. Thus we can set our sites still higher Si '
but we must never lose sight of the fact that the costs o at
scientific research invariably grow faster than the aver-
age inflationary rate. Even with a substantial infusion of ni
Robertson Research funds, we found it necessary last in
year (for the first time in many years) to draw upon our
very limited uncommitted cash reserve to keep us going. B(
sa
fuLosses to scientific staff and new appointments
The fact that we are unable to offer permanent position! re
to most of our staff means that each year we must expec to
that several staff members, who we have come to regarc co
as irreplaceable, will move on to positions that offe M
more long-term security. Leaving us in October for asRe
permanent position at the University of Heidelberg wa;
Walter Keller, who came to James lab in the fall of 197(01'
and subsequently played a major role in its develop Ext
ment as a leading center for tumor virus molecula Ca
biology. Another major loss was the departure of Ton fir
Maniatis in early 1977 for an Associate Professorship a Ha
Caltech. Tom came here in January 1975, on leave fromabl
Harvard, to study animal cell culture methods, intend hel
ing to return within a year when Harvard's P3-type la latE
was to be completed. Tom subsequently became
casualty of the recombinant DNA debacle in Can- mit
bridge, and the stay of his group here began to acquire As
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Maryalice Cladding, surrounded by friends and family, at her retirement party
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semipermanent status. Unfortunately, our luck could
not continue indefinitely, and having come to believe
that he could not count on the rapid return of Harvard's
Biological Labs to a nonhysterical state, Tom decided to
accept a most attractive offer from Caltech. While Tom
was here, his research kept us in the center of recombi-
nant DNA studies, and with great regret we accepted the
inevitability of his departure.
Also leaving us were several talented Postdocs-Al
Bothwell to join David Baltimore's group at the Mas-
sachusetts Institute of Technology; Sharon Endow for
further postdoctoral research in Edinburgh; Sara Lavi to
return to the Weizmann Institute; and Eugene Lukanidin
to go back to the Molecular Biology Institute in Mos-
cow. We also miss the talented protein chemist, Charles
Miller, who spent his sabbatical year from Case Western
Reserve Medical School in David Zipser's lab.
I also must note the retirement of Maryal ice Gladding,
who for twelve years served with dedication and skill as
Executive Secretary in Nichols. First ably assisting John
Cairns, then me, and finally Bill Udry, she gracefully, yet
firmly, oversaw most of our administrative functions.
Happily, her many close friends at the Laboratory were
able to join in honoring her services at a special dinner
held at the Robertson House just before Christmas, and
later at a general staff luncheon held at Blackford Hall.
Newly appointed to the staff is Lan Bo Chen, who
initially came as a Postdoc doing graduate work at MIT.
As of January 1, 1977 he assumed the position of Senior
Staff Investigator in charge of our Protein 'Chemistry
section. Also promoted from the Senior Postdoc level to
Staff Investigator positions were Louise Chow, Richard
Gelinas, and Bill Topp.
An extremely talented supporting staff
The high quality of our scientific staff is known through-
out the world. Less well appreciated, but equally impor-
tant to our success, is the devoted excellence of our
nonscientific personnel. For example, our library knows
no equal for efficient functioning, and full credit for this
must go to Susan Gensel, our most professional, yet
cheerful, librarian.
Equally important has been the most imaginative
work of Bruce De Troy, who heads our electronics and
machine shop. Without his untiring efforts, our
Neurobiology program would never have succeeded so
well.
The feeling of gracious hospitality experienced by all
who have stayed at Robertson House is owed in great
part to the charm and diplomacy of Joan Cook, who has
been in residence there with her two daughters. And
given the potential chaos engendered by our constant
level of new construction, the fact that our neighbors
and visitors can still take delight in our grounds is a
credit to the abilities of Hans Trede.
Mentioning these particular people is all too arbitrary,
given the excellent work of so many here. I hope by
singling our these few, the outside world can begin to
appreciate the magnitude of our day-to-day activities,
which each year become more and more like those of a
small, high-quality university.
A very large and intellectually demanding
Symposium on Immunology
This past June we were host to some three hundred and
twenty-five immunologists who attended our 41st Sym-
posium, entitled "Origins of Lymphocyte Diversity."
There were some eighty-six formal presentations, as
well as hours of informal discussion, most of which took
place in small groups over meals or during the free
afternoons. From the beginning one could sense this
was not a gathering from which it would be possible to
take home simple answers. How so many different an-
tibodies are made has become an even more challeng-
ing problem than we could have predicted possible at
the end of our 1967 Symposium. At the heart of our
confusion is why so many classes of lymphocytes exist.
Conceivably we may know how to think once we iden-
tify biological functions for the major histocompatibility
proteins and the newly discovered immune-response
(19 antigens. We were most fortunate in being able to
call upon Niels Jerne to set the tone of the meeting with
his incisive opening address and to have Gerry Edelman
for his perceptive summary of the state of the field.
Once again, following a long tradition, many of our
neighbors gave dinner parties for the speakers, and we
wish to thank, in particular, Mrs. Charles 0. Ames, Mr.
and Mrs. Robert Cummings, Mr. and Mrs. Roderick
Cushman, Mr. and Mrs. Norris W. Darrell, Jr., Mr. and
Mrs. Clarence E. Galston, Mr. and Mrs. Angus P. McIn-
tyre, Mr. and Mrs. Samuel D. Parkinson, Mr. and Mrs.
Edward Everett Post, Mr. and Mrs. Richardson Pratt, Mr.
and Mrs. Edward Pulling, Mr. and Mrs. Richard J.
Weghorn, Mr. and Mrs. Willi am A. Woodcock, Mr. and
Mrs. George Lindsay, and Mr. and Mrs. Franz
Schneider.
Most satisfying were the many letters received from
speakers telling us that it was the most stimulating meet-
ing they had attended in years.
The most comprehensive meeting yet held on the
origins of human cancer
Several years ago, Howard Hiatt and I discussed the
possibility of the Laboratory hosting a meeting designed
specifically to give a broad overview of the various
factors that may give rise to human cancer. This goal
was realized in early September with a mammoth
gathering at which some one hundred and twenty pa-
pers were presented. The topics ranged from pure
epidemiology to public-policy considerations affecting
the extent of human exposure to potential carcinogens.
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Sir Richard Doll at Origins of Human Cancer meeting
Luckily we received a great deal of high-quality advice
on how the program should be arranged, and John
Cairns, Bruce Ames, and George Todaro deserve spe-
cial mention for their help. Without the encouragement
given by the National Cancer Institute, with its Director,
Dick Rauscher, telling us to go ahead and think big, I
doubt we would have had the courage to carry through
on a meeting whose proceedings will require three large
volumes to encompass.
We were most pleased when Sir Richard Doll gra-
ciously accepted our invitation to come from Oxford to
deliver the opening address and were happy that we
were able to provide such distinguished visitors as Sir
and Lady Doll with the type of relaxing accommoda-
tions now available to us at Robertson House. Equally
pleasing, the meeting prcvided the welcome opportu-
nity to bring John and Elfie Cairns back to Cold Spring
Harbor. John, given the assignment of summarizing the
meeting, performed this almost superhuman task with
his usual grace, clarity, and insight, and at the end we
knew that this was a meeting that most definitely had
been needed and one for which we could be rightfully
proud.
A four-month-long summer program
Our "summer" commenced in early May with a large
meeting on Dictyostelium, the first of ten meetings held
this year on our grounds. It was followed by a most
stimulating meeting on DNA Insertion Sequences,
jumping genetic elements, the first of which was found
by Barbara McClintock here some twenty years ago but
whose universal significance has only come to be ap-
preciated recently. Ahmad Bukhari was the principle
organizer, a job much more complicated than initially
12
conceived when he told us that he wanted to organize a
small meeting of some forty-five to fifty people. The
RNA Tumor Virus meeting came next, with over one
hundred formal presentations, a semicatastrophe from
which we learned our lesson and so arranged poster
sessions for the August SV40-Adenovirus meeting. The
middle of the summer saw a meeting on the Lactose
Operon organized by Jeffrey Miller and Bill Reznikoff.
Again the logistics were almost too much, not because
of its size but because it overlapped our courses. Intel-
lectually, it went very well and showed that E. coli was
still very much alive.
The Robertson Research Fund maintains our
freedom for innovation
The fact that we now have available the income from a
sizable endowment fund established for the specified
purpose of supporting research gives us the much
needed flexibility to respond to new research advances
by acquiring new instrumentation or by quickly com-
mitting funds to bring or keep talented younger scien-
tists here. Over the past year, we committed approxi-
mately two-thirds of our Robertson funds toward the
support of younger scientists, with the remainder going
toward the completion of the Davenport lab renovation ur
and toward the necessary complex equipment needed 41,(
for the experimental work on the central nervous system -le
in Jones lab.
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Summer research in Neurobiology now a reality
When our summer courses in Neurobiology began in
1971, we knew they should be complimented by a et(
program of pure research. But as long as we were lim- Ev
ited to our facilities in McClintock lab, we also knew itti
that having any research program would necessarily ID;
diminish our teaching efforts. The now completely ren- vo
ovated and fully equipped John D. Jones Laboratory ibll
allows us to take a big step forward toward our goal of off,
making Cold Spring Harbor a leading center for ,th:
Neurobiology research. This past summer Jones lab
played two important roles: as the site of a marvelous
new course on the central nervous system, which we
believe to be the first of its kind; and as the center for a S
three-month research project on the synapse, which lilt
was ably organized by Rami Rahamimoff. Money It1(
needed for the operating expenses of the synapse pro- 1Y
gram came from the Sloan Foundation grant, which was
awarded to us last year to cover a three-year effort aimed ars
at bringing together leading younger neurobiologists to
share their experimental and theoretical know-how.
Vital to the success of all these efforts was our second 11131
year of support from the Marie H. Robertson Fund, a n-le
special fund established by the Banbury Foundation for "Ys,
the support of Neurobiology at Cold Spring Harbor. So r°v
far these funds have been used for the creation of newl Dus
laboratory facilities and their equipment. These tasks. °se
should be finished by the fall of 1977, and we hope then attE
ar
initiate, gradually, year-round efforts focusing on the
organize a 'ay nerve cells grow and form synapses.
.ople. The lur publications list grows even more distinguished
over one is past year saw the publication of new additions to
;ed pos7er Jr three main series: Volume 40 of the Symposia, a
yen-hundred-and-fifty-page book on "The Synapse";
eting. The 31ume 4 of our Cell Proliferation series, a three-book
"eznik_s,e. t on "Cell Motility" which comprised over fifteen
indred pages; and "RNA Polymerase," a nine-
not because
ndred-page book in our Molecular Biology mono-
purses. Intel- tph series. All resulted from meetings held here, and
atE. coli was
cause of their uniformly high intellectual quality, they
)uld be well received.
Ne worry, however, that because of the widespread
of copying machines they will not be bought in the
1.1conle from a nbers that are necessary to cover the truly large costs
)1 *le sPedied )ciated with such large books. Our dilemma is two-
s us the much I: The first problem arises from the fact that our
search advances stings are so large that we cannot issue reasonably
by quickly con- d (200-400 pages) books without abandoning our
d younger scien- :lice of publishing all papers presented by invited
emitted approxi- Akers. The second aspect of our dilemma concerns
'unds toward the desire to publish thoroughly attractive volumes
!remainder going )se is appropriate to the high quality of
on lab renovation nce they contain. Now we are trying to drastically
quipment needed er costs through the use of computer-assisted photo-
al nervous system procedures. But even this may not provide us with
financial edge needed to protect us from having
y percent of a book xeroxed rather than the com-
Iww a
reality
volume bought.
biology began
in /en with all these serious problems, we are still
b' a ing out perhaps the highest quality advanced booksnplimented
as we
were lim- iology and owe much to the deep and intelligent
bi we also knew3tion shown by Ms. Nancy Ford, who heads our
ould nleec e s sa rinly. I ications department, and by her most competent
coil te1 y re Annette Zaninovic, Roberta Salant, and Paul
ones
LaboratorYfige.
ward 001 g°alfc,°r istruction of the new Williams House
ding
center
s lab ?, of the more striking dwellings on the Lab grounds
ioner lonedous been Williams House, a whaling-period structure
.e of a rnakrivcove I t to house persons connected with the whaling ac-
ystern,w" fora les long associated with Cold Spring Harbor. Heated
asthecentei,rhich y by fireplaces, it has served as summer housing for
aF ney forty-five years it has belonged to the Lab. For many
3rnirnof rs, we pondered whether it could be renovated to
thesYnaP5
ido
5.r-round use, only finally to conclude reluctantly
i,rant .,,ed t, never a firm dwelling to start, it had deteriorated
y'eareff°11a11"..toiond repair, a conclusion rather dramatically con-
bi0g1515 ned when we found that we could topple the chi m-ur0
kow.
I know' d (s with a push. So we have had our architects, Moore,
5ecoo
,asotif dov er & Harper, draw up plans for a new Williams
IS,' poi
kart500 formse, whose external features will almost duplicate
oifr tiOrlova 50)se of the preexisting structure. The interior is another
Harbo' Irtter-five modern apartments, four of them duplex-
oring ow,
aton ksr and all with magnificent views of the harbor. The
"e 01" ,*
lent' pe the',
vie h°
:nu
ls our
actual construction work became a reality when LIBA
took on the financing, and as soon as last summer
ended, a bulldozer arrived to knock down the by then
thoroughly stripped and sad-looking building. The
whole demolition task took less than two hours, allow-
ing foundation work to start in October. The unex-
pectedly severe winter has set back our plans for a June
1 completion, and now July 4 appears to be the date
when the first occupants will arrive.
LIBA fund drive for the new Williams House
continues its vigorous course
Throughout its now fifty-three-year-old existence, the
Long Island Biological Association (LIBA) has taken on
the task of raising funds for the construction of many of
our needed laboratories and residences. Their latest
major effort is the financing of the new Williams House,
and, toward this end, its Chairman, Edward Pulling,
prepared an especially attractive fund-raising brochure
showing the building as we hope it will soon look.
Already more than seventy-five percent of the final
$225,000 goal has been reached, a most remarkable
achievement, and once again it is brought home to us
how lucky we are to have the support of such marvelous
neighbors.
Unfortunately, the untimely death of Dorcus Cum-
mings this past fall deprived us of one of our most fervent
supporters. Dorcus had been a member of LIBA for over
twenty years and a Director for eight years. We will long
remember her devotion to the work of the Laboratory
and the extraordinary skill with which she contributed
to the preservation of the beauty and ecology of the Cold
Spring Harbor environment. A memorial fund has been
established in her honor by her LIBA friends.
This year, two .major scientific presentations were
arranged for LIBA members. The first, on May 16, was
by the noted science writer and lecturer, Isaac Asimov,
who spoke on "The Moon-Threshold to Outer Space."
It was a most entertaining occasion and concluded with
dinner under a tent on the Airslie lawn. The second
lecture was given by Professor Alexander Rich of the
Massachusetts Institute of Technology at our Annual
Meeting on December 4. His topic was the Viking mis-
sion to Mars and its search for any possible forms of life.
Professor Rich brought with him many of the extraordi-
nary photos taken from the surface of Mars, and every-
one agreed that his presentation was one of the most
fascinating ever presented before a LIBA audience.
Many of the LIBA Directors also served as hosts for a
dinner party given at Airslie on Saturday, September 11
for the participants of our Origins of Human Cancer
meeting.
Departing from the LIBA Board at the conclusion of
their maximum terms were Bentley Glass and Edward
Kozlik. Hoyt Ammidon, Jr., because of his move to
Princeton, New Jersey, was forced to resign.
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Directors newly elected at the annual meeting in
December were: Walter N. Frank, Charles S. Gay,
George J. Hossfeld, Jr., and William Parsons, Jr.
Our Board of Trustees has a very unique
composition
Ours is the only major scientific organization whose
Board of Trustees is composed about equally of leading
citizens from the surrounding community and of noted
scientists deeply conversant with its scientific activities.
So there is no need for a scientific advisory board, and
our Trustees, by themselves, can come quickly to many
crucial decisions which need both financial and scien-
tific input. Always a most important plus on our side is
our Chairman, Harry Eagle, whose ability to lead the
Board through complicated agendas with speed, accu-
racy, and humor is unsurpassed.
Because our By-laws limit Trustees to a maximum of
six years continuous service, we must accept the loss of
the valuable services of Dr. David Jacobus, Mrs. George
Lindsay, and Mr. William Woodcock. All have gener-
ously dedicated themselves to our good on innumerable
occasions, and we were happy to be able to use
Robertson House for a special dinner after our October
26th Annual Meeting to express, in but a small way, our
thanks for their help.
Newly elected to the Board at the Annual Meeting
were Dr. Emilio Collado of Oyster Bay, former Execu-
tive Vice President of the Exxon Corporation; Mr. Wil-
liam Grant of Oyster Bay, President of the brokerage
house Smith, Barney, Harris, Upham and Company,
Inc.; and Mrs. Franz Schneider of Laurel Hollow, a
long-time friend of the Laboratory and a former Director
of LIBA.
Adequate future funding of high-level science must
not be taken for granted
The uproar this year about recombinant DNA has kept
us from facing up to a much more serious long-term
issue-the fact that the amount of public monies now
going toward research is not keeping pace with infla-
tion, yet the number of institutions with large staffs of
talented younger scientists is rising. So a crisis atmo-
sphere already exists in many labs, and the number of
excellent scientists who lack even minimally adequate
funding is growing at an alarming pace. Unfortunately, I
do not see any simple way out of this dilemma. I sense
that the public is growing increasingly concerned that
the results of science may be generating more social
problems than they solve, and that this mistrust will not
be easy to overcome. One must be aware that the high
regard that the public once had for science has greatly
diminished. Ten years ago, for example, it would have
been highly unlikely that we could see the current im-
pulsive rush of our legislators to legitimize by law the
unfounded and desperate hopes of laetrile or to declare
that, because we are not rats, saccharin will never cause
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cancer. As long as this mood predominates in the na-
tion, we shall be lucky if we succeed in keeping our bad
situation from getting even worse. As scientists, we shall
have to spend more time educating the public, not only
about our idealistic dreams, say to conquer the common
cold or cancer, but also with regard to the old-fashioned
idea on which I was brought up, that the pursuit of
knowledge about the nature of life and about the uni-
verse in which it exists is a glorious endeavor that should
be undertaken for its own sake. In this way, we shall not
be so easily faulted, say for our failure to produce fusion
before the price of oil leads to political, economic, and
social chaos, or for our failure to yet conquer cancer and
so set the stage for a counter-reaction in which scientif-
ically unfounded benefits are attributed to the natural
apricot and the rational conclusions of educated minds
are ignored.
I am, of course, aware of the conventional wisdom
that we can never sell the public on supporting science
on a big scale solely as an intellectual endeavor, and
there must be the promise of at least some worldly
goodies before we can expect a commitment to the
intellect equivalent to the cost of one of our modern
nuclear submarines. If we must venture beyond our
expertise, however, I suspect we are better equipped to
do so as historians than as politicians. With more than a
modicum of conviction, we can say that our society
now moves because of the fruits of science, and that,
were rational investigation to grind slowly to a halt, the
meanness from which we have emerged over the past
four hundred years would all too soon be back with us.
Today we hear much revisionist talk about the wonders
of the Victorian era and the gracefulness of the architec-
turally outlandish houses which dominated the sylvan
landscapes of 19th-century America. The more relevant
fact is that the life of the common man then was much
more harsh than livable, and I have never met anyone
over twenty-five who would want to sacrifice indoor
plumbing or penicillin in a return to the so-called gra-
cious life style of our Victorian past.
A very strong case can thus be made that we are
needed for what we do best-to seek the laws of nature
and to learn more of them. If we continue along this
course, the chances are good that we may escape still
further from the limitations of our evolutionary past.
Naturally, our future paths cannot be delineated that
simplistically, nor without caution. We must be pre-
pared for the fact that some future options might not be
tenable, and that we must then cry "stop" with all the
strength we possess. We must think very carefully, how-
ever, before we take a negative tack, because if the
concept of the scientist as the pessimist takes hold, then
the scientist as the villain might well be the next item on
the agenda.
Thus our main task at Cold Spring Harbor is to remain
on the course that we have followed for the past
in the na-
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we can keep our ideals and self-confidence high, we
can then look forward to the future with some degree of
optimism.
June 30, 1977 J.D. Watson
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tEAR-ROUND RESEARCH
eVIOLECULAR BIOLOGY OF TUMOR VIRUS
. SAMBROOK, G. Ballantyne, M. Botchan, A. Bothwell, G. Fey, D. Galloway, R. Greene, T. Grodzicker, J. Hassell,
Jungreis, R. Kelch, W. Keller, S. Lavi, M. Lazarus, A. Lewis, E. Lukanidin, M. Mathews, R. McGuirk, R. Pashley, U.
pettersson, P. Reichel, J. Schneider, M. Sleigh, R. Tjian, A. Tolun, W. Topp, S. Weirich, I. Wendel, S. Young
during the last year work has progressed on several
najor projects:
3.
4.
1.
2.
5. identification and mapping of small species of
adenovirus mRNA and virus-associated RNAs,
6. analysis of field strains of type-C adenoviruses
which appear to be recombinants of the standard
,,i, serotypes,
7. isolation of deletion m'itants of SV40, and
8. analysis of the structure of integrated viral DNA in
transformed cells and revertants.
physical mapping of adenovirus mutations and
structural genes,
analysis of the genomes of defective adenovirus
2 -SV40 hybrid viruses,
characterization of mutants, including amber and
ochre nonsense mutants, of adenovirus 2 - SV40
hybrids,
purification and characterization of SV40 T anti-
gen and of adenovirus-SV40 fusion proteins
which contain the C-terminal end of SV40 T anti-
gen
iysical mapping of mutations and
ructural genes of adenoviruses
lutations
,e have continued studies whose aim is to position
any temperature-sensitive (ts) mutations and struc-
ral genes at physical locations on the viral genome
d to thereby assign mutations to the genes for specific
A-al proteins. This, combined with physiological
udies of ts mutants, helps clarify the function and role
hese polypeptides in the viral replication cycle. The
,proach we have used has been described in detail
previously; see J. Sambrook et al., I. Mol. Biol. 97:369
(1975) and T. Grodzicker et al., Virology (in press),
wherein we reported the map positions of seven Ad5
mutants and four Ad2+N D1 ts mutants.
In collaboration with Joe Weber, we have mapped
the sites of the lesions in a set of Ad2 ts mutants. Over
100 wild-type recombinants were selected from 12
crosses between 4 Ad2 ts mutants and 3 Ad5 ts mutants.
The DNA structures of about half of these have been
determined with restriction endonucleases and have
been compared with those of the parental genomes to
deduce the locations of the ts mutations. All of the four
Ad2 ts mutants mapped are defective in late functions
and have been classified into separate complementa-
tion groups. The positions of the Ad5 ts mutations were
determined previously [J. Sambrook et al., J. Mol. Biol.
97:369 (1975)] and have now been localized to more
precise coordinates on the adenovirus physical map.
Structural genes
Many of the polypeptides expressed during lytic infec-
tion by Ad2 and Ad5 can be distinguished by their
differing mobilities on SDS-polyacrylamide gels [T.
Grodzicker et al., Virology (in press); J. Weber and J.
Hassell (in preparation)]. By analyzing the polypeptides
expressed by recombinants of known genetic constitu-
tion, we can locate the structural genes for several pro-
teins on the physical map and assign ts mutations to
specific genes. Analysis of the set of Ad2'N Dl/Ad5
recombinants allowed us to map the positions of the
genes for hexon, 100K protein, and fiber. Studies of the
polypeptides expressed by the Ad2/Ad5 recombinants
have allowed us to map the genes for three additional
proteins: penton, the minor core protein V, and 36K
protein.
ockwise from top left: Louise Chow, Ahmad Bukhari and Mike Mathews, Tom Maniatis, Jim McDougall,
nise Galloway, Mike Botchan, Ray Gesteland 17
Defective adenovirus 2SV40 hybrid viruses
Two adenovirus 2 -SV4G hybrids (Ad2+1D1 and
Ad2132) have been isolated from the Ad2++HEY popu-
lation. Both hybrids are defective and require helper
Ad2 for productive infection of simian cells. The DNA
structures of Ad2±D1 and Ad2+D2 have been deter-
mined by analysis with restriction endonucleases, hy-
bridization, and electron microscopy. Ad2±D1 contains
a 3.2-kb insertion of SV40 DNA which includes the
entire "early" region of the SV40 genome between
positions 11 and 71. The SV40 insertion replaces a
3.5-kb segment of Ad2 DNA which maps between 0.64
and 0.74 fractional genome length from the left end of
the viral DNA molecule and is oriented such that the
SV40 A gene is transcribed from right to left. Ad2+D2
contains a 4.8-kb insertion of SV40 DNA which re-
places a 7.9-kb segment of adenovirus DNA mapping
between 0.76 and 0.96 fractional genome length from
the left end. The insertion, which includes the entire
"late" region of the SV40 genome together with a por-
tion of the early region, lacks only those SV40 se-
quences between 54 and 62. In contrast to Ad2+D1, the
"early" SV40 sequences in Ad2±D2 are transcribed
from left to right.
The expression of the SV40 sequences in Ad2±D1
and Ad2+D2 has been determined by hybridization of
cytoplasmic RNA extracted at early and late times after
infection to the separated strands of defined
fragments of SV40 DNA. RNA complementary to the E
strand of fragments encompassing the "early" region of
SV40 DNA was detected at both early and late times
following infection with Ad2+D1. Cytoplasmic RNA
extracted at early times after infection with Ad2±D2
contains no sequences complementary to SV40 DNA.
At late times, cytoplasmic RNA complementary to the E
strand of a portion of the "early" region of SV40 DNA
was readily detected. We suggest that the early Ad2+D1
mRNA complementary to the "early" region of SV40
DNA maps entirely within the SV40 insertion and is
subject to the same controls operating in simian cells
infected with SV40. In contrast, cells infected with
Ad2-D2 contain cytoplasmic transcripts complemen-
tary to only part of the SV40 "early" region, which are
detected at late times. It seems likely that the 5' termini
of these transcripts map within adenovirus-2 sequences
and that their 3' termini map within SV40 sequences.
The expression of this transcript is undoubtedly under
adenovirus-2 control.
Proteins antigenically related to SV40 T antigen have
been detected in cells infected with Ad2+131 and
Ad2+1D2 by immunofluorescence and by immunopre-
cipitation with sera from hamsters bearing tumors in-
duced by SV40-transformed cells. Ad2+D1 induces the
synthesis of a 96,000-dalton-molecular-weight protein
which is precipitated with SV40 T-reactive antiserum, is
1R
phosphorylated, and comigrates with SV40 T anti-1
gen from lytically infected cells through SDS-.
polyacrylamide gels. By the criteria cited above, the
Ad2+D1 96,000-dalton protein appears to be identical,
to SV40 T antigen.
The major polypeptide species precipitated with,
SV40 T-reactive antisera from extracts of Ad2+D1-1
infected HeLa or CV1 cells has an apparent molecularvl
weight of 115,000 daltons, and it too is phosphorylated.e
The 115,000-dalton protein is probably a fusion poly-1(
peptide whose amino terminus is encoded withirV
adenovirus-2 sequences and whose carboxy terminus isle
specified by the SV40 A gene. The 96,000-dalton prou
tein induced by Ad2±D1 is detected by immunofluoresle
cence at both early and late times after infectionie
whereas the 115,000-dalton protein induced b)efl!
Ad2±D2 is detectable only at late times. These resulthai
are consistent with the observation that transcripts corxaf
responding to the "early" region of SV40 DNA aro th
synthesized at early and late times during infection ID, \(\'
Ad2±D1 but only at late times after Ad2+D2 infectionitif
The DNA structures of Ad2±D1 and Ad2+1D2 arrow
unrelated to each other or to any of the hybrids in thlice
Ad2++H EY population. It therefore seems unlikely tVaill
they have arisen by recombination among the hybrOtr1(
members of the Ad2++HEY pool or by rearrangement cever
their genomes. Though the mechanism of formation c
Ad2+D1 and Ad2+D2 remains enigmatic, it seems likel
that they were generated by recombination betwee
free SV40 (Ad2++HEY is genetically unstable and yielc
SV40 with high efficiency) and adenovirus 2.
Host-range mutants and revertants of Ad2±ND1
We reported last year the characterization of host-rang
mutants of the nondefective adenovirus 2 -SV40 hybri-
virus Ad2±N D1. Unlike Ad2, which grows poorly i-
monkey cells, Ad2±N D1 grows equally efficiently i
human and monkey cells. This extended host range
presumably due to the expression of the integrated SV4
sequences which map between 0.28 and 0.11 fraction_
unit on the SV40 map. The seven host-range mutant-
which grow well in human cells comprise one con-
plementation group, grow poorly and are defective i
the synthesis of late proteins in monkey cells, and, lik
Ad2, are complemented for growth in monkey cells b
SV40. Thus they behave as if they have lost the er=
hancement or "helper" function provided by SV4C
Ad2±ND1 expresses a 30,000-MW protein that is code,
for in part by the SV40 sequences it contains. Wherea
four of the host-range mutants synthesize a 30K protei
in infected human cells and are probably missense mL
tants, three of the host-range mutants synthesize no 30,
protein. Instead, mutants 71, 140, and 162 direct th,
synthesis of 10K, 19K, and 19K fragment, respectivelgure
In collaboration with Ray Gesteland and Jim Lewis, w.aPs°
`.4ave looked at the synthesis of fragments and the 30K
5UAJ D1 protein directed by mRNA isolated from mutant-
6..nfected human cells, selected by hybridization to SV40
IIIIONA and translated in mammalian cell-free systems
upplemented with yeast suppressor tRNA. In the pres-
\11i5nce of yeast ochre tRNA (but not amber or su- tRNA),
-DinRNA from mutant 71 is translated into 30K protein as
ivell as the 10K fragment, whereas mutants 140 and 162
lletl. eh av e as amber nonsense mutants. We hope to use
)okiiiiese mutants to assay for in vivo activity of suppressor
ithirRNAs and to look for suppressor cells. On the basis of
usne size of the fragments produced by the nonsense
pro.iutants, and assuming that the carboxy-terminal end of
ireHe 30K protein lies near the SV40Hin11,111G-B junction,
inve can estimate the approximate positions of the non -
byiense codons in the mutants. The position of the base
suli5hanges in the mutants relative to Ad2+ND1 is being
corixamined by sequence analysis of the DNA and mRNA
01 the region of interest.
pb', We have also isolated revertants of the nonsense
ioqhutants 162 and 71 which have regained the ability to
genomes appear identical to that of wild-type
Ad2+ND1. However, several revertants of the ochre
mutant 71 appear to contain deletions or genome rear-
rangements in the region of the SV40 insertion. One of
these, the deletion revertant Ad2+ND14-1, has lost the
SV40 sequences which map from position 0.28 to ap-
proximately 0.21 (Fig. 1). When 14-1 mRNA selected by
hybridization to SV40 DNA is translated in vitro, an 18K
protein is produced. This suggests that the deletion has
removed the chain-terminating mutation and that only
the C-terminal end of the 30K protein actually carried
the helper function. Two other revertants, Ad2+ND1-2
(see Fig.1) and Ad2+ND1 -1, have rearrangements in the
region of the SV40 insertion and share common fea-
tures. In both revertants the parental SV40 insertion is
intact; however, to the right of this is a partial duplica-
tion comprising the initial sequences of the adjacent
adenovirus fiber gene and distal sequences of the origi-
nal SV40 insertion. Ad2+ND1-2 and 1 -1 both produce
the 10K 71 fragment and a new protein unique to the
revertant. The new protein (23K) produced by 1-2 has
ely and shown to contain pep-
th adenovirus fiber and SV40 T
e revertant 1 -1 contains more
plicated region and produces a
molecular weight of approxi-
1 ar row efficiently on monkey cells. The proteins
iiiiEuced by revertants in vivo and in vitro have
thecamined, and their genomes have been analyzed
,mkstriction-enzyme mapping and heteroduplex analysis.
oiotevertants of 162 produce a 30K protein, and
In of
kely
el
fields
pro- been analyzed
been tides in common
by antigen (see below).
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mately 55,000. We have isolated two other classes of
host-range mutants. The first consists of mutants of the
revertant Ad2+N D1-2 which no longer grow on mon-
key cells. These mutants no longer produce the 23K
protein unique to the revertant. The genome structure of
these mutants will be analyzed with restriction enzymes
to detect possible changes in the mutant DNA. In addi-
tion, we have isolated a host-range mutant of Ad2+ND4
which has lost the ability to grow on monkey cells but
can be complemented by SV40. Ad2+N D4 contains
SV40 sequences which map between positions 0.59
and 0.11 on the SV40 map and produces polypeptides
which can be immunoprecipitated with antibody to T
antigen. Human cells infected with the Ad2' N D4 host-
range mutant do not produce polypeptides which react
with anti-T antibody. The genome of this mutant has
been analyzed with restriction enzymes and appears
identical to the parental Ad2+N D4.
Fused proteins from Ad2-SV40 hybrid viruses
HeLa human cells and CV1 monkey cells infected with
the new hybrid virus Ad2+ND1-2 contain a new protein
of apparent molecular weight 23,000. This protein is not
found in cells infected by the parental virus, Ad2+ND1
H71, a host-range mutant which is unable to grow in
monkey cells. Indeed, the 23K protein represents the
only major difference between the protein patterns of
H71 and 1-2 and it is therefore a good candidate for a
"helper protein." In this respect it is similar to the 30K
protein found in Ad2±ND1-infected cells. Unlike the
30K protein, which is synthesized both early and late in
the infectious cycle and only in moderate amounts, the
23K protein appears late but is made in great
quantity-comparable to the 100K and hexon proteins.
Cells infected with 1-2 also contain a new cytoplas-
mic polyadenylated RNA species which maps at the site
of the new insertion of SV40 DNA in the 1-2 genome
and contains both adenovirus and SV40 sequences. As
described above, these sequences correspond to the
N-terminal portion of the Ad2 fiber protein and the
C-terminal portion of the SV40 A-gene product (T anti-
gen). In collaboration with J. Lewis, we have shown that
1-2 mRNA selected by hybridization to SV40 DNA or to
the Ad2 EcoRl E fragment directs the synthesis of the 23K
protein in a cell-free system. The cell-free product has
the same isoelectric point and proteolytic breakdown
pattern as the 23K protein isolated from infected cells.
This indicates that the 23K protein is translated from the
new hybrid mRNA.
From detailed considerations of the genome structure
we inferred that the 23K protein should be a fusion
product, with its N terminus derived from Ad2 fiber and
its C terminus from SV40 T antigen. To test this idea, the
lysine-labeled tryptic peptides of the 23K protein were
compared with those of Ad2 fiber and SV40 T antigen by
high-resolution column chromatography. Of the eight
lysine-containing peptides from 23K protein, six corre-
sponded to fiber peptides and two did not. Immuno-d
precipitated SV40 T antigen appears in two elec-1
trophoretically distinct forms, 96K and 88K. Both of
these give rise to a large number of lysine-containing;
peptides, including the two peptides of the 23K protein.
which are lacking from Ad2 fiber. Thus the 23K proteinri
is a hybrid structure, containing both adenovirus fiber]
peptides and SV40 T-antigen peptides in a single poly-f
peptide chain. The protein is phosphorylated, and sincek
the fiber protein does not carry this modification
whereas T antigen does, the phosphorylation site isP
possibly contributed by the T-antigen moiety.
The 23K protein and the 96K form of T antigen alsof
share a very prominent proline peptide which is absent$9
from the 88K form. The correspondence between the
lysine-labeled peptides of the 96K and 88K T-antigeri'
molecules shows that the two forms are closely related
to one another and suggests that the 88K form may bP
derived from the 96K form. Such processing would ID(c
likely to occur from one end of the molecule, and sincJ[
the SV40 DNA sequences contained in the new inser-;35
tion in the 1-2 genome can only code for the C- terminal
end of the A-gene product, we conclude that the 23K
protein shares the C-terminal proline-rich tryptic pep-
tide with the 96K form of T antigen. Structural analysis oi u
this peptide, now in progress, will permit assignment oi
the reading frame for T antigen when the nucleic acicpr(
sequence in this region of SV40 DNA becomes avail
able.
We conclude that the C-terminal portion of the 23K
protein has helper-function activity. Since this protein 41
produced in large amounts, it should be useful foP1'
biochemical studies of the helper function. The firsP
steps of purification have shown that it is largely locatecul
in the cytoplasm, mostly in the postribosomal superna
tant. From there it can be greatly enriched by phas
partition with polyethylene glycol and dextran.
uf
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Characterization and purification of SV40 T antigen 111C
Early after infection by SV40, permissive monkey cell.
produce a large protein which is coded by the A gene o
the virus. Recent work done in this laboratory as well a, I1E
DIin several other laboratories [Rundell et al., J. Virol
21:636 (1976)] has shown that the A-gene product, 1
antigen, is a phosphorylated protein that migrates it
SDS gels as a 96K species. Although this protein
preferentially immunoprecipitated by antibody raise(
against SV40 T antigen, sometimes two additiona
phosphorylated proteins of 92K and 88K coprecipitat
However, if a rapid isolation procedure is used and car(
is taken to avoid in vitro proteolytic degradation durin
extraction, the resulting immunoprecipitate contain'
very little, if any, of the smaller proteins. These data an
recent tryptic peptide analysis of the 92K protein
strongly suggest that these smaller species are indee( If
specific degradation products of the large 96K T anti-
gen. We have also observed that in vitro proteolytic
degradation is most prominent during immunoprecipi-
ation of T-Aq from monkey cells. In contrast, T-Aq from
human cells lytically infected with a Ad2-SV40 hybrid
(D1) or from human and rat cells transformed by SV40
displays a greatly reduced tendency to break down to
It he smaller proteolytic products [Ahmad-Zadeh et al.,
OProc. Nat!. Acad. Sci. USA 73:1097 (1976); Tegtmeyer
inceet al., J. Virol. 21:647 (1977)].
tion In an attempt to characterize further T-Aq and
eisperhaps elucidate its functional role, we have purified
T-Aq in its native form. Thus far, T-Aq from either lyti-
disocally infected cells or transformed cells has been
senpurified some 500-fold. The isolation procedure em-
theploys a phase-partitioning step during the initial extrac-
Igertion of the nuclear lysate, followed by standard
31e(Fhromatographic techniques, including gel filtration,
ybpEAE Sephadex chromatography, phosphocellulose
11)(0 romatography, and DNA cellulose chromatography.
nal-he T-Aq was isolated both from radiolabeled extracts
seri"S and "P) and from unlabeled extracts. The T-Aq was
napssayed at every stage of purification by immuno-
23Kprecipitation and SDS gel analysis as well as by corn-
)ep.plement fixation. The final product is usually 30-50%
isopure as judged by SDS gel analysis and contains the 96K
itoprotein as well as varying amounts of the 92K and 88K
aciproteolytic breakdown products. The purified T-Aq re-
vagnains highly antigenic, is phosphorylated, and retains
he ability to bind DNA.
23i, Work is in progress to characterize further the ability
flpf the purified T-Aq to bind to specific sites on the SV40
fopNA. To determine the specific binding of T-Aq to
firspNA, we shall employ a combination of two standard
ateechniques: (1) UV cross-linking of proteins to BrdU-
,ubstituted DNA and (2) antibody affinity chromatogra-
va
hasE)H1_, Y*
Finally, we have begun to test the biological activity
>f the purified T-Aq in in vitro nuclear DNA replication
din RNA transcription systems.
cdmall adenovirus-coded RNAs
neo-he studies on virus-associated (VA) RNA have con-
ainued. This RNA accounts for a large proportion of the
/froldral transcripts synthesized late in infection, but its
ct, -Junction remains tantalizingly unknown. As a result of
ir,ecent work it has been established that there are two
in ilpecies of VA RNA, a major one called VA RNAI and a
liseminor one, VA RNA', There is little sequence homology
onoetween the two VA RNAs, and they exhibit different
ljatefinetics of synthesis. Both are made early as well as late
on the infectious cycle, but the synthesis of the major
jrinjpecies accelerates dramatically after the onset of viral
tain)NA replication, whereas production of the minor
lancpecies holds steady. The synthesis of both species can
oteine initiated in vitro, and both start with a pppGp residue.
dee(
This indicates that RNA polymerase initiation sites are
associated with the structural genes for both VA RNA
species and suggests that a determination of the se-
quence of the DNA in these regions should be informa-
tive.
The locations of the genes for the two RNA species
have been determined with considerable accuracy. The
gene for VA RNAI is bisected by a Barn restriction-
enzyme cleavage site at position 30 on the physical map
of the viral genome. The gene for VA RNAH lies
downstream from that of the major species (relative to
the direction of transcription) and is separated from it by
a short spacer region. The spacer is only about 80 base
pairs long and must contain signals for completion of
VA RNAI synthesis as well as for commencement of VA
RNAII synthesis. Sequence analysis in and around the
gene for the major RNA species is largely completed,
and the complementary studies in the vicinity of the
minor species are under way.
In the course of experiments designed to screen for
additional species of VA RNA-a search which proved
unsuccessful-an RNA species of substantially greater
length was detected. This RNA is 550 bases long, sedi-
ments at 9S, and contains the poly(A) tract characteristic
of messenger RNAs. Its map position has been found to
lie at position 10 on the viral genome, a considerable
distance from the location of the VA RNA genes. In a
cell-free system for protein synthesis, the 9S RNA is
translated into a polypeptide known as protein IX. It is a
structural component of the adenovirus particle and is
only synthesized late in the infectious cycle. The DNA
sequences coding for it are transcribed both early and
late, however, so there must be a mechanism to prevent
the premature translation of this protein. One possibility
under investigation is that in the early RNA the 9S
mRNA sequences occur in a modified form, such that
the signals for the initiation of polypeptide IX synthesis
are incomplete or hidden.
Structure of naturally occurring strains of adenovirus
Several field strains of adenovirus, isolated over several
years from a number of locations, were obtained from
Dr. J. Hierholzer at the Center for Disease Control,
Atlanta, Georgia. By standard serological tests, which
recognize principally the viral fiber protein, these
strains had been classified as normal adenovirus types
1, 2, or 5. We have isolated the DNA from such natural
strains and analyzed it by digestion with several restric-
tion enzymes. Maps of the cleavage sites show that the
DNA of each field strain differs markedly from the DNA
of the standard serotype with which it had been iden-
tified. We have also analyzed the proteins made in cells
infected by the natural isolates. Again, the pattern of
polypeptides is not identical to that elicited by the stan-
dard serotypes. On the basis of the DNA and protein
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studies, it would appear that the characteristics of the
standard strains occur in the natural isolates in reas-
sorted combinations. One possibility is that the natural
strains originated by recombination between two stan-
dard serotypes, a process which occurs readily under
laboratory conditions. In order to identify the crossover
points for different recombinations, regions of homol-
ogy between the DNAs of the standard and field strains
are being examined by heteroduplex mapping.
Isolation of viable SV40 mutants
The restriction enzymes Taq and Bg II each make a
single cut in the SV40 genome, at map positions 0.57
and 0.67, respectively. When circular form-I SV40 DNA
is cleaved with both of these enzymes and the resulting
mixture of fragments is used to infect monkey cells, virus
is produced. The progeny of individual plaques were
grown in monkey cells and their genomes were ana-
lyzed by digestion with restriction enzymes. Although
no virus was found whose DNA was resistant to cleav-
age by BO, 5% of the virus clones contained DNA
which was resistant to Taq digestion. These Taq-
resistant mutants have suffered deletions of up to 4%
around the Taq cleavage site. Nevertheless, these mu-
tants appear to grow normally and to produce normal T
antigen. Their ability to transform rat cells is currently
being tested. Mutants with deletions in the same region
have been isolated by Shenk et al. [J. Virol. 18:664
(1976)]. Infection of monkey cells with DNA altered at
the Bgll site (by Bgll cleavage followed by digestion with
exonuclease or single-strand-specific endonuclease to
remove single-stranded tails) also failed to produce a
Bgll-resistant mutant among approximately 200 plaque
isolates tested. Since the Bgll cleavage site lies at or
close to the origin of DNA replication, it is possible that
the DNA sequence in this area cannot be altered with-
out loss of viability.
Analysis of the structure of integrated viral DNA
in transformed cells and revertants
Over the past year significant progress has been made in
our analysis of the arrangement of viral sequences in
transformed cells. To a large extent, we have brought to
a conclusion hybridization experiments which were
initiated several years ago, through the application of E.
Southern's "transfer technique" and the development
of efficient hybridization probes. The experiments fol-
low the general design described in the 1974 Annual
Report; however, they differ in certain particulars of
procedure. High-molecular-weight DNA, extracted
from transformed cells, is cleaved by a sequence-
specific restriction endonuclease. The resulting DNA
fragments are fractionated by electrophoresis through
an agarose gel, denatured in situ, transferred to a nitro-
cellulose filter as described by Southern [I. Mol. Biol.
98:503 (1975)], and hybridized to viral DNA that has
77
been labeled in vitro to high specific activity by th(
"nick-translation" reaction [Kelly et al., I. Biol. Chem
245:39 (1970)1. The distribution of viral sequence<
among the different-sized fragments of transformed-cel
DNA is then determined by autoradiography. The im
portant feature of this method of hybridization is that th(
labeled viral DNA used as a probe is present in vas
excess and provides the driving force for the reaction
From the results of these experiments we have drawr
the following conclusions concerning SV40 integration
1. After transformation, selection, and subsequen
cloning, the chromosomal location for the SV4('
genes within any cell line is stable. For example,
hamster transformed cell line (The-2) was injectec
into a hamster, and the solid tumor that was eventu
ally isolated from this animal contained SV40 DNif
integrated in its cell chromosomes in the same man,
ner as in the tumor-inducing cell line.
2. There can be multiple copies of intact or partial vira
genomes integrated at different chromosomal loca
tions. We have now examined the distribution o
restriction sites surrounding integrated SV40 DNA in
16 independently transformed Fisher rat cell line
No indication of a specific chromosomal insertior-
site was found.
3. The junction points between viral DNA and cellula
DNA contain viral sequences which map at differen
positions on the viral genome (see Fig. 2). In thre(
cell lines the viral DNA appears to have been incor
porated into the chromosome by a simple recombi
nation event. That is, the integrated SV40 DNA ha
the same break points on both sides of the insertion
In these cases, then, we can say that the viral genom(hg
probably does not have a special sequence (unless i35(
is small and reiterated) for integration. In a fourth ce1.5v,
line (rat c19) the integrated viral DNA is arranged ir1,te
the form of a tandem duplication. The stretch of virao1
DNA is equivalent in length to about 1.5 copies ()'
the SV40 genome.
In our rat and mouse cells transformed by SV40,
circular viral DNA has not been detected. However, tO
situation seems much more complex in human cetal
transformed by SV40. In collaboration with Ji101(
McDougall, we have been analyzing the viral
present in human fibroblast cells transformed by SN/4e
Preliminary results from experiments addressed to t1111
specificity of integration of SV40 DNA in these cells am
parallel to those in rat and mouse cells. However, frDnh
molecules of closed-circular SV40 viral DNA can al121
be extracted from all of these cell lines. Some cell li n:611
produce on the average of 1000 molecules of free SV41n
per cell. By in situ hybridization techniques, it appe:le
that only a small fraction of the cells contain larnle
amounts of free viral DNA at any given time. The nu N
ber of these cells is equivalent to the number
Restriction maps of integrated SV40 genomes
cl 17
0 o A
0 10 20 30 40 50 60 70
76 86 76 86
2.1 x 106
109
ion d
ertio
116
fermi
thri
incor
offibi !
lR11
c1 14 B
A
98 20
30 40 50 60 70 80 90
98 20
7.1x106
A
40 50 60 70 80 90 0 10 20 30 40 50 60
cl 9 14 38
cl 12
80
66 M
3.2 x 106
90 0 10 20 30 40
0.46 x 106
68V7:"."-%'""N.
50 60
66\76.\-rwi-N-/N
figure 2
aps of viral DNA sequences integrated into the genomes of four lines of SV40-transformed rat cells. The maps were constructed
s described in detail in the text. The wavy lines represent flanking cellular DNA sequences; the solid lines represent integrated
-V40 DNA. V indicates the regions of the SV40 map which contain the junctions between cellular and viral DNA sequences. The
rites of cleavage within the integrated viral sequences were identified as described in the text. The symbols represent the various
estriction enzymes used: () Hi nclIll; Hpai; (0) EcoRl; (0) Bgll; (CI) BamHl. The lines marked - represent the length of the
all segment of cellular DNA into which the SV40 DNA is inserted. The molecular weights of these segments, calculated as
lescri bed in the text, are given in daltons.
veifiV-antigen-positive cells in the culture. Thus SV40 repli-
ocation seems to be induced in a certain constant fraction
th
jpf cells from any given cloned line. The induction of
Dj\SV40 DNA replication in these cells brings into promi-
,onence the problem of SV40 excision from chromosomes
to,jr) general. We now know that SV40 DNA can be res-
oacued from nonpermissive transformed cells that have
,'effjpnly single copies of SV40 DNA (e.g., rat clones 17 and
412) by fusion of these cells with permissive monkey
Quite remarkably, very early in this rescue process
'esRin some cases 12 hours after fusion) perfect SV40 cir-
are formed within the heterokaryons. How a stably
in
!larptegrated piece of viral DNA which is joined to cell
nipNA at different sites can be excised from the chromo-
ome remains a mystery. Current models which are
being investigated involve the activation of the viral
origin for DNA synthesis while the viral DNA is still
integrated.
Human transformed cell lines have also been
selected after exposure to specific segments of SV40,
obtained by the use of restriction endonucleases, that
lack substantial portions of the late region of the viral
genome. These lines, if they are similar to whole virus
transformants, may provide a source of cloned defective
SV40 DNA molecules that have been propagated in the
absence of infectious helper virus and are suitable for
use as vectors in recombinant DNA research. By prop-
agating the recombinant molecules in transformed
cells, it should be possible to carry large segments of
foreign DNA and circumvent many of the problems
imposed by the packing of DNA into virus particles.
The state of the integrated viral DNA has also been
studied in several lines of rat-embryo cells transformed
by adenovirus 2. Data from recent experiments utilizing
Southern's technique complement the results of our
earlier renaturation kinetic analyses. Thus, in DNA from
cell lines such as F17, F18, and 2T4, the pattern of
fragments observed on autoradiograms is consistent
with the presence of only the leftmost 14% of the
adenoviral genome in these cells. By renaturation kinet-
ic analysis, F18 has three copies and 2T4 has seven
copies of this 14% of the adenoviral genome. Surpris-
ingly, only one adenovirus DNA insertion is seen in F18,
and only two in 2T4. This finding suggests that the
number of initial integration events in any given cell is
small, and that the multiple copies of viral genes found
in the stable transformants may be due to aneuploidy or
to amplification of the chromosomal region that con-
tains integrated viral sequences.
DNA fragment transformation
Experiments were conducted during the past year to
determine the amount of viral genetic information nec-
essary for transformation of nonpermissive cells by
SV40. We have used the calcium phosphate technique
of Graham and van der Eb [Virology 54:536 (1973)] for
DNA infection of an established rat fibroblast line,
measuring transformation by the number of dense foci
in 5% serum. Our results show that only restriction
fragments that contain DNA corresponding to the entire
"early" region of SV40 give a measurable frequency of
transformation. Defining AA as the amount (in map
units) of "late" DNA attached at the 5' end of the
"early" region and AB as the amount of "late" DNA
present at the 3' end, we find that the efficiency of
transformation is directly proportional to the product
AAAB. The purely statistical nature of this dependence
argues against the existence of one or a few specific
integration sites within the virus and suggests that inte-
gration (by whatever mechanism) of SV40 into rat cells
is not site-specific. We also find that the region of SV40
capable of complementing TsA (early) mutants of SV40
in a lytic infection is almost exactly coextensive with the
transforming region, and that the efficiency of this
complementation shows the same dependence on
AAAB as does transformation. The only exception is the
restriction fragment generated by cleavage with restric-
tion endonucleases Barn HI and Bgll, which will com-
plement TsA but which will not transform. It is unknown
Nhether the block to transformation by this fragment lies
in the integration or in the expression of the DNA.
Revertants of SV40-transformed cells
Revertant cell lines selected from SV40-transformed
cells have in general been T-antigen-positive; on the
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other hand, a direct role for the viral genome in thd
maintenance of transformation was indicated from the
temperature-sensitive growth properties of cells trans-
formed by the TsA mutant of SV40. Many reasons have
been proposed to explain these paradoxical findings,
including the following: (1) The SV40 genome is nog
directly involved in maintaining the phenotype for
which reversion is selected. (2) There are so many cellu-
lar genes involved in maintaining transformation that
finding a revertant with an altered viral genome would
be unlikely. (3) The cell lines used had multiple copies,
of an active dominant viral gene (T antigen), so that d
cellular variant would necessarily be selected.
In collaboration with Betty Steinberg and Bob Pollack
at Stony Brook,we have been reexamining this question
The transformed rat cell line 14B contains one copy o
SV40 DNA per cell [see Fig. 2 and Botchan et al., CO,
9:269 (1976)]. Line 14B contains nuclear T antigen a!,
determined by indirect immunofluorescence and im
munoprecipitation. It grows to a very high density
grows in low serum and in methocel, and is highly
tumorigenic in "nude" mice. Revertant cells which
have been isolated from 14B by FdU selection exhibit
the T-antigen-minus phenotype. These T-antigen-
negative revertant cell lines can be divided into three
classes: those in which the integrated SV40 DNA
retained with no detectable changes, others in whicf
the integrated SV40 DNA is retained but has acquired
small deletion in the T-antigen gene, and those in
which the integrated viral DNA is completely lost. Al
three groups are T-antigen-negative under both spars(
and confluent culture conditions and after passage a
32°C. All three groups are density-inhibited and do no
grow in methocel. Finally, some of the revertants can be
retransformed with SV40 DNA.
These findings reinforce the earlier conclusion tha
some of the growth properties of transformed cells are
the direct consequence of the continued expression o
the integrated SV40 A gene.
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Suppression
Last year, we showed that the yeast ochre and amber
nonsense suppressors could function in a cell-free sys-
tem derived from eukaryotes [R. F. Gesteland et al., Cell
7:381 (1976)]. It was shown that this suppression is due
to the tRNA fraction from suppressor-carrying cells.
Perhaps this provides a foot in the door toward the
development of a suppressing system for mammalian
cells.
Purification of the suppressing tRNAs
The recessive lethal amber suppressor RL1, isolated by
M. C. Brandress et al. [Genetics 79:551 (1975)], inserts
serine in response to an amber codon and can be as-
sayed by suppression of an amber mutation in the Q/3
RNA phage synthetase gene. Using this assay we have
partially purified the suppressing species on a benzo-
lated DEAE (BD) cellulose column where the serine-
accepting activity comes off in a late and rather broad
peak and the suppressor activity is on the leading edge.
The active fractions are then chromatographed on
Sepharose 4B, where at least one of the serine-accepting
species separates from the suppressing activity, which
again comes off late, giving a good purification. At least
50% of the tRNA in the preparation accepts serine, and
the preparation has a high specific activity for suppres-
sion. With Peter Piper, who was here for a visit this
summer, we showed that this partially purified fraction
has a mobility on two-dimensional gels that corre-
sponds to the mobility of a component that has a UCG-
decoding tRNA sequence. Furthermore, he has shown
that this component has a major and a minor UCG-
decoding tRNA, which differ by a few nucleotides, and
that it is the minor species which is mutated to a se-
quence that will read the amber codon in the amber
suppressor. We also showed that if the crude tRNA from
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the amber-suppressing strain is run on a two-dimenP
sional RNA gel, the suppressing activity can be recov°
ered in the spot predicted by Piper's results. We do notobil
yet know whether our column-fractionation schema
discriminates between major and minor UCG-decodine
species; if it does not, we will make an effort to fine'I'd
some method that will discriminate between these. Po
We are at the same time purifying the suppressin
tRNA from a strain which carries an ochre allele of thil°I
amber suppressor. The ochre suppressing species is aswe,
sayed by read-through of the normal terminator UAA aro
the end of the Q0 synthetase gene. In this latter case wt,
would like to look at the sequence of the suppressinop
tRNA to ask why the yeast ochre suppressors are specif4
for ochre, whereas the coli ochre suppressors read botlo
ochre and amber.
Suppression in mammalian systems
uOur original cell-free suppression experiments werstlis {lh r
done in mixed systems having a yeast S-100 fraction ari(},11°Ila
other components from a mammalian source. We ha4(6e
now found conditions under which we can get higl!.°(
levels of suppression in the standard mammalian systerifi,r31°,`
that we use [M. Schreier and T. Staehelin, J. Mol. Biauic
73:329 (1973)] by adding just the yeast tRNA. LowerinPf
the temperature of incubation to 25°C seems to be thellts
major factor in attaining higher suppression levels, anccmvei
purification of the tRNA species allows inclusion
more suppressing tRNA without concomitant add itior
of other species that tend to inhibit protein synthesis°2
which also results in higher levels of suppression. Vent°1611
recently we have found that we can also get high leve[I'c°Il
of suppression in the very simple reticulocyte lysatd;galaI
system described by Pelham and Jackson, from whichns
the endogenous messenger RNA activity is removed 0,S1
treatment with micrococcal nuclease. This provides mull!
every simple, active, and clean system for doing these
,experiments.
Together with Terri Grodzicker we are using the
,cell-free suppression system to ask whether any of the
'host-range mutants of Ad2±ND1 that she has isolated
and characterized are amber or ochre mutants. We have
.good evidence that a number of these mutants make, at
least in vitro, fragments rather than the normal gene
product; also, we have preliminary evidence that one of
the mutants, which makes a 19,000-molecular-weight
fragment, can be suppressed by an amber suppressor in
vitro to give back some of the 30,000-MW wild-type
oroduct. Hence we conclude that this particular mutant
an amber mutant, and we hope this can be used to
el p develop suppressing cell lines. These host-range
Gifu iutants are defective in the SV40 function that allows
denovirus to grow on monkey cells. The purpose of
-one of our current experiments is to see whether we can
suppress these mutations in vivo by getting suppressing
-din -RNA into mutant-infected monkey cells and then see
reehether or not virus is produced. We are trying this by
edorusing red blood cells preloaded with purified tRNA
scher3 pecies with the infected monkey cells. To make a sup-
iecodioression system useful it will obviously be necessary to
p.ind mutant monkey cell lines that are capable of sup-
Dressing this amber mutant.
pressil
le of
loning
iesisWe are trying to clone the suppressor genes from yeast,
rst to study their structure and second to develop vec-
rcasetors carrying these genes. T. Petes, D. Botstein, and P.
ppressINVensink have constructed a set of 2500 clones, each
esPeaWith a randomly generated piece of yeast DNA inte-
readbograted into the coli PMB9 plasmid. We have screened
these with "P-labeled leucine and serine tRNAs and
have identified a number of clones that have these
sequences. The serine-tRNA-containing plasmids are
being investigated further by restriction-nuclease diges-
eitiion and Southern-type blotting experiments to identify
actOthose fragments specifically carrying the tRNA se-
Oe!quen ces. These fragments will then be made very
ngelbradioactive by nick translation and used as probes for
liaOhybridization to restriction digests of DNA from the
to suppressor-carrying cells to identify those DNA frag-
ments that are of interest. These can then be cloned by
conventional ligation into PMB9.
P-Galactosidase synthesis in E. coli
Jim Manley has finished his thesis work on the synthesis
of abnormal proteins from the /3- galactosidase gene of
1:. coll. He has been able to identify fragments of
-galactosidase that result from premature termination
of translation of the messenger RNA, both in vitro and in
vivo. Such fragments had been observed in other cases
among in vitro products, and it had been assumed that
this was an artifact of cell-free systems. However, it is
now clear that the same fragments are produced in vivo,
in surprisingly large amounts. The calculation in Man-
ley's experiments says that one out of three ribosomes
that start translating the /3- galactosidase gene in vivo
does not make it to the end but falls off prematurely. He
has ruled out that this is due to proteolytic degradation.
He has also shown that the internal restarts (initiation by
ribosomes at internal sites in the message rather than at
the normal start site) can be demonstrated in vitro, and
that the resulting fragments are stable in the cell-free
system whereas in vivo they are usually rapidly de-
graded. The restart fragments made in vitro have a funny
solubility problem; at 37°C they are in some large com-
plex that sediments very rapidly but when made at 25°C
they are in the soluble fraction and can be readily de-
tected. He has also made the surprising observation that
if the Zubay-type cell-free system is run at a lower than
normal temperature one sees suppression of amber
mutants under otherwise nonsuppressing conditions.
Yeast his genes
Ray Bigelis here, in collaboration with Gerry Fink at
Cornell, has been looking at the expression of the hisA,
B, and C genes in yeast. He has obtained very good
antibody against the purified histidinol dehydrogenase
protein and has been able to show that the three genes
produce one large protein of MW 90,000 which can be
cleaved to give some separation of the activities. He is
now looking at various fragments produced by non-
sense mutations within the cluster and trying in vitro
synthesis of the gene product to identify the primary
translation product.
Yeast galactose genes
Jim Broach is initiating work to clone the gal genes in
yeast. This is an interesting system in that three structural
genes of the operon are controlled together by two
controlling genes that map at other locations in the
genome. He is currently screening the Petes collection
of clones for those that contain the gal gene sequences
by using 32P- labeled or iodinated RNA from induced
and uninduced cells. Since the gal messages should be
among the relatively abundant species, it should be
possible to pick up these clones by the difference in
hybridization of these RNA preparations. Broach is also
fractionating mRNA so that partially purified probes can
be used for screening if that becomes necessary. The
long-term hope here is to understand the organization of
this cluster and to get at the function of the two control-
ling genes.
Abortive infection of monkey cells by Ad2
A new variant of Ad2 has been isolated that multiplies
efficiently on monkey cells without the aid of SV40. The
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variant was selected after
mutagenesis by sequential
passage on monkey cells. The kinetics
of its growth, its
burst size, and the efficiency
of plaque formation are
similar on human and monkey cells. Electron-micro-
scope, restriction-endonuclease,
and hybridization
analyses have failed to ctdete
any differnces between
the genomes of the variant and its
parente. The pattern of
protein synthesis of the variant is
the same in human
cells and in monkey cells, with the
full complement of
viral protein being synthesized in normal
amount. This
is in marked contrast to the much
reduced synthesis of
late viral proteins, particularly fiber, during
Ad2 infec-
tion of monkey cells. The mutation
appears to act in
trans, since it enhances the
synthesis of Ad5 fiber pro-
tein in coinfections of monkey cells.
Together with John
Hassell we are mapping the mutation responsible
for the
increased host range by modified marker rescue
tech-
niques.
5' Ends of fiber and 100K mRNAs
Our earlier studies on the block to Ad2 multiplication in
monkey cells indicated that although the concentration
of fiber mRNA was approximately ten times lower in
abortive than in productively infected monkey cells, the
synthesis of fiber protein was below the level of detec-
tion. Recently, with the more sensitive technique of
immunoprecipitation, fiber was found to be synthesized
at only 0.3% of the level observed in productively in-
fected monkey cells. This large difference in fiber syn-
thesis between the two types of infection, compared
with the more modest difference in fiber mRNA levels,
suggested that the mRNA should be examined. We have
looked specifically at the 5' ends and have found that in
both types of infection the fiber mRNA and also the
100K mRNA are capped. Unexpectedly, the fiber and
100K mRNAs both contain similar (if not identical) T,
oligonucleotides at their 5' ends. These oligonu-
cleotides have a structure and nucleotide composition
consistent with that found by R. Gelinas and R. Roberts
for the major cap-containing oligonucleotides found in
mRNAs late in Ad2 infection of human cells. Mild nu-
clease digestion of the RNA in the DNA-RNA hybrid
state removes the oligonucleotide from these two mes-
sengers, which suggests that this common oligonu-
cleotide may not be encoded at the beginning of each
gene. To investigate this we are doing fine-structure
mapping of the sequence corresponding to the 5' end of
fiber mRNA in the Ad2 genome, and together with R.
Roberts' group, we hope to compare the DNA sequence
of this region with the sequence of the common 5' T,
oligonucleotide.
Mapping of adenovirus genome
This year efforts have continued to identify and charac-
terize the protein products of the Ad2 genes, particularly
the early genes. As we reported last year, cell-free trans-
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cific fragments of Ad2 DNA identified
lation of early mRNA selected by
early,
from cells infected at much higher multi
mRNAs. Experiments this year, using
pfu/cell compared to 10-25 pfu/cell
used previously)A'
plicity
(2001'1
have identified additional polypeptides
as
cell-free translation of Ad2 early mRNA. Curr
d ro'rnii7ieach of the two right (75.9-83.4, 89.4-98.5)
Ad2
are summarized in Table 1.
The existence of multiple polypeptide products f
earlymRNAs raises the question of whether
there is morethan one mRNA coded for by either
or both of thestoi
regions of the genome, or whether either
of theseilf"'
mRNAs might be polycistronic. To investigate th'question further, these mRNAs were given to L. Chow
R. Roberts, and T. Broker for R-loop analysis
in they
electron microscope. The mRNAs complementary
tothe region 75.9-83.4 were found to be heterogeneous
i
size, but the rightmost region coded for only
one ver ilhomogeneous population of molecules, which
coverer
map positions 91.5-96.8, that is, an estimated
codin:
capacity of 68,000 daltons of protein. The five polypep
tides resulting from cell-free translation of this mRN,
total 92,000 MW. Some of these polypeptides
may thu
be overlapping in sequence. This possibility is current*
being investigated by peptide mapping. If at least
some.,
of these polypeptides are unique in sequence, then this'..
mRNA is a particularly attractive candidate to study ,3,1'
an example of a eukaryotic polycistronic mRNA.
Of particular interest are those early proteins that
are
products of the transforming gene(s) of Ad2. To this
encl,
we have been especially interested in characterizing the
41 K -57K and 15K proteins, since the genes for at lent
the 41 K -57K and possibly also the 15K map within the
transforming region of Ad2. The 41K-57K protein a,
synthesized in vitro is heterogeneous, in that a numbc
of bands in the range 41,000-57,000 apparent molecu
lar weight are found in different experiments. R-loop
analysis of this mRNA by our Electron Microscopy Sec
tion has shown that this mRNA maps between 1.3 an
4.0 map units and thus can code for only 36,000dalton
da
Table 1
Identification of polypeptide products of cell-free translation
Portions of DNA within
which sequences
complementary to
mRNA map
(map units)
Polypeptide products
of cell-free translation
(K)
0 - 4.4 41 -57
4.4 - 17.0 15
58.5 - 70.7 72
75.9 - 83.4 15.5, 14,* 13*
89.4 - 98.5 24,* 21,* 19, 17,* 11
*New polypeptides not seen with RNAs prepared at lower multiplicithi
of infection.
12ot protein. Thus the heterogeneity of this polypeptide as
'synthesized in vitro must be due to some variable de-
%ree of posttranslational modification, which also pre-
;umably confers upon the polypeptide an anomalously
`'1°'s-low mobility on SDS-polyacrylamide gels. Indeed,
de comparison of the peptides produced by partial diges-
11rHon of these polypeptides with protease has shown that
-wo prominent in vitro products of 43,000 and 46,000
cisV1W have very closely related sequences.
c12` This year we have also shown that proteins of 15K,
is''42K, and 50K can be specifically labeled early after
oftr-nfection of cells with Ad2; that is, they are not found in
of irJninfected cells. These proteins are best resolved from
'ate lost-cell proteins of similar molecular weight by two-
ti
'
C L:limensional isoelectric focusing-SDS-polyacrylamide
siciel
electrophoresis. Preliminary studies comparing
ntah')eptides produced by partial protease digestion indi-
leoLHate that the 42K and 50K in vivo proteins are very
le'timilar to each other and to the 43K and 46K in vitro
:°\)olypeptides. Similarly, the 15K protein synthesized in
coc
'Ivo gives a partial digestion peptide pattern very similar
oho that of the in-vitro-synthesized 15K. Thus the two
mR\)olypeptides (41 K -57K, 15K) shown by our in vitro
tu les to be the products of the genes associated with
urrerhe transforming activity of Ad2 can now be correlated
IstslYvith particular proteins found in infected cells. This
hen opens up the possibility of purifying these proteins
stud\
A.
that
izih1
oteio
nr
nO,
.00
)p\
jr
11a
ldalto
/-
in their native form from infected or transformed cells by
using two-dimensional gels as an assay.
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This year has seen not only the transfer of much of our
work from the Department of Cancer Studies at Birm-
ingham University Medical School, England, but also
the beginning of very promising collaborations with
other established sections at Cold Spring Harbor. Our
main research interests are (1) the biological charac-
teristics of cells transformed to a neoplastic state by a
variety of agents (e.g., viruses and chemicals), (2) the
extent to which the in vivo behavior of such cells is a
reflection of their in vitro properties, (3) the cytogenetics
of tumor cells, with particular reference to specific
translocations and deletions in experimentally induced
animal tumors and in human tumors, and (4) the
cytogenetic changes induced in human cells after virus
infection in relation to the induction and localization of
human genes.
From this it can be seen that our intent is to deal with
the same question previously posed for this section by
Bob Pollack: What allows cancer cells to grow where
normal cells are inhibited? Our method of study is to
search for the comparisons which can be made in the
properties of tumor cells induced in the same species by
different oncogenic agents. We already know that not
all cells which exhibit the properties of cancer cells in
vitro are tumorigenic in vivo; this phenomenon pro-
vides us with a basis for studying those characteristics
which correlate with cancer induction but are absent
from both normal cells and cells only partly along the
pathway to becoming malignant.
We have enjoyed a valued collaboration over the past
three years with Frank Ruddle's group at Yale and with
Raju Kucherlapati at Princeton, pursuing our joint in-
terests in somatic-cell hybrids. One of the many benefits
of being at Cold Spring Harbor is that these mutual
interests are continuing without the problems of trans-
atlantic experiments.
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Transformation of human cells by SV40
We have initiated a series of experiments designed t
study the integration of SV40 into the chromosomes
c
human cells. Human cells are semipermissive for th
replication of SV40 virus, and transformed cells tend
have multiple copies of virus DNA. In order to exannin,
the association of viral DNA with particular chromo.
somes, we fuse the parental SV40-transformed clone,
cell lines with mouse cells, using polyethylene glycol
tc,
promote fusion. The resultant hybrid cells, which in
tially contain a full complement of froir.
each species, lose most of the human chromosome,'
during subsequent divisions of the hybrid. The loss O.
human chromosomes, with some exceptions, is ran-
dom, and thus a panel of cloned hybrid cell lines
developed in which different complements of huma,
chromosomes are represented. By examining the hybrk
cell lines for virus-transformed phenotypes (e.g., T anti.
gen) and for viral DNA, it is possible to assign virk
integration sites to particular chromosomes. The initik
results of Croce et al. [Proc. Natl. Acad. Sci. USA 71
1397 (1975)] suggested a specific integration site ink
only one human autosome, C7, but subsequent studie
in this and other laboratories argue for a more comply ,
situation", with integration of virus DNA into more tha
one chromosome. In parallel with our experiments
somatic-cell hybrids, the SV40-transformed cells
being examined by Michael Botchan and Joe Sambro
for both integrated and free viral DNA. Apart from I
integration studies, one of the properties amenable
study in these somatic-cell hybrids is replication of fre
viral DNA in the established cell lines. We are examir
ing the hybrids for both integrated SV40 and continue
extrachromosomal viral DNA synthesis in order to ei
tablish which human chromosomes carry genes whit.
regulate SV40 DNA replication.
In collaboration with Raju Kucherlapati at Princeton,
a large suite of hybrids formed from the fusion of long-
established SV40-transformed human cells and mouse
cells is being examined for viral markers. These hybrid
cell lines will extend our ability to determine associa-
tions between human genetic markers and integrated
SV40 virus.
Transformation by adenoviruses
Ad2 transformation of rodent cells, a semipermissive
system, results in cell lines which share many charac-
teristics while differing in others. Epithelioid morphol-
ogy, growth to high density, increased protease produc-
tion, and virus-specific T antigen are all common
-phenotypes, and the integration of a minimum segment
,)of the left end of the virus genome [Sambrook et al.,
Ws.Cold Spring Harbor Symp. Quant. Biol. 39:615 (1974)]
F.s consistently observed. Further studies on these cell
lines and an Ad5-transformed human cell line [Graham
ka'fit al., Cold Spring Harbor Symp. Quant. Biol. 39: 637
,igned(1974)] carried out by Phil Gallimore in Birmingham
oilesand in this laboratory have identified other phenotypes
eforithat are not uniformly expressed: serum-independent
Istencgrowth, tumorigenicity in syngenic rats or "nude" mice,
examand the synthesis of large, external, transformation-
chrorsensitive (LETS) protein. Anchorage-independent
dclorgrowth, as measured by the ability to form colonies in
'giVornethylcellulose, did not give a good correlation with
ihichtumorigenicity in adult athymic nude mice, as two of the
mesiiseven lines tested plated well in methylcellulose but
mosorwere nontumorigenic in adult nude mice. This is in
kontrast with the results reported for SV40-transformed
s, is icel Is [Shin et al., Proc. Natl. Acad. Sci. USA 72: 4435
II 101 975)L where growth in methylcellulose and tumori-
)f hurigenicity appear to be well correlated.
heillib The distribution of the cell-surface LETS protein on
gi,Taihese cell lines does, however, correlate well with
sign humor induction. These experiments were carried out in
The inkollaboration with Lan Bo Chen and are reported fully in
USA6 Cell Biology section. The only other factor identified
sites having an association with oncogenicity of these cell
ostAnes is the initial virus input used to transform the cells.
ecoAdenovirus-2-transformed cell lines derived from dish-
rficOs infected at a virus/cell ratio of 50 plaque-forming
5,inefitinits (pfu):1 can produce tumors in syngenic animals
d 'ithout immunosuppression [Harwood and Gallimore,
,sarobr` t. 1. Cancer 16: 498 (1975)]. Cell lines initiated from
aro( ,shes infected with 1-40 pfu/cell may only produce
inooumors in immunosuppressed syngenic animals, and
li000llhose initiated with less than 1 pfu/cell are, with one
nontumorigenic. There is a significant differ-
idcori-nce between the behavior of another serotype (Ad12)
mo nd Ad2 in this respect: Ad12-transformed cell lines are
oruoe,ill highly oncogenic and have most or all of the viral
Se
.enome incorporated.
Exposure of cells to higher virus doses (Ad2) or inte-
gration of more of the viral DNA molecule (Ad12 and
possibly Ad2 at high m.o.i.) may result in an increased
probability of integration into a specific site(s) in the host
genome. Our recent results from studies with somatic-
cell hybrids suggest that at the host chromosome level
there is no indication that Ad2 sequences integrate at
specific loci. As most virus-transformed cell lines are
derived from primary embryo cell cultures, there may
be transformation of cell types at varying stages of dif-
ferentiation, and a particular differentiated state could
exhibit increased growth potential both in vitro and in
vivo. The probability of transformation of particular
"target" cells is increased at higher virus m.o.i. It may be
that transformation results from the random integration
of fragments of viral DNA which include the transform-
ing genes but that further conversion to the tumorigenic
state requires a genetic change in the host such as
randomly induced mutation following virus infection,
or even a stable epigenetic change.
One interpretation of all these facets of Ad2 -
transformed cells is that oncogenicity is the result of at
least a two-stage progression. Viral transformation in
vitro can be achieved by infecting cultures with 0.25
pfu/cell of Ad2 or by transfection with DNA of
molecular weight 1.6 x 106 daltons, and the cell lines
will have the virus-associated transformation
phenotype yet be unable to establish tumors. The in-
creased oncogenicity of cells transformed at higher
virus m.o.i. may reflect other effects on the cell genome,
e.g., increased structural damage to cell DNA, which
can in fact be seen at the cytogenetic level. Induction of
chromosome damage by adenoviruses, and other DNA
viruses, is dose-dependent. Although the majority of
cells with chromosome aberrations do not survive,
error-prone repair of damage may be one of the most
important factors in oncogenesis.
A series of hybrid cell lines resulting from the fusion of
Ad2-transformed rat cell lines F4, F17, and F18 with
mouse cells has been made. The rat/mouse hybrids
segregate rat chromosomes, and established cell lines
contain only a limited number of rat chromosomes.
None of the chromosomes consistently segregates with
adenovirus T antigen, although in Ad2/F18, for exam-
ple, a cell line containing an estimated 2.9 copies of the
14% left end of the viral DNA molecule [Sambrook et
al., Cold Spring Harbor Symp. Quant. Biol. 39: 615
(1974)1, T antigen is associated with retention of rat
chromosome no. 14. The absence of this chromosome
from some T-antigen-positive hybrids made from Ad2/
F17 or Ad2/F4 argues strongly for random integration
sites in the host.
Transformation by herpesvirus
Herpes simplex virus type 2 (HSV-2) has been as-
sociated with carcinoma of the human cervix by
seroepidemiological criteria, reported recovery of
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virions, and detection of virus-specific antigens in cer-
vical carcinoma cells. The oncogenic potential of the
virus has been investigated by transforming rodent cells
in vitro. We have taken one line of Syrian hamster cells
transformed by UV-inactivated HSV-2 and, after clon-
ing, analyzed the cloned lines cytogenetically for
tumorigenicity and for virus mRNA by in situ hybridiza-
tion. The original cell line [333-8-9; Duff and Rapp,
Nat. New Biol. 233: 48 (1971)] is hyperdiploid with a
mode of 49 chromosomes and contains a spectrum of
cytogenetic marker chromosomes present in varying
frequencies. The clones demonstrate a segregation of
these marker chromosomes and other abnormal
chromosomes. Cloned lines have distinct stern-cell
types, with the characteristic abnormal chromosomes
present in a high percentage of cells. The marker
chromosomes have been identified by Giemsa banding
techniques. All the clones have distinctive, persistent in
vitro morphologies, ranging from purely epithelial to
purely fibroblastic. They differ from the line 333-8-9
and among themselves in tumorigenicity, varying from
the highly tumorigenic to the entirely nontumorigenic.
Herpesvirus-2-specific sequences have been detected
in the original cell line and in all but two of the clones.
There does not appear to be any obvious correlation
between the three parameters of detection of HSV-2
information, marker-chromosome occurrence, and
tumorigenicity. As with the Ad2-transformed rat cell
lines described above, one characteristic which showed
a clear correlation with oncogenicity of the clones was
the distribution of LETS surface protein.
We are using fragments of HSV-2 DNA to transform
rodent cells in two ways. LMTK-, mouse cells deficient
in thymidine kinase, have been converted to TK+ using
either restriction-endonuclease (EcoRI and Hind Ill)
fragments or sheared viral DNA. Cytosol extracts of the
cloned cell lines possess TK activity identical to
the enzyme synthesized de novo in HSV-2-infected
cells, as determined by thermolability, mobility on
polyacrylamide gel electrophoresis, and substrate
specificity. The Eco RI and HindlIl fragments which
convert TK- cells of TK+ overlap on the map of HSV-2
and therefore allow a suggested assignment of the TK
gene to the long unique region of the viral genome
between map units 53.2 and 64.6. Whether in fact the
HSV-2 DNA fragments are integrated into cellular
DNA remains to be determined, but the TK activity
has remained stable through eight passages in non-
selective medium. These experiments demonstrate
that defined fragments of HSV-2 DNA can transform
cells in culture. We have also transformed primary rat
liver cells using sheared HSV-2 DNA; the cloned lines
have cytogenetic abnormalities and are positive for
HSV-specific antigens by immunofluorescence. We
will be testing the oncogenic potential of these cell
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lines and of others being derived by transformation of
cells with defined fragments of HSV DNA.
Cytogenetics of tumor cells
In experimental systems it is clear that some chromo-
somes are more frequently involved in rearrangement of
the karyotype than are others. We have observed that rat pu
cells transformed by adenoviruses, SV40, and herpes-
viruses all show similar marked chromosomes, and that
two of the autosomes regularly involved in rearrange-
ments in adenovirus-transformed cells are also pref-
erentially involved in marker formation in chemical
transformants. In hamster cells transformed by adenovi-
rus, herpesvirus, polyoma virus, or carcinogenic chem-
icals, identical chromosome rearrangements have been
described; some of these were cataloged during our
studies of the 333-8-9 cell line. This could suggest
involvement of specific loci on the autosomes which
carry genes important in the regulation of cell growth
and therefore of malignancy.
A survey of 287 human neoplasms carried out by
Mittelman and Levan [Hereditas 82: 167 (1967)], and
since extended by these workers to include more cases,
has identified a limited number (nos. 1, 7, 8, 9, 14, 17,
21, and 22) of chromosomes regularly involved in
structural aberrations. We are studying interactions
between viruses and human chromosomes, and it is
perhaps of more than passing interest that six of the
seven human chromosomes (nos. 1, 7, 9, 14, 17, and
22) which we and others have reported as specifically
affected by adenoviruses, herpesviruses, and SV40 fall
into the same group. Although no virus etiology is im-
plied, the nonrandom involvement of a chromosome in
human neoplasms [Rowley,). Natl. Cancer Inst. 52: 315
(1974)] and in cellular responses to virus infection may
point out important regulatory pathways. In collabora-
tion with Janet Rowley in Chicago and Felix Mittelman
in Lund, Sweden, we are examining these phenomena
in detail.
Human gene mapping
Our previous work in this area has used adenovirus-
induced uncoiler regions on human chromosomes nos.
1 and 17 to facilitate the localization of the gene coding
for thymidine kinase, galactose kinase, lactate
dehydrogenase-A, and esterase-A4 and the major locus
for 5S DNA on chromosome 1. We are currently inves-
tigating in somatic-cell hybrids three further uncoiler
regions induced by adenovirus 12 on chromosome 1 in
order to determine whether there is an association be-
tween these regions and the gene loci for adenylat
kinase-2, guanylate kinase-1, and uridine monophos-
phate kinase, all of which are known to map on
chromosome 1. Recent results obtained in Frank Rud-
ratio
dle's laboratory at Yale show that collagen-4 can be
assigned to chromosome 17; we are currently col-
laborating in examining virus-infected somatic-cell
hybrids to investigate the extent of linkage between TK,
Gal-K, and this gene.
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Protein degradation
We have known for many years that Escherichia coli is
able to selectively degrade aberrant proteins. For
example, proteins loaded with an amino acid analog,
the polypeptide termination and reinitiation fragments
produced by nonsense mutants, and the small fragments
produced by premature termination after treatment with
puromycin are rapidly and selectively degraded,
whereas their normal counterpart proteins are com-
pletely stable. Our laboratory has been studying both
the genetic and the biochemical bases of this phenome-
non. In the past we have isolated mutants in the degra-
dation system itself, and, in collaboration with Susan
Gottesman of the National Institutes of Health, we have
continued our mapping of these mutants. So far, all deg-
mutations mapped have been shown to be in the same
location as the Ion gene of E. coli, as was shown for the
original deg- mutation several years ago by Barry
Sh ineberg.
So far in the study of the substrates of the deg system
only proteins with relatively large aberrations, such as
those described above, have been used. In order to
simplify our study we decided to look at proteins which
were altered in only one amino acid-that is, missense
mutations-to see if they too were substrates for the deg
system of E. coli.
Over the past decade our laboratory has isolated a
large number of Z- mutants, many of which have been
tentatively classified as missense mutants. During the
course of this year we confirmed that many of these
were missense mutants-a somewhat complex job-
and then tested them to see if any were degraded. We
found that of 32 independently isolated missense mu-
tants mapping at 17 different sites, seven were unstable
and the rest were stable. These seven mapped at only
three sites, five at a single site and the other two at
separate sites. Thus we conclude that degrading mis-
sense mutants are a minor class of all missense mutants
34
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in /3- galactosidase. This suggests that the system whickr
recognizes aberrant proteins needs some prominen
alteration in the protein to distinguish it from the nati(,
configuration. We hope that further study of what 1,.
wrong with these missense mutants will give us sorne,;,
clue as to what this distinguishing feature of aberran
proteins is.
An obvious question to ask is"What is the effectofthE
deg mutations on the degradation of the degradablE;:
missense mutants?" This was tested in a straightforwarc'
way which showed that all deg mutations slowed th(
degradation of the degradable missense mutants to
considerable degree, implying that the degradation o
missense mutants is carried out by the same system usecs,
to degrade nonsense fragments. Presumably the onIct
reason that nonsense mutations are more likely to leac,,
to unstable proteins is the much greater alteration they:o.
produce. ,g0
From January through August, Professor Charles Mil=d
ler from Case Western Reserve University was worki 021
full-time in our laboratory. Dr. Miller has isolated muta
tions in a large number of genes known to specify prolhe?
tease or peptidase mutants in bacteria. He was inNtl
terested in finding out if any of these mutants, whiclietin,
lack a known protease or peptidase, is in any wa,,vhicl
deficient in degrading aberrant proteins. He studied th6ome
two major proteases of bacteria, proteases I and II, anoacF
about five peptidases. An extremely careful and externem
sive study showed that there was no difference in thetcon
degradation of a variety of nonsense mutants in th(oh
absence of any or all of these protein degradation funchatti
tions. In addition, he tested for the presence of knowidace
proteases and peptidases in the deg- strains. There walop,(
no alteration whatsoever in the pattern of these enoiolo
zymes, including several proteases for which no mulhatis
tants yet exist. Thus, whatever the function lacking in.oatt.
deg- mutant, it is not among the known proteolytirvsee
enzymes of the cell.
Clearly, one way to get a handle on which enzymes
are doing the degradation would be to have the degra-
dation take place in vitro, and thus have an assay for
purification of the system. Although this is relatively
trivial with most protein-degradative enzymes, in the
case of the deg system there are certain problems. First
of all, the deg system is known to require energy for
degradation. Also, it does not function-at least it does
not function nearly as actively-in vitro as in vivo. For
example, in the case of the long nonsense fragment X90,
degradation is completely blocked by cyanide in vivo,
completely blocked by the addition of toluene to the
cells, and completely blocked by opening of the cells in
any manner we have yet employed. Stymied in using a
- long nonsense fragment, we decided to use the smallest
possible piece of /3- galactosidase we could detect, and
-chose the auto-a fragment, which is a peptide of about
7500 molecular weight that comes from the N-terminal
,mwhicend of (3-galactosidase and can be detected in a corn-
rominerplementation assay. We were able to show that extracts
nati\:led to the disappearance of the complementing activity
what:of auto-a. This disappearance has a nonlinear kinetics,
us sonlgoing on for a short period and then stopping. It is very
aberradifficult to get all of the auto-a activity to disappear, but
the 75-80% that does disappear does so quite rapidly. A
lectoftli variety of other features of this reaction suggest that it is
,gradahlof considerable interest. For example, it does not in-
itfowa,volve any of the known peptidases or proteases of E.
Thus, at the very least, it may represent the action of
ants to a new proteolytic enzyme. However, we have not
dation shown that the auto-a activity is disappearing because it
teal is degrading. It could conceivably be disappearing for
the or,other reasons. In order to distinguish between these
possibilities, we engaged in making pure labeledly to le
itionth auto-a. With this material, disappearance due to bind-
ing or some form of chemical addition could be distin-
arlesiguished from disappearance of complementing activity
due to actual cleavage of the peptide.
'tedn'r The X attachment site
recutre
war Another project in which we engaged was an attempt to
ntob define the minimum physical structure of the DNA of X
which is required for attachment to the host chromo-
odied, some. In pursuit of this, a fine-structure map of the
attachment site and the surrounding DNA region has
'ai"dc,i, been constructed with the use of 39 restriction enzymes.
:ce It contains 227 sites, 180 of which are in a 5000-base-
pair EcoRI fragment containing the Xatt site. We hope
that this detailed mapping will enable us eventually to
atolfoe place limits on the sequence of DNA used for integra-
tion. One of the problems in such a study is to devise a
is
assay for the attachment site. An approach
thc th s now showing some signs of success is to cut out
din° an att-site-containing piece of DNA with restriction en-
zymes and clone it on a plasmid. A piece about 420
nucleotides long was chosen, which was certain to
contain the attachment site. This piece was then in-
serted, by ligation, into plasmid PBR313 at a Barn
HindlIl site. Since the plasmid can be opened with these
two restriction enzymes, which are the same as those
used to define the attachment-site DNA piece, simple
annealing and ligation served to close the plasmid. The
plasmid was then grown up in the appropriate bacteria.
Subsequent restriction-enzyme analysis indicated that
the desired piece had been cloned. Now, how do we
know that this Barn Hindlll piece contains a functioning
attachment site? We are testing a variety of approaches
to answer this question. One that seems to show con-
siderable promise is infecting the plasmid-containing
strain with wild-type X. When this is done, it is found
that the number of X-immune survivors from a cloned
attachment-site strain is ten times fewer than from the
control. This result was expected, but unfortunately
there are a rather large variety of explanations. All,
however, involve the presence of a Xatt site on the
plasmid. For example, the plasmid could be competing
with the bacterial chromosome for X. Once the X inte-
grates into the plasmid, the now greatly enlarged plas-
mid is at such a disadvantage in replication that it will
soon be replaced by the much smaller non-X-containing
plasmids. This is an effective way of preventing the
development of the stable lysogen. Another possibility
is that the integration system of X integrates plasmids
carrying attachment sites into the host chromosome;
this is known to lead to the death of the host chromo-
some because of the extra replication origin in the
plasmid. This would also lower the number of surviving
immune cells. We appear to have the beginning of a
biological assay for the X attachment site, but consider-
ably more work is needed before this is completely
clarified.
Phage Mu
Another area in which our laboratory is working is the
somewhat enigmatic bacteriophage Mu. This phage in-
tegrates at random into the bacterial chromosome. Its
integration appears to be necessary for its replication,
and indeed the phage is always associated with bacte-
rial DNA, even in the virion state, having a little piece of
bacterial DNA at one end and a large piece at the other
end. One of the more bizarre features of Mu is the G
loop. This is a region of DNA which can invert, appar-
ently because of the presence of short inverted DNA
repetitions at each of its ends. The inversion, however,
occurs only upon induction of a lysogen, when the
phage particles produced have an approximately equal
mixture of G loops in each possible orientation. When
the phage is grown lytically, the G loops all point in one
particular orientation, called the G± orientation. By a
somewhat fortuitous means, we have been able to iso-
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late mutants that do not rotate their G loops; that is,
mutations seem to have occurred in a function, which
we call Gin-, which is responsible for G-loop rotation.
The function maps in the /3 region of Mu, and the
mutation producing the effect is a deletion which does
not overlap the G loop. All the Gin- phage mutants
initially obtained have their G loops pointing in the G+
direction and grow lytically, form lysogens, and insert
randomly into the chromosome in a manner very like
that of wild-type Mu. If a lysogen of a Gin- G+ Mu is
induced, the progeny phage particles all have their G
loops pointing in the G+ direction. The G loop can,
however, be rotated if a wild-type Mu phage is intro-
duced into the cell, for instance on an episome. The
episome, with its wild-type Mu, can be removed by
curing, and among the cured progeny are cells which
have apparently had the G loop rotated. When these are
induced, the cells lyse and liberate phage particles
which can be purified and visualized in cesium chloride
gradients but which themselves do not produce any
plaques. Analysis of the DNA from these noninfectious
particles shows them to have G loops all pointing in the
opposite direction, that is, the G- direction.
The repressor of Mu has been mapped at the extreme
left end of the phage by genetic means. In order to define
its exact physical position, we decided toclone a HindlIl
fragment, about 1000 base pairs long, which contains the
left end of Mu including the attached bacterial DNA.
Since the bacterial DNA end of this fragment is random
in sequence, it was not possible to clone it by ligation,
and so terminal transferase was used instead to add
poly(A) to the fragment and poly(T) to an EcoRI-
restricted PMB9 plasmid. From this, a series of PMB9
plasmids containing the left end of Mu were isolated.
Strains carrying these plasmids could be divided into
two major classes, one immune to Mu and the other
sensitive. Preliminary restriction-enzyme analysis i ndi-
cates that the ones that are immune contain a reasonably
large insertion into the PMB9 plasmid, consistent with
the hypothesis that most of the 1000-base-pair Hindlll
fragment has been cloned, whereas some of those that
are sensitive appear to contain less cloned DNA.
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Further analysis of those that were immune
showedthat they seem to overproduce the
repressor tremen-
dously. This is not unexpected since there
are perhaps
20 copies of the PMB9 plasmid in the cell whereas thereis generally only one copy of Mu in a normal lysogen.
Overproduction was demonstrated by the observation
that even virulent Mu did not form plaques
on the repres-
sor plasmid-containi ng strai ns. Th is indicatesthatthereis
no feedback control of Mu repressor on these plasmids.
The 20-fold excess of repressor should greatly facilitate
identification of its protein, which has so far not been
physically detected. Our initial attempts to find it ontwo-dimensional gels are still in progress and have notyielded a positive result. Another strategy which we arein the process of tryi ng is to al low the plasmid to segregate
into minicel Is. These have a very simple pattern of plas-
mid proteins and should greatly facilitate the identifica-
tion of the Mu repressor protein.
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INSERTION ELEMENTS AND PLASMIDS
A.I. BUKHARI, L. Ambrosio, F. DeBruijn, S. Froshauer, H. Khatoon, E. Ljungquist
For the last few years we have been trying to develop a
genetic and biochemical framework for analyzing the
insertion system of the temperate bacterial virus Mu.
This bacteriophage presents an extraordinary model for
studying integrative recombination. It inserts its DNA at
randomly distributed sites on the genome of its host
bacterium E. coli and has many properties strikingly
different from those of other temperate phages. Work
done by us during the past year has indicated that Mu
deviates from the classic Campbell model for X integra-
tion. This work has led to the proposal that the form of
DNA active in integrative recombination is generated
by the replication of Mu DNA. We think this type of
mechanism may be shared by transposable elements in
general. Thus Mu might represent a class of elements,
different from most temperate phages, in which replica-
tion of the inserting molecule is a necessary step in the
process of its integration.
Structure and packaging of the Mu genome
Experiments initiated during the previous year on the
structure of Mu DNA have now been completed and
have provided direct proof that both ends of mature Mu
DNA contain heterogeneous host sequences. The two
end fragments generated by endonucleases from Mu
DNA specifically hybridize to E. col/ DNA. All parts of
the E. coli chromosome are represented at the ends of
Mu DNA. The left end, called the c end, contains about
100 host base pairs, whereas the S end contains from
500 to 3200 host base pairs (mean length: 1500 base
pairs). The heterogeneous host sequences arise because
of headful packaging of DNA from maturation pre-
cursors in which Mu DNA is flanked by host sequences.
The packaging reaction apparently starts from the c end
and terminates at the S end when a headful is reached.
In collaboration with Louise Chow, we have shown that
insertion of Tn9 (a 2800-base-pair transposon carrying a
gene for chloramphenicol resistance) results in a loss of
host sequences as well as part of Mu DNA at the S end.
The insertions, however, do not affect the presence of
host sequences covalently linked to the c end. The
packaging proteins thus recognize a specific Mu se-
quence at the c end, but the DNA is cut to the left of the
recognition sequence.
Genetic studies on the Mu life cycle
Mode of heterogeneous circle formation
We have shown that when an Hfr E. coil strain contain-
ing a temperature-inducible Mu prophage is heat-
induced, F' episomes are generated. These F' episomes
carry markers adjacent to the integrated F factor and are
formed even if the Mu prophage is located away from
the F factor in the chromosome of the Hfr strain. Almost
all of these F' episomes have at least one copy of Mu.
The F' episomes apparently represent the circular DNA
molecules of varying sizes that can be detected during
the lytic cycle. Since each of the F' episomes generated
after Mu induction appears to carry a Mu prophage, it
can be inferred that integration of Mu is a necessary step
in the formation of heterogeneous circles.
Excision of the X mutants
We have previously described prophage Mu mutants
that can be excised from the host chromosome at a low
frequency (10 -3 to 10' per cell). Precise excision of the
prophage DNA can restore the activity of the gene into
which Mu was inserted. However, prophage excision
generally does not lead to restoration of the gene activ-
ity. Experiments with newly isolated Mu X mutants have
shown that for every precise excision, 10 to 100 impre-
cise excision events can be detected. Imprecise excision
frequently results in a deletion covering both sides of the
prophage. Some deletions are several hundred base
pairs long, but most are exceedingly small, covering less
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than 100 base pairs. Precise excision cannot be de-
tected in recA- host cells. Imprecise excision can be
seen in recA- cells but it occurs at a lower frequency
(by a factor of 2 to 10). Our working hypothesis is that
excision of the Mu X mutants involves two separate
steps: precise cutting of Mu DNA from the host chromo-
some and repair of the host chromosome. Mu-specific
functions are involved in recognition of the Mu-host
junction, and various host functions, including the recA
function, might be needed for repair of the chromo-
some. Deletions would occur because of degradation of
host DNA before it is fully resealed.
Biochemical studies on Mu integration
An important step in understanding the process of Mu
integration would be the elucidation of the form of Mu
DNA which inserts itself into the host chromosome. We
define this form as the integrative precursor. To examine
the Mu integrative precursor, we have studied the fate of
Mu DNA after infection of cells and the behavior of
prophage Mu DNA upon induction.
Inability of Mu DNA to become circular
We infected Mu-sensitive and Mu-immune (lysogenic)
cells with "P-labeled phages and examined the intracel-
lular forms of the labeled DNA at different times after
infection. No circular form of Mu DNA was detected by
sucrose gradient centrifugation, CsCIethidi urn
bromide density centrifugation, or restriction-
endonuclease cleavage analysis of the DNA. We have
reached the conclusion that Mu lacks an efficient
mechanism for fusing its ends to form circles. Most of
the infecting DNA remains in a linear form. A form of
Mu DNA moving twice as fast as linear DNA in neutral
sucrose gradients is seen upon infection of immune
cells. This form apparently represents a protein-DNA
complex which protects Mu DNA from degradation.
Failure of infecting DNA to be integrated
Not only does the infecting parental DNA not become
circular, it is not even integrated into host DNA. We
have separated Mu DNA from host DNA by elec-
trophoresis in 0.3% agarose gels. About 90% of the
"P-label remains in the phage DNA band as late as 40
minutes after infection. This is a highly intriguing result
since we know that integration of Mu DNA is a neces-
sary step in the growth cycle of Mu. This result implies
that Mu DNA first replicates and then the replication
products are used for integration into host DNA.
State of prophage DNA upon induction
We have examined the fate of prophage Mu DNA in
situ, at different sites on the host chromosome, after
induction. The prophage DNA was located with a
technique in which DNA of the lysogenic cells is
cleaved with a restriction endonuclease and fraction-
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ated on agarose gels. The DNA fragments
are denatured
on gels, transferred to nitrocellulose paper, and hybrid-ized with "P-labeled mature phage DNA.
The frag-
ments containing prophage DNA become
visible after
autoradiography. In experiments with X lysogens,
wecould readily monitor excision of X DNA. The phage-
host junction fragments disappeared after induction
andthe fragments containing the Xatt site appeared.
No such
excision could be seen with prophage Mu. The Mu-hostjunction fragments remained intact well into the lytic
cycle, when Mu DNA had undergone many rounds of
replication and many copies of Mu DNA had integrated
at different sites on the host chromosome. (As pointed
out above, Mu DNA is continuously integrated into the
host during the lytic cycle.) Figure 1 shows the
results of
results of a similar experiment in which a X lysogen and
a Mu lysogen were induced for a long time in the
presence of nalidixic acid, an inhibitor of DNA synthe-
sis. This figure emphasizes the difference between
the A
system and the Mu system-whereas X is excised
promptly after induction, no change in prophage Mu
DNA can be seen. These experiments thus show that Mu
DNA is not excised but replicates in situ after induction.
It should be noted that although a mechanism for the
excision of Mu DNA exists (i.e., excision of the X mu-
tants), induction of a prophage with subsequent integ-
ration of Mu DNA at different sites apparently does not
involve excision of prophage DNA. In the transposable
element systems also, the present evidence suggests that
transposition not require excision of the element.
The transposable element can be excised, but the ele-
ment is, in general, lost upon excision. Perhaps both Mu
and transposable elements undergo replication, giving
rise to copies which are integrated into host DNA. It is in
view of this mechanistic similarity that we have pro-
posed that Mu is a representative of transposable ele-
ments.
I he G segment of Mu
The G segment is an invertible 3-kilobase sequence of
Mu DNA. Mu particles grown by induction of a lysogen
have both G orientations (about 50% have the "flip"
orientation; the other 50% have the "flop" orientation).
Mu particles grown by infection almost always have the
"flip" orientation. The flip-flop process of G is an inter-
esting model for an on-and-off switch for gene expres-
sion. In collaboration with Louise Chow, we have
found that the G segment of Mu is homologous to the
invertible segment found in bacteriophage P1. We have
extensively analyzed homology between P1 and Mu by
DNA-DNA hybridization techniques. These experi-
ments have shown that endonuclease-generated frag-
ments from the G segment of Mu hybridize to the frag-
ments from the P1 invertible segments. These results
raise the possibility that P1 and Mu have acquired the G
sequence by transposition from another source. The
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Figure 1
Comparison of X and Mu systems. A X lysogen and a Mu lysogen, carrying temperature-inducible prophages, were
heat-induced in the presence of nalidixic acid. Samples were taken at different times (indicated in minutes) after
induction and the DNA was extracted. DNA from the X lysogen was digested with the exonuclease Bg1// and DNA from the
Mu lysogen was digested with Ball. The fragments were fractionated by electrophoresis on agarose gels, "blotted" onto
nitrocellulose paper, and hybridized to 32P- labeled X or Mu DNA. In X, the fragment containing the att site appears with
time, while the host-phage junction fragments disappear. In Mu, the host-phage junction fragments persist (Ljungquist
and Bukhari 1977a).
idea that G in Mu or in P1 may be a transposable
element (G in P1, as compared to G in Mu, has longer
inverted repetitious sequences at its ends) is being
tested.
Transposition elements
IS1 and Tn9
The X mutations in Mu are generally caused by the
insertion of IS1, an 800-base-pair transposition element
found in the chromosomes and plasmids of many pro-
karyotic organisms. Mu X mutants can also be generated
by the insertion of Tn9, a transposon carrying a gene for
chloramphenicol resistance. These insertions occur
near the c end of Mu DNA and cause the Mu prophage
to become defective. The Mu X mutants with IS1 inser-
tions and Tn9 insertions have also been studied by
electron microscopy in Dr. Chow's laboratory. Both IS1
and Tn9 have the same insertion sites in Mu DNA, and it
has now been shown that Tn9 contains one copy of IS1
at each end in direct repeats.
We have been able to study the Tn9 transposon both
genetically and biochemically by using the Mu X::Tn9
mutants. The Tn9 transposon can be precisely excised
from Mu DNA. However, the Tnq insertions in Mu fall
into two categories with respect to excision. One class
of Mu X::Tn9 mutants loses the Tn9 at a frequency of
10-3 to 10-5, whereas the other class reverts to Mu wild
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type at a frequency of about 10-7. Structural organiza-
tion of the Tn9 transposon in these mutants is being
examined. The Tn9 segment encoding chloram-
phenicol resistance can be purified by cleaving the
DNA molecules carrying Tn9 with the restriction en-
donuclease Ball (Ball cleaves the 151 element once).
Furthermore, EcoRl cleaves Tn9 approximately in the
middle. Thus Tn9 can be used, in vivo or in vitro, to
introduce an EcoRl cleavage site at a given position in a
DNA molecule.
151 in phage P1
We have discovered by DNA-DNA hybridization
techniques that bacteriophage P1 has two copies of IS1.
This finding has prompted us to explore further the
structural relationship between the genomes of Mu, P1,
and R plasmids.
DNA insertions meeting
The sudden emergence of insertion sequences as genet-
ic elements of fundamental interest was reflected at the
meeting on DNA insertions organized by the Cold
Spring Harbor Laboratory in May, 1976. It was the first
such meeting devoted specifically to a discussion of
insertion phenomena, and it brought together biologists
working in many different areas. The complete program
of this exciting meeting appears elsewhere in this an-
nual report. The Cold Spring Harbor Laboratory is pub-
lishing a comprehensive monograph based on the pa-
pers presented at the meeting.
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ELECTRON MICROSCOPY
T. R. BROKER, L. T. CHOW, J. M. Scott, J. N. Roberts
This has been a particularly active and productive year
for electron-microscopic analyses of the organization of
chromosomes from adenovirus 2, E. coli, and bac-
teriophages, Mu, lambda, P1, and 029. Descriptions of
those projects follow.
Adenovirus transcription map
Together with Jim Roberts, an undergraduate visiting
our lab for the summer, we used a recently developed
method, RNA-loop mapping, to refine the transcription
map of adenovirus 2. The map had previously been
determined by other techniques, including genetics,
restriction-endonuclease cleavage of the DNA, satura-
tion hybridization of RNA to DNA, and in vitro transla-
tion of RNA. Duplex adeno DNA, or restriction frag-
ments of it, was mixed with an equivalent amount of
RNA extracted from the cytoplasm of human KB cells at
either early or late times after infection. (The DNA was
provided by R.J. Roberts and the RNA was isolated by
J.B. Lewis.) The DNA-RNA mixture was adjusted to 70%
formamide and incubated at a temperature at which the
duplex DNA was largely denatured. Under these con-
ditions, RNA is still able to form stable hybrid duplexes
with complementary DNA sequences. When the solu-
tion was chilled, diluted, and prepared for electron-
microscopic examination, the partially melted DNA
paired again, except where RNA transcripts had hybrid-
ized. There, the homologous DNA strand remained
displaced as loops (Fig. 1). Thus the loops in each DNA
molecule indicated the precise coordinates of the
transcripts. About 1000 loops were analyzed in order
that we might determine the adenovirus transcription
map to 0.5% (200-base-pair) accuracy. Our results are
summarized in Figure 2.
Additional conclusions:
(1) Some early (e.g., 19K-11K) and some late (IVa2-
11X, hexon, and fiber) messages have very discrete sizes,
whereas others (e.g., in the penton region, the 100K
region, and the E15.5 region) have a limited hetero-
geneity in length at either or both the 5' and 3' ends. We
believe this reflects variability in endonucleolytic pro-
cessing of primary nuclear transcripts.
(2) Switch points where transcription changes from
one DNA strand to the other could be visualized. Loops
with RNA hybridized to the left portion of one limb of
the loop and the right portion of the other limb were
observed. The junction between RNA:DNA hybrid and
single-stranded DNA toward the middle of both limbs
revealed the position of the strand switch.
(3) The message for the fiber protein uniquely forms a
reproducible branch near its 3' end. This may result
from secondary structure within the RNA which restricts
it from pairing with the DNA.
Our attention in the future will be directed toward
those regions of the adenovirus chromosome with het-
erogeneous transcripts.
Visualization of covalent protein-DNA complexes
Covalent association of proteins with nucleic acids has
been reported in a diverse group of viral and plasmid
chromosomes. The most probable linkages are between
5'-terminal phosphoryl groups of the nucleic acid and
lysine or seri ne residues of the protein. Potential roles of
the proteins in DNA metabolism include protection of
termini from exonucleases and ligases, initiation of
strand displacement during replication, interaction with
the cell membrane during replication, and orientation
of the DNA during conjugation or during packaging into
the virion.
The proteins range in size from 7000 daltons to
70,000 daltons on various chromosomes. Direct visu-
alization of such small proteins by electron microscopy
is at best tedious and difficult and may not be certain
unless the presence and location of the proteins can be
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Figure 1
Adenovirus-2 DNA containing RNA loops formed by transcripts from the hexon, 100K protein, and fiber regions.
The branch atthe 3' end of the fiber message is reproducible. Collapsed molecules in the background are unhybridized RNA.
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Figure 2
Adenovirus transcript coordinates determined by electron microscopy of RNA loops on adenovirus-2 DNA. Arrows
iis
indicate the direction of transcription, which was determined by Sharp et al. [Cold Spring Harbor Symp. Quant. Biol.39:457 (1974)] and Philipson et al. [Cold Spring Harbor Symp. Quant. Biol. 39:447 (1974)]. Thin arrows show the positionsof early transcripts and thick arrows show the positions of late transcripts. Dashed lines indicate the positions ofinfrequently observed R loops. Vertical bars on arrows indicate preferential 5' termini. The cleavage sites of EcoR/ and Sallendonucleases are also represented.
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stablished in advance by other techniques. T. Broker
'nd L. Chow have recently developed a relatively easy,
efficient, and reliable method to detect and study
\rotein-nucleic acid complexes. It uses the standard
/lasic protein film technique rather than direct adsorp-
:on methods. The proteins are visualized with ferritin
,bets. The basis of our labeling technique is the ex-
.aordinary affinity of the egg-white protein avidin for
;.tamin H (biotin) characterized by a Kdiss of 10-16 M.
pis binding is a million times stronger than that of a
,.00d antibody-antigen complex. Avidin can be
)upled to ferritin (an electron-dense iron-storage pro-
:, in from spleen) in a variety of ways. Biotin is coupled
:.)amino groups of macromolecules via the reactive N-
4ydroxysuccinimide ester of biotin. Thus ferritin can be
t'-tached to macromolecules through an avidin-biotin
okage, a labeling scheme also devised independently
H. Heitzmann and F.M. Richards [Proc. Natl. Acad.
. USA 71:3537 (1974)]. Proteins bound covalently to
ucleic acids were derivatized with biotin and were
localized with (ferritin-biotin2,,:avid in),1-20
,,olymeric labels. We have refined our chemical de-
:vatization and labeling protocols to allow greater than
!IP% efficiency in attaching ferritin to the proteins at the
of adenovirus-2 (Fig. 3) and B. subtilis phage
>29 DNAs. We have confirmed that proteins are stably
nked to both ends of these chromosomes. Further-
:lore, these terminal proteins are present in and pre-
umably are responsible for the cyclized and con-
catemerized structures observed by electron micro-
scopy of isolated complexes. In control experiments,
the labels do not bind to single-stranded DNA or to
deproteinized double-stranded DNA. We shall use our
labeling techniques to identify other protein-nucleic
acid conjugates and to study in detail the formation and
structures of protein-DNA conjugates during DNA rep-
lication.
Chromosome structures of viable Mu mutants
A Mu lysogen established by Dietmar Kamp was found
by Chow to contain an unknown insertion of 2.6
kilobases (kb) in the Mu beta region. The insertion is
sufficiently long to force Mu chromosome deletions in
nonessential regions in order to package Mu DNA that
will be viable in the next round of infection. Indeed,
Regine Kahmann and Dietmar Kamp have isolated
seven independent, nondefective Mu mutant phages
from this lysogen. The sequence arrangements of the
mutant chromosomes were characterized by Chow
using EM heteroduplex methods. The DNA of each
mutant contains either a deletion or a substitution in the
G and/or beta regions. The regions deleted are thus
nonessential. The lengths of the bacterial DNA on the S
(or right) end of these mutants varied according to the
amount of DNA inserted or deleted from the Mu
genome. Therefore, the model of headful encapsidation
of Mu DNA from the c (or left) end proposed by A.I.
Bukhari and A.L. Taylor [Proc. Natl. Acad. Sci. USA
gure 3
'denovirus DNA dimer. The proteins at both termini and at the internal concatemer junction are labeled with
otin:avidin-ferritin conjugates.
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Figure 4
Heteroduplex between the G loop of renatured Mu DNA and the G segment of a single-strand restriction fragment of P7 ledDNA. The beta region and the split ends (SE) of Mu and the 0.62-kilobase stem formed from the inverted duplicationsflanking the P1 G segment are also indicated in the schematic representation.
44
2:4399 (1975)] was strongly supported. We have also
Kalized at least part of the Mu G inversion system (gin)
)the left portion of the beta region, for deletions there
ireyent inversion. All mutants have their G sequence in
he lytic orientation regardless of whether or not the G
egment is intact. No deletions have been observed
vithin the left 2000 bases of the G sequence in the lytic
orientation. Thus essential functions may be encoded
iere. Finally, our preliminary results indicate that Mu
ihages with the G loop fixed in the nonlytic orientation
re not viable.
iomology between bacteriophage P1 and Mu DNAs
:how has shown, by electron-microscopic studies, that
'he G sequence of phage Mu DNA, an invertible region
)kb in length near theS end, is identical to the invertible
.egion found in phage P1 DNA. The first indication of
heir relatedness came with the observation that they
lave the same pattern of secondary structure. Their
homology was confirmed by the formation of perfect
heteroduplex pairing between the P1 and Mu G se-
quences (Fig. 4). Since the P1 and Mu are quite different
phages in most respects, and no other sequence homol-
ogy has been found between their DNAs, the G se-
quence has probably moved from one phage to another
by translocation.
Identification of insertion sequence 1 (IS1)
in Mu X and Mu Xcam
In last year's report, Chow presented a preliminary re-
port on the characterization of DNAs from Mu mutants,
Mu Acam. Briefly, Mu Xcam DNAs have a transposa-
ble chloramphenicol resistance element of 2.8-kb pairs
near the c end. The observation of the complete loss of
their split-end bacterial DNA in the Mu Xcam mutants
further supports the headful packaging model of Bu-
khari and Taylor.
This year Chow has continued to characterize the
Mu -X and Mu Xcam mutant DNAs. Mu -X mutant had
been shown by Bukhari and Taylor to have a 0.8-kb
insertion near the c end of the Mu genome [Proc. Natl.
Acad. Sci. USA 72:4399 (1975)]. Chow has found, by
electron-microscopic-heteroduplex studies, that the in-
sertion in Mu X is an 151 sequence, and that the cam
insertion in the Mu Xcam consists of the chloram-
phenicol resistance marker flanked by two IS1 elements
in direct order. This is the same as the structure of the
Cam transposon in phage lambda cam, determined by
L.A. MacHattie and J.B. Jackowski [in DNA Insertion
Elements, Plasmids, and Episomes (ed. A.I. Bukhari et
31.), Cold Spring Harbor Laboratory, Cold Spring Har-
)or, New York (in press)).
nverted sequences in the E. coli chromosome
:how has studied the arrangements of insertion se-
tuences in the E. coli chromosome. These elements can
the sites of recombination of bacterial chromosomes
and episomes such as the fertility factor and drug resis-
tance determinants. Some of the approximately seven
different insertion sequences also modulate RNA
transcription. Total E. coli DNA was denatured, rean-
nealed, and observed by electron microscopy. The
single-strand DNA lengths ranged from about 50 to 150
kb. In some molecules, a short duplex region with a
single-stranded fork at each end was observed. The
duplex lengths were 0.75 kb, 1.30 kb, 5.22 kb, and 5.62
kb, which correspond to those of IS1 and of IS2, IS3, or
IS4 of the ribosomal RNA genes and of the y8 sequence,
respectively. Duplexes of 1.0 kb and 0.5 kb were also
found. Most of the duplexes of lengths 0.5 kb, 0.75 kb, 1
kb, and 1.3 kb were observed as intramolecular stem-
loop structures and were therefore interpreted to be
sequence duplications in inverted order on the same
DNA strand. Surprisingly, the separation of the putative
inverted insertion sequences was often around 22 and
27.5 ± 1.5 kb. About 18% of the E. coli chromosome is
estimated to be involved in the sequence arrangements
that give rise to stem-loop structures upon denaturation
and reannealing. Continuing studies will attempt to lo-
cate some of the inverted duplications with respect to
bacterial markers and to determine whether the unusual
arrangement of large blocks of the bacterial chromo-
some has a function.
Underwound heteroduplex loops can indicate
inverted duplications
Broker and Chow have identified and characterized a
new heteroduplex structure. DNA that contains in-
verted duplications of at least 20 base pairs separated by
noninverted sequences of at least 600 base pairs can
form characteristic "underwound loops" when it is de-
natured and reannealed. An underwound loop is a par-
tially duplex, partially denatured circle between the
inverted duplications and is produced as follows: Dur-
ing the early stages of the reannealing, intrastrand stem-
loop structures form with first-order kinetics when the
inverted duplications pair. In a slower, second-order
reaction, complementary strands (each with a stem
loop) pair. The stem-loop structures may be retained to
produce a cruciform. The cruciform can isomerize to a
linear duplex by double-strand exchange with coordi-
nated axial rotation of the four duplex arms. In this
process, the loops rotate in opposite directions with
respect to one another. But if the loops start to pair with
one another, axial rotation is prevented and the stem-
loop structures are trapped. However, there can be no
net interwinding of the strands of separate, closed rings.
As a result, the loops observed by electron microscopy
have variable patterns of single-stranded denaturation
bubbles and duplex segments with both right-handed
and left-handed winding, and they may also have a few
tertiary twists.
Wehave used underwound loops to identify a short
inverted duplication flanking the y5 recombination se-
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quence of E. coli F factor (isolated on 080 d :3 ilv+ trans-
ducing phage by Larry Soll) and to study the G segments
of DNA from phages Mu and P1, which are flanked by
inverted duplications. When deproteinized adenovi-
rus-2 DNA is denatured and reannealed, some under -
wound circles, the length of the entire chromosome, are
observed by EM. These result from the restricted in-
teraction of complementary single-strand rings gener-
ated when pairing of the short inverted terminal dupli-
cations closes the ends of single strands. Another type of
underwound loop is seen in heteroduplexes containing
complementary insertion loops located at different po-
sitions in the hybridized strands, such as occur with P1
cam DNAs. All these underwound structures are similar
in appearance to the hybrids formed when topologically
separate, complementary single-strand circles of Col-
icin E1 DNA are allowed to anneal.
Recombination of the bacterial y5 sequence
On the basis of our discovery that the y5 sequence is
flanked by inverted duplications, Broker has developed
a recombination model to explain their function. Unlike
the Mu and P1 G loops, which also have flanking in-
verted duplications, inversion of the y5 sequence has
not been observed. Recombination generally requires
two complete copies of y5. Despite the presence of the
inverted sequences, recombination can occur with only
one orientation. Synapse must therefore include pairing
of the internal y5 sequences. The model postulates that
crossover initiates at a single-strand nick at one end of
the y8 sequence, continues with double-strand ex-
change through the entire y5 segment, and terminates
5700 base pairs away at a nick in the flanking duplica-
tion at the other end.
Modifications of the Philips 201 electron microscope
An audible alarm system was designed and installed by
John Scott to minimize the possibility that the specimen
holder of a Philips 201 or Philips 301 electron micro-
scope may be left accidentally in the airlock prepump
position. The modification is simple, inexpensive, and
readily performed by laboratory electronics personnel.
It can prevent contamination of the microscope column
with oil vapor backstreaming from the mechanical vac-
uum pump.
Scott and Broker adapted a simple closed-circuit
television (CCTV) system for use with a Philips EM 201
transmission electron microscope. A similar video sys-
tem was previously developed at Cold Spring Harbor by
G. Albrecht-Buehler and B. DeTroy for light micro-
scopy. The system can be assembled at a modest cost of
approximately $1200. The television display has been
particularly valuable for the summer courses using
electron microscopy and for other demonstrations to
large groups.
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NUCLEIC ACID CHEMISTRY
R. J. ROBERTS, J. Bonventre, B. Doretsky,
S. A. Endow, R. E. Gel i nas, T. R. Gingeras, M. Moschitta, P. A. Myers, M.
Zabeau, S. Zain
New restriction endonucleases
The search for new restriction endonucleases con-
tinues, and nearly 100 such enzymes are now known,
showing more than 50 different specificities. Among the
endonucleases isolated recently, Xbal (from Xantho-
monas badrii) seems useful for mapping as it makes
relatively few cuts on most DNAs examined. It has
proved particularly useful during the mapping of her-
pesvirus DNA. The endonucleases Bbyl (from Bacillus
brevis),Pfa I (from Pseudomonas facilis), Hin 1 0561 (from
Haemophilus influenzae 1056), and SacIll (from Strep-
tornyces achromogenes) make many cuts on most
DNAs and should prove useful for DNA sequence anal-
ysis. Recognition sequences have been deduced for
Bglll (FJGATCT) from Bacillus globiggi, Xmal
(C4'CCGGG) from Xanthomonas malvacearum, and
Mbol ( GATC) from Moraxella bovis.
Mapping
The Ball, Xbal, and Bg111 maps of the adenovirus-2
genome are now complete and have been related to
maps previously derived for six other restriction en-
don ucleases.
Mapping of SV40 has also been continued, and the
sites for the single-hit enzymes Kpnl, Taql, Uba I, and
Bgll have been located. In addition, maps for Pstl (two
cuts) and Hphl (five cuts) have been obtained. The site at
which Bgll cleaves the SV40 genome is of particular
interest. It cleaves the sequence
5'-G-G-C-C-G-A-G-G-C-G-G-C-C-T-IC-G-G-C-C-3'
at the positions indicated by the arrows to generate a
linear molecule containing 9-nucleotide 3' single-
stranded extensions. The center of this 9-nucleotide
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Ise
stretch is also the center of a 27-nucleotide palindrome
which has been suggested as the origin of replication inSV40. The mode of cleavage by Bgll is
unusual, and the
precise sequence recognized by this enzyme cannot be
deduced from this single site.
Integration site sequenced
,od
The nondefective hybrid virus Ad2±N D1 is a recombi
nant between adenovirus 2 and SV40 in which a sec lc.
tion of the SV40 genome replaces a nonessential sectiood
of the Ad2 genome. A restriction-endonuclease fragio
ment containing one of the junctions between Ad2 anc
SV40 sequences had been identified earlier and anothe
fragment containing the corresponding sequences froniO°
the parental Ad2 genome had also been identified. Th(
sequences of both these fragments have now been de!
termined and compared with the corresponding se-
quences from the parental SV40 DNA, determined by
Zain and Weissman. No obvious homology exists be-
tween the parental SV40 and Ad2 DNAs within 30
nucleotides of the site at which the recombination event
took place. This finding suggests (a) that recombination
in these viral systems does not depend on the presence
of homologous sequences within the parent molecules,
and (b) that the selection of the recombination sites on
both SV40 and Ad2 was determined by some feature
other than DNA sequence homology. The Ad2 DNA
sequence immediately adjacent to this recombination .luite
site should prove of great interest. The 5' end of the,,00t
messenger RNA for fiber, one of the major structural mists
proteins of the Ad2 capsid, appears to map within this
region of the Ad2 genome. From companion studies on
the 5' ends of Ad2 mRNAs, the sequence present at the
5' end of the fiber mRNA should soon be available, and
it will then be possible to locate it within the DNA
sequence adjacent to this integration site.
1(
4denovirus-2 mRNA
new and general method has been developed for the
solation of oligonucleotides containing the 5 '-termi nal
equences of eukaryotic mRNA. The method depends
ipon the presence of a 7-methylguanosine residue at-
ached by a 5'-5'-triphosphate linkage to the 5'-ter-
iinal nucleotide of the messenger RNA (the "capped"
:ructure). Since this nucleotide is linked through a
'-phosphate group, it contains a 2'-3'-cis-diol struc-
ire, and oligonucleotides containing such a structure
an be purified using an affinity column of dihydroxy-
oryl cellulose. When the method is applied to RNase
oligonucleotides derived from Ad2 mRNAs iso-
ed late after infection, a single oligonucleotide has
_een isolated. This oligonucleotide, m7G5"ppp'
l'AmCmU[C_,UGp, appears to be the only "capped"
gonucleotide found at the 5' end of all late Ad2
NAs. It is present on different size classes of RNA and
also present on RNA selected by hybridization to
li erent fragments of the Ad2 genome. Furthermore, it
o ifferent from the 5'- terminal RNase T, oligonucleo-
e obtained from Ad2 mRNA isolated early during
ection. Experiments are in progress (a) to determine if
e homology among the various mRNAs extends be-
)nd these first 10 nucleotides, (b) to determine at what
)ints on the adenovirus-2 genome this structure is
,Yoded, and (c) to assess the significance of this particular
latucture (e.g., is it part of some signal for the control of
560te transcription?).
Oi.rminal structure of the adenovirus-2 genome
odetails of the structure and the nucleic acid sequence
the ends of the Ad2 genome become clearer, their
onction remains enigmatic. Direct confirmation of the
,dspected covalent linkage between the terminal pro-
n and the ends of the DNA has now been obtained by
ed isolation and characterization of covalently linked
gonucleotide-oligopeptides. The nature of the bond
tween the terminal protein and the 5' ends of the
A has not yet been elucidated, and the significance
,fthis covalent linkage is unknown.
Another interesting feature of the termini is that upon
eatment with exonuclease III, the resulting 5' strand at
ach end is capable of secondary-structure formation.
his has been observed by electron microscopy and
wolves nucleotides within the inverted terminal repeti-
on; however, the exact nature of the secondary struc-
Jre is unclear. Much of the DNA sequence of this
.gion is now available, and several possible secondary
io
structures can be drawn. Further experiments are in
progress to clarify the remaining doubts in the sequence
and hence allow the derivation of the most stable sec-
ondary structure.
A model for the initiation of DNA replication has
been proposed which invokes this capacity for
secondary-structure formation and suggests a mecha-
nism by which the terminal protein becomes covalently
bound to the DNA. Several predictions of this model are
now being tested experimentally.
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EUKARYOTIC GENE REGULATION
T. MANIATIS, D. Goldberg, L. Villa Komaroff, E. Lacy, G. K. Sim
Molecular cloning of eukaryotic genes
This year we have continued efforts to develop an ap-
proach for isolating eukaryotic structural genes and the
DNA sequences which flank them. The goal of this
work, which is being carried out in collaboration with
Argiris Efstratiadis and Fotis Kafatos at Harvard Univer-
sity, is to understand the structure of eukaryotic genes
and the mechanism by which their expression is con-
trolled.
The approach we have chosen involves the in vitro
synthesis of full-length, double-stranded DNA copies of
mRNA using the sequential enzymatic activities of AMV
reverse transcriptase, DNA polymerase I, and S1 nucle-
ase. The synthetic duplex DNA is then purified by
polyacrylamide gel electrophoresis, joined to a bacte-
rial plasmid, and amplified using molecular cloning
techniques. Thus it is possible to obtain large amounts of
eukaryotic gene sequences which can be studied di-
rectly or used as specific hybridization probes for iden-
tifying and isolating flanking sequences in chromo-
somal DNA.
One chimeric plasmid (p0G-1) constructed in this
manner carries a synthetic DNA copy of rabbit 0-globin
mRNA and has been characterized in detail (see Fig. 1).
Last year an in-depth analysis of the globin insertion in
p/3G -1 was undertaken to show that the sequence is a
faithful copy of the mRNA and that no sequence re-
arrangements occurred during the cloning or propaga-
tion of the chimeric plasmid DNA in E. coil. This year
we have extended this characterization in order to ad-
dress the question of the validity of using recombinant
DNA techniques to determine the primary structure of
eukaryotic mRNA. Taking advantage of the detailed
restriction map of the insertion derived by Gek Kee Sim
and using the rapid DNA sequencing method of Maxam
and Gilbert, the nucleotide sequence of the entire
/3- globin insertion in p/3G -1 was derived (see Fig. 2). The
50
sequence is in complete agreement with previously re-
ported partial mRNA sequencing data and with thE'i
predictions from the primary structure of the protein,:
Moreover, the globin DNA insertion is missing only 11 ,
nucleotides corresponding to the 5'-terminal sequence,'`
of the mRNA. The rabbit /3- globin mRNA consists of att.
coding region of 438 nucleotides, flanked by a 5' noniy,1
coding region of 57 nucleotides (including the initiation. I
codon AUG but excluding the 7-methylguanine of the'',
"cap structure") and by a 3' noncoding region of 95#
nucleotides (including a UGA termination codon). ThE,
faithful representation of 13-globin mRNA in p/3G -1 es-1
tablishes th'e validity of using cloned DNA, initially'
derived from double-stranded DNA transcripts oi
mRNA, for studying the structure of eukaryotic struc-ol
tural genes.
To guide the development of procedures for isolating)
DNA sequences which flank the /3- globin gene, we are!
mapping the position of restriction-endonuclease
cleavage sites located at either side of the gene in rabbitq
chromosomal DNA. We are using the procedure ern-
ployed by Botchan, Topp, and Sambrook [Cell 9:269r,
(1976)] to study the structure of integrated SV404,
genomes. In this procedure, chromosomal DNA is di
gested with a restriction enzyme,
yintE
Gek Kee Sim and Lydia Villa Komaroff are studying the'.'z'
frac-
tionated by agarose gel electrophoresis and transferred,;,
MoI. Biol. 98:503(1976)], and the filters are hybridizedirei
to in-vitro-labeled DNA. By constructing plasmids4e
to nitrocellulose paper by the method of Southern [I.
end of globin mRNA, it is possible tc locate restriction,
which carry sequences from either the 5' end or the 3'7tii
the products are
lob
espo
organization of developmentally regulated genes in theqd.
silk moth, Antherea polyphemus. During the terminalsby
sites at either end of the gene.
Chorion genes
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io)p) Restriction map of the P- globin DNA insertion of pgG-1. The wavy lines indicate the dA-dT sequences at each endthe globin DNA insertion. The hatched bar represents plasmid pMB-9 DNA. PL and PR: pMB-9 restriction fragmentsf7erated by the combined digestion with the enzymes EcoRl and Hha. GL and GR: pgG-1 DNA restriction fragments0:responding to PL and PR, respectively. The orientation of the globin insertion and the distribution of the coding andr-icoding globin sequences are also shown. The numbers of base pairs between restriction sites are indicated.printed, with permission, from Maniatis et al., Cell8:163 (1976).]
Bottom) Localization of the globin insertion in p0G-1 using the R-loop displacement method. The plasmidp0G-1 wasi'arized by digestion with the restriction enzyme Hindlll and mixed with globin mRNA under partially denaturingellclitions which result in the formation of an mRNA-DNA duplex and the displacement of the complementary DNAile)nd. The arrow indicates the position of the double-stranded globin RNA-DNA duplex. The electron micrograph wasle'n by Tom Broker and Louise Chow of Cold Spring Harbor Laboratory. Magnification: 160,000x.
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Figure 2
The primary structure of /3- globin mRNA. The numbers below the sequence indicate the positions of the nucleotides, numbered,
by reference to the first nucleotide in the codon for the N-terminal valine (position 1). The amino acid sequence of /3-globin and
the RNA sequence predicted by the genetic code are listed above the derived sequence. Restriction-endonuclease recognition4,0
sites are underlined; also shown are the 5' and 3' untranslated regions, with the AUG and UGA initiation and terminationcodons!(n
enclosed by solid lines. Within the 3' untranslated region, a single potential initiation AUG and two contiguous potential UAAhdis,
terminators, all in phase with the globin UGA terminator, are enclosed in dashed lines. hdE
'ery
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stages of oogenesis in this animal, an egg shell (chorion)
consisting of approximately 50 structural proteins is
synthesized and assembled. This process occurs in dis-
r tinct, identifiable stages (see Fig. 3), and the large
number and size of the eggs in each female provide the
opportunity for biochemical analysis of each stage. In
particular, it is possible to isolate chorion mRNAs from
$1 each stage. In order to study the temporal expression of
specific chorion genes, we have synthesized and cloned
double-stranded DNA copies of the mRNA for use as
hybridization probes. On the basis of restriction-
endonuclease cleavage analysis, heteroduplex analysis,
and nucleic acid hybridization experiments, approxi-
mately 20 different chorion gene plasmids have been
identified. We are presently trying to classify each of
these gene sequences on the basis of its ability to hybrid-
ize developmental-stage-specific chorion mRNA. In
addition, sheared chromosomal DNA has been cloned,
and the colonies are being screened for chorion se-
quences using in-vitro-labeled chorion mRNA.
Chimeric plasmids containing chorion sequences can
then be assigned to a specific stage in development by
hybridization to the previously staged cDNA clones.
We anticipate that a detailed analysis of these chorion-
specific chromosomal insertions will reveal interesting
features of the sequences that flank coordinately ex-
pressed genes.
SV40 chromatin
As a means of establishing conditions for the in vitro
transcription of eukaryotic genes, Liz Lacy and Walter
Keller have been studying the in vitro transcription of
-,?1 SV40 mini chromosomes by the endogeneous RNA
polymerase activities associated with isolated SV40
chromatin. In addition, the transcripts made by exoge-
nous RNA polymerases isolated from E. coli or from
human cells is being studied. Although specific tran-
scripts have not been observed using exogenous
polymerases, specific "late" SV40 transcripts have been
observed with nuclear extracts or purified minichromo-
somes isolated from SV40-infected cells late in infec-
tion. We are presently using these extracts in an attempt
to establish conditions for the specific in vitro initiation
of SV40 transcription.
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Figure 3
'A silk moth ovariole. One of the eight strings of eggs carried by each female silk moth is shown. The anterior (youngest)
end is at the lower right and the posterior (oldest) end is at the upper left. A cellular cord connects the developing eggs(follicles) in a linear array. The choriogenic follicles in the upper row are separated in time by approximately 3-4 hours.
Ninety percent of all protein synthesis in these cells is devoted to the production of the chorion.
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CELL BIOLOGY
G. ALBRECHT-BUEHLER, K. Burridge, A. Bushnell, S. Chait, L. B. Chen, W. Gordon, R. Gudor, L. Jordan, R
Lancaster
Since the majority of the scientists at the Cold Spring
Harbor Laboratory work on tumor viruses and tumor-
virus-related topics, the Cell Biology section was estab-
lished about a year ago to provide the cell-biological
basis for and to interact with the tumor-related research
at the Laboratory. Our predominant research topics are
the primary functions of animal cells, such as cell motil-
ity, structure and composition of the cell surface, and
means of cell-cell communication. Not only does the
understanding of such fundamental aspects of animal
cells seem mandatory from a general biological point of
view, it would seem in particular to be a prerequisite for
the understanding of tumor formation and metastasis in
animals and humans.
Last year's annual report of our group concentrated
on two aspects of animal cells. One aspect was the
motility of the surface protrusions and their biological
function. Since the time of that report, we have found a
convenient way of quantitating the motile actions of
surface protrusions in large numbers of cells and estab-
lished some of the basic parametric dependencies of
these actions. The method immediately suggested a way
also to quantitate cellular locomotion. One of the first
applications of this method suggested a rather funda-
mental relationship between daughter cells in an estab-
lished cell line-in contrast with the tacit assumption of
biologists that those daughter cells are identical twins,
they seem to be mirror images of each other.
Another aspect of last year's report was the localiza-
tion by indirect immunofluorescence of structural pro-
teins of muscle in nonmuscle cells. Elias Lazarides, the
protagonist of the application of indirect immunofluo-
rescence to non muscle cells at Cold Spring Harbor, left
for Boulder, Colorado, in the fall of 1975 to work as a
postdoctoral fellow in Keith Porter's laboratory. Bill
Gordon succeeded him in position and interest; he has
added various new aspects to the localization studies
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and is now working on promising ways to localized
cellular antigens on the electron-microscopic level.
During the past year, Keith Burridge developed
.a:1
valuable research tool both for our group and for others:
Using this method, it is now possible to further analyzerg
and identify cellular glycoproteins as to their antigenic;
1i
character and sugar composition after they have already
art
been separated on gels. This method promises to allow,rsl
rapid determination of changes in the glycoproteinm
composition of cells following transformation and dif-,o
ferentiation. T\
With the arrival of Lan Bo Chen from the Mas-i6
sachusetts Institute of Technology, a new and very excit-4
ing aspect of cell-surface structure was introduced intq4
our group's efforts to understand primary functions otoic
animal cells. Lan Bo Chen's major object of research is(1
the so-called large, external, transformation -sensitive
(LETS) protein. Its intriguing nonhomogeneous distribu .4
tion on cell surfaces and the fact that it eventually form As
three-dimensional networks connecting all cells of 4J11
normal fibroblast culture may lead to a new understand -iii,
ing of cell surfaces. During the last year, Lan Bo founc.(ys
that this protein originates from cell-cell contact area44
and that its distribution changes drastically durinqopi
myogenesis. Furthermore, in collaboration with Jameirm
McDougall of the Mammalian Cytogenetics Section, hE
found an inverse correlation between tumorigenicit 1ii
and the expression of this protein on the cell surface. ;al
The past year was a period of consolidation of th(r-1
group and exploration of the potential of the metho&alic
which we developed. We are now confident that ou je
approaches, the studies of cell movements, of intracel cofi
lular contractile elements, and of the structure an011
function of the major surface glycoproteins, form ichi
promising basis for our future joint efforts toward a morids.
fundamental understanding of normal and transformel s
animal cell behavior. ite(
A quantitative description of the extension and
retraction of surface protrusions in spreading 3T3
mouse fibroblasts
Small particles placed on a cell substrate can be picked
up by cells and transported to the perinuclear region.
We found that gold particles 0.2-0.4 pm in diameter
coat a glass coverslip very densely and evenly. If sus-
pended cells are plated on such a coated substrate, the
particles are removed around 80-90% of the cells
within 30-60 minutes. Easily identifiable rings can be
seen which have twice the diameter of the cell bodies,
with most of the cells still spherical. Live-cell studies
confirmed the conclusion suggested by this observa-
tion: The cells extend projections which reach as far as
the perimeter of the rings, attach to the loose particles,
- and transport them to the cell body either by a cen-
tripetal flow mechanism or by retraction as a whole
together with the particle.
Making use of this phenomenon under standardized
and experimentally controlled conditions, one can
readily quantitate the capacity of cell projections to
perform extensions followed by retraction by determin-
ing the percentage of cells that produce particle-free
rings.
Studying 3T3 cells with this assay, we found that the
presence of Na+, K+, CI-, and Mg++ or Ca++ in a neutral
or slightly alkaline phosphate or bicarbonate buffered
solution is sufficient to support the optimal particle re-
dii moval by the cells for at least 50 minutes.
Two metabolic inhibitors, 2,4-dinitrophenol and
Na-azide, inhibit the particle removal. If D-glucose is
«it- added along with the inhibitors, particle removal can be
into restored, whereas the addition of three glucose analogs
sal which are generally believed to be nonmetabolizable
:his cannot restore the activity.
iiiE Serum is not required for the mechanism(s) of the
;bu- motile actions of surface protrusions in spreading 3T3
os cells. However, it contains components which can
010 neutralize the inhibitory actions of bovine serum albu-
01- min and several amino acids, particularly L-cystine or
)uoc L-cystein and L-methionine. Furthermore, serum
iteg codetermines which of the major surface extensions,
filopodia, lamellipodia, or lobopodia, is predominantly
ate= active.
11,A quantitative description of cellular displacements
ce.
So far, time-lapse cinematography, followed by a very
otime-consuming frame-by-frame analysis, and the mi-
:oration of cells from a confluent sheet into a "wound"
have been the only ways to study quantitatively cellular
301 locomotion in culture. The use of gold-particle-coated
06substrates offers a new and more convenient way to
study and quantitate the total displacements of single
0 As mentioned above, if freshly suspended cells are
'' 'plated on top of a gold-particle-coated coverslip, they
lit
di
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tei
produce various surface protrusions and remove the
particles within a ring around each cell during the first
hour. Within the following 10 hours, the cells begin to
locomote while cleaning more particles out of their
way. The particles become partly internalized; partly
the cells accumulate them on their backs in big clumps
which are pinched off once in a while and can be found
floating in the medium.
In order to distinguish locomotion on plain surfaces
from this combination of phagocytosis and cellular dis-
placement, we suggest the use of the term "phagokine-
tics." The particle-free tracks (phagokinetic tracks) can
be visualized conveniently in dark-field illumination as
black lines (Fig. 1).
Figure 1
Phagokinetic tracks of mitotic 3T3 cells (48-72 hr after plating
in culture medium with 10% or 20% calf serum) suggesting
mirror-symmetric directional changes of the cells even after
spatial separation. Locations of the cells are indicated by ar-
rows. Second-generation cells are shown in panel B.
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We examined various different cell lines in this assay
and found quite different track patterns. The tracks can
be used for rapid quantitative screening of the extracel-
lular parameters which are required for cellular dis-
placements. At first, however, we concentrated on a
rather startling aspect of animal cell structure and
movement which was an immediate result of the study
of phagokinetic tracks.
The mirror symmetry of daughter 3T3 cells
Branching isolated tracks with the cells located at the
ends of the branches indicate mitosis and subsequent
Figure 2
s
bet
the
oilit
'ema
ter
Actin patterns of daughter 3T3 cells in phagokinetic tracks (symmetry relationships between daughter cells after spatial
separation). The insets show the tracks formed by the same cells, which are shown in indirect immunofluorescence. Bar in inset "heti
a-b indicates 250 gm; bar in panel c indicates 20 ,um. With the exception of the cell in panel b, which was rotated by 180°, the ouo
cells in the fluorescence micrographs are shown in the same orientation as in the insets. The numbers around the cells' peripherie, ,re,c
indicate shape characteristics which we suggest correlate in the daughter cells. They are also to help the reader to follow
corresponding fluorescent bundles inside the cells. Our interpretation as to the symmetry is as follows. (a,b): symmetrical
patterns; (c,d): identical patterns in elongated cel/;(e,f): identical patterns. one
or d
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6eparate movement of both daughter cells (Fig. 1). At
more than 48 hours after plating of the cells, we found
branching tracks with further branching at each end
,Fig. 1 B), showing the four descendents of the cell which
started the track. The observed simultaneous occur-
.ence of all four second-generation cells suggests that in
:ells which do not collide with or cross the tracks of
) thers, the length of the cell cycle is the same in both
laughter cells.
More startling, however, was that 40% of such
tracks showed mirror symmetry in the sense that one
daughter cell made directional changes opposite to the
-Aber at approximately the same positions of their re-
; Tective tracks. Fourteen percent of the tracks were
ientical in the sense that both daughter cells made the
Tie directional changes relative to their direction of
Nement (Fig. 1). The remaining 47% could not be
etermined because the branches either showed no
iirectional change or were overly distorted.
As to the split angle between the branches, we found
he two ranges 80°-120° and 80°-180°. About two-
birds of the observed angles were between 80° and
120°.
The branching tracks of mitotic cells allow an easy
dentification of daughter cells, even after spatial sep-
aration. Therefore, we examined the actin patterns of
laughter pairs in indirect immunofluorescence after
hey had formed branching phagokinetic tracks. We
ound a strong resemblance in the complex bundle
)atterns and shape characteristics of the daughter cells,
is shown in Figure 2. This finding suggests that these
patterns are likely to be predetermined by the parental
:ell.
As to the symmetry relationships between the pat-
erns, out of 42 daughter-cell pairs examined we found
34% symmetrical (Fig. 2a, b), 24% identical (Fig. 2c, d,
0, and 42% unrelated actin-bundle patterns.
We consistently found about twice as many cases of
mirror symmetry as of identity among the examined
patterns and tracks. Therefore if any of the two relation -
;hips between daughter cells holds in general, it is more
'ikely the symmetry. The additional occurrence of iden-
ity and unrelatedness is not surprising, considering the
Possibility that a daughter cell can be rotated to various
degrees during cleavage.
It remains to be seen whether the symmetry between
he actin patterns and the directional changes of two
laughter 3T3 cells reveals a fundamental consequence
,)f the spindle formation during mitosis of animal cells,
Oa; nd whether it presents the cellular basis for the univer-
she(
ally found bilateral symmetry of organisms. As to the
-ccurrence of split angles around both 90° and 180°,
llow,ine may suspect that mitotic cells are programmed to
rical hove one of the daughter cells vertically out of a cell
ayer or a string of cells.
Localization of contractile elements in nonmuscle cells
Studies described in last year's annual report on actin,
myosin, and a-actinin localization in a variety of cell
types have continued. Antibodies to these three proteins
have been made and rigorously characterized by im-
munochemical tests. Myosin has been the main interest
Figures 3-5
Indirect immunofluorescent localization of myosin in cells
fixed normally or pretreated with contraction or rigor buffers
containing Triton X-100 for various times prior to fixation. Bar
= 10 gm.
Fig. 3: Rat-embryo fibroblast, myosin.
Fig. 4: Human skin fibroblast, rigor, 2 min, actin.
Fig. 5: Human skin fibroblast, contraction, 30 sec, myosin.
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because it carries the enzymatic activity of the ac-
tomyosin system and was the least well described pro-
tein in previous studies. The observations of Weber and
Groschel-Stewart [Proc. Natl. Acad. Sci. USA 71:4561
(1974)] have been reconfirmed in our finding that
myosin is localized periodically along stress fibers every
1.5 However, we have shown that myosin is also
localized between stress fibers in "sheets" of periodici-
ty. This arrangement is particularly common at the ends
of stress fibers, where they appear to splay out into
smaller units. Myosin has also been localized in the
polygonal network pattern of rat-embryo cells (see Fig.
3). It is like tropomyosin in that it is absent from the
vertices, occurring only between them.
The localization studies have given a static image of
the distribution, with only a few hints of the dynamics
that must occur in vivo with force production. "Con -
tracti le models" of muscle fibers, that is, fibers that have
been completely permeabilized by glycerol or deter-
gent treatment, provided a major step forward in the
study of muscle physiology [for review, see N.I. Arronet,
Motile Muscle and Cell Models (Consultants' Bureau,
New York, 1973)] in that they allowed the use of defined
buffers to determine the exact ionic conditions for con-
traction, relaxation, and rigor. Hoffmann-Berling
[Naturwissenschaften 50:256 (1963)] pioneered the use
of contractile models in the study of non muscle cells.
Following up the ideas of Hoffmann-Berling, we have
recently begun studying contractile models of human
fibroblasts. The localizations of actin, myosin, and
a-actinin have been determined in cells permeabilized
by detergent (Triton X-100) made up in contraction (10'
to calcium, 1 mM ATP), relaxation (10-7m calcium, 1 mM
ATP), and rigor (10-7 nit calcium, no ATP) buffers. Cells
grown on glass coverslips were removed from the cul-
ture medium and placed directly into contraction, re-
laxation, or rigor buffer containing Triton X-100. At
various times after this treatment, the cells were fixed
and stained for immunofluorescence. In rigor buffer, the
patterns of actin, myosin, and a-actinin are stabilized,
and no significant change occurs for hours while the
cells are kept in rigor buffer (see Fig. 4). Contraction
buffer at 21°C produces a dynamic retraction and com-
plete rounding up of the previously well-spread cells
within 2 minutes. If the retraction process is stopped
after 30 seconds by fixation and staining, considerable
changes can be observed in the actin and myosin distri-
butions. The most striking change is in the myosin pat-
tern, which loses all signs of periodicity, appearing in a
solid staining of stress fibers with no remaining "sheets"
of periodicity (see Fig. 5). Interruptions appear in the
actin staining pattern, though they are not regular
enough to be called periodic. The a-actinin pattern
remains periodic, though somewhat altered. From these
results it appears that the normal distribution of actin,
myosin, and a-actinin in well-spread fibroblasts repre-
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sents a rigor configuration. Certain ionic conditions
,1
which appear to be the addition of ATP and
calcium oice
can cause redistribution of the force-generating corn Ihl
ponents actin and myosin. iE
In an attempt to gain a higher level of resolution thare
immunofluorescence provides, transmission electroddi
microscopy was applied to the contractile models
o
human fibroblasts as well as to normally fixed,
unper
meabilized cells. A new technique of specimen prepa.
ration devised by Buckley and Porter U. Microsc. (oxf.,
104:107 (1975)] was used for these studies. Cells wer
grown on Formvar-coated glass coverslips. After beings
treated with detergent in contraction, relaxation, o,
rigor buffer, or without any treatment at all, the celk
were fixed by standard procedures (using glutaral-
dehyde and osmium tetroxide), the Formvar was re-
moved from the coverslips and mounted on electror
microscope grids, and the cells were dehydrated
anc
finally critical-point-dried. The advantage of preparin
cells in this way is that they can be viewed directly, i.e.
unsectioned, in the 80-kV Philips 201 electron micro
scope. The image is that of the internal components
o
the entire cell. If the specimen stage is tilted and pairs o
micrographs are taken at various angles of tilt, a stere
viewer can be utilized to give a three-dimensional vie
of the internal components. This 3-D image provide
much more information than the usual two-dimensiona
thin-section image of resin-embedded cells. Studies al
ready completed with this "whole-mount" techniqu
have shown that dynamic ultrastructural changes occu
in the contractile models. Work is in progress to deter-
mine the correlations between immunofluorescent im
ages and the 3-D whole-mount images.
LETS protein and oncogenic transformed cells
There are several adenovirus-transformed cell lines tha
are nontumorigenic. For instance, cell lines Ad2/F1
and Ad2/F18, which are rat-embryo cells transforme
by adenovirus type 2, are T-antigen-positive and able t(
grow in low serum and to high saturation density, yE
they are nontumorigenic in normal syngenic rats, im
munosuppressed newborn syngenic rats [P.H. Galli
more, J. Gen. Virol. 16:99 (1972)], and "nude" MiCE
Ad2/F19, on the other hand, is tumorigenic in nud
mice but not in rats, whether immunosuppressed or no
In comparison with the other Ad2 lines studied, Ad:
F19 showed a lower level of tumor induction in nud
mice. Ad2/F19 tumors had a longer latency period tharirure6
the other lines (e.g., T2C4-7.5 days, REM-8.5 dayslaffecti,
F4-19 days, F19-30 days), and whereas T2C4,
and F4 showed invasion of local mouse tissues, this wa!ktostoer".
not the case with Ad2/F19, which classified histologi1,81,4,
cally as a benign tumor (P.H. Gal limore, manuscript ihekg,
preparation). Ad2/F4 and Ad2/REM are tumorigenic irivastj
immunosuppressed syngenic rats, and, at the other ex 'esenl
treme, some lines (e.g., T2C4) are tumorigenic in
syngenic rats without immunosuppression. This series
of cell lines thus provides a spectrum of oncogenicity
within a single species.
We decided to examine the surface characteristics of
these cells as a starting point toward understanding the
gradation of oncogenicity of this series of adenovirus-
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,d Indirect immunofluorescent stains of normal and adeno-
rovirus-2-transformed rat-embryo fibroblasts with anti-LETS
\`cantiserum. Photographs A, C, E, G, and I are fluorescent
'Photomicrographs of normal rat cells and cell lines F18,
00 F17, 81, and T8 stained with anti-LETS antiserum, respec-
intittively; B, D, F, H, and J are the corresponding phase-
: ricontrast photomicrographs of the same cell lines. The bar
11' represents 20 Am.
transformed cells. We used indirect immunofluores-
cence techniques to study the distribution of the cell -
surface LETS protein on normal, transformed, and
tumorigenic cells (Fig. 6). The results of these experi-
ments have been published in detail elsewhere [Chen,
Gallimore, and McDougall, Proc. Natl. Acad. Sci. USA
73:3570 (1976)]. In brief, a correlation has been estab-
lished between the expression of fibril-like LETS protein
and the oncogenic capabilities of a series of
adenovirus-transformed cell lines. In cells expressing a
transformed phenotype in vitro, LETS protein is only
detected in cell-cell contact areas, whereas in "untrans-
formed" cells, LETS is distributed over the cell surface.
Transformed cells capable of inducing invasive tumors
and the cells of established tumor lines have low or
undetectable levels of LETS, as measured by this meth-
od. The results indicate that LETS protein has a role in
cell-cell adhesion, and that reduced expression of this
protein at the cell surface is related to the oncogenic
phenotype. This relationship has been established for
both experimentally induced and spontaneous tumors.
At the moment, we do not know why there should be
a correlation between the loss of LETS protein and tumor
induction. The simplest explanation may be that LETS
protein is directly involved in growth control, and that
the loss of LETS protein is responsible for unrestricted
growth during tumor formation. Our previous finding
[Teng and Chen, Proc. Natl. Acad. Sci. USA 72:413
(1975)] argues against this possibility. In view of the
distribution of LETS protein in adenovirus-transformed
cells reported here and the findings of Yamada et al.
[Proc. Natl. Acad. Sci. USA 73:1217 (1 976)1, it is pos-
sible that LETS protein may be the "glue" involved in
the extracellular matrix system. Classical embryology
tells us that the extracellular matrix plays an important
role in differentiation and organogenesis. Perhaps the
maintenance of a normal pattern of cell growth in vivo
depends on a proper intercellular matrix system. The
integrity of such a matrix may be impaired by the loss of
one (LETS protein) or two (LETS protein and, for exam-
ple, collagen) of its elements.
LETS protein and myogenesis
Recently we have shown that the replacement of
12Siodide by 131 iodide and the use of gradient polyacryl-
amide gels can greatly increase both the number of
detectable cell-surface proteins and the resolution of
protein bands in SDS polyacrylamide gel electrophore-
sis [Teng and Chen, Nature 259:578 (1976)]. When
such procedures were applied to compare prefused,
fused, and postfused stages of Yaffe's myogenic cell line
L8, twice as many bands were detected as with
1"iodide, but, in agreement with Hynes [Biochim.
Biophys. Acta 458:73 (1976)], no significant changes
were found.
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As a continuation of these studies, cell-surface altera-
tions during myogenesis have been investigated in Yaf-
fe's myogenic cell line L8 using indirect immunofluo-
rescence with an antibody against the LETS protein
[Chen, Cell (1977, in press)]. Whereas lactoperoxi-
dase-catalyzed iodination shows no changes during
myogenesis in the composition of cell-surface compo-
nents, including LETS protein, the immunofluorescent
technique reveals a substantial alteration in the distri-
bution of this surface antigen. With the prefused myo-
blasts, LETS protein is dispersed all over the cell surface
and is particularly prominent in the regions of cell-cell
contact and cell-substrate contact. However, following
myoblast fusion, this pattern is markedly changed. All of
the fibril-like surface LETS protein disappears, and in
some myotubes discrete clusters of LETS protein be-
come conspicuous.
Whether LETS-protein clusters play a role in muscle
development is currently being studied in collaboration
with Dr. Eric Frank of Harvard Medical School. In par-
ticular, we will explore whether LETS-protein clusters
are involved in the interaction of motor neuron and
muscle fiber.
Identification of antigens and specific glycoproteins
in SDS gels
Last year two of us (K.B. and W.G.) were involved in the
localization of structural proteins in nonmuscle cells
using the immunofluorescent-antibody technique.
Whenever antibodies are used, it is important to know
their specificity. While we were testing the specificity of
our antisera by conventional immunological methods,
it occurred to us that some (perhaps many) proteins
might preserve their antigenicity during SDS gel elec-
trophoresis. It seemed that if this were so, a useful way to
test the specificity of antisera would be to "stain" SDS
gels directly with antisera and then to reveal the an-
tigenic gel bands by using a second antiserum which
was labeled in some way (e.g., with a radioactive, en-
zymatic, or fluorescent tag). Accordingly, we decided to
test this idea and tried to "stain" gels with a specific
antiserum and then follow with a second, radioactively
labeled antibody directed against the first antiserum.
The radioactivity was detected by autoradiography.
Somewhat to our surprise, the technique has worked
successfully for more than a dozen different antisera
tested. So far only an antiserum against collagen has
failed to react with its antigen on SDS gels.
While developing this technique we realized that
besides antibodies recognizing antigens, other types of
interaction might also be possible in SDS gels. For
example, it seemed probable that SDS gel elec-
trophoresis would not affect the carbohydrate portion of
glycoproteins and these might still be able to bind plant
lectins. This prediction was soon confirmed by applying
radioiodinated lectins directly to gels. Moreover, by
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using lectins with different carbohydrate specificities,
different sets of glycoproteins could be visualized. The
technique seemed to offer a new means of analyzing,
glycoproteins according to both their apparent molecu-
lar weight and their carbohydrate specificity. Shortly
before we presented this technique at the 1976 Cold
Spring Harbor Symposium, it was a disappointment to
find out that essentially the same technique had already,
been developed independently by two other laborato-
ries [Robinson et al., FEBS Lett. 58:330 (1975); Tannek.
and Anstee, Biochem. 1. 153:265 (1976)]. Nevertheless,
the techniques should have many applications. So far
we have concentrated on analyzing the glycoproteins o,
normal, transformed, and tumorigenic cells (Burridge,
1976b). Now we are also using the two techniques tc
analyze glycoproteins in a number of developmenta
systems. Certainly, in the area of developmental biol
ogy, both the antibody and the lectin techniques may be
useful, since even in differentiation the expression o
new surface antigens, many of which will also bi
glycoproteins, is critical.
The glycoproteins of 3T3 cells and various virus s t\
transformed 3T3 cells have been analyzed by the direc,,sior
application to SDS gels of four iodinated lectins
11(1K
different specificities (Con A, ricin, WGA, and Pliff.,!1\s,
(Burridge 1976b). With all four lectins differences ar10\\
seen between the normal and the transformed ce.-nod
types. On the gel of 3T3 cells, for example, WG,
strongly stains a doublet with a molecular weight c,..orn
about 190,000 and another band at about 205,000, bi
mrWGA does not stain equivalent bands in the tran ,look
formed cells or stains them only very weakly. Glycopr(thei
tein differences are also seen among the various tram
. pformants. For example, a band at about 250,000 clE-':,11,13
tons, the region to which the LETS protein moves,
.L
labeled in all four cell types by Con A and PHA, but tl-F` I.
band is labeled strongly with WGA and ricin only in tr
gels of the SV101 and Py3T3 cells. Since glycoprot;d:a.I
differences are seen between the two lines of SVLI'dhsenti
transformed 3T3 cells (SV513 and SV101), this sugge'E:esting
\vi r
that at least some of the differences arise from c17I:
sub
s4boe.ir
variations unrelated to viral transformation. curs
The glycoproteins of normal and RSV-transformquatic
chick cells have also been analyzed. Here the n-
partprominent glycoprotein differences involve the Li
ced anprotein. In the normal chick cells, this band is stair,
strongly by all four lectins, and it would seem, therefuesveic
that LETS not only contains considerable carbohydrcm;L
but exposes several different terminal specificities.
the RSV-transformed chick cells, the staining of th,,dtothe
band is reduced, and other glycoprotein bands appe,ct,iti,
or become more prominent.
Recently, Chen, Gal limore, and McDougall at Co.
Spring Harbor have found a correlation between t1-.0rani
tumorigenicity of many transformed cell lines and tl-
reduction of LETS protein expressed on these cells' sur-
faces. With the lectin technique, we have begun to
examine the glycoproteins of the series of
adenovirus-2-transformed rat fibroblasts which show a
range of tumorigenicity and which Chen et al. [Proc.
Acad. Sci. USA 73:3570 (1976)] have correlated
with reduction in LETS. So far we have examined F18
.and T8 cells. F18 is nontumorigenic and expresses LETS
on its surface, whereas T8 is highly tumorigenic and
does not express LETS. A prominent band is stained in
the region of the LETS protein by both ricin and PHA in
gels of F18 but not in gels of T8. Similarly, a band just
'below this is stained by PHA in the F18 gel, whereas in
'the T8 gel an additional band, with an approximate
'molecular weight of 40,000, is stained by Con A.
We have used anti-LETS antiserum to identify this
,,,,antigen in SDS gels of the various normal, transformed,
tumorigenic cell types mentioned above. The anti-
,.i)ody stained a high-molecular-weight band found in
Ahe gel of each cell type, but the intensity of this staining
varied considerably; the lowest level was seen in the
tumorigenic, adenovirus-transformed rat cell line T8.
he intensity of this band was also much reduced in the
SV-transformed chick cells compared with that in the
ormal chick fibroblasts. An unexpected result was that
e gels of two of the 3T3 cell transformants (SV101 and
y3T3) showed increased intensity of staining with the
ETS antibody.
The staining of gels with the anti-LETS protein anti-
ody is complementary to the examination of intact
ells by immunofluorescent microscopy. This latter
ethod looks at the LETS expressed on the surface,
hereas the antibody applied to gels of whole cells can
veal the presence of LETS within these cells even
ough it may not be expressed on the surface. This is
e case with the RSV-transformed chick cells. Both the
4`iltibody staining and the lectin staining on gels of these
0111)11s confirm the presence of LETS within them, though
lYcl). is absent from their surfaces. These lectin results are
'50L'eresting since they indicate that at whatever stage
liss''TS is being degraded or lost from these chick cells, it
rofilt.curs subsequent to the glycosylation process. With
SV40- and polyoma-transformed 3T3 cells, a differ-
roost( t situation exists. These cells do express some surface
e the IS, particularly when highly confluent, but in re-
e tbe ced amounts when compared with confluent 3T3
Adis -GIs. However, the intensity of the antibody staining on
0,these gels indicates that the transformants have at least
oihrmuch LETS as the normal cells. This would suggest an
ieoccumulation of LETS within these cells, perhaps re-
ivaioted to the incomplete expression on the surface. In this
b?spect, it is interesting that the LETS band of the Py3T3
SV101 cells binds significantly greater amounts of
bth ricin and WGA, indicating either an increased
!vel or an altered pattern of glycosylation.
I
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POSTGRADUATE
TRAINING PROGRAMS
;UMMER 1976
Since its inception, the postgraduate program at Cold Spring Harbor
,
aboratory has been aimed toward meeting the rather special need for
,.,raining in new interdisciplinary subjects that are either so new or so
opecialized that they are not adequately treated by universities. The
,'. ntention is to provide intensive training in the most recent develop-
ents and techniques in each of the subjects so that it should be
ossible for the students to enter directly into research in the particular
rea.
To do this, we bring together a workshop staff from many laborato-
-I-ies around the world. These instructors direct intensive laboratory and
- ecture programs supplemented with a continuous series of seminar
opeakers which ensures up-to-date coverage of current research work.
kNIMAL CELL CULTURE, June 10 - June 30
INSTRUCTORS
Coon, Hayden, Ph.D., National Cancer Institute, Bethesda, Maryland
Sato, Gordon, Ph.D., University of California, San Diego, California
\SSISTANTS
Yarkin, Rhoda, B.A., National Cancer Institute, Bethesda, Maryland
Ambesi, Saverio, M.D., National Institutes of Health, Bethesda, Maryland
Izumi, Hayashi, B.A., University of California, San Diego, California
The course consisted of a series of laboratory exercises and lectures
elated to laboratory procedures. Initial exercises-covered such basic
vulture techniques as propagation of established cell lines, initiation of
orimary cultures, growth of differentiated cells from various em-
bryonic tissues, cloning, mycoplasma assays, and karyotype analysis
.sing quinacrine fluorescence of trypsin banding. Experiments utiliz-
ing more specialized techniques were also performed. These experi-
ments included cell synchronization, autoradiography, induction and
selection of HGPRT mutations, enucleation of chloramphenicol-
-esistant cells and formation of cytoplasmic hybrids, and the prepara-
tion and use of liposomes to effect cell fusion. Sendai-virus-mediated
sell fusion was used to study complementation of Gly- mutants in
HO cells and to microinject proteins into culture cells by fusion with
protein-loaded red blood cells. Cell-surface antigens on human-
mouse hybrid cells were studied using the mixed hemadsorption
assay. Induction of hemoglobin synthesis in erythroleukemia cells and
immunoglobulin production in mouse myeloma cells were also
1)tudied. Cells were grown in medium in which the serum was replaced
with complexes of hormones. Each evening a guest lecturer spoke on
recent developments in cell biology.
PARTICIPANTS
f411
Aaronson, Robert P Ph.D., Mount Sinai School of Medicine, New York, New York 0Bade, Ernesto, M.D., University of Konstanz, Konstanz, Federal Republic of Germany
leBarnes, David W., B.A., Vanderbilt University, Nashville, Tennessee 1
HoBhaysar, Prabhakar, M.S., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
0Damsky, Caroline H., Ph.D., Wistar Institute, Philadelphia, Pennsylvania
g63Ebisuzaki, Kaney, Ph.D., University of Western Ontario, London, Ontario, Canada
01Elson, Elliot, Ph.D., Cornell University, Ithaca, New York
VidGerace, Larry R., B.A., Rockefeller University, New York, New York 0Hemperly, John, B.S., Rockefeller University, New York, New York
`'el
Ho, Ching, Ph.D., University of Cincinnati, Cincinnati, Ohio
Jessup, John M., M.D., National Institutes of Health, Bethesda, Maryland 6N'
Jetten, Anton, Ph.D., Massachusetts Institute of Technology, Cambridge
Ada
Junghans, Richard P., Ph.D., University of California, Berkeley.
;teoKoppel, Dennis E., Ph.D., Cornell University, Ithaca, New York doh
Lee, Lih-Syng, Ph.D., Roswell Park Institute, Buffalo, New York
Of
---Liao,Lon Lon, Ph_D_Alhert Einstein College, Bronx, New York
f efilNash, William G., Ph.D., George Washington University, washington, D.C.
Washington, Willie J., Ph.D., Central State University, Wilberforce, Ohio
Webster, Robert E., Ph.D., Duke University, Durham, North Carolina
Wolfe, Jason, W., Ph.D., Wesleyan University, Middletown, Connecticut ON
SEMINARS
0111
Green, H., Massachusetts Institute of Technology. Life of the epidermal keratinocyte-A lesson learned f
Kates, J., State University of New York, Stony Brook. Reconstruction of cells from cytoplasts
and karyoprloarnstsi
Hsie, A., Oak Ridge National Laboratory. Quantitative mutagenesis in vitro.
the study
o')1ST1h1 3131:vY
Pollack, R., State University of New York, Stony Brook. A strategy for the in vitro analysis of the oncogenic process.Blobel, H., Rockefeller Institute. Processing of secretory proteins.
teratomas.
Anderson, W.F., Arthritis Institute, NIH. Use of mouse erythroleukemia cells in the study of globin gene expression. ae ailMeiss, H., New York University Medical School. Temperature-sensitive mutants.
iodudEisenstadt, J., Yale University. Behavior of cytoplasmic genes in mammalian cells.
THE NERVOUS SYSTEM OF THE LEECH, June 10-June 30
INSTRUCTORS
Sawyer, Roy, Ph.D., University of California, Berkeley, California
Jansen, Jan, Ph.D., M.D., University of Oslo, Oslo, Norway
Muller, Kenneth J., Ph.D., Carnegie Institution of Washington, Washington, D.C.
Nicholls, John, Ph.D., M.D., Stanford University Medical School, Stanford, California
Bixby
,uperior
Rechsteiner, M., University of Utah. Studies on human-mouse hybrid cell formation and chromosome segregation.Scharff, M., Albert Einstein Medical School. Mutants of mouse myeloma cells.
Sambrook, J., Cold Spring Harbor Laboratory. Nucleic acid studies in transformed cells.
Shin, S., Albert Einstein Medical School. Use of "nude" mice in cancer research.
ootx
The aim of this workshop was to provide students with an intensive lab and seminar course that would enablE Grob,
for recording from leech cells, now considered straightforward and relatively easy, which took much time anc 'ass,
them to pursue independent work on the leech. To this end, we hoped to provide the students with technique Jarvis
effort to be refined. With this knowledge, they might avoid many of the trivial technical difficulties that bedevi Reid
anyone starting on the nervous system of the leech or other animals.
116aleo:
11101
EeBottmici
The initial work was devoted mainly to recognizing the individual cells, learning how to record from then
'tions. The students then progressed to more difficult experiments, such as recording synaptic potentials Bunk,
hitherto unknown South American leech was explored in detail. This animal may provide a uniquely usefullonP(
with intracellular and extracellular electrodes, getting familiar with the equipment, and performing dissec
-
while changing the fluid bathing the preparation or injecting individual cells with marker substances in Freerorder to study their geometry.
d,
proved to be of sufficient interest to be pursued in greater detail. For example, the nervous system of a
i(ar,
The final phase of the course consisted of devising and performing original experiments, some of which HKIub(
,
preparation for examining the organization and development of a simple brain.
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PARTICIPANTS
Buckley, Kathleen M., B.A., Harvard Medical School, Boston, Massachusetts
Ferster, David, B.S., Harvard Medical School, Boston, Massachusetts
Hogan, Patrick, B.A., Harvard Medical School, Boston, Massachusetts
Kavinsky, Clifford J., B.A., University of Chicago, Chicago, Illinois
Ready, Donald, B.A., California Institute of Technology, Pasadena, California
Singh, Satpal, M.S., Tata Institute, Bombay, India
Victor, Jonathan, B.A., Rockefeller University, New York, New York
Weeks, Janis, B.S., University of California, San Diego, California
Weisblat, David, B.A., California Institute of Technology, Pasadena, California
MINARS
Adal, M., Stanford University School of Medicine. Fine structure of cultured, regenerating CNS.
Stent, G., and W. Kristan, University of California. Locomotion and heartbeat (I, II, III).
Cohen, L., Yale Medical School. Recording without electrodes.
Sawyer, R., University of California, Berkeley. Biology of leeches.
Fernandez, J., University of California, Berkeley. Development of leech CNS.
TECHNIQUES FOR STUDYING THE VERTEBRATE CENTRAL NERVOUS SYSTEM, June 10-July 5
INSTRUCTORS
Kirkwood, Peter, Ph.D., Institute of Neurology, London, England
Shatz, Carla, Ph.D., Harvard Medical School, Boston, Massachusetts
Stryker, Michael, Ph.D.,-Harvard Medical School, Boston, Massachusetts
ASSISTANT
Mates, Sharon, B.A., Harvard Medical School, Boston, Massachusetts
Dne aim of the course was to provide students with the basic technical competence necessary for
conducting independent experimental work. Another was to provide an introduction to the functional
r organization of several different areas in the vertebrate central nervous system. The course consisted of four
different laboratory exercises. In all labs students learned the appropriate surgical techniques, the prepara-
It :ion of microelectrodes, and simple histological procedures for reconstructing electrode tracks. In one lab the
45,-'eflex activity of motoneurons in the cat's spinal cord was studied using both intracellular and extracellular
'ecording techniques. Two other labs focused on the visual system. In one, extracellular recordings were made
lom the cat's visual cortex, and the response properties of neurons tovisual stimuli were examined. In the other,
;tereotaxic techniques were used to place electrodes within deeper structures (lateral geniculate nucleus and
'uperior colliculus) for recordings. The retrograde transport of horseradish peroxidase injected into these
tructures was used to trace afferent connections. In the fourth lab, the regions of the cortex and superior
.olliculus receiving somatosensory input from the whiskers of the rat were studied. The relationship between
ihese two structures was examined using both anatomical and extracellular recording techniques. Additional
.natomical methods, such as silver stains selective for degenerating fibers, were demonstrated.
to,tARTICIPANTS
Bixby, John, B.A., California Institute of Technology, Pasadena, California
, Botticelli, Lawrence J., M.S., Harvard School of Public Health, Boston, Massachusetts
Demian, Jeff, M.S., State University of New York, Stony Brook.
'000 Grobstein, Carolyn Smith, B.A., University of Chicago, Chicago, Illinois
,oe'i Jarvis, Charlene D., Ph.D., National Institutes of Health, Bethesda, Maryland
Nass, Menasche, Ph.D., Brown University, Providence, Rhode Island
11e3' Norris, Charles, Ph.D., Tulane Medical School, New Orleans, Louisiana
01 Reichardt, Louis, Ph.D., Harvard Medical School, Boston, Massachusetts
EMINARS
Bizzi, E., Massachusetts Institute of Technology. Central and peripheral contributions to the coordination of eye and head
lis5eci movements studied in alert animals.
!litial9 Burke, R., National Institutes of Health. Physiological and histochemical characterization of a spinal motoneuron pool.
0ini Freeman, J.A., Vanderbilt University Medical School. Organization of the frog optic tectum studied using current source
density analysis and electrical models of tectal cells.
Hubei, D.H., Harvard Medical School. Functional organization of the monkey's visual cortex.
#111' Kiang, N., Massachusetts Eye and Ear Infirmary and Massachusetts Institute of Technology. Functional organization of
10fai primary relay sites in the auditory system.
Kuno, M., University of North Carolina at Chapel Hill. Trophic interactions between motoneurons and muscle.
Schiller, P.H., Massachusetts Institute of Technology. Role of the superior colliculus in eye movement and vision.
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MOLECULAR CYTOGENETICS, June 13 - July 3
INSTRUCTORS
3PP(
Pardue, Mary Lou, Ph.D., Massachusetts Institute of Technology, Cambridge
Cr
Call, Joseph, Ph.D., Yale University, New Haven, Connecticut ,L10
ASSISTANT
Erba, Harry, Yale University, New Haven, Connecticut PART
Sl
The molecular cytogenetics course emphasized the integration of classical and molecular techniques for the (.5`
analysis of chromosome structure and function. Current problems of chromosome structure were approached
c'rc,
by chromosome banding techniques, DNA renaturation kinetics, the isolation of chromatin subunits, in situ Cu
hybridization, visualization of transcription, restriction-enzyme digestion of DNA, nucleic acid sequencing, DI
and heteroduplex mapping. A new technique introduced this year was the localization of proteins in cytological Du
preparations by fluorescent antibodies. As always we benefited from the many contributions of bara °1'
McClintock. Far
HYStudents came from Denmark, England, Germany, and Israel as well as various parts of the U.S., and d
ion
primarily biochemical training. Previous research experience of the students ranged from Drosophila embryc Lies
culture to analysis of chloroplast DNA, so participants contributed a wide range of expertise. Iju
10"
PARTICIPANTS \ec
Bohr, Vilhelm A., Ph.D., Panum Institute, Copenhagen, Denmark p dti
Carlson, Jonathan, Ph.D., University of Colorado, Denver Rod
Donady, James J., Ph.D., Wesleyan University, Middletown, Connecticut she
Gershoni, Jonathan, B.S., Hebrew University, Jerusalem, Israel Spa
Goldberg, Sheldon, B.S., New York University Medical Center, New York, New York ve
Jamrich, Milan, M.S., Institut Molekulare Genetik, Heidelberg, Federal Republic of Germany OIN
Lockwood, Arthur H., Ph.D., New York University, New York, New York
McKnight, Steven L., B.A., University of Virginia, Charlottesville. 1 Bo
Silver, Louise S., B.A., New York University, New York, New York
Morgan, Garry T., B.S., University of Leicester, Leicester, England
SEMI NARS
Hsu, T.C., M.D. Anderson Hospital and Tumor Institute. Cytochemical analysis of mammalian chromosomes.
Cech, T., Massachusetts Institute of Technology. Psoralen cross-linking as a probe for in vivo chromatin structure.
Judd, B., University of Texas. Gene-chromomere relationships in Drosophila.
Gall, J., Yale University. Gene amplification in Tetrahymena
Pardue, M.L., Massachusetts Institute of Technology. The "heat shock" response in cultured Drosophila cells.
Elgin, S., Harvard University. Studies on Drosophila chromosomal proteins.
Davis, R., Stanford University. Expression and mapping of eukaryotic genes in Escherichia coli.
Roberts, R., Cold Spring Harbor Laboratory. Restriction-type enzymes.
. Nucleic acid sequencing.
Noll, M., Universitat Basel. Chromatin structure in eukaryotes.
Bakken, A., University of Washington. Visualization of transcription in mouse oocytes.
ADVANCED BACTERIAL GENETICS, July 6 - July 26
INSTRUCTORS
Miller, Jeffrey, Ph.D., University of Geneva, Geneva, Switzerland
Botstein, David, Ph.D., Massachusetts Institute of Technology, Cambridge, Massachusetts
Wensink, Peter, Ph.D., Brandeis University, Waltham, Massachusetts
BelleiWinston, Fred, A.B., Massachusetts Institute of Technology, Cambridge, Massachusetts
Beser
St. John, Tom, B.S., Stanford University, Stanford, California
Lowenberg, Joel, B.S., Brandeis University, Waltham, Massachusetts
Davis, Ronald, Ph.D., Stanford University, Stanford, California
ASSISTANTS
Bell
Ecklut
Cde
Students in the course carried out complete in vitro recombination experiments in which fragments of i
DNA were joined to E. coil plasmid vehicles by the terminal transferase method and to phage X vehicles by th
restriction endonuclease-polynucleotide ligase method. The in vitro recombinants were analyzed by methoc °51`
including colony hybridization to radioactive yeast ribosomal RNA, heteroduplex analysis in the electro Erkin
microscope, and attempted genetic complementation of specific genetic defects in the bacterial hosts.
In order to make available a larger group of mutants suitable for complementation tests with in v' l Hsu, \
recombinant DNA, insertion mutations (i.e., mutations caused by insertion of a translocatable drug resist [belga
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element) were isolated directly in highly transformable E. coil strains. One of these, cys: :Tn5 insertion mutation,
appeared to be complemented by a yeast DNA fragment.
Concurrently with these experiments, students isolated and analyzed a large number of new nonsense
suppressors with well-defined specificities of amino acid insertion. In addition, some of the students found some
possibly interesting regulatory mutations affecting efficiency of nonsense suppression.
PARTICIPANTS
Allen, Robert G., Ph.D., General Foods Corp., White Plains, New York
'rthEr Bach, Marie-Louise, Ph.D., Institute de Biologie, Strasbourg, France
died Conrad, Susan E., B.S., California Institute of Technology, Pasadena
Crabeel, Majolaine, Ph.D., University of Brussels, Brussels, Belgium
Cunningham, Thomas S., B.S., Temple University, Philadelphia, Pennsylvania
icirlgj DiLauro, Roberto, M.D., National Cancer Institute, Bethesda, Maryland
lgical Duck, Peter, Ph.D., National Research Council, Ottawa, Ontario, Canada
rbaii Duncan, Craig H., B.S., University of Rochester, Rochester, New York
Farber, Florence, Ph.D., Baylor College, Houston, Texas
Hynes, M.J., La Trobe University, Victoria, Australia
;that Jones, Lily A., Ph.D., Wayne State University, Detroit, Michigan
lb% Liebke, E. Hope, Ph.D., University of Connecticut, Storrs
Ljungquist, Siv, B.S., Karolinska Institute, Stockholm, Sweden
Lowrie, Robert J., Ph.D., Food Research Institute, Ottawa, Ontario, Canada
Neugebauer, Kristina, M.S., University of Heidelberg, Heidelberg, Federal Republic of Germany
Patterson, Bruce, Ph.D., National Cancer Institute, Bethesda, Maryland
Royer, Hans-Dieter, M.D., Max-Planck-Institut, Tubingen, Federal Republic of Germany
Sherman, Fred, Ph.D., University of Rochester, Rochester, New York
Spandidos, Demetrios, Ph.D., McGill University, Montreal, Quebec, Canada
Wenzl, Wilfried, Ph.D., Hygiene Institut, Graz, Austria
SEMINARS
Botchan, M., Cold Spring Harbor Laboratory. Structure of integrated SV40 DNA in transformed cells.
Maniatis, T., Cold Spring Harbor Laboratory. In vitro synthesis and molecular cloning of eukaryotic chains.
Barklay, E., National Institutes of Health. Application of physical containment methods in recombinant DNA experiments.
Gartland, W., National Institutes of Health. Summary of the draft NIH guidelines on recombinant DNA research.
ANIMAL VIRUSES, July 6 - July 26
NSTRUCTORS
Diggelman, Heidi, M.D., Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland
Beard, Peter, Ph.D., Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland
'.SSISTANT
Mueller, Verena, Technical Assistant, Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland
'he course consisted of morning lectures covering the major classes of animal viruses. The laboratory exercises
,eld each afternoon included preparation of primary cell cultures, growth of continuous tissue-culture cell lines,
tell fusion, preparation and purification of virus stocks, extraction and purification of viral nucleic acids and
iral proteins, restriction-enzyme analysis of viral DNA and viral chromatin, translation of viral RNAs by
ell -free extracts, kinetic-complexity analysis of different RNAs by hybridization, and isolation of viral proteins
rom infected cells using immunological techniques. A variety of evening lectures were held to review some
,articular aspects of modern animal virology.
In addition to the formal laboratory exercises, some individual research projects were carried out in
ollaboration with the permanent staff of the Cold Spring Harbor Laboratory.
ARTICIPANTS
Bell, Anne P., B.S., Cornell University, Ithaca, New York
Bellemann, Peter, Ph.D., University of Tubingen, Tubingen, Federal Republic of Germany
Besemer-Rosenwirth, Brigitte, Ph.D., University of Cologne, Köln, Federal Republic of Germany
Cohen, Maurice, Ph.D., California Institute of Technology, Pasadena
Corden, Jeffry L., B.S., Oregon State University, Corvallis
Dorsky, David J., B.A., Harvard Medical School, Boston, Massachusetts
Ecklund, Peter S., Ph.D., Children's Hospital, Detroit, Michigan
Erkinger, Sigrid, Ph.D., University of Graz, Graz, Austria
Graessmann, Monika, Ph.D., Institut fiir Molekularbiologie, West Berlin, Germany
Hsu, Wen-Tah, Ph.D., University of Chicago, Chicago, Illinois
lbelgaufts, Horst, M.A., Max-Planck-Institut, Köln, Federal Republic of Germany
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Johansson, Katarine, B.S., Uppsala University, Uppsala, Sweden
McClain, Donald A., B.A., Rockefeller University, New York, New York
Parmeggiani, Andrea, M.D., Ecole Polytechnique, Palaiseau, France
Sarasin, Alain, Ph.D., Stanford University, Stanford, California
Scholia, Clara, B.S., Sloan-Kettering Institute, New York, New York
Weber, Lee A., Ph.D., State University of New York, Albany
Wiegand, Roger C., B.A., Yale University, New Haven, Connecticut
SEMINARS
Pollack, R., State University of New York, Stony Brook. Cell growth and behavior.
Beard, P., Swiss Institute for Experimental Cancer Research. Papovavirus growth and cell transformation.
Shatkin, A., Roche Institute. Reovirus.
Diggelmann, H., Swiss Institute for Experimental Cancer Research. RNA tumor virus replication.
Wimmer, E., State University of New York, Stony Brook. Poliovirus.
Stark, G., Stanford University. Papovavirus tumor antigen.
Lilly, F., Albert Einstein College of Medicine. Genetic factors in murine viral leukemia.
Hynes, R., Massachusetts Institute of Technology. Cell surfaces of normal and transformed cells.
Eckhart, W., Salk Institute. Genetics of papovaviruses.
Sambrook, J., Cold Spring Harbor Laboratory. Genetics of adenovirus.
Lewis, J., Cold Spring Harbor Laboratory. Synthesis of adenovirus RNA and proteins in vivo and in vitro.
Ward, D., Yale University. Parvoviruses.
Lenard, J., Rutgers University. Envelopes of myxo and paramyxoviruses.
Kolakofski, D., University of Utah. Replication of myxo and paramyxovirus RNA.
Joklik, W.K., Duke University. Vaccinia virus.
Pizer, L., University of Pennsylvania. Herpesviruses.
Sugden, W., University of Wisconsin. Epstein-Barr virus.
Davis, R., Cold Spring Harbor Laboratory. In vitro recombination of DNA.
EXPERIMENTAL TECHNIQUES IN NEUROBIOLOGY, July 6-July 30
INSTRUCTORS
Kehoe, JacSue, Ph.D., Ecole Normale Superieure, Paris, France
thiararrdini, Dante, M:D., New York University, New York, New York
Stefani, Enrique, M.D., Institute Politecnico Nacional, Mexico City, Mexico
Kado, Ray, Ph.D., Centre National de la Recherche Scientifique, Gif-sur-Yvette, France
In this Neurobiology II course the neuromuscular junction of the frog and the central ganglia of the mollusc
Aplysia were used as experimental preparations for training students in basic electrophysiological methods for
cellular neurobiology. Examination of certain characteristics of the resting potential, action potential, and
synaptic potentials of these two preparations served as a framework for introducing the following techniques:
microdissection, fabrication of single and multibarrelled capi Ilary microelectrodes, intracellular and extracellu-
lar recording and stimulating procedures, current-clamp and voltage-clamp circuitry, extracellular and intracel-
lular application of ions and drugs (ionophoresis and pressure injection), and intracellular staining for light and
electron microscopy.
The last few days of the course were devoted to individual experimental projects chosen by the students-
projects that permitted them to try techniques not taught in the course and to use biological preparations that
they intended to study upon returning to their own laboratories.
PARTICIPANTS
Gaathon, Ariel, Ph.D., Columbia University, New York, New York
Gaensler, Karin, Harvard University, Cambridge, Massachusetts
Greenspan, Ralph, B.A., Brandeis University, Waltham, Massachusetts
Ko, Patrick, B.S., McGill University, Montreal, Quebec, Canada
Maxell, Gerald, Ph.D., Harvard Medical School, Boston, Massachusetts
Nass, Menasche, Ph.D., Brown University, Providence, Rhode Island
Reiness, C. Gary, Ph.D., Harvard Medical School, Boston, Massachusetts
Schatz, Genevieve, B.S., University of Geneva, Geneva, Switzerland
Schneps, Sue, B.S., Massachusetts Institute of Technology, Cambridge
Walicke, Patricia A., B.S., Harvard Medical School, Boston, Massachusetts
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MOLECULAR BIOLOGY AND GENETICS OF YEAST, July 28 - August 17
INSTRUCTORS
Fink, Gerald, Ph.D., Cornell University, Ithaca, New York
Sherman, Fred, Ph.D., University of Rochester, Rochester, New York
Petes, Thomas, Ph.D., Massachusetts Institute of Technology, Cambridge, Massachusetts
ASSISTANT
Hicks, Jim, Ph.D., Cornell University, Ithaca, New York
This program emphasized the major laboratory techniques used in the genetic analysis of yeast: tetrad analysis,
mitotic recombination, and fine-structure mapping. The isolation and characterization of both chromosomal
and cytoplasmic mutants were undertaken. Biochemical studies were performed with chromosomal and
mitochondrial mutants.
Studies on chromosomal and extrachromosomal DNA were pursued by electron microscopy. The cell
division cycle was studied by fluorescence microscopy. These new techniques were integrated with genetic
analysis in order to study the cell cycle.
PARTICIPANTS
Cross, Heide S., M.S., University of Wien, Wien, Austria
DeAngelo, Joseph, B.S., Massachusetts Institute of Technology, Cambridge
Foor, Forrest, Ph.D., Massachusetts Institute of Technology, Cambridge
Fukasawa, Toshio, Ph.D., Keio University, Tokyo, Japan
Gancedo, Juana M., Ph.D., Harvard Medical School, Boston, Massachusetts
Goewert, Robert, B.S., St. Louis University, St. Louis, Missouri
Hixon, Sharon, Ph.D., Fondation Curie, Orsay, France
Koh, Youh T., Ph.D., University of Basel, Basel, Switzerland
Miller, Mark J., Ph.D., University of California, San Diego
Rouslin, William, Ph.D., Rutgers University, New Brunswick, New Jersey
Schekman, Randy, Ph.D., University of California, La Jolla
Sinha, Navin K., Ph.D., Princeton University, Princeton, New Jersey
Solioz, Marc, Ph.D., University of Basel, Basel, Switzerland
Stephens, John, B.S., University of California, Irvine
Tatti, Kathleen, B.S., Wayne State University, Detroit, Michigan
Tye, Bik-Kwoon, Ph.D., Stanford University, Stanford, California
;EMINARS
Davis, R., Stanford University. Cloning of yeast DNA.
Hartwell, L. H., University of Washington. Cell cycle of yeast.
---. Control of cell division in yeast.
Byers, B., University of Washington. Cytology of the yeast life cycle.
Esposito, M. S., University of Chicago. Genetic recombination and genes controlling sporulation of yeast.
Petes, T. D., Massachusetts Institute of Technology. Structure and replication of yeast RNA.
Rosbash, M., Brandeis University. Classes of yeast mRNA, especially ribosomal protein mRNA.
McLaughlin, C. S., University of California, Irvine. Mutations and antibiotics that affect protein synthesis in yeast.
Mortimer, R. K., University of California, Berkeley. Genetic mapping in yeast.
---. Gene conversion and postmeiotic segregation.
Fink, G. R., Cornell University. The yeast killer factor.
Sherman, F., University of Rochester. Nonsense suppression in yeast.
---. Regulation of the iso-cytochromes c.
Butow, R. A., University of Texas, Dallas. Genetic and biochemical aspects of mitochondrial biogenesis.
Robinow, C. F., University of Western Ontario. Light microscopy of nuclear behavior in yeasts,
Marmur, J. and R. Needleman, Albert Einstein College of Medicine. Studies of the yeast mitochondrial genome.
Warner, J., Albert Einstein College of Medicine. Are syntheses of ribosomal RNA and of ribosomal protein related?
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MMUNOGENETICS AND TUMOR IMMUNOLOGY, July 28 - August 17
NSTRUCTORS
Fleissner, Erwin, Ph.D., Sloan-Kettering Institute, New York, New York
Nowinski, Robert, Ph.D., Fred Hutchinson Cancer Center, Seattle, Washington
SSISTANTS
Ledbetter, Jeff, B.S., Fred Hutchinson Cancer Center, Seattle, Washington
Ellis, Ron, B.S., Sloan-Kettering Institute, New York, New York
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The course focused on current research in immunogenetics as it relates to differentiation, tumor biology, and het
host-virus interactions, primarily in the mouse. Among the topics covered were cellular immunology, differ_ ble
entiation of lymphoid cells in vivo and in vitro, the H-2 and TL loci, the Gix system, the T locus, and the pAi
physiology and genetics of type-C viruses. Approaches at the molecular level were stressed, particularly with
I
respect to genetic specification of normal and malignant cell surfaces.
The course consisted of lectures by instructors and invited speakers, discussions, and laboratory experiments
in tissue-culture systems and in specially constructed genetic crosses between inbred mouse strains.
PARTICIPANTS
Barnes, David, B.A., Vanderbilt University, Nashville, Tennessee
Baron, Diethard, Ph.D., Sidney Farber Cancer Center, Boston, Massachusetts
Brown, Joseph, Ph.D., Fred Hutchinson Cancer Center, Seattle, Washington
Burnette, Neal, Ph.D., Albert Einstein College, Bronx, New York
Chen, Betty, Ph.D., Johns Hopkins University, Baltimore, Maryland
Ganguly, Asok, Ph.D., National Institutes of Health, Bethesda, Maryland
Harrison, Earl, Ph.D., Columbia University, New York, New York
Klitzman, Jack, M.S., Fred Hutchinson Cancer Center, Seattle, Washington
Lewis, John, B.S., Sloan-Kettering Institute, New York, New York
Mastro, Andrea, Ph.D., Penn State University, University Park, Pennsylvania
Novis, Peter, Ph.D., Swiss Institute, Lausanne, Switzerland
Pauli, Georg, Ph.D., Institut Virologie, Giessen, Federal Republic of Germany
Pratt, Diane, M.A., Harvard Medical School, Boston, Massachusetts
Torano, Alfredo, Ph.D., Indiana University, Bloomington.
SEMINARS
Nowinski, R., Fred Hutchinson Cancer Center. Basic aims and techniques of cell-surface immunogenetics.
Lilly, F., Albert Einstein College of Medicine. Genetic control of viral leukemogenesis in mice.
Hammerling, U., Sloan-Kettering Institute. Cellular basis of humoral immunity.
Bach, F., University of Wisconsin. Cell-mediated immunity.
Klein, J., University of Texas. The major histocompatibility antigens.
Cunningham, B., Rockefeller University. Structures of immunoglobulins and histocompatibility antigens.
Goldstein, G., Sloan-Kettering Institute. Physiology of lymphoid cell differentiation.
Waelsch, S., Albert Einstein College of Medicine. The T
Martin, G., University of California at San Francisco. Teratomas as models for differentiation.
Flaherty, L., New York State Health Department. The W and steel loci.
Schachner, M., Harvard University. Differentiation antigens of the nervous system.
Scharff, M., Albert Einstein College of Medicine. Somatic cell genetics of immunoglobulin production.
Zinkernagel, R., Scripps Clinic. Histocompatibility restriction in cell-mediated cytotoxicity.
Hellstrom, I., Fred Hutchinson Cancer Center. Mechanisms of tumor rejection.
Fleissner, E., Sloan-Kettering Institute. Biology of RNA tumor viruses.
Vogt, P., University of Southern California. Genetics of RNA tumor viruses.
Duesberg, P., University of California, Berkeley. Structure of RNA tumor virus genomes.
Fleissner, E., Sloan-Kettering Institute. Proteins of murine leukemia viruses.
Stephenson, J., National Institutes of Health. Polymorphism of murine leukemia viruses.
Jaenisch, R., Salk Institute. Experimental integration of leukemia virus genes in a mouse germ line.
Nowinski, R., Fred Hutchinson Cancer Center. Natural immunity to leukemia viruses and leukemia cells.
Lerner, R., Scripps Institute. Physiology of leukemia virus protein expression in normal mouse tissues.
PHYCOMYCES, August 2 - August 23
INSTRUCTORS
Delbruck, Max, Ph.D., Sc.D., California Institute of Technology, Pasadena
Sutter, Richard P., Ph.D., University of West Virginia, Morgantown
Cerda-Olmedo, Enrique, Ph.D., University of Seville, Seville, Spain
Cohen, Robert J., Ph.D., University of Florida, Gainesville
Lipson, Edward D., Ph.D., California Institute of Technology, Pasadena
ASSISTANT
Presti, David, M.S., California Institute of Technology, Pasadena
This course was designed for graduate students and research workers interested in the cellular and molecula
biology of signal handling. Lectures, discussions, and laboratory exercises dealt with Phycomyces, a single
celled, multinucleate organism which responds to a variety of environmental stimuli.
Experimental work included measurements of responses to light, gravity, obstacles, and wind; isolation a
mutants; phenotypic characterization of mutants; qualitative and quantitative complementation, using.
70
5011c
Li
St
and heterokaryons produced by microsurgical fusion; genetic crosses and recombination; and biochemical varia-
ifir- bles (cAMP, chitin synthetase) related to the sensory transduction processes.
i the PARTICIPANTS
Bacher, Adelbert, M.D., Universitat Hohenheim, Stuttgart, Federal Republic of Germany
Gauger, Wendell L., Ph.D., University of Nebraska, Lincoln
Koman, Ahmet S., B.S., Uppsala University, Uppsala, Sweden
Lapointe, David S., B.A., University of Florida, Gainesville
Lopez-Diaz, Isabel, M.S., University of Seville, Seville, Spain
Radin, David M., Ph.D., University of California, Berkeley
Torres-Martinez, Santiago, M.S., University of Seville, Seville, Spain
SEMINARS
Cerda-Olmedo, E., University of Seville. Mutagenesis of coenocytic organisms.
. Mutants of Phycomyces.
. Qualitative and quantitative complementation.
Phenotypic and genetic classification of behavioral mutants.
. Nuclear interaction and recombination in the sexual cycle.
Lipson, E., California Institute of Technology. Phototropism and the light growth response.
Other sensory responses.
Adaptation.
Cohen, R., University of Florida. The avoidance response.
DelbrOck, M., California Institute of Technology. The photoreceptor.
Sutter, R., University of West Virginia. Regulation of the first stage of sexual development.
with
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HARBOR SYMPOS I UM
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LYMPHOCYTE DIVERSITY
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Some ten years ago the concept that antibody specificity resided in
precise amino acid sequences became generally accepted. Serious
thought then began as to whether this meant that a separate germ-
line gene would exist for each of the very large number of light and
heavy immunoglobulin chains that are used to construct the many
thousands of different antibodies that a single vertebrate animal is hail
capable of generating. Though much discussion on this topic oc-
curred during our 1969 Symposium on antibodies, it was clear then 6'6
that many new facts had to be obtained before the genetic origin(s)
of antibody diversity would be understood. re
Over the past few years many of the experimental methodologies
necessary to give us these facts have emerged. Nucleic acid hy-
bridization techniques, for example, now provide a direct way to C`
count gene copies. So we thought the time was again ripe for a Br
Symposium to discuss the diversity question and hopefully this time re
to come up with firm answers-but with the qualification that the A'
answers might not be as simple as we once guessed.
Now the immunological response is no longer regarded as the irr
simple calling into action by antigens of lymphocytes already pre- .13'
determined for the synthesis of single antibodies. Not only are an
lymphocytes divisible into the broad B and T categories, but the
'EH
B-cell response generally requires some form of interaction with the mf
T lymphocyte. For reasons which are still unclear, a diversification bu
of the lymphocytes themselves is necessary for most immunological
responses. In this process, key roles are played by immune response Ca
genes that are coded by the same gene complex responsible for the tR.E
major histocompatibility surface antigens.
We thus suspect that we may not understand antibody diversity at
a fundamental level until we understand more deeply the
underlying cellular processes which generate so many lymphocyte
classes, each capable of finely tuned interaction with the others. So 'ess'c
we decided to use this Symposium to discuss antibody diversity :hairs
within the much broader field of lymphocyte diversity. This meant,
1.3.1however, that we would be looking over almost all of immunology,
and that we would be bringing together people with widely different stu
objectives and vocabularies. Choosing the right speakers was not \I D'
simple, and we are much indebted for advice given by Baruj Mi
Benacerraf, Gerald Edelman, Herman Eisen, Avrion Mitchison, Martin
Raff, and Matthew Scharff. The final program witnessed 87 formai ME
presentations before a total audience of 326, most of whom stayed for To
the entire week.
1,As in the past, key financial support was provided by the National , .e
sn
Institutes of Health, the National Science Foundation, and the United States Energy Research and Develop-
ment Administration. The very large number of speakers from abroad required still additional sources of
funds, and we are most indebted to Merck Sharp and Dohme Research Laboratories and Hoffmann-La
Roche, Inc., for their generous responses to our last-minute requests for assistance.
TUESDAY EVENING, June 1
Welcoming remarks: J.D. Watson, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Opening address: N.K. Jerne, Basel Institute for Immunology, Basel, Switzerland
TI in LYMPHOCYTE FUNCTION
ions
?f111-
WEDNESDAY MORNING, June 2
and
-lam, Session 1: T-cell markers and differentiation
Jai is Chairperson: R. Good, Memorial Sloan-Kettering Cancer Center; New York, New York
, or.
then G. Goldstein, M. Scheid, E.A. Boyse, A. Brand*, and D. Gilmour*, Memorial Sloan-Kettering Cancer Center;
*New York University Medical Center, New York: Thymopoietin and bursopoietin: Induction signals
regulating early lymphocyte differentiation.
I.L. Weissman, Department of Pathology, Stanford University Medical Center, California: Thymus and T-cell
id h. maturation.
say Lu
H. Cantor and E.A. Boyse*, Department of Medicine, Harvard Medical School, Sidney Farber Cancer Center,
Mora
Boston, Massachusetts; *Memorial Sloan-Kettering Cancer Center, New York: Regulation of the immune
is time
response by subclasses of T lymphocytes.
iatthe
L.A. Herzenberg, L.A Herzenberg, R.D. Stout, K. Okumura, and M.R. Loken, Department of Genetics,
Stanford University School of Medicine, California: Membrane antigens and receptors of the cells in
as the
immune response networks.
A.B. Gottlieb, M. Engelhard, and H.G. Kunkel, The Rockefeller University, New York: An unusual Ig (kappa)
antigen on the membrane of T and B lymphocytes.
ply are
out
the a.F. Williams, A.N. Barclay, M. Letarte-Muirhead, and R.J. Morris, MRC Immunochemistry Unit, Depart-
iith the
ment of Biochemistry, Oxford University, England: Purification, chemical composition, and tissue distri-
cation
bution of the rat Thy-1 antigens.
). Baltimore, P. Kung, A. Silverstone, T. Harrison, and R. McCaffrey, Center for Cancer Research, MIT,
i,,brise Cambridge, Massachusetts: Specialized DNA polymerases in lymphoid cells.
;the 3.R. Bloom, Albert Einstein College of Medicine, New York: Interactions of viruses with lymphocytes.
,rsity at
)Iy the
OcYLe ession 2: B-cell differentiation and commitment
iers, So
iiver5ity :ha irpers on : E. Diener, MRC Transplantation Group, University of Alberta, Edmonton, Alberta, Canada
meaflt, LT. Owen, Department of Anatomy, University of Newcastle upon Tyne Medical School, England: In vitro
1101°gYi studies of T and B lymphocyte maturation in the mouse embryo.
iiiierellt/I.D. Cooper, J.F. Kearney, P.M. Lydyard, C.E. Grossi, and A.R. Lawton, Departments of Pediatrics and
ofasncit Microbiology, University of Alabama, Birmingham: Comparative analysis of B-cell generation in mouse,
y Baru) man, and chicken.
tartio Melchers and R.A. Phillips*, Basel Institute for Immunology, Switzerland; *Ontario Cancer Institute,
/forillai Toronto, Canada: Immunoglobulin synthesis and turnover and mitogen reactivity of murine B lympho-
filed fc)ii cytes during ontogeny.
Pernis, Basel Institute for Immunology, Switzerland: Synthesis of multiple immunoglobulin classes by
National single lymphocytes.
WEDNESDAY EVENING, June 2
73
E.S. Vitetta, j. Can bier, J. Kettman, J. Forman, M.K. Sawyer, D. Spiva, and J.W. Uhr, Department of H.
Microbiology, University of Texas Southwestern Medical School, Dallas: Functional properties of subsets
of B lympbocytes bearing different receptor isotypes. K,
N.R. Klinman, N.H. Sigal, E.S. Metcalf, P.). Gearhart, and S.K. Pierce, Department of Pathology, University
of Pennsylvania School of Medicine, Philadelphia: The interplay of evolution and environment in B-cell
diversification. 1,1
J.J. Oebra, P.H. Gearhart, R. Kamat, S.M. Robertson, and J. Tseng, Department of Biology, The Johns
Hopkins University, Baltimore, Maryland: Origin and differentiation of lymphocytes involved in the
secretory IgA response. A.
J. Andersson, A. Coutinho, F. Melchers, and T. Watanabe, Department of Immunology, University of
Uppsala, Sweden, and Basel Institute for Immunology, Switzerland: Growth and maturation of lympho-
DN
cytes in culture. li
P.W. Kincade and P. Ralph, Sloan-Kettering Institute for Cancer Research, Rye, New York: Regulation of
c
clonal B- lymphocyte proliferation by anti-immunoglobulin or anti-la antibodies.
THURSDAY MORNING, June 3 J,v1
Session 3A: Helper and suppressor T cells and their products
Chairperson: B.H. Waksman, Yale University School of Medicine, New Haven, Connecticut
R.K. Gershon, D.D. Eardley, K.F. Naiford, and W. Ptak, Department of Pathology, Yale University School of
Medicine, New Haven, Connecticut: Factors involved in the generation of antigen-specific suppressor T
cells in vitro.
A. Basten, R. Lob lay, and E. Chia, Immunology Unit, University of Sydney, Australia: T-cell-dependent
influences in antibody production.
rH.N. Claman and J.W. Moorhead, Departments of Medicine and Microbiology, University of Colorado Bi
\1Medical School, Denver: Tolerance-Two pathways of negative immunoregulation in contact sensitivity 1
to DNFB.
M. Feldmann, P.C.L. Beverley, M. Dunk ley, P. Erb, S. Howie, A. Maoz, M. Mathies, I. McKenzie*, and J. 1A'
Woody, ICRF Tumor Immunology Unit, Department of Zoology, University College, London; Depart- U1
ment of Medicine, Austin Hospital, Victoria, Australia: Heterogeneity of T lymphocytes-Relationship to '.61
cell interactions in antibody production in vitro. lrr
T. Tada and M. Taniguchi, Laboratories for Immunology, School of Medicine, Chiba University, Japan: The thi
suppressive T-cell factor as an I- region gene product: Properties and the subregion assignment.
Session 3B: B-cell activation and tolerance
Chairperson: N.A. Mitchison, University College, London, England
pr(
Silo
Pa
' I
G. Moller, Division of Immunobiology, Wallenberg Laboratory, Karolinska Institute, Stockholm, Sweden: DE
The mechanism of B-cell activation.
G.J.V. Nossal, J.W. Stocker, B.L. Pike, and J.W. Goding, The Walter and Eliza Hall Institute of Medical Ke
Research, Melbourne, Australia: Hapten-specific B lymphocytes-Enrichment, cloning, receptor analysis, Fra
and tolerance induction.
..Ost
M.C. Raff, MRC Neuroimmunology Project, Department of Zoology, University College, London, England: Un
Immunoglobulin receptors for antigen on B lymphocytes.
THURSDAY EVENING, June 3
Session 4: Receptors Ihairi
Chairperson: H. Eisen, Massachusetts Institute of Technology, Cambridge, Massachusetts
\Vz
J.J. Marchalonis, J.M. Decker. D. DeLuca, J.W. Goding, J.M. Moseley, and G.W. Warr, The Walter and Eliza,
Na
Hall Institute, Parkville, Victoria, Australia: Lymphocyte surface immunoglobulin-Evolutionary origins;
ugland role in activation.
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H. Binz and H. Wigzell, Department of immunology, Uppsala University, Sweden: Naturally occurring
antigen-binding, idiotypic T-cell receptors.
K. Eichmann, C. Berek, G. Hammer ling, S. Black, and K. Rajewsky, Institute for Immunology and Genetics,
German Cancer Research Center, Heidelberg, and Institute for Genetics, University of Cologne, Federal
Republic of Germany: Genetic control of T- and B-cell receptor specificity in the mouse.
K. Rajewsky, U. Krawinkel, G.J. Hammerling, K. Eichmann, M. Cramer, S.J. Black, and C. Berek, Institute for
Genetics, University of Cologne, Federal Republic of Germany: Receptors and receptor interactions in
the immune system.
M. Nabholz and V. Miggiano, Basel Institute for Immunology, Switzerland: The generation of T-cell
specificity-A hypothesis.
D.H. Sachs, J.A. Berzofsky, A.N. Schechter, C.G. Fathman, D.S. Pisetsky, and R.H. Schwartz, National
Institutes of Health, Bethesda, Maryland: The immune response to staphylococcal nuclease-A probe of
cellular and humoral antigen-specific receptors.
P.A. Cazenave, D. Juy, and C. Bona, Institut Pasteur, Paris, France: Functional characterization of rabbit
lymphocytes carrying Fc receptor.
H.M. Grey, C. Anderson, K. von Eschen, C. Heusser, and J. Chiller, National Jewish Hospital and Research
Center, Denver, Colorado: Structural and functional heterogeneity of Fc receptors.
THE MAJOR HISTOCOMPATIBILITY COMPLEX
FRIDAY MORNING, June 4
Session 5: Structure of molecular products
2Pelld6' Chairperson: 0. Smithies, University of Wisconsin, Madison, Wisconsin
Color?'
J. Bridgen, C. Barnstable*, W.F. Bodmer*, M.J. Crumptont, P. Goodfellow*, and D. Snaryt, Laboratory of
Molecular Biology, Cambridge; *Genetics Laboratory, Oxford; tNational Institute for Medical Research,
3ensir London, England: Isolation and structure of histocompatibility (HL-A) antigens.
B.A. Cunningham, R. Henning, R.J. Milner, K. Reske, J.A. Ziffer, and G.M. Edelman, The Rockefeller
University, New York: Structure of murine histocompatibility antigens.
S.G. Nathenson, J.L. Brown, B.M. Ewenstein, J.H. Freed, and D.W. Sears, Department of Microbiology and
.iogs Immunology and Department of Cell Biology, Albert Einstein College ofMedicine, New York: Studies on
the structural properties of H-2K and H-2D transplantation antigens.
J.L. Strominger, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Biochemistry of
products of the major histocompatibility complex on the human lymphocyte surface.
J. Silver, M. Cecka, M. McMillan, and L. Hood, Division of Biology, California Institute of Technology,
Pasadena: Chemical characterization of products of the H-2 complex.
J.W. Uhr, H.D. Capra, E.S. Vitetta, J. Klein, D.G. Klapper, K. Artzt, E.A. Boyse, D. Bennett, and F. Jacob,
Department of Microbiology, University of Texas Southwestern Medical School, Dallas; Department of
Anatomy, Cornell University Medical College, New York; Immunology Division, Memorial Sloan-
Kettering Cancer Center, New York; Laboratoire de Genetique Cellulaire, Institut Pasteur et College de
France, Paris: Primary structure of products of chromosome 17 in the mouse.
or' L. os.tberg, L. Rask, and P.A. Peterson, Institute of Medical and Physiological Chemistry, Biomedical Center,
University of Uppsala, Sweden: ,82-Microglobulin and associated cell-surface antigens.
FRIDAY EVENING, June 4
Session 6: Genetics of the MHC and associated products
Chairperson: H.O. McDevitt, Stanford University School of Medicine, Stanford, California
D.C. Shreffler, C.S. David, S.E. Cullen, J.E. Neiderhuber, and J.A. Frelinger, Department of Genetics,
Washington University, St. Louis, Missouri; Immunology Branch, National Cancer Institute, Bethesda,
Maryland; Department of Microbiology, University of Michigan, Ann Arbor; Department of Microbiol-
ogy, University of Southern California at Los Angeles: Serological and functional subdivision of the I
region of the H-2 complex.
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J. Klein, V. Hauptfeld, and M. Hauptfeld, Department of Microbiology, University of Texas Southwestern
Medical School, Dallas: Number and relationship of H-2 loci coding for la and histocompatihility
antigens. VV.
F.H. Bach, M.L. Bach, B.J. Alter, H.W. Sol linger, and 0. Kuperman, lmmunobiology Research Center,
University of Wisconsin, Madison: Major histocompatibility antigens in allograft immunity. If'
W.F. Bodmer, C. Barnstable. J.G. Bodmer, E. Jones, B. Arce-Gomez, D. Snary*, and M.J. Crumpton*
Genetics Laboratory, University of Oxford; National Institute for Medical Research, London, England:
'
Genetics and serology of human HL-A linked la antigens. P,1
B. Benacerraf, M.E. Dorf, J.A. Kapp, and J. Theze, Department of Pathology, Harvard Medical School,
1
Boston, Massachusetts: The control of specific immune responses and specific immune suppression by '1'Y '
/-region genes.
R. Hyman and I. Trowbridge. The Salk Institute for Biological Studies, San Diego, California: Somatic )H
genetic studies on cell-surface-antigen variants. li
SATURDAY MORNING, June 5
Session 7: Role of histocompatibility gene products in T-cell cytolysis
Chairperson: J.F.A.P. Miller, The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia
R.M. Zinkernagel and P. C. Doherty*, Scripps Clinic and Research Foundation, La Jolla, California: *The ibsi
Wistar Institute, Philadelphia, Pennsylvania: H-2 antigens and specificity of virus-immune T
Altered-self or physiological interaction?
G.M. Shearer, A.M. Schmitt-Verhulst, T.G. Rehn, and G. Cudkowicz, Immunology Branch, National Cancer JR.
Institute, Bethesda, Maryland, and Department of Pathology, State University of New York, Buffalo: di
Generation of F, hybrid anti-parent cytotoxicity in vitro. 4F
M.J. Bevan, The Salk Institute for Biological Studies, San Diego, California: Recognition of minor histocom- Jo
patibility antigens by cytotoxic T lymphocytes. irr
U. Kozinowski and H. Ertl, Institute of Microbiology, University of Gottingen, Federal Republic of Germany:
Recognition of early vaccinia surface antigens by cytotoxic T lymphocytes (CTL) and dependence of 8(
syngeneic target cell lysis on SD antigen concentration. Ca
H. von Boehmer, J. Sprent, and W. Hass, Basel Institute for Immunology, Switzerland: The influence of H-2
gene products on cell-mediated and humoral immune responses. Be
J.W. Schrader, R. Henning, R.J. Milner, and G.M. Edelman, The Rockefeller University, New York: Interac-:161
tion of viral and H-2 antigens at cell surfaces. Ins
SATURDAY EVENING, June 5
Session 8: Expression of la antigens sio
Chairperson: D.C. Shreffler, Washington University, St. Louis, Missouri ulag
H.O. McDevitt, T.L. Delovitch, and J.L. Press, Division of Immunology, Department of Medicine, Stanford
University School of Medicine, California: Cellular expression of la antigens.
D.B. Murphy, K. Okumura, L.A. Herzenberg, and H.O. McDevitt, Division of Immunology, Department of Lan
Medicine, Stanford University School of Medicine, California: A Unique set of I-region-controlled Ins1
determinants on T but not B lymphocytes. allc
J.J. van Rood, A. van Leeuwen, M. Jonker, J. Keuning, and B. Bradley, Department of Immunohaematology,:kfi
University Hospital, Leiden, The Netherlands: Polymorphic B-cell determinants in man. ler
Nis
SUNDAY MORNING, June 6 Bray
ado
Session 9: Antigen presentation and T-B-cell interactions 'Cos
idio
Chairperson: B. Benacerraf, Harvard Medical School, Boston, Massachusetts L CI,
C.W. Pierce, J.A. Kapp, and B. Benacerraf, Department of Pathology, Harvard Medical School, Boston, rep(
76
;tern Massachusetts: Genetic restrictions in macrophagelymphoid cell interactions in antibody responses in
vitro.
W.E. Paul, E.M. Shevach, S. Pickeral, and A.S. Rosenthal, NIAID, National Institutes of Health, Bethesda,
It, Maryland: Genetic restriction in T- lymphocyte activation by antigen-pulsed peritoneal exudate cells.
J.F.A.P. Miller and M.A. Vadas, Experimental Pathology Unit, The Walter and Eliza Hall Institute of Medical
Aon' Research, Melbourne, Australia: Activation of distinct T-cell subsets by different major histocompatibility
;land complex gene products.
P. Lake and N.A. Mitchison, ICRF Tumour Immunology Unit, Department of Zoology, University College,
:hoof, London, England: Control of the immune response to cell-surface antigens.
onb\ S.L. Swain, P.E. Trefts, H. Tse, and R.W. Dutton, Department of Biology, University of California at San
Diego: The significance of T-B collaboration across haplotype barriers.
mati( D. H . Katz, Department of Pathology, Harvard Medical School, Boston, Massachusetts: The role of the
histocompatibility gene complex in lymphocyte differentiation.
alia
96ession 10: Antibody combining site
cells- Chairperson: E.A. Kabat, Columbia University, New York, New York
alco,,D.R. Davies and E.A. Padlan, NIAMDD, National Institutes of Health, Bethesda, Maryland: The three-
Buii, dimensional structure of the antibody combining site.
R.J. Poljak, L.M. Amzel, B.L. Chen, Y.Y. Chiu, R.P. Phizackerley, and F. Saul, Department of Biophysics, The
Johns Hopkins University School of Medicine, Baltimore, Maryland: Three-dimensional structure of
immunoglobulins.
E. Haber, M.N. Margolies, and L.E. Cannon, Massachusetts General Hospital and Harvard Medical School,
Boston: The combining site and framework structures of the variable domains of rabbit antipneumococ-
!Ildes' cal polysaccharide antibodies.
M. Potter, S. Rudikoff, M. Vrana, and N.D. Rao, Laboratory of Cell Biology, National Cancer Institute,
Bethesda, Maryland: Primary structural differences in myeloma proteins that bind the same haptens.
Givol, M. Gavish, R. Zakut, and M. Wilcheck, Department of Chemical Immunology, The Weizmann
Institute of Science, Rehovot, Israel: Synthetic approach to the problem of antibody diversity.
IMMUNOGLOBULINS
SUNDAY AFTERNOON, June 6
MONDAY MORNING, June 7
session 11: Allotypes and idiotypes
chairperson: R.M. Krause, National Institute of Allergy and Infectious Diseases, National Institutes of
Health, Bethesda, Maryland
, 51: R.G. Mage, G.O. Young-Cooper, J. Rejnek, A. Ansari, C. Alexander, E. Appella, M. Carta-Sorcini, C.
Landucci-Tosi, and R. Tosi, NIAID and NCI, National Institutes of Health, Bethesda, Maryland, and
03(5 Institute Superiore Sanita and CNR Laboratory for Cell Biology, Rome, Italy: Rabbit immunoglobulin
10(4 al lotypes-Complexities of their genetics, expression, structural basis, and evolution.
.B.A. Fraser, A.P. Johnstone, and T.J. Kindt, Laboratory of Immunology and Immunochemistry, The Rockefel-
)101' ler University, New York: Diversity in the rabbit antibody response to streptococcal immunization.
A. Nisonoff and S.-T. Ju, Department of Biology, Rosenstiel Basic Medical Sciences Research Center,
Brandeis University, Waltham, Massachusetts: Immune suppression of a cross-reactive idiotype and
adoptive transfer fo private idiotypes by cells from spleen or ascites.
H. Cosenza, A.A. Augustin, and M.H. Julius, Basel Institute for Immunology, Switzerland: Involvement of
idiotype and anti-idiotype interactions in immunoregulation.
Claflin, Department of Microbiology, University of Michigan, Ann Arbor: Uniformity in a clonal
repertoire-A case for a germ-line basis of antibody diversity.
sch'
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0. M5kela, K. Karjalainen, M. Julin, and A. Cattan, Department of Serology and Bacteriology, University of
Helsinki, Finland: Characterization of V,_, gene products by the fine-specificity and isoelectric focusing
antibodies.
W.R. Geckeler, B. Blomberg, C. de Preval, and M. Cohn, The Salk Institute for Biological Studies, San
Diego, California: Response genetics to a-1.3 dextran in mice.
MONDAY AFTERNOON, June 7
Session 12: Generation of diversity. 1. Biological aspects
Chairperson: M. Cohn, The Salk Institute for Biological Studies, San Diego, California
pl
'dita
B.A. Askonas, National Institute of Medical Research, London, England: Life style of B cells and the 01
constancy of the Ig product during clonal expansion. yyll
A.J. Cunningham, Department of Microbiology, John Curtin School, Australian National University, Can-
berra: Rapid variation among stimulated lymphocytes helps to generate the immune repertoire. 123
L. DuPasquier and M.R. Wabl, Basel Institute for Immunology, Switzerland: The ontogenesis of lymphocyte
diversity in amphibians.
D.H. Margulies, B. Dharmgrongartama, S.L. Morrison, M.L. Geftner, W. Cieplinski, and M.D. Scharff,
Department of Cell Biology, Albert Einstein College of Medicine, New York: Regulation of immuno-
globulin expression in mouse myeloma cells. ,Sess
C. Milstein, K. Adetugbo, D. Kerr, G. Kohler, and D.S. Secher, MRC Laboratory of Molecular Biology, la
Cambridge, England: Somatic cell genetics of antibody-secreting cells-Studies of clonal diversification
and analysis by cell fusion.
T.M.D. Cotner and H.N. Eisen, Center for Cancer Research and Department of Biology, MIT, Cambridge, A,C
Massachusetts: Regulation of production of an immunoglobulin light chain.
P.D. Gottlieb and P.J. Durda, Center for Cancer Research and Department of Biology, MIT, Cambridge, ti
Massachusetts: Genetic and structural studies of the IB-peptide marker in mouse VL regions and the 0
genetically linked Ly-3 thymocyte surface antigen.
11
R.P.
TUESDAY MORNING, June 8
th
Session 13: Generation of diversity. 2. Structural aspects
Chairperson: M.E. Koshland, University of California, Berkeley, California of
toL. Hood, P. Barstad, B. Eaton, V. Farnsworth, E. Loh, J. Hubert, J. Silver, and M. Weigert, Department of
DI
Biology, California Institute of Technology, Pasadena: Some genetic and evolutionary features of i m-
Ki
munoglobulins and transplantation antigens.
R. Riblet and M. Weigert, The Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia,
TrPennsylvania: Diversity of mouse antibodies.
jaiJ.D. Capra, D.G. Klapper, A. Tung, and A. Nisonoff, Department of Microbiology, University of Texas
PaHealth Science Center at Dallas, Southwestern Medical School, Dallas, and Rosenstiel Research Center,
WBrandeis University, Waltham, Massachusetts: Identical hypervariable regions in light chains of differing
VK subgroups.
P. Leder, D. Swan, T. Honjo, and J. Seidman, NICHD, National Institutes of Health, Bethesda, Maryland: say
reThe origin of antibody diversity-Evidence from hybridization studies.
G.P. Smith, University of Missouri, Columbia: Significance of hybridization kinetic experiments for theories Ca
of antibody diversity. an
S. Tonegawa, N. Hozumi, G. Matthyssens, and R. Schuller, Basel Institute for Immunology, Switzerland: M,
GcSomatic changes in content and context of immunoglobulin genes.
Sri
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stel
Summary: G. Edelman, The Rockefeller University, New York, New York
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Session 1: Genes and their transcripts
WEDNESDAY EVENING, May 12
131°1°R' Chairperson: J. Gross, Imperial Cancer Research Fund Laboratories,
iificatior London, England
mbridgc A. Cockburn, G. Frankel, R.A. Firtel, and M.J. Newkirk, Department
of Biology, University of California at San Diego, La Jolla: Struc-
mbrik tural organization of Dictyostelium ribosomal genes.
andthE N. Maizels, The Biological Laboratories, Harvard University, Cam-
bridge, Massachusetts: Using cloned DNA to look at the struc-
ture of Dictyostelium's genome.
R.P. Dottin, A.M. Weiner, and H.F.Lodish, Massachusetts Institute of
Technology, Cambridge: 5'-Terminal nucleotide sequences of
the messenger RNAs of Dictyostelium discoideum.
A.M. Weiner, R.P. Dottin, and H.F. Lodish, Massachusetts Institute
of Technology, Cambridge: The relationship between 5'-
terminal blocking groups and messenger RNA processing in
Dictyostelium discoideum.
00' K. Kindle, R.A. Firtel, W. Rowekamp, and G. Frankel, Department
of Biology, University of California at San Diego, La Jolla:
Transcription of single-copy genes in Dictyostelium.
A. Jacobson, C.D. Lane*, T. Altont, A. Goldin, M. Rosbash**, C.
offe` Palatnik, B. Beck, R. Davis*, M. Thomas*, C. Mabie, and C.
:he, Wilkins, University of Massachusetts Medical Center, Worcester;
,fdiffer'' *Medical Research Council, Mill Hill, London, England; +Mas-
sachusetts Institute of Technology, Cambridge; **Brandeis Uni-
rod0 versity, Waltham, Massachusetts; *Stanford University, Palo Alto,
California: Fractionation and purification of slime mold RNAs
y the° and their homologous genomic DNAs.
C. Mabie, K. Lowney, M. Koomey, C. Wilkins, T. Pedersen*, A.
vitie0 Goldin, and A. Jacobson, University of Massachusetts Medical
School, Worcester; *Worcester Foundation for Experimental
Biology, Shrewsbury, Massachusetts: In vitro transcription of the
Dictyostelium genome.
B.B. Young and H.F. Lodish, Massachusetts Institute of Technology,
Cambridge: Characterization of rRNA precursors in Dictyo-
stelium discoideum.
THURSDAY MORNING, May 13
Session 2: Biochemical differentiation and pattern formation
Chairperson: M. Sussman, University of Pittsburgh, Pittsburgh, Pennsylvania
B.E. Wright, Boston Biomedical Research Institute, Massachusetts: Enzyme expression in Dictyostelium EH
discoideum.
W.F. Loomis and S.R. Thomas, Department of Biology, University of California at San Diego, La Jolla:
Computer modeling of biochemical differentiation.
I. Takeuchi, Department of Botany, Kyoto University, Japan: Cell differentiation in Dictyostelium, with and
without morphogenesis.
P. Farnsworth, Department of Biology, University of California at San Diego, La Jolla: Quantitation of the 11
spatial distribution of prespore vacuoles in pseudoplasmodia. ;ft
C.D. Town, R.R. Kay, and J.D. Gross, Imperial Cancer Research Fund, London, England: Analysis of stalk 0
cell induction by cyclic AMP and the isolation of mutants with an altered response. 1'6
C.L. Rutherford, J.F. Harris, B.L. Jefferson, and J.B. Wilson, Department of Biology, Virginia Polytechnic
Institute and State University, Blacksburg: Cell-specific events occurring during differentiation of Dictyo- Fo
stelium discoideum.
M.A. Clark, University of Texas, Arlington: Nonrandom distribution of wild-type cells in mixed populations ,R,
of cellular slime molds. Zu
K.A. Killick, Boston Biomedical Research Institute, Massachusetts: The effect of endogenous polyribonuc- act
leotide phosphorylase activity on the assay of trehalose-6-P synthetase from myxamoebae of Dictyo-
stelium discoideum. fo
J. Sternfeld, Department of Biology, Princeton University, Princeton, New Jersey: Differentiation of Dictyo- du
stelium in submerged cultures. ,H,
chi
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THURSDAY EVENING, May 13
Session 3: Genetics and gene products
Chairperson: K. Raper, University of Wisconsin, Madison, Wisconsin
M.A. Wallace and K.B. Raper, Department of Bacteriology, University of Wisconsin, Madison: The bowre of
blisse: Development of macrocysts in Dictyostelium discoideum.
R.L. Dimond and W.F. Loomis, Massachusetts Institute of Technology, Cambridge; University of California,
at San Diego, La Jolla: The role of /3- glucosidase activity and relationships between the isozymes.
D.L. Welker and R.A. Deering, Department of Biochemistry and Biophysics, Pennsylvania State University,
University Park: Genetic analysis of radiation-sensitive mutations in the slime mold.
T. Muroyama, Y. Hashimoto, M. Sameshima, and T. Yamada, Genetics Laboratory, Tokyo Metropolitan on
Isotope Research Institute, Tokyo, Japan: The chromosome of the cellular slime molds.
,Irp(
R.C. Higgins and M.E. Dahmus, Department of Biochemistry and Biophysics, University of California at
Davis: Analysis of protein synthesis during development of Dictyostelium discoideum.
T. Alton and H.F. Lodish, Massachusetts Institute of Technology, Cambridge: Analysis of the pattern of Reg,
protein synthesis during development of discoideum and assay of the specific mRNAs by cell-free II, p,
translation.
'and
S.J. Free*, R.T. Schimket, and W.F. Loomist, *Stanford University, California; tUniversity of California at Kohl,
San Diego, La Jolla: The structural gene for a-mannosidase-1 in Dictyostelium discoideum. \ew
T. Pederson, Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts: Purification and n101(
composition of Dictyostelium chromatin. Fder
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FRIDAY MORNING, May 14
'Session 4: Membranes
Chairperson: H. Hohl, University of Zurich, Zurich, Switzerland
-B.H. Long and E.L. Coe, Biochemistry Department, Northwestern University Medical School, Chicago,
Illinois: Fatty acid composition of lipids from vegetative cells and mature sorocarps of Dictyostelium
discoideum.
;3. Weeks, Department of Microbiology, University of British Columbia, Vancouver, Canada: Manipulation
of the fatty acid composition of Dictyostelium discoideum and its effect on differentiation.
Poff and M. Skokut, MSU/ERDA Plant Research Laboratory, Michigan State University, East Lansing:
Thermosensory transduction by Dictyostelium discoideum.
..D. Rosen, P.C. Haywood, and S.H. Barondes, Department of Psychiatry, University of California at San
if Diego, La Jolla: Isolation of receptor for pallidin, a cell-surface lectin from the cellular slime mold,
Polysphondylium pallidum.
Siu, S.T. Stolp, and R.A. Lerner, Department of Immunopathology, Scripps Clinic and Research
Foundation, La Jolla, California: Expression of an endogenous lectin-ligand system during development of
Dictyostelium discoideum.
Hohl, E. Wehrli, and M. Buhlmann, Institute of Plant Biology, Cytological Laboratory, University of
Zurich, Switzerland: Ultrastructural and permeability changes of the plasma membrane following heat
i( activation of Dictyostelium discoideum.
I.E. Geltosky, C.-H. Siu, and R.A. Lerner, Department of Immunopathology, Scripps Clinic and Research
Foundation, La Jolla, California: Con A binding proteins on the cell surface of Dictyostelium discoideum
during development.
A.H. Hanna and E.C. Cox, Department of Biology, Princeton University, Princeton, New Jersey: Cell-surface
changes in developing Polysphondylium violaceum.
I.S. Eckert, R.W. Rubin, and R.N. Warren, Department of Biological Structure, University of Miami School
of Medicine, Florida: Developmental changes in contractile protein content of Dictyostelium amoebae.
.C. Mockrin and J.A. Spudich, Department of Biochemistry, University of California at San Francisco:
Control and assembly of contractile proteins from Dictyostelium discoideum.
gib
ession 5: Growth
tdI1
FRIDAY AFTERNOON, May 14
-hairperson: R. Deering, Pennsylvania State University, University Park, Pennsylvania
at
.T. Marin, Division of Biological and Medical Sciences, Brown University, Providence, Rhode Island:
of Regulation of early development in Dictyostelium discoideum by amino acid starvation and cell contact.
fee .W. Parish and U. Muller, Institute of Plant Biology, Cytological Laboratory, University of Zurich, Switzer-
land: Studies on the phagocytic vacuoles of Dictyostelium discoideum.
a1. Kobilinsky, B.I. Weinstein, and D.S. Beattie, Department of Biochemistry, Mt. Sinai School of Medicine,
New York, New York: Effects of ethidium bromide on mitochondrial biogenesis in the cellular slime
and mold Dictyostelium discoideum.
. Felenbok, F. Monier, M. Scrive, J. Leal, and J.F. Guespin-Michel, Institut de Microbiologie, University de
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Paris XI, Orsay, France: Effect of a thymidine analog, 5-bromodeoxyuridine, on Dictyostelium di 01
coideum development. New York, New York: Effect of division inhibitor
ondit6'M.D. Hanish, Biology Department, Hunter
College,
macromolecular synthesis in Dictyostelium discoideum in vivo.
IAM. Sameshima, T. Muroyama, Y. Hashimoto, and T. Yamada, Tokyo Metropolitan Isotope Research Institute, 0
Genetics Laboratory, Tokyo, Japan: The appearance of multinuclear cells in the life cycle of axe.g
strains of Dictyostelium discoideum.
Incorporation
H.M. Tsuchiya and J.F. Drake, Department of Chemical Engineering and Materials Science and Departme
nt
1b
of Microbiology, University of Minnesota, Minneapolis: Predation of E. coil by Dictyostelium discoideu
in chemostat cultures.
R.A. Deering, Department of Biochemistry and Biophysics, Pennsylvania State University,
Uptake of labeled precursors into nuclear and mitochondrial DNA during development of Dictyostelium
discoideum NC-4: Changes induced by radiation. !
P ark
qUO
J.H. Gregg and G.C. Karp, Department of Zoology, University of Florida, Gainesville:
3H-fucose by Dictyostelium discoideum.
haii
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SATURDAY MORNING, May 15 1.-1.
Ur
Session 6: Aggregation
NQ
Chairperson: J. Bonner, Princeton University, Princeton, New Jersey Ge
Jar
L. Kobilinsky and D.S. Beattie, Department of Biochemistry, Mt. Sinai School of Medicine, New York, Ne
ele
York: The induction of filopodia in Dictyostelium discoideum by cyclic adenosine monophosphate. Ahr
P. Wier, Department of Biology, Princeton University, New Jersey: The relation of cyclic AMP and
alit
cell-bound phosphodiesterase to the duration of the interphase period in Dictyostelium. Mic
P. Brachet, M. Darmon, C. Klein, J. Barra, P. Barrand, and L.H. Pereira da Silva, Department of Molecula00
Biology, Institut Pasteur, Paris, France: Intercellular communications and cell aggregation in Dicty0Vai
stelium discoideum. Pd
A.S. Tsang and M.B. Coukell, Department of Biology, York University, Downsview, Ontario, Canada]Hisl
Genetic and biochemical evidence for the existence of multiple cAMP phosphodiesterases in Dictyo4A
stelium purpureum. Gels
W.J. Kuo and E.L. Coe, Biochemistry Department, Northwestern University Medical School, Chicago Cali
Illinois: Response of suspensions of Dictyostelium discoideum amoebae to additions of cAMP, cGM13'
folic acid, and prostaglandins detected by light-scattering changes.
R.P. Futrelle, Department of Genetics and Development, University of Illinois, Urbana: Computer analysis o
cell motion in Dictyostelium development. I. Simulations. II. The GALATEA film analysis system. pion
H.V. Rickenberg and H.J. Rahmsdorf, Division of Molecular and Cellular Biology, National Jewish Hospit4
and Research Center, and Department of Biophysics and Genetics, University of Colorado School oiairpe
Medicine, Denver, Colorado: The inhibition of the formation of cAMP and of development in Dictyo
stelium discoideum by metabolizable sugars. Mitst
B. Wurster, Biozentrum der Universitat Basel, Switzerland: Stimulation of cell development in DictyosteliurrMea
discoideum by folic acid pulses.
la
J. Sampson, Imperial Cancer Research Fund, Mill Hill, London, England: Protein kinase activity during th(Depa
development of Dictyostelium discoideum.
rON'
E.F. Rossomando and M.A. Hesla, Department of Oral Biology, University of Connecticut, FarmingtonE lac
Time-dependent changes in Dictyostelium discoideum adenylate cyclase activity upon incubation wit Postg
ATP.
to
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DNA INSERTIONS
Arranged by
AHMAD I. BUKHARI, Cold Spring Harbor Laboratory
JAMES SHAPIRO, University of Chicago
SANKAR ADHYA, National Institutes of Health
126 participants
TUESDAY EVENING, May 18
\l'elcoming remarks: A. I. Bukhari, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
'ntroduction: J. Shapiro, University of Chicago, Chicago, Illinois
6ession 1: The IS-type sequences
-Chairperson: M. Malamy, Tufts University, Boston, Massachusetts
HH. Ohtsubo and E. Ohtsubo, Department of Microbiology, State University of New York at Stony Brook:
Isolation of inverted repeat sequences, including IS1, IS2, and IS3 in the E. coli plasmids.
L.T._ Chow, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York: The organization of insertion
sequences on the E. coli chromosome.
Schmidt, J. Besemer, and P. Star linger, Institut fur Genetik der Universitat Köln, Weyertal, Federal
Republic of Germany: The isolation and characterization of IS1 and IS2 DNA.
H.-J. Reif and H. Saedler, Institut fOr Genetik der Universitat KOln, Weyertal, and Institut fur Biologie III,
Universitat Freiburg, Federal Republic of Germany: IS1-dependent deletion formation in the gel region of
E. coli.
°. Nevers, H.-J. Reif, and H. Saedler, Institut fur Biologie III, Universitat Freiburg, Federal Republic of
Germany: A mutant of Escherichia coli defective in IS1-mediated deletion formation.
H. Saedler, Institut fur Biologie III, Universitat Freiburg, Federal Republic of Germany: The role of the DNA
so elements IS1 and IS2 in the evolution of chromosomal and some plasmid DNAs.
A. Ahmed, Department of Genetics, University of Alberta, Edmonton, Alberta, Canada: Reversion of the gal3
di's mutation of E. coli.
Mickel, E. Ohtsubo, and W. Bauer, Department of Microbiology, State University of New York at Stony
all' Brook: Small plasmids generated from R-factor R12 by in vivo recombination at an IS1 sequence.
1. Van Montagu*t, Ch. Genetello t, G. Englert J.-P. Hernalsteens*, I. Zaenent, N. van Larebeket, A. de
Picker t, and J. Schell*t, *Laboratorium Genetische Virologie, Vrije Universiteit Brussel; t Laboratoria
lada: Histologie en Genetika, Rijksuniversiteit Gent, Belgium: Inserts and gene transposition in a large plasmid
of Agrobacterium tumefaciens.
Geisselsoder, L. Souza, A. Hopkins, and R. Calendar, Department of Molecular Biology, University of
California at Berkeley: P4 phage carrying nonhomologous DNA.
WEDNESDAY EVENING, May 19
ssion 2A: Drug resistance translocation elements
hairperson: D. Botstein, Massachusetts Institute of Technology, Cambridge, Massachusetts
ctl°i
1
iI Mitsuhashi, H. Hashimoto, S. lyobe, Y. Ike, and R. Katsumata, Department of Microbiology, School of
1
, Medicine, Gunma University, Maebashi, Japan: The formation of conjugative drug resistance (R) plasmid.
t.A. Jacoby, A.E. Jacob*, and R.W. Hedges*, Massachusetts General Hospital, Boston: *Bacteriology
Department, Royal Postgraduate Medical School, London, England: Recombination between Pseudo-
monas aeruginosa plasmids of incompatibility groups P-1 and P-2.
E. Jacob, R.W. Hedges, N. Datta, N.J. Grinter, and P.T. Barth, Department of Bacteriology, Royal
'i Postgraduate Medical School, London, England: Characterization of transposons determining resistance
' to ampicillin and streptomycin, and trimethoprim and streptomycin.
83
D.B. Clewell and Y. Yagi, University of Michigan, Ann Arbor: Amplification of the tetracycline resistance
determinant on the Streptococcus faecalis plasmid pAMa1.
L.A. Mac Hattie and J .B. Jackowski, Department of Medical Genetics, University of Toronto
Massachusetts:
Loss
Structure and excision properties of an IS 1 -bracketed drug resistance determinant carried by phage Xcam.
L. Rosner and M. Gottesman*, Laboratory of Molecular Biology, NIAMDD, National Institutes of Health,
Bethesda, Maryland; *Department of Anatomy, Harvard Medical School, Cambridge,
ss of the chloramphenicol-resistance gene from Xcam.
A.I. Bukhari and S. Froshauer, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York: Some
properties of the TnC element.
D.E. Berg, Department of Biochemistry, University of Wisconsin, Madison: The transposable kanamycin
resistance determinant TnK(1).
B. Allet and D. Berg, University of Geneva, Switzerland; University of Wisconsin, Madison: Deletions of the
transposable element TnK(1) and restriction-endonuclease and EM-heteroduplex mapping of TnK(1).
WEDNESDAY AFTERNOON, May 19
Session 28: Drug resistance translocation elements
Chairperson: R. Novick, Public Health Research Institute of the City of New York, New York, New York
N. Kleckner, K. Reichardt, and D. Botstein, Department of Biology, Massachusetts Institute of Technology
Cambridge: Imprecise excision of the translocatable tetracycline resistance element TnT(1).
R. Jorgensen, D. Berg, and B. Allet*, University of Wisconsin, Madison; *University of Geneva, Switzerland
Restriction fragments and RNA polymerase binding sites of the TnT(1) element.
J. Brevet, P. Nisen, D.J. Kopecko, and S.N. Cohen, Stanford University School of Medicine, California
Promotion of insertions and deletions by translocating segments of DNA carrying antibiotic resistance
genes.
F. Heffron, P. Bedinger, J. Champoux, and S. Falkow, Department of Microbiology, University of Washing-
ton, Seattle: Biochemical deletion mutations affecting transposition of TnA.
G. Weinstock and D. Botstein, Massachusetts Institute of Technology, Cambridge: Specialized transduction
of ampicillin resistance by phage P22.
J.-P. Hernalsteens, R. Villarroel-Mandiola, M. Van Montagu, and J. Schell, Laboratorium Genetische Vir-
ologie, Vrije Universiteit Brussel, Belgium: Insertion of TnA in R factors.
P.J. Kretschmer and S.N. Cohen, Stanford University School of Medicine, California: Selection for replicons
containing the TnA translocation segment: General method for selected translocation.
Session 3: Nomenclature of insertion elements
Chairperson: H. Lewis, National Science Foundation, Washington, D.C.
Discussion
WEDNESDAY EVENING, May 19
Session 4: Bacteriophage Mu
Chairperson: A.L. Taylor, University of Colorado Medical Center, Denver, Colorado
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A. Toussaint and M. Faelen*, Universite Libre de Bruxelles, Department de Biologie Moleculaire, Rhode St. e(
Genese, Belgium; *UNAM Instituto de Investigaciones Biomedicas Mexico, Mexico: Mu-mediated il-
Chlegitimate recombination.
P. van de Putte, G.C. Westmaas, C.A. Wijffelman, and M. Giphart, Department of Biochemistry, University, do
,s,
of Leiden, The Netherlands: On the kil gene of bacteriophage Mu.
A.I. Bukhari, S. Froshauer, L. Chow, E. Ljungquist, H. Khatoon, and F. DeBruijn, Cold Spring Harbo Oh
Laboratory, Cold Spring Harbor, New York: Integration and excision of bacteriophage Mu. el
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B.T. Waggoner, M.L. Pato, and A.L. Taylor, Division of Molecular and Cellular Biology, National Jewish
Hospital and Research Center, and Department of Microbiology, University of Colorado Medical Center,
Denver: Characterization of heterogeneous circular (Hc) DNA from heat-induced bacteriophage Mu-1
lysogen
L.T. Chow, R. Kahmann, and D. Kamp, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York:
Electron microscopic studies of viable Mu phage containing deletions and substitutions.
E. Ljungquist and A.I. Bukhari, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York: Bac-
teriophage Mu-The problem of circles.
M.M. Howe, M. Schnos, and R.B. Inman, University of Wisconsin, Madison: Packaging of bacteriophage
Mu DNA.
L.T. Chow and A.I. Bukhari, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York: The invertible
G sequence of phage Mu DNA is identical to the invertible sequence of phage P1 DNA.
D. Figurski, R. Meyer, D. Miller, and D.R. Helinski, Department of Biology, University of California at San
Diego, La Jolla: Generation in vitro of deletions of the P-type plasmid RK2 using Mu insertions and a
restriction endonuclease.
D.D. Moore, J.P. Schumm, M.M. Howe, and F.R. Blattner, University of Wisconsin, Madison: Insertion of
Mu DNA fragments into phage X in vitro.
M. Van Montagu*t, S. Van den Elsackert, G. Englert, J.P. Hernalsteens*, A. Silvat, F. Van Vliet*, and J.
Schell*±, *Laboratorium Genetische Virologie, Vrije Universiteit Brussel; taboratoria Histologie en
Genetika, Rijksuniversiteit Gent, Belgium: The translocation of chromosomal genes onto R plasmids with
a wide host range.
Session 5A: The eukaryotic systems
THURSDAY MORNING, May 20
Chairperson: M. Meselson, Harvard University, Cambridge, Massachusetts
R.F. Baker and C.A. Thomas, Jr., Department of Biological Chemistry, Harvard Medical School, Boston,
ion Massachusetts: Palindromes in the Drosophila genome.
R.F. Baker and D.G. Dickinson, Department of Biological Sciences, University of Southern California at Los
Jir Angeles: Methylation of palindromes in sea urchin embryo DNA.
R. Egel, Institut fiir Biologie III, Universitat Freiburg, Federal Republic of Germany: Transposition of mating
on` type genes in fission yeast.
B. McClintock, Carnegie Institution of Washington, Cold Spring Harbor, New York: Transposable chromo-
somal elements in maize.
I.M. Greenblatt, Genetics and Cell Biology Section, Biological Sciences Group, University of Connecticut,
Storrs: Enhancement of crossing over by modulator in maize.
P.A. Peterson, Department of Agronomy, Iowa State University, Ames: The position hypothesis for control-
ling elements in maize.
Session 5B
Chairperson: J. Sambrook, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
M. Botchan, W. Topp, and J. Sambrook, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York:
The structure of simian virus 40 genes in transformed cells.
J. Skare and W.C. Summers, Yale University School of Medicine, New Haven, Connecticut: Nucleotide
sequence arrangements in the genome of herpes simplex virus and their relation to insertion elements.
le R.J. Jacob, G.S. Hayward, S.C. Wadsworth, and B. Roizman, Department of Microbiology, University of
II Chicago, Illinois: The inverted repeat regions of herpes simplex virus DNA. I. A structural characteriza-
tion
G.S. Hayward, T.G. Buchman, R.J. Jacob, and B. Roizman, Microbiology Department, University of
Chicago, Illinois: Inverted repeat regions in the DNA of herpes simplex virus. II. Sequence diversity in
dibo relation to various inter- and intramolecular recombination events.
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THURSDAY AFTERNOON, May 20
Session 6: Influence of insertion elements on gene expression
Chairperson: R. Weisberg, National Institutes of Health, Bethesda, Maryland
S. Adhya, D. Court, A. Das, M. Gottesman, S. Hilliker, and 0. Reyes, National Institutes of Health, Bethesda
Maryland: Influence of insertion elements on gene expression.
A. Das, D. Court, and S. Adhya, National Institutes of Health, Bethesda, Maryland: Insertional polarity is
mediated by the transcription termination factor rho.
N.C. Franklin, Department of Biological Sciences, Stanford University, California: Possible polar insertions
in the N operon of A.
P.K. Tomich and D.I. Friedman, Department of Microbiology, University of Michigan, Ann Arbor: Mutations
in an insertion sequence that relieve polarity.
E. Mosharrafa, W. Pilacinski, J. Zissler, M. Fiandt*, W. Szybalski*, Department of Microbiology, University '11
of Minnesota, Minneapolis; *McArdle Laboratory for Cancer Research, University of Wisconsin, Madi-
son: Polar and antipolar insertion sequences IS2 near the gene for prophage A excision.
J. Besemer, Institut fdr Genetik der Universitat Koln, Weyertal, Federal Republic of Germany: Suppression of
C
insertion mutations within the gal operon of E. coli.
S. Torti, F. Halpern, and M. Malamy, Department of Biology, Tufts University School of Medicine, Boston,
Massachusetts: Effect of external suppressor on insertion polarity. la
B. Rak, Institut hir Genetik der Universitat Koln, Weyertal, Federal Republic of Germany: IS2 carries
a [r
promoter and a signal for specific RNA cleavage. ,
S.R. Jaskunas and M. Nomura, Institute for Enzyme Research, University of Wisconsin, Madison: Use of
insertion mutations to study the organization of ribosomal protein genes in E. coli. !1
1 II
REFRIDAY MORNING, May 21
Session 7: Integrative recombination
It(
Chairperson: A. Campbell, Stanford University, Palo Alto, California prf
R.A. Weisberg, Laboratory of Molecular Genetics, NICHHD, National Institutes of Health, Bethesda, 131
Maryland: What we think we know about site-specific recombination in phage
L.W. Enquist and R.A. Weisberg, Laboratory of Molecular Genetics, NICHHD, National Institutes of Health, 'Pe
Bethesda, Maryland: Genetic studies of site-specific recombination in phage A. tCC
H.A. Nash, National Institute of Mental Health, National InstitUtes of Health, Bethesda, Maryland: The
biochemistry of site-specific recombination of phage
H.I. Miller and D.I. Friedman, Department of Microbiology, University of Michigan, Ann Arbor: Isolation of ous
site-specific recombination.E. coli mutants unable to support A.
A. Campbell and L. Heffernan, Department of Biological Sciences, Stanford University, California: Regula-
tion of A integrase.
D. Court and S. Adhya*, National Institute of Mental Health and *National Cancer Institute, National
CanInstitutes of Health, Bethesda, Maryland: Regulation of the genes for A integration and excision.
G. Schulz and M. Stodolsky, Department of Microbiology, Loyola University, Stritch School of Medicine,
.1
p ri
Maywood, Illinois: Specialized PlargF transducing phage.
K. Shimada, S. Maeda, and Y. Takagi, Department of Biochemistry, Kyushu University School of Medicine, Can
Fukuoka, Japan: Translocation of ampicil lin resistance from Rldrd onto CoIE1 -gua plasmids. sari
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Summary: S. Brenner, University of Cambridge, Cambridge, England
FRIDAY AFTERNOON, May 21
Special session: Use of insertion elements for in vivo genetic engineering
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NINA TUMOR VIRUSES
rranged by
IiTHOMAS AUGUST, Albert Einstein College of Medicine
424 participants
WEDNESDAY EVENING, May 26
i°11)pening Address: Thomas August, Albert Einstein College of Medicine, Bronx, New York
ion
-,ession 1: Endogenous viruses
sitaairperson: H. Temin, McArdle Laboratory, University of Wisconsin, Madison, Wisconsin
icli-
:.V. Prochownik, S. Panem, and W.H. Kirsten, Departments of Pathology and Pediatrics, University of
nal Chicago, Illinois: Induction of infectious type-C virus from clonal populations of normal human cells by
2-deoxy-D-glucose and 5-iodo-2'-deoxyuridine.
.tonr).R. Rapp*, W. Mark+, and R. Callahan*, *National Institutes of Health, Bethesda, Maryland, and +McArdle
Laboratory, University of Wisconsin, Madison: Endogenous ecotropic C-type viruses from non-
es a transformed and transformed cells of AKR, C3H, and BALB/c.
Wong-Staal, D. Gillespie, and R. Gallo, Laboratory of Tumor Cell Biology, National Cancer Institute,
National Institutes of Health, Bethesda, Maryland: Proviral sequences related to a baboon endogenous
type-C RNA virus in DNA from human leukemic tissues.
. Moroni, N. Teich, and J. Schumann, Friedrich Miescher Institut, Basel, Switzerland; Imperial Cancer
Research Fund, London, England; Research Department, Pharma Division, CIBA-Geigy Ltd., Basel,
Switzerland: Mitogen induction of endogenous C-type viruses.
.0. Warnaar, J. to Velde, G. van Muijen, F. Prins, and J.C.H. de Man, Department of Pathology, University
Medical Center, The Netherlands: Biochemical and electron-microscopical evidence for the
presence of oncornaviruses in spleen tissue of two patients with hematological malignancies.
+1.L. Niman*, J.R. Stephenson+, M.B. Gardner**, and P. Roy-Burman*, Departments of **Pathology and
A, *Biochemistry, University of Southern California School of Medicine at Los Angeles; +Viral Car-
'°`" cinogenesis Branch, National Cancer Institute, Bethesda, Maryland: Analysis of feline RNA-tumor-virus-
specific gene expressions in various types of cat neoplasia.
1ZC. Gallo, F. Wong-Staal, R.E. Gallagher, P. Markham, F. Ruscetti, R.G. Smith, D.H. Gillespie, and M.S.
Th
Reitz, National Cancer Institute and Litton Bionetics, Bethesda, Maryland: Distribution of replicating
type-C virus, proviral DNA, and viral RNA in different tissues of a gibbon ape (H. lar) with "spontane-
ous" leukemia-lymphoma.
n 'V. Klement, M.L. Bryant, M.B. Gardner, and M.F. Dougherty, Departments of Pediatrics, Microbiology, and
Pathology, University of Southern California School of Medicine at Los Angeles: Wild mouse leukemia
Pk virus complex.
_,1.14/.N. Drohan, D. Colcher, and J. Schlom, Meloy Laboratories, Inc., Springfield, Virginia, and National
I° Cancer Institute, Bethesda, Maryland: Natural distribution of Mason-Pfizer monkey virus sequences in the
primate population.
)I' -.J. Sherr, R.E. Benveniste, M.M. Lieber, and G.J. Todaro, Viral Leukemia and Lymphoma Branch, National
Cancer Institute, Bethesda, Maryland: Type-C viruses containing endogenous primate and Kirsten-
P sarcoma-related gene sequences.
R.E. Benveniste, C.J. Sherr, and G.J. Todaro, Viral Leukemia and Lymphoma Branch, National Cancer
Institute, Bethesda, Maryland: Baboon type-C viral genes-A study of primate evolution and interspecies
viral transfer.
ii. Ikawa, Y. Uchiyama, M. Aida, and M. Obinata, Laboratory of Viral Oncology, Cancer Institute, Tokyo,
Japan: Differentiation and virus release among several Friend leukemia cell lines of different origin.
i.C. Chen and P.K. Vogt, Department of Microbiology, University of Southern California School of Medicine
at Los Angeles: New endogenous RNA tumor viruses isolated from normal avian cells.
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The Nether)P. Bentvelzen, J. Brinkhof, and J.J. Haaijman,
Radiobiological Institute TNO, Rijswijk
Genetic and epigenetic control of the expression
of endogenous murine mammary tumor viruses. ands:tic
Callahan, R.E. Benveniste, G.J. Todaro, and C.J. Sherr, Viral Leukemic and Lymphoma Branch, National
,
Cancer Institute, Bethesda, Maryland:
Isolation of infectious type-B and type-C viruses from the
rodent Mus cervicolor.
 Asian
K. Huebner, C.L. Green, and C.M. Croce, Wistar Institute of Anatomy and Biology, Philadelphia, pen '
vania: Induction of endogenous BALB viruses in mouse-human hybrids segregating mouse chrom osonme
syH
THURSDAY MORNING, May 27
Session 2: Virus-cell interaction
Chairperson: D. Baltimore, Massachusetts Institute of Technology, Cambridge, Massachusetts a.
D. Tsuei and C. Friend, Center for Experimental Cell Biology, Mt. Sinai School of Medicine of the Cit.
University of New York: Synthesis of virus in Friend leukemia cells in vitro.
N. Rosenberg and D. Baltimore, Center for Cancer Research, MIT, Cambridge, Massachusetts: In vitrn
transformation by Abelson murine leukemia virus.
J.S. Rhim and R.J. Huebner, Microbiological Associates, Inc., and National Cancer Institute, NIH, Bethesda
Maryland: Transformation of rat epithelial cells by Kirsten sarcoma virus. "I
G. Calothy and B. Pessac, Institut du Radium, Orsay, France: Growth stimulation of chick embryo neuroret.
inal cells infected with Rous sarcoma virus and morphological transformation: Further genetic analysis.
R.L. Heberling, S.S. Kalter, J.W. Eichberg, and B. McCullough, Southwest Foundation for Research
ancEducation, San Antonio, Texas: Fibrosarcomas in dogs and nonhuman primates induced by a baboon.
type-C-virus-murine-sarcoma pseudotype.
J.W. Gautsch, H.G. Bedigian, and H. Meier, The Jackson Laboratory, Bar Harbor, Maine: A short
-terry
quantitative XC assay for murine leukemia virus and the influence of steroid hormones on syncyti
formation.
H.W. Snyder, E. Fleissner, M. Fox, and T. Pincus, Memorial Sloan-Kettering Cancer Center, New York,
anc
Stanford University Medical Center, California: Antigenic specificities of antibodies in normal humar
sera reactive with antigens in preparations of mammalian type-C viruses.
G.J. Vosika and B.J. Kennedy, University of Minnesota, Minneapolis: Antibody to C-type RNA viral protein,
in human sera.
T. Aoki, M. Liu, M.J. Walling, G.S. Bushar, and K.C. Hsu, Laboratory of Viral Carcinogenesis, Nationa
Cancer Institute, Bethesda, Maryland, and Department of Microbiology, Columbia University, New York G.
Human natural antibody to type-C viruses from primates.
G.B. Rossi, A. Dolei, L. Cioe, G.P. Matarese, A. Benedetto, and G. Rita, Section of Virology, Institut
Superiore Sanita, and Institute of Virology, University of Rome, Italy: Differentiation inhibition of Frien0(
leukemia cells by interferon.
B.J. Weimann*, J. Schmidt*, W. Ostertagt, J.C. Kriegt, N. Kluge-I-, P. Swetly**, and J. Pragnellt, *Basal,(
Institute for Immunology, Switzerland; ±Max-Planck-Institut fur Experimentelle Medizin, Gottingen
Federal Republic of Germany; **Ernst-Bohringer-Institut fiir Arzneimittelforschung, Wien, Austria; tE3ea
son Institute for Cancer Research, Glasgow, Scotland: Intracisternal A-type particles in virus-positive an I
-negative mouse and human cells in culture. G.F
B.A. Wolf and A.R. Goldberg, The Rockefeller University, New York: Isolation of Rous sarcoma viru
transformed cells having low levels of plasminogen activator activity. S.
V. Mautner, R. Eisenman, P.W. Robbins, and R.O. Hynes, Center for Cancer Research and Department (
Biology, MIT, Cambridge, Massachusetts: Immunological detection of cell surface alterations in virus
transformed fibroblasts.
E. Wang and A.R. Goldberg, The Rockefeller University, New York: Changes in surface topography an
microfilament organization upon transformation of chick embryo fibroblasts with Rous sarcoma virus.
M. Okayama, S. Roth, J. Chi, M. Muto, M. Yoshimura, and A. Kaji, Department of Microbiology, School Ses
Medicine, University of Pennsylvania, Philadelphia: Transformation of chicken chondrocytes by Rm.
sarcoma virus. Cha
88
si
l0
vit
es(
roe
sis,
bor
t-tel
!pi
lug
bleu
itioN
0
THURSDAY EVENING, May 27
Session 3: Viral proteins
Chairperson: Thomas August, Albert Einstein College of Medicine, Bronx, New York
P. O'Donnell, E. Stockert, and A. De Leo, Memorial Sloan-Kettering Cancer Center, New York: Induction of
G1 and GCSA cell-surface antigens after infection by ecotropic and xenotropic MuLVs in vitro.
M. Barbacid, J.R. Stephenson, and S.A. Aaronson, National Cancer Institute, Bethesda, Maryland: The gag
gene of mouse type-C RNA viruses.
O.N. Witte and I.L. Weissman, Department of Pathology, Stanford University Medical Center, California:
Cellular maturation of oncornavirus glycoproteins-Topological arrangement of two forms in cellular
membranes.
A. Sen and G.J. Todaro, National Institutes of Health, Bethesda, Maryland: Type specificity of binding of
viral p12 core protein to homologous viral RNA in the gibbon-woolly monkey type-C virus group.
R. Eisenman, R. Shaikh, and M. Linial*, Center for Cancer Research, MIT, Cambridge, Massachusetts; *Fred
Hutchinson Cancer Research Center, Seattle, Washington: Aberrant precursor polypeptides in cells
infected with cloned recombinants of RAV -O and PR-RSV.
S. Hino, J.R. Stephenson, and S.A. Aaronson, National Cancer Institute, NIH, Bethesda, Maryland: Glycopro-
teins of endogenous mouse type-C viruses.
B.M. Gallis*, R.N. Eisenman+, and H. Diggelmann*, *Swiss Institute for Experimental Cancer Research,
Lausanne, Switzerland; +Center for Cancer Research, MIT, Cambridge, Massachusetts: Synthesis of the
precursor to avian RNA tumor virus internal structural proteins early after infection.
P. Roy-Burman, E.G. Hayman, H. Niman, and B.K. Pal, Departments of Pathology and Biochemistry,
University of Southern California School of Medicine at Los Angeles: Phosphoproteins of RNA tumor
viruses: Further structural and biological studies.
M.M.C. Lai and M.J. Hayman, Department of Microbiology, University of Southern California School of
Medicine at Los Angeles: On the structure of envelope glycoproteins in Rous sarcoma virus.
R.B. Naso, R.B. Arlinghaus, L.J. Arcement, G.A. Jamjoom, and W. L. Karshin, Department of Biology, The
University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston: A
model for the synthesis and cleavage of Rauscher leukemia virus proteins.
M.S. Halpern and R.N. Leamnson, Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania: The
subunit structure of the glycoprotein complex of avian tumor virus.
E.J. Smith, J. Ignjatovic, and L.B. Crittenden, Regional Poultry Research Laboratory, East Lansing, Michigan:
Expression of avian leukosis sarcoma virus antigens in chicken lines.
G. Schochetman and J. Schlom, Meloy Laboratories, Inc., Springfield, Virginia, and National Cancer
Institute, NIH, Bethesda, Maryland: Independent polypeptide chain initiation sites for the synthesis of
sii10
different classes of mouse mammary tumor virus proteins.
S.K. Ruscetti, E.M. Scolnick, and W.P. Parks, National Cancer Institute, NIH, Bethesda, Maryland: Charac-
terization of the feline oncornavirus-associated cell membrane antigen.
W.G. Robey*, M.K. Oskarrson*, M. Scherert, C. Long+, P.J. Fischinger**, and G.F. Vande Woude*,
*Laboratory of DNA Tumor Viruses, National Cancer Institute, NIH, Bethesda, Maryland; Flow
Laboratories, Rockville, Maryland; **Laboratory of Viral Carcinogenesis, National Cancer Institute, NIH,
Bethesda, Maryland: Properties of ml Moloney murine sarcoma virus P60.
G.F. Okasinski and L.F. Velicer, Department of Microbiology and Public Health, Michigan State University,
East Lansing: The synthesis of precursor polypeptides of FeLV structural proteins.
1 -S. Tung, J.H. Elder, R.A. Lerner, E. Fleissner, and E.A. Boyse, Memorial Sloan-Kettering Cancer Center,
New York, and Scripps Clinic and Research Foundation, La Jolla, California: Polymorphism of MuLV
gp70 envelope proteins expressed in mouse cells.
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FRIDAY MORNING, May 28
Js,
ill( Session 4: Mutant or defective viruses
ROL Chairperson: H. Hanafusa, The Rockefeller University, New York, New York
89
J.G. Levin, Laboratory of Molecular Genetics, NICHHD, NID1-1-,trBeeattheedsdcea,llsM:
murine leukemia virus messenger RNA in actinomycin
with virions lacking high-molecular-weight viral RNA.
D. Galehouse and P. Duesberg, Department of Molecular Biology, University of California at Berkeley;
Differences in the glycoproteins of avian tumor virus recombinants: Evidence for intragenic crossing.
over.
M.S. Reitz, C.D. Trainor, A.M. Wu, and R.C. Gallo, National Cancer Institute, NIH, Bethesda
Loss of viral genetic information in A revertants of mouse fibroblasts nonproductively transformed with r
Kirsten murine sarcoma virus.
LicH.M. Murphy, Imperial Cancer Research Fund Laboratories, London, England: Genetic analysis of 5
sarcoma viruses defective in replication.
A.E. Frankel and P.J. Fischinger, Laboratory of Viral Carcinogenesis, National Cancer Institute, NiHod,
Bethesda, Maryland: The nature and distribution of the Moloney sarcoma virus genome.
S. Kawai, H. Hanafusa, and P.H. Duesberg, The Rockefeller University, New York, and Department
of 111Molecular Biology, University of California at Berkeley: Transformation defective mutants of RSV-(
Formation of wild-type sarcoma virus by recombination with a temperature-sensitive mutant.
S. Kawai and H. Hanafusa, The Rockefeller University, New York: Recombination between a temperature-
so
sensitive mutant and a deletion mutant of Rous sarcoma virus.
J.A. Bilello, M. Strand, and J.T. August, Department of Molecular Biology, Albert Einstein College of Sc
Medicine, Bronx, New York: Phenotypic and genotypic mixing during rescue of murine sarcoma virus se
transformed cells.
D. Myerson, R. Rongey*, V. Klement*, and J.T. August, Department of Molecular Biology, Albert Einstein
Cl
College of Medicine, Bronx, New York; *University of Southern California School of Medicine at Los
Angeles: A defective Kirsten murine sarcoma virus-woolly monkey virus pseudotype.
; L
W.S. Mason and C. Yeater, The Institute for Cancer Research, Philadelphia, Pennsylvania: A mutant of Rous
sarcoma virus with a conditional defect in the determinant(s) of viral host range.
,o
F. Tato, J.A. Beamand, and J.A. Wyke, Department of Tumor Virology, Imperial Cancer Research Fund
Laboratories, London, England: Early function affected in the RSV temperature-sensitive mutant is LA30m (3
PR-A.
Ho
D.A. Zarling and H.M. Temin, McArdle Laboratory for Cancer Research, University of Wisconsin, Madison:
Spontaneous mutation of avian sarcoma virus B77. kl
E.M. Scolnick, D. Williams, J. Maryak, and R.J. Goldberg, National Cancer Institute, NIH, Bethesda,I.Bis
Maryland: Naturally occurring and exogenously produced nonproducer cells containing the rat se -'Mir
quences of Kirsten sarcoma virus.
of
P.T. Peebles, E.M. Scolnick, and R.S. Howk, Laboratory of Tumor Virus Genetics, National Cancer Institute, Stu
NIH, Bethesda, Maryland: Increased sarcoma-virus-specific RNA in cells transformed by usually non-
transforming RNA leukemia type-C viruses: A model for leukemogenesis.
FRIDAY EVENING, May 28
Session 5: RNA structure and sequence
hairy
Chairperson: P. Vogt, University of Southern California, Los Angeles, California M.;
Ser
P.T. Peebles, M. Strand, and J.T. August, Laboratory of Tumor Virus Genetics, National Cancer Institute, Vosl
NIH, Bethesda, Maryland, and Department of Molecular Biology, Albert Einstein School of Medicine, car
Bronx, New York: Moloney leukemia virus gp69/71 and p30 protein expression of the Moloney sarcoma frib
virus and models for a common gene map for oncogenic mammalian type-C viruses and for generation of Hai
their deletion mutant sarcoma viruses.
E. Hunter, M. Hayman, and A. Tereba, Department of Microbiology, University of Alabama, Birmingham, Net
and Department of Microbiology, University of Southern California at Los Angeles: A mechanism for k
genetic recombination in the avian RNA tumor viruses.
P.H. Duesberg, L.-H. Wang, P. Mellon, W.S. Mason*, and P.K. Vogt f, Department of Molecular Biology and uni
Virus Laboratory, University of California at Berkeley; *Institute for Cancer Research, Philadelphia,
riav
90
Pennsylvania; 1-Department of Microbiology, University of Southern California at Los Angeles: Towards a
complete genetic map of Rous sarcoma virus.
D. Dina, K. Beemon, and P. Duesberg, Department of Molecular Biology and Virus Laboratory, University of
California at Berkeley: The 28S Moloney sarcoma virus RNA contains leukemia virus-specific nucleotide
R sequences.
G. Shanmugam, Institute for Molecular Virology, St. Louis University School of Medicine, Missouri: Cleav-
age of murine leukemia virus 35S RNA and double-stranded polynucleotides by microsome-associated
id nuclease.
R. Joho, E. Stoll, R. Friis*, M. Billeter, and C. Weissmann, Institut fdr Molekularbiologie I, Universitat Zdrich,
lir Switzerland; *Institut fur Virologie, Giessen, Federal Republic of Germany: Partial genetic map of Rous
sarcoma virus RNA.
IN.). Hayman and P.K. Vogt, Department of Microbiology, University of Southern California School of
Medicine at Los Angeles: Subgroup-specific antigenic determinants of avian RNA tumor virus structural
:0 proteins-Analysis of virus recombinants.
V-1P.E. Neiman, D. Mac Donnell, S. Das, and C. McMillin, University of Washington and Fred Hutchinson
Cancer Research Center, Seattle: Distribution of "exogenous" nucleotide sequences in polyadenylated
ur0 subunits of RSV RNA.
Balduzzi, J.R. Christensen, and Y.M. Pearson, Department of Microbiology, University of Rochester
ec School of Medicine and Dentistry, Rochester, New York: Provisional genetic mapping of temperature-
yin sensitive mutants of avian sarcoma virus defective in transformation.
W. Bender, S. Hu, Y.H. Chien, P. Chandler, S. Dube, H.J. Kung, N. Davidson and J. Maisel*, Department of
.slE Chemistry, California Institute of Technology, Pasadena; *Department of Molecular Biology, University of
ti California at Berkeley: A common structure for the high-molecular-weight RNAs of all type-C viruses?
S. Hu, N. Davidson, M.O. Nicolson, and R.M. McAllister, Department of Chemistry, California Institute of
R( Technology, Pasadena, and Childrens' Hospital, University of Southern California School of Medicine,
Los Angeles: A heteroduplex study of the sequence relations between RD-114 and BKD RNAs.
Junghans, S. Hu, C.A. Knight, and N. Davidson, Department of Molecular Biology, University of
gCr California at Berkeley, and Department of Chemistry, California Institute of Technology, Pasadena:
Heteroduplex studies of avian RNA tumor virus genomes.
lisoM Bondurant, S. Hashimoto, and M. Green, Institute for Molecular Virology, St. Louis University Medical
School, Missouri: Methylation of Moloney murine leukemia virus RNA subunits.
K. Bister, W. Bender*, Y. Chien*, N. Davidson*, H.E. Varmust, E. Hunter, and P.K. Vogt, Department of
0- Microbiology, University of Southern California School of Medicine at Los Angeles; *California Institute
of Technology, Pasadena; tDepartment of Microbiology, University of California at San Francisco:
50 Studies on the inactivation of RNA tumor viruses by UV irradiation.
(0'
SATURDAY MORNING, May 29
3ession 6: Provirus
:Chairperson: P. Neiman, University of Washington, Seattle, Washington
= Zhdanov, D.I. Ivanovsky Institute of Virology, Moscow, USSR: Double and triple integrations of viral
genomes by cell DNA.
F. Yoshimura, D. Smotkin, and R.A. Weinberg, Department of Biology and Center for Cancer Research, MIT,
0, Cambridge, Massachusetts: Restriction endonuclease mapping of the proviral DNA of Moloney MuLV.
Fritsch, N. Battula, and H.M. Temin, McArdle Laboratory for Cancer Research, University of Wisconsin.
04 Madison: Formation and properties of the provirus of spleen necrosis virus.
'A.J. van den Berg, K. Nooter, J.B. de Vries, and P. Bentvelzen, Radiobiological Institute TNO, Rijswijk, The
00, Netherlands: Transfection of murine hemopoietic cells with proviral DNA of the Rauscher leukemia
for virus.
M.A. Baluda, M. Shoyab, M.N. Dastoor, and R.M. Evans, Department of Microbiology and Immunology,.
i0 University of California School of Medicine at Los Angeles: Studies on integration site of avian oncor-
.
13i navirus proviral DNA.
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cells.
, wash
I
H. Okabe, J. Du Buy, and R.V. Gilden, National Cancer Institute, NIH, Bethesda
y, ,nivets't
'
M. Hatanaka,
' MarYla d ,/Flow Laboratories Inc., Rockville, Maryland, and The Frederick Cancer Research Center, Seattk,, ,-NY.
ington: A possible factor determining the persistent production of RNA tumor viruses from
G. Ringold, K. Yamamoto, and H.E. Varmus, Departments of Microbiology and Biochemists I I ;
California at San Francisco: Infection of rat hepatoma cells with mouse mammary tumor vi1"11
rus_Characterization of viral DNA and studies on the mechanism of glucocorticoid action.
P.R. Shank, J.M. Bishop, and H.E. Varmus, Department of Microbiology, University of California
Medic
f i
Center, San Francisco: A cytoplasmic precursor to covalently closed circular avian sarcoma virus DNA
l
1N. Mueller-Lantzsch, L.E. Hatlen, and H. Fan, The Salk Institute for Biological Studies, San Diego Cali,nia: Immunoprecipitation of murine leukemia virus-specific polyribosomes-Identification
of virus-speci°c1
f
messenger RNA. ,co
D. Spector, T. Padgett, H.E. Varmus, J.M. Bishop, and C. Moscovici*, Department of MicrobiologyUniversity of California Medical Center, San Francisco; *Tumor Virology, Veterans Administration
a
Hospital, Gainesville, Florida: RNA related to the transforming gene(s) of avian sarcoma viruses
in norm
and chemically transformed avian cells.
.
W.S. Hayward and H. Hanafusa, The Rockefeller University, New York: Expression of avian RNA tumo
virus genes.
D.J. Fujita, J. Tal, H.E. Varmus, J.M. Bishop, S. Kawai, and H. Hanafusa, Department of Microbiology.
University of California at San Francisco, and The Rockefeller University, New York: cDNAgpA,
a probespecific for the envelope glycoprotein gene of avian tumor viruses.
isii91
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SATURDAY AFTERNOON, May 29
tgi
CarSession 7: Host control
roo
Chairperson: R. Risser, NIAID, National Cancer Institute, Bethesda, Maryland
Cal
hugA. Ishimoto, W.P. Rowe, and J.W. Hartley, Laboratory of Viral Diseases, National Institute of Allergy ant(
Infectious Diseases, NIH, Bethesda, Maryland: Host-range restriction in mouse cells of xenotropic MuL\
Misgenome with ecotropic virus coat.
H.S. Tucker, J.H. Weens, P. Tsichlis, R. Khiroya, and R.S. Schwartz, Hematology Service, New Engla4
Medical Center Hospital, Boston, Massachusetts: Genetic resistance to MuLV related to the H-2 complex
R. Risser, M. Cancro, M. Potter, and W.P. Rowe, NIAID and National Cancer Institute, NIH, Bethesd401
Maryland: Genetic control of susceptibility to Abelson murine leukemia virus.
N. Hopkins, K. Whalen, and P. Traktman, Department of Biology and Center for Cancer Research, MIP(
Cambridge, Massachusetts: N-tropic variants obtained after coinfection with N- and B-tropic murinIMUI
ternleukemia viruses.
k IP. Jolicoeur* and D. Baltimore, Department of Biology and Center for Cancer Research, MIT, CambridgEhrid
Massachusetts: Effect of Fv-1 gene product on accumulation of virus-specific DNA and on integration c,Hiz
proviral DNA in permissive and nonpermissive murine cells infected with MuLV.
A.F. Gazdar, J.E. Delarco, H.K. Oie, and J.D. Minna, Veterans Administration Hospital, Washington, D.C.Dur
and the National Cancer Institute, NIH, Bethesda, Maryland: Expression of surface receptors for murin
leukemia virus strains on hamster x mouse hybrid cells.
W.K. Yang*, R.W. Tennant* and A. Brown-t-, *Biology Division, Oak Ridge National Laboratory, Tennessee
tDepartment of Microbiology, University of Tennessee, Knoxville: Cellular RNA specific for transfer
Fv-1 locus restriction of murine leukemia viruses.
M. Linial, Department of Medicine, Division of Oncology, University of Washington School of Medicin
and The Fred Hutchinson Cancer Research Center, Seattle, Washington: Infection of C/B chicken cells blem
tipsubgroup B Rous sarcoma virus.
CoreS.K. Datta and R.S. Schwartz, Hematology Service, New England Medical Center Hospital, Boston, Ma'frar
sachusetts: Genetics of expression of xenotropic virus and autoimmunity in NZB mice.R. Soeiro and M.M. Sveda, Departments of Medicine and Cell Biology, Albert Einstein College of Medicin
Bronx, New York: Host restriction of Friend leukemia virus.
relai
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Kashmiri*, A. Rein*, R.H. Bassint, and B.I. Gerwint, *Litton Bionetics, Inc. and t National Cancer
14 Institute, Bethesda, Maryland: NB-tropic MuLV phenotypically acquires B-tropism during mixed infection
1 with B-tropic MuLV.
3. Duran-Troise*, R.H. Bassin*, B.I. Gerwin*, and A. Reint, *National Cancer Institute, NIH and tLitton
16-
Bionetics, Inc., Bethesda, Maryland: Abrogation of Fv-1 restriction in BALB/3T3 cells following infection
with N-tropic MuLV.
Q,-1.L. Robinson, Division of Infectious Diseases, Stanford University School of Medicine, California: An
intracellular restriction on the growth of induced subgroup E avian C-type viruses in chicken cells.
114W O'Brien, J.M. Simonson, and C.W. Boone, National Cancer Institute, NIH, Bethesda, Maryland: A new
edit genetic locus which restricts endogenous type-C virus production in feline x mouse hybrid cells.
)11:1
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ession 8: Reverse transcriptase
SUNDAY MORNING, May 30
ihairperson: K. Moelling, Max Planck Institute for Molecular Genetics, West Berlin, Germany
V.K. Yang*, A.M. Wut, and R.C. Gallo**, *Biological Division, Oak Ridge National Laboratory, Tennessee;
tBionetic Research Laboratory, Bethesda, Maryland; **Laboratory of Tumor Cell Biology, National
Cancer Institute, NIH, Bethesda, Maryland: Cellular proline tRNAs-Specific interaction with high-
molecular-weight-form (HMW) reverse transcriptase and 30-40S RNA of MuLV.
).P. Nayak, A.R. Davis, and B.S. Vayuvegula, Department of Microbiology and Immunology, University of
California School of Medicine at Los Angeles: Studies on RNA templated DNA polymerase reactions in
human bladder tumor cells in culture.
V) P. Grandgenett and A.J. Faras*, Institute for Molecular Virology, St. Louis University Medical Center,
Ng\ Missouri, and *Department of Microbiology, University of Minnesota, Minneapolis: Different states of
avian myeloblastosis virus DNA polymerase and their binding capacity to primer tRNAT").
ig131(
.F. Gerard, Institute for Molecular Virology, St. Louis University School of Medicine, Missouri: Multiple
nbonuclease H activities in mammalian RNA tumor viruses.
hes°. Moelling and R.R. Friis, Max Planck Institute for Molecular Genetics, West Berlin, and Institute for
Virology, University of Giessen, Federal Republic of Germany: Comparative studies between avian and
murine viral reverse transcriptase-RNase H complex and analysis of the DNA polymerase of two avian
oft
temperature-sensitive mutants.
Haseltine* and D. Baltimore, Department of Biology and Center for Cancer Research, MIT, Cam-
rl bridge, Massachusetts: Ordered transcription of RNA tumor virus genomes.
Hizi and W.K. Joklik, Department of Microbiology and Immunology, Duke University Medical Center,
Durham, North Carolina: Isolation, characterization, and enzymic activities of the polypeptide chain of
avian sarcoma virus DNA polymerase.
Olin Lei s and R. Smith, Departments of Surgery and Microbiology and Immunology, Duke University Medical
Center, Durham, North Carolina: DNA transcription by processive AMV polymerase with 60S and 34S
lesseE vi rus RNA.
sfOf wWu *, W.-K. Yangt, T. LeBon, and R.C. Gallo**, *Bionetics Research Laboratory and **Laboratory of
Tumor Cell Biology, NCI, Bethesda, Maryland; tBiological Division, Oak Ridge National Laboratory,
dicin Tennessee: Functional significance of high-molecular-weight-form (HMW) mammalian virus reverse
transcriptase.
Cordell, H.M. Goodman, and J.M. Bishop, Department of Microbiology, University of California at San
Mair Francisco: The nucleotide sequence of primer required for binding to the avian sarcoma virus genome
and for the initiation of DNA synthesis.
licirli-H. Lai and I.M. Verma, Tumor Virology Laboratory, The Salk Institute, San Diego, California: Structural
relationship of subunits of reverse transcriptase from avian myeloblastosis virus.
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MOLECULAR ASPECTS OF 1(ic OPERON
CONTROL
arranged by
WILLIAM REZNIKOFF, University of Wisconsin
JEFFREY MILLER, University of Geneva
117 participants
WEDNESDAY EVENING, June 30
A Tribute to Jacques Monod: Melvin Cohn, The Salk Institute, San Diego, California
Session 1: Genetic studies of the repressor
Chairperson: S. Bourgeois, The Salk Institute, San Diego, California
J.H. Miller, C. Coulondre, U. Schmeissner, A. Schmitz, and P. Lu*, Department of Molecular Biology,
,(University of Geneva, Switzerland; *Department of Chemistry, University of Pennsylvania, Philadelphia:
1r'Genetic analysis of the lac repressor.
M. Schlotmann, N. Geisler, and K. Beyreuther, Institut fur Genetik der Universitat Koln, Weyertal, Federal
Republic of Germany: Biochemical characterization of mutant lac repressors.
M. Pfahl, The Salk Institute, San Diego, California: Tight-binding repressors and consequences
of an r
increased affinity of a repressor for DNA.
J.R. Sadler and J.L. Betz, Department of Biophysics and Genetics, University of Colorado Medical Center, NfDenver: Tight-binding mutants of the repressor.
1(A. Schmitz, C. Coulondre, and J.H. Miller, Department of Molecular Biology, University of Geneva,Ir
Switzerland: Altered repressors which bind operator more tightly resulting from suppressed nonsense
mutations.
J.R. Sadler, C.R. Norwood, J. Miwa, M. Tecklenburg, T.F. Smith, and J.L. Betz, Department of Biophysics anct
Genetics, University of Colorado Medical Center, Denver: The modularity of the lactose repressor'
operator interaction.
raTHURSDAY MORNING, July 1
Session 2: Structural studies on the lac repressor
Chairperson: W. Gilbert, Harvard University, Cambridge, Massachusetts
S. Bourgeois*, R.L. Jernigan**, E.A. Kabatt, S.C. Szu**, and T.T. WO, *The Salk Institute, San Diego
California; **Laboratory of Theoretical Biology, National Cancer Institute, Bethesda, Maryland; ±Nationa
Cancer Institute, Bethesda, Maryland and Columbia University, New York; tDepartment of Engineerir
Sciences, Northwestern University, Evanston, Illinois: Composite predictions of secondary structure of lac!
repressor.
K. Weber*, N. Geisler*, and J.G. Filest, *Max Planck Institute for Biophysical Chemistry, Gottingen, Federa
Republic of Germany; tDepartment of Cell Biology, University of Colorado, Boulder: Studies orq
repressor fragments.
K. Beyreuther, Institut fur Genetik der Universitat Koln, Weyertal, Federal Republic of Germany: Analysis o
-a
lac repressor conformations by proteolysis-The mechanisms of induction.
CK.S. Matthews, A.A. Burgum, B.E. Friedman, R.B. Gorman, and C.F. Sams, Department of Biochemistry, Ricc,
University, Houston, Texas: Chemical studies on lac repressor.
P. Lu, M. Jarema, M. Lillis, H. Sommer, and J. Miller*, Department of Chemistry, University of Pennsylvania
Philadelphia; *Department of Molecular Biology, University of Geneva, Switzerland: Spectroscopir,
studies on lac repressor.
C.-W. Wu, F.Y.-H. Wu, and P. Bandyopadhyay, Department of Biophysics, Albert Einstein College o
Medicine, New York: Allosteric transition of lac repressor from Escherichia coli.
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J.C. Maurizot, M. Charlier, F. Cu lard, and C. Helene, Centre de Biophysique Moleculaire, Orleans, France:
Interaction of inducers and anti-inducers with lac repressor-A circular dichroism study.
M.T. Record, Jr., T.M. Lohman, and P.L. de Haseth, Department of Chemistry, University of Wisconsin,
Madison: Interpretation of ion effects on lac repressorDNA interactions.
ACI.G. Berg and C. Blomberg, Department of Theoretical Physics, Royal Institute of Technology, Stockholm,
Sweden: Mass action relations in vivo.
THURSDAY EVENING, July 1
Session 3: The lac operator and its recognition by the repressor
Chairperson: J. Miller, University of Geneva, Geneva, Switzerland
W. Gilbert, Harvard University, Cambridge, Massachusetts: The contacts between lac repressor and DNA.
C.P. Bahl*, R. Dickerson+, K. Itakurat**, S. Lin**, S.A. Narangt, A.D. Riggs**, J. Rosenberg+ and R. Wu*,
*Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, New York; +California
)111a Institute of Technology, Pasadena; **City of Hope National Medical Center, Duarte, California; tDivision
of Biological Sciences, National Research Council of Canada, Ottawa, Ontario: Studies on lac repressor
ref' recognition of synthetic lac operator molecules.
M.H. Caruthers, D.V. Goeddel, R. Loder, D. Cribbs, and D. Yansura, Department of Chemistry, University of
,1 Colorado, Boulder: Synthesis of lac operator DNA sequences.
P.H. von Hippel, A.P. Butler, R.B. Winter, A. Revzin, A. Wang, and Y.K. Huang, Institute of Molecular
NitEr Biology and Department of Chemistry, University of Oregon, Eugene: Interaction of lac repressor with
non-operator DNA.
ie\a,
;e0
M. Charlier, J.C. Maurizot. F. Cu lard, and C. Helene, Centre de Biophysique Moleculaire, Centre Nationale
de Recherches Scientifiques, Orleans, France: Circular dichroism, fluorescence, and photochemical
, studies of lac repressorinducerDNA interactions.
5 anUJ. Rosenberg*, C.P. Bahl+, H. Boyer**, R.E. Dickerson*, H.M. Goodman**, H. K. Itakura**, 0.
essol Kallai*, M. Kopka*, S. Lint, S.A. Narang§, A.D. Riggst, R. Scheller*, J. Shine**, and R. Wu+, *California
Institute of Technology, Pasadena; tCornell University, Ithaca, New York; **University of California at
San Francisco; tCity of Hope National Medical Center, Duarte, California; §National Research Council
of Canada, Ottawa, Ontario: The insertion of chemically synthesized lac operator DNA into plasmid
DNA and demonstration of biological activity.
M. Pfahl and S. Bourgeois, The Salk Institute, San Diego, California: Isolation of "super-operator" mutants.
)iego
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FRIDAY MORNING, July 2
ofiac?ession 4: More on the R-0 interaction and studies on the lac I gene promoter
Phairperson: W. Reznikoff, University of Wisconsin, Madison, Wisconsin
'Ora
t/rr.J. Richmond and T.A. Steitz, Department of Molecular Biophysics and Biochemistry, Yale University, New
Haven, Connecticut: Crosslinking of lac repressor to poly[d(A U -HgX)] -The size of the DNase protected
° oligonucleotides.
R.T. Ogata, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Cross-linking of lac
,Ric`' repressor to BrdU-substituted lac operator.
Farabaugh, The Biological Laboratories, Harvard University, Cambridge Massachusetts: The secondary
,anla repressor binding site acts as an attenuator in vivo.
Maxam, W. Gilbert, G. Copenhaver, H. Donis-Keller, N. Rosenthal, and D. States, Department of
Biochemistry and Molecular Biology and Department of Biology, Harvard University, Cambridge, Mas-
ge u sachusetts: Extended nucleotide sequences in the lac operon.
1.W. Chan and R.D. Wells, Department of Biochemistry, University of Wisconsin, Madison: Mung bean
nuclease causes a specific single-stranded nick at the control region of the lactose operon.
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Geneva,U. Schmeissner, D. Ganem,
and J.H. Miller, Department of Molecular Biology, University of
Switzerland: Deletion analysis of the I gene
and its regulatory region.
D.A. Steege, Department of
Molecular Biophysics and Biochemistry, Yale University, New Haven, Connec-
ticut: Nucleotide sequence of
the 5 end of E. coli lactose repressor mRNA.
B. Muller-Hill, Institut hir Genetik
der Universitat Köln, Weyertal, Federal Republic of Germany: pro
mutations of the I gene.
Promoter
FRIDAY EVENING, July 2
Session 5: The lac promoter and its
recognition by RNA polymerase and CAP
Chairperson: A. Riggs, City of Hope
National Medical Center, Duarte, California
W. Reznikoff, W. Barnes, R.
Dickson, and J. Abelson, Department of Biochemistry, University of Wisconsin,
Madison, and Department of Chemistry, University
of California at San Diego: The lac promoter
and its
recognition by RNA polymerase.
J. Majors and L. Johnsrud, The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Interactions between CAP factor, RNA
polymerase, and the lac promoter.
R. Musso, R. DiLauro, B. de Crombrugghe,
and I. Pastan, Laboratory of Molecular Biology, National Cancer
Institute, Bethesda, Maryland: Structure
and function of the regulatory region of the galactose operon of
E. coli.
A. Ullmann, Departement de Biochimie et Genetique
Microbienne, Unite de Biochimie Cellulaire, Institut
Pasteur, Paris, France: Catabolite modulating compound-A possible mediator of catabolite repression. it,
E. Eilen, C. Pampeno, and J.S. Krakow, Department of Biological Sciences, Hunter College of the City
University of New York: Studies on proteolytic and sulfhydryl modification of cAMP receptor protein or-109
E. coli
W.J. Schrenk and D.E. Morse, Department of Biological Sciences, University of California, Santa Barbara:
Suppression of leaky mutations by deletion of the Ion gene.
S. Mitra, G. Zubay, and A. Landy*, Department of Biological Sciences, Columbia University, New York;I
*Division of Biological and Medical Sciences, Brown University, Providence, Rhode Island: Restrictiorr
fragments-A model system for studying the regulation of the lac operon.
SATURDAY MORNING, July 3
Session 6: 13-Galactosidase and other lac systems
Chairperson: I. Zabin, University of California, Los Angeles, California
III
lsioa
Casa
A.V. Fowler, A.J. Brake, and I. Zabin, Department of Biological Chemistry, UCLA School of Medicine, abMole(
Molecular Biology Institute, University of California at Los Angeles: The structure of /3- galactosidase. studyi
F. Celada, Departments of Biological Chemistry and Bacteriology, University of California at Los Angele0a,
and Laboratorio di Biologia Cellulare, Italian Research Council, Rome: Immunological studies cider
/3- galactosidase. nit
C.C. Jones, R.S.T. Loeffler, M.L. Sinnott, P.J. Smith, I.J.L. Soucbard, and S.G. Withers, Department of OrganiNshn
Chemistry, University of Bristol, United Kingdom: Catalytic mechanism of f3- galactosidase.
J.M. Yon, O.M. Viratelle, and P.J. Deschavanne, Laboratoire d'Enzymologie Physico-Chimique efhulor
Moleculaire, Universite de Paris-Sud, Orsay, France: Enzymatic properties of /3-galactosidase from #14ge
coli. Comparison between the wild-type enzyme and a point mutant-C.Z.P. protein. I 3rur
R.E. Huber, R. Sept, and M. Babiak, Department of Biochemistry, University of Calgary, Alberta, Canadvnst
Evidence for partially separate mechanisms of /3- galactosidase (E. coli) for allolactose production and fiTing,
galactose and glucose production. et,
J. Manley, Cold Spring Harbor Laboratory, New York: Abnormal polypeptides encoded by the lac Z gene. oell
N. Guiso and A. Ullmann, Departement de Biochimie et Genetique Microbienne, Unite de Biochimi1,1
Cellulaire, Institut Pasteur, Paris, France: Expression and regulation of lactose genes carried by plasmids.
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E.C.R. Reeve, Institute of Animal Genetics, Edinburgh, Scotland: Differences between the lac operons of
Klebsiella and Escherichia coll.
B.G. Hall, Faculty of Medicine, Memorial University of Newfoundland, Canada: Regulation of the second E.
coli f3- galactosidase ebg enzyme.
SATURDAY AFTERNOON, July 3
"Session 7: p-Calactoside permease and the y gene
T.H. Wilson and J. Flagg, Department of Physiology, Harvard Medical School, Boston, Massachusetts:
Lactose transport and its energetics.
n'W.D. Nunn and J.E. Cronan, Jr., Department of Molecular Biophysics and Biochemistry, Yale University,its New Haven, Connecticut: Integration of the permease and membrane lipid synthesis.
R.C. Tuttle, M.J. Newman, and M.H. Saier, Jr., Department of Biology, University of California at San Diego,
Allosteric regulation of lactose and melibiose transport in Escherichia coli cells and membrane vesicles.
A.C. Hobson, D. Gho, and B. MO Iler-Hill, Institut fiir Genetik der Universitat Köln, Weyertal, Federal
Ker, Republic of Germany: Genetical analysis of the lac y gene.
"A.L. Koch and D.R. Purdy, Microbiology Department, Indiana University, Bloomington: The energy cost of
galactoside transport to Escherichia coli.
Yariv, Department of Biophysics, Weizmann Institute of Science, Rehovot, Israel: Alkylation of g-
oo. galactosidase and of f3- galactoside permease with a specific label.
Andrews and E.C.C. Lin, Department of Microbiology and Molecular Genetics, Harvard Medical School,
ell° Boston, Massachusetts: Thiogalactoside transacetylase as a detoxification enzyme in Escherichia coli
K-12.
big
Yo
'601
SUNDAY MORNING, July 4
ssion 8: Uses of the lac system
lairperson: J. Beckwith, Harvard Medical School, Boston, Massachusetts
Casadaban, T. Silhavy, L. Guarente, H. Shuman, and J. Beckwith, Department of Microbiology and
a1 Molecular Genetics, Harvard Medical School, Boston, Massachusetts: The use of lac operon fusions for
studying biological processes.
kngeleKania, G. Heidecker, D. Brown, and B. Willer-Hill, Institut fiir Genetik der Universitat Koln, Weyertal,
dies
c,Federal Republic of Germany: Gene fusions in the trp-lac systems of E. coli produce active chimeric
proteins.
Ptashne, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Using lac to study
X.
Coulondre and J.H. Miller, Department of Molecular Biology, University of Geneva, Switzerland:
utagenic specificity in E. coli determined using the lac system.
an Brunt and G. Edlin, Department of Genetics, University of California at Davis: Use of lac transposition
trains to probe the mutagenic topography of the E. coli chromosome.
)11
Spears, and H. Weissbach, Department of Biochemistry, Roche Institute of Molecular Biology,C. s
Zutley, New Jersey: DNA-directed in vitro synthesis of f3-galactosidase in a partially purified system.
eye vvennell, H. Riezman, J.E. Schneider, and L.W. Lim, Department of Microbiology and Immunology,
Bi°61.
ashington University, St. Louis, Missouri: Ribosome initiation frequencies, decay lac messages, and
natural polarity.
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SV40, POLYOMA, AND ADENOVIRUSES
arranged by
TERRI GRODZICKER, Cold Spring Harbor Laboratory
MICHAEL BOTCHAN, Cold Spring Harbor Laboratory
262 participants
WEDNESDAY EVENING, August 18
Session 1: Genetics
Chairperson: T. Grodzicker, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
C. Cole, T. Landers, S. Goff, S. Manteuil-Brutlag, and P. Berg, Department of Biochemistry, Stanford
University Medical Center, California: Deletion mutants of SV40.
Y. Gluzman and E. Winocour, Department of Virology, Weizmann Institute of Science, Rehovot, Israel;.
Marker rescue of SV40 is mutants passaged on transformed permissive monkey cells.
M. Fluck, R. Staneloni, J. Feunteun, L. Sompayrac, and T. Benjamin, Department of Pathology, Harvarc
Medical School, Boston, Massachusetts: Relationships between nontransforming mutants of polyom
,
virus.
W. Eckhart, Tumor Virology Laboratory, The Salk Institute, San Diego, California: Complementation be
tween polyoma mutants defective in cell transformation.
J. Rabek, V. Zakian, and A.J. Levine, Princeton University, New Jersey: SV40-mediated suppression of ai
adenovirus DNA-negative mutant.
J. Sambrook, J. Hassell, S. Zain, and E. Lukanidin, Cold Spring Harbor Laboratory, New York: Adenovirus
SV40 hybrids. I. New adenovirus genomes that contain SV40 sequences and SV40 genomes that contair
adenovirus sequences.
G. Fey, J. Sambrook, J. Lewis, and E. Lukanidin, Cold Spring Harbor Laboratory, New York: Adenovirus,,,
SV40 hybrids. II. Expression of the SV40 sequences.
S. Goff and P. Berg, Department of Biochemistry, Stanford University Medical Center, California: Construe
qltion, propagation, and expression of a hybrid virus containing SV40 and lambda DNA segments.
D.H. Hamer, Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts: SV4(
carrying a bacterial suppressor tRNA gene.
THURSDAY MORNING, August 19
Session 2: Integrated genomes
Chairperson: P. Berg, Stanford University Medical Center, Stanford, California
sy
N,
In
N
Ur
pry
C.M. Croce, The Wistar Institute, Philadelphia, Pennsylvania: Chromosome assignment of the integrated.
bicSV40 genome in different SV40- transformed human cells.
M. Botchan, W. Topp, and J. Sambrook, Cold Spring Harbor Laboratory, New York: The structure of simi4gli'
,R(
virus 40 genes in transformed cells.
D.M. Anderson and W.R. Folk, Department of Biological Chemistry, University of Michigan, Ann Arbcylot
Analysis of polyoma virus DNAs rescued from transformed BKH 21 cell lines. Bic
I. Prasad, D. Zouzias, and C. Basilico, Department of Pathology, New York University School of Medicinrof(
New York: The state of viral DNA in rat cells transformed by polyoma and SV40. D.Sai
K. Yoshiike and V. Defendi, Department of Pathology, New York University School of Medicine, New Mr! Rep
Addition of extra DNA sequences to SV40 DNA in vivo. pro;
M.F. Singer, M. Garner, G.R.K. Rao, M. Rosenberg, and S. Segal, National Cancer Institute, Bethesd , (
Maryland: Characterization of the monkey repetitive DNA sequences in a substituted defective SV
isol,genome.
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K.C. Lee and S. Mak, Biology Department, McMaster University, Hamilton, Ontario, Canada: Adenovirus-
type-12 genomes in hamster tumor cells.
C. Tyndall, H.B. Younghusband, and A.J.D. Bel lett, John Curtin. School of Medical Research, Australian
National University, Canberra, and National Institute for Medical Research, London, England: Integration
of adenovirus DNA into cell DNA.
K. Baczko, J. Groneberg, and W. Doerfler, Institute of Genetics, University of Cologne, Federal Republic of
Germany: Characterization of integrated viral sequences in adenovirus-infected and -transformed cells.
THURSDAY AFTERNOON, August 19
Session 3: SV40 and polyoma--Poster session
M. Berebbi, G. Meyer, and R. Cramer, INSERM, Marseille, France: Viral inhibiting factor in polyoma-
transformed cells.
C. Chang, S.W. Luborsky, J. Anderson, and R.G. Martin, Macromolecular Biology Section, NCI, and
Laboratory of Molecular Biology, NIAMDD, National Institutes of Health, Bethesda, Maryland: Com-
parative behavior of SV40 T antigen and specific surface antigen(s) during partial purification.
J.Y. Chou, Section on Developmental Enzymology, Laboratory of Biomedical Sciences, NICHHD, National
vas
Institutes of Health, Bethesda, Maryland: Simian virus 40 mutants carrying two temperature-sensitive
mutations.
oml R. Dhar, K. Subramanian, B. Thimmappaya, S. Zain, J. Pan, and S. Weissman, Department of Human
Genetics, Yale University School of Medicine, New Haven, Connecticut: Nucleotide sequence of SV40
DNA.
A. Gonenne, P. Asekawa, and T. Friedmann, Department of Pediatrics, University of California at San
otai Diego: Altered virion protein VP2 components in polyoma ts3.
P. Gruss and G. Sauer, Insitut fur Virusforschung, Deutsches Krebsforschungszentrum, Heidelberg, Federal
Republic of Germany: A new class of replicating linear SV40host DNA sequences.
L. Hallick, J. Bartholomew, and J. Hearst, Departments of Chemistry and Chemical Biodynamics, University
of California, Berkeley: Cross-linking as a probe for the structure of SV40 chromatin.
vik P.M. Howley, G. Khoury, K.K. Takemoto, and M.A. Martin, Laboratory of Pathology, NCI, and Laboratory of
the Biology of Viruses, NIAID, National Institutes of Health, Bethesda, Maryland: Polynucleotide se-
stO quences common to the genomes of simian virus 40 and the human papovaviruses JC and BK.
W.F. Mangel*, R. Hewick, S.T. Bayley, T. Wheeler, and A.E. Smith, *Departments of Cell Regulation, Protein
Chemistry and Molecular Virology, Imperial Cancer Research Fund, London, England: The in vitro
synthesis and identification of the virus-coded polypeptides of the late polyoma genes.
R. Martin, C. Edwards, and S. Stein, Laboratory of Molecular Biology, NIAMDD, National Institutes of
Health, Bethesda, Maryland: The cell cycle and origins of DNA synthesis in SV40-transformed cells.
E. May, N.P. Salzman, J.V. Maizel, and M. Sullivan, Laboratory of Molecular Genetics, NICHHD, National
Institutes of Health, Bethesda, Maryland: Mapping of SV40 viral mRNA by electron microscopy.
C. Mueller, M. Graessmann, and A. Graessmann, Institut fur Molekularbiologie and Biochemie der Freien
Universitat Berlin, West Berlin, Germany: The biological activity of specific SV40 DNA fragments
produced by Hpa I and Hpa II restriction endonucleases.
F.J. O'Neill and D. Carroll, Veterans Administration Hospital, Research Service, and Department of Micro-
biology, University of Utah, Salt Lake City: Variant viral DNA following SV40 propagation in human
glioblastoma cells.
sir°31.A. Robb, Department of Pathology, University of Calfornia, San Diego: Identification of SV40 U antigen.
S. Rozenblatt, M. Gorecki, R.C. Mulligan, and B.E. Roberts, Center for Cancer Research and Department of
Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts: Direct biochemical mapping
of SV40 DNA utilizing a linked transcription-translation system.
Sauer and P. Gruss, Institut fur Virusforschung, Deutsches Krebsforschungszentrum, Heidelberg, Federal
or, Republic of Germany: Infectious linear SV40host DNA sequences-Properties of superhelical and linear
progeny.
,esthM. Shani, E. Birkenmeier, E. May, and N.P. Salzman, Laboratory of Biology of Viruses, NIAID, National
:10 Institutes of Health, Bethesda, Maryland: Properties of simian virus 40 transcriptional intermediates
isolated from nuclei of permissive cells.
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A.J. Buckler-White
and V. Pigiet, Department of
Biology and McCollum-Pratt Institute Johns H
Maryland: Presence of T antigen and polyoma DNA species on the nuclear
University, Baltimore,
E. Yakobson, C. Prives,
J. Hartman, E. Winocour,
and M. Revel, Virology Department,
Tumor
Science, Rehovot, Israel:
Inhibition of SV40 DNA and protein synthesis by interferon treatment I
lytic cycle.
i adelphia
N. Yamaguchi, K. Segawa,
K. Yamamoto, S. Kito., and K. Oda, Department of 
Ph.issociated
Institute of Medical Science,
Tokyo, Japan: Association of SV40 T antigen with ribosomes.
York: Studies
Session 4: Adenoviruses-Poster
session
Huebner, C.M. Croce, F.L.
Graham, and R. Weinmann, The Wistar Institute,
L. Aiello, K.
Pennsylvania, and McMaster
University, Hamilton, Ontario, Canada: Adenovirus-5 sequences a
with specific human chromosomes
in human-mouse hybrids.
S.G. Baum, Department of
Cell Biology, Albert Einstein College of Medicine, New York, New y .
)1, Missouri:.
of the biology of adenovirus-SV40
enhancement.
i y School of
G.E. Blair and W.C. Russell, National
Institute for Medical Research, Mill Hill, London, England: P I
. oiypep_
genome in
tide phosphorylation in adenovirus
infection.
G. Chinnadurai, Y.-H. Jeng, and
Z. Gilead, Institute for Molecular Virology, St. Louis University,
gle, Centre'
Early polypeptides induced by adenovirus
12.
G. Chinnadurai, H.M. Rho, and
M. Green, Institute for Molecular Virology, St. Louis University
Medicine, Missouri: Messenger RNA
from the transforming segment of the adenovirus-2
of Germany: A16
productively infected and transformed cells.
L. Delbecchi, L. Raptis, D.
Bourgaux-Ramoisy, and P. Bourgaux, Departement de Microbiolo
Hospitalier Universitaire, Sherbrooke, Quebec,
Canada: Replication of adenovirus-type-2 DNA.
R. Dunker and D.T. Brown,
Institute of Genetics, University of Cologne, Federal Republic f 
tubular morphological variant of adenovirus.
E. Fanning and W. Doerfler,
Institute of Genetics, University of Cologne, Federal Republic of Germany: Vi f4To
DNA sequences in hamster cells
abortively infected and transformed with adenovirus type 12.
D. Galloway and J. Sambrook, Cold Spring Harbor
Laboratory, New York: The arrangement of viral DNA idal
at early-
adenovirus-2-transformed cells.
S. Hashimoto, K. Brackmann, and M.
Green, Institute for Molecular Virology, St. Louis University School o
Medicine, Missouri: Methylation studies of
adenovirus-specific messenger and nuclear RNA
stages of productive infection.
Y. Jeng, M. Harter, W. Wold, and M. Green,
Institute for Molecular Virology, St. Louis University School olv`
Medicine, Missouri: Identification of adenovirus-2-induced
early proteins. i516
AOY. Jeng, W. Wold, K. Sugawara, and Z. Gilead,
Institute for Molecular Virology, St. Louis University SchocPes
2 DNA binding protein.
of Medicine, Missouri: Posttranslation modification of the adenovirus-
J.K. Mackey, P.M. Rigden, and M. Green, Institute
for Molecular Virology, St. Louis University, Missouri: DO
A6:
highly oncogenic group-A human adenoviruses cause human cancer?-Analysis of human tumors fd\°f
adenovirus-1 2-transforming DNA sequences.
K. Mann, T. Hunter, and G. Walter, Tumor Virology Laboratory, The Salk Institute, San Diego, Californi2
Tryptic peptide analysis of SV40-specific proteins in HeLa cells infected with nondefective adenoviruf
2 SV40 hybrid viruses.
H.C. Meissner, J. Meyer, J.F. Maizel, Jr., and H. Westphal, Laboratory of Molecular Genetics, NICHH[
National Institutes of Health, Bethesda, Maryland: Visualization of large nuclear adenovirus RNA.
qt
K. Raska, Jr. and F. Varricchio*, CMDNJ-Rutgers Medical School, Piscataway, New Jersey; *Memor.,06,0
Sloan-Kettering Cancer Center, New York, New York: Synthesis of VA RNA in productive and abortii
infections with adenovirus type 1 2.
imi,
K.H. Scheidtmann, J. Ortin, R. Greenberg, M. Westphal, and W. Doerfler, Institute of Genetics,
University ]mbric
Cologne, Federal Republic of Germany: Transcription maps of adenovirus-type-12 DNA in infected a
,rol(
transformed cells. cit,,
K. Shiroki, H. Shimojo, and K. Yamaguchi, Institute of Medical Science, University of Tokyo, Japan: T
inclusions and viral DNA synthesis in adenovirus-1 2-infected cells. ,reed
J.R. Smiley and S. Mak, Biology Department, McMaster University, Hamilton, Ontario, Canada: Transcrildie
tion of adenovirus-type-1 2 DNA.
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j. Weber*, G. Khitto*, and J. Hasse
*Department of Microbiology, Centre Hospitalier Universitaire,
University of Sherbrooke, Quebec, Canada;
-1-Cold Spring Harbor Laboratory, New York: An
adenovirus-2 is mutant defective for DNA encapsidation.
R. Weinmann, The Wistar Institute, Philadelphia, Pennsylvania: Adenovirus-specific low-molecular-weight
RNA species.
THURSDAY EVENING, August 19
Session 5: Virus-cell interactions
Chairperson: W. Eckhart, The Salk Institute, San Diego, California
1K. McDougall and L.B. Chen, Cold Spring Harbor Laboratory, New York: Adenovirus oncogenicity and
LETS protein
C.C. Fareed, M.A. Gimbrone, Jr.*, and K.K. Takemotot, Molecular Biology Institute and Department of
Microbiology and Immunology, University of California at Los Angeles; *Department of Pathology, Peter
Bent Brigham Hospital, and Harvard Medical School, Boston, Massachusetts; tNIAID, National Institutes
of Health, Bethesda, Maryland: Interaction of SV40 and human papovaviruses, BK and JC, with human
vascular endothelial cells.
Brockman, Laboratory of Molecular Biology, NIAMDD, National Institutes of Health, Bethesda,
Maryland: Temperature sensitivity of the transformed phenotype of BALB 3T3 cells transformed by
different SV40 tsA mutants.
D. Tenen*, J. Andersont, D. Livingston*, and R. Martint, *Sidney Farber Cancer Center, Harvard Medical
School, Boston, Massachusetts; tLaboratory of Molecular Biology, NIAMDD, National Institutes of
Health, Bethesda, Maryland: T antigen in Chinese hamster lung cell lines transformed by tsA mutants and
their revertants.
Pollack, Department of Microbiology, State University of New York at Stony Brook: SV40 T antigen is
necessary for the cytoskeletal changes characteristic of tumorigenic transformed cells.
1\,,C. Chang, A. Schultz, L. Couvillion, and P. Mora, Macromolecular Biology Section, National Cancer
Institute, Bethesda, Maryland: In vivo selection of cells for tumorigenicity and against SV40-specific
antigens.
Zamansky, L.F. Kleinman, J.B. Little, P.H. Black, and J.D. Kaplan, Department of Medicine, Mas-
sachusetts General Hospital and Departments of Microbiology and Molecular Genetics and Medicine,
i Harvard Medical School, Boston, Massachusetts: The effect of caffeine on the ultraviolet-light induction
of SV40 virus from transformed hamster cells.
Graessman, M. Graessmann, and C. Mueller, Institut flit- Molekularbiologie and Biochemie der Freien
Universitat Berlin, West Berlin, Germany: Regulatory mechanism of simian virus 40 gene expression in
c permissive and in nonpermissive cells.
Norkin, Department of Microbiology, University of Massachusetts, Amherst: Cytocidal and persistent
' SV40 infections.
FRIDAY MORNING, August 20
.11( ssion 6: SV40 and polyoma-Transcription and replication
pegtalrperson: G. Khoury, NIAID, National Institutes of Health, Bethesda, Maryland
3:1
Mertz, J.B. Gurdon, and E.M. DeRobertis, Medical Research Council Laboratory of Molecular Biology,i\e Cambridge, England: Transcription of SV40 DNA in Xenopus oocytes: A model system for studying
control of transcription in eukaryotes.
Condit, A. Cowie, and R. Kamen, Department of Molecular Virology, Imperial Cancer Research Fund,London, England: Purification and properties of a polyoma virus transcription complex.
. Green, J. Allan, and T.L. Brooks, Department of Biology, University of California at San Diego: The
template for SV40 transcription.
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Maryland:
E. Birkenmeier, E. May, M.
Shani, and N.P. Salzman, Laboratory of Biology of Viruses, NIAID, N
Institutes of Health, Bethesda,
Maryland: Characterization of simian virus 40 TsA58 transcriptional
a ional
intermediates at nonpermissive temperatures.
P
Y. Aloni, Y. Groner, 0. Laub, and Y. Reuveni, Departments
of Genetics and Virology, The weizmann
Institute of Science, Rehovot, Israel:
Regulation of simian virus 40 gene expression.
M.W. Gutai and D. Nathans, Department of Microbiology, Johns
Hopkins University, Baltimore,Mary
1
The
The origin of SV40 DNA replication.
K.N. Subramanian, R. Dhar, and
S.M. Weissman, Department of Human Genetics, Yale University Sch ool
Medicine, New Haven, Connecticut: Nucleotide sequence
at the origin of DNA replication in SV40
G. Kaufmann, S. Anderson, and M.L.
DePamphilis, Harvard Medical School, Boston , Massachusetts:
distribution and dynamics of RNA-DNA linkages
in replicating SV40 DNA.
H.J. Edenberg and J.A. Huberman*, Department
of Biology, MIT, Cambridge, Massachusetts; *Department
Medical Viral Oncology, Roswell Park Memorial Institute, Buffalo, New York: In vitro SV40 D
synthesis in a subnuclear system.
NA
FRIDAY EVENING, August 20
Session 7: SV40 and polyoma-Proteins
Chairperson: D. Nathans, Johns Hopkins University, Baltimore, Maryland
D.M. Livingston, D. Jesse', and D. Tenen, The Sidney Farber Cancer Center, Harvard Medical School
Boston, Massachusetts: Interactions of SV40 T antigen with SV40 DNA.
J. Anderson, C. Chang, P. Mora, D. Livingston, and R. Martin, Laboratory of Molecular Biology, NIAMDD
and Macromolecular Biology Section, NCI, National Institutes of Health, Bethesda, Maryland, and Sidne,
Farber Cancer Center, Harvard Medical School, Boston, Massachusetts: Relationship of SV40 tumor
specific transplantation antigen (TSTA) to tumor antigen (TA).
K. Rundell, P. Tegtmeyer, P. Wright*, and G. DiMayorca*, Department of Microbiology, State University c.
New York, Stony Brook; *Department of Microbiology, University of Illinois Medical Center, Chicago
COmparison of SV40 and BKV protein A.
S.I. Reed, G.R. Stark, and J.C. Alwine, Department of Biochemistry, Stanford University Medical CenteL
California: Autoregulation of simian virus 40 gene A.
R. Weil, M. Lichaa, H. Tiirler, B. Allet*, and C. Ahmad-Zadeh*, Institute of Molecular Biology, University c
Geneva; *Institut d'Hygiene, Geneva, Switzerland: Studies on SV40 T antigen.
R. Carroll, Department of Pathology, New York University School of Medicine, New York: The significanc
of the molecular-weight forms of T antigen in various SV40-infected permissive, semipermissiye, an
nonpermissive cell lines.
C. Prives, Y. Gluzman, E. Gilboa, M. Revel, and E. Winocour, Virology Department, Weizmann Institute
Science, Rehovot, Israel: The synthesis of early and late SV40 polypeptides.
K. Shah, H. Ozer, H. Ghazey, and T. Kelly, Jr., Department of Pathobiology, Johns Hopkins Universit\
School of Hygiene and Public Health, Baltimore, Maryland; The Worcester Foundation for Experiments
Biology, Shrewsbury, Massachusetts; Department of Microbiology, Johns Hopkins University School c;
Medicine, Baltimore, Maryland: A common structural antigen of papovaviruses of the SV40 polyomiia
subgroup.
lok
W. Gibson, W. Eckhart, T. Hunter, and B. Cogen, Tumor Virus Laboratory, The Salk Institute, San Dieg(ic
California: Altered virion proteins of a late temperature-sensitive mutant of polyoma virus ts59
odic
SATURDAY MORNING, August 21
Session 8: DNA-protein interactions
Chairperson: J.D. Watson, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York ool
A.J. Robinson, D.M.K. Rekosh, A.J.D. Bellet, and W.C. Russell, Imperial Cancer Research Fund, Londmers
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11 England, and National Institute for Medical Research, London, England: Characterization of A protein
I bound to the ends of adenovirus-type-5 DNA.
P.A. Sharp, C. Moore, and J.L. Haverty, Center for Cancer Research, MIT, Cambridge, Massachusetts: The
infectivity of adenovirus-5 DNA-protein complex.
T.R. Broker and L.T. Chow, Cold Spring Harbor Laboratory, New York: Visualization of the terminal proteins
of adenovirus-2 DNA with ferritin-biotin:avidin labels.
M. Wu and H. Kasamatsu, Division of Chemistry and Chemical Engineering and Division of Biology,
Ir California Institute of Technology, Pasadena: A nicked DNA-protein complex isolated from simian virus
40.
[hf B. Ponder and L. Crawford, Department of Molecular Virology, Imperial Cancer Research Fund, London,
England: Positioning of the nucleosomes in polyoma and SV40 nucleoprotein complexes.
to' J. Corden and G. Pearson, Department of Biochemistry and Biophysics, Oregon State University, Corvallis:
1Nq Adenovirus chromatin.
A.A. Qureshi and P. Bourgaux, Departement de Microbiologie, Centre Hospitalier Universitaire, Sherbrooke,
Quebec, Canada: Polyoma and SV40 nucleoprotein complexes from productively infected cells.
M.P. DiLauro, D. Livingston, and R. Martin, Laboratory of Molecular Biology, NIAMDD, National Institutes
of Health, Bethesda, Maryland, and Sidney Farber Cancer Center, Harvard Medical School, Boston,
Massachusetts: SV40 chromatin interaction with T antigen.
- K. Segawa, N. Yamaguchi, and K. Oda, Department of Tumor Virus Research, Institute of Medical Science,
Tokyo, Japan: Phosphorylation of chromatin- and ribosome-associated proteins in SV40-transformed
cells.
hoof
SATURDAY AFTERNOON, August 21
CD_
Idoe,ession 9: Adenoviruses-Proteins
Chairperson: A. Levine, Princeton University, Princeton, New Jersey
c'f. Hunter and G. Walter, Tumor Virology Laboratory, The Salk Institute, San Diego, California: In vitro
synthesis of SV40-specific proteins.
D. Klessig, Cold Spring Harbor Laboratory, New York: Isolation and characterization of a variant of human
adenovirus serotype 2 (Ad2) which multiplies efficiently on monkey cells.
A. Levinson, A.J. Levine, and J. Williams, Princeton University, New Jersey: Immunoprecipitation and
it'( identification of the group-C adenovirus tumor antigens.
WM. Chin, A.M. Lewis, Jr., and J.V. Maizel, Jr., Laboratory of Molecular Genetics, NICHHD, and
Laboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, Maryland: The composition
on' of adenovirus-2 T antigen.
K.K. Biron and K. Raska, Jr., CMDNJ-Rutgers Medical School, Piscataway, New Jersey: Purification of T
vie(
antigen from adenovirus-type-12-transformed hamster cells.
Rekosh and W.C. Russell, National Institute for Medical Research, Mill Hill, London, England:
Proteolytic cleavage of the major core protein precursor in adenovirus type 5.
11,.B. Carstens and J. Weber, Department of Microbiology, Centre Hospitalier Universitaire, University of
o01( Sherbrooke, Quebec, Canada: Pleotropic effects of a hexon defective mutant.
Gilead, K. Sugawara, Y. Jeng, H.M. Rho, M. Harter, W. Wold, and M. Green, Institute for Molecular
Virology, St. Louis University School of Medicine, Missouri: Tentative identification of adenovirus-2-
Ig induced early proteins involved in cell transformation.
Sugawara, Z. Gilead, and M. Green, Institute for Molecular Virology, St. Louis University School of
Medicine, Missouri: Studies on the adenovirus-2 coded DNA binding protein-Purification, characteri-
zation, and immunofluorescent visualization in infected and transformed cells.
SUNDAY MORNING, August 22
Session 10: Adenoviruses-Transcription and replication
ndotChairperson: P.A. Sharp, Massachusetts Institute of Technology, Cambridge, Massachusetts
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M. Arens, T. Yamashita, R.
Padmanabhan, T. Tsuruo, and M. Green, Institute for Molecular Virology, s
1Louis University School of Medicine,
Missouri: Characterization of the in vitro products
and enzyn)componentsof a soluble adenovirus-2 DNA replication complex.
B. Weingartner, R. Schilling,
and E.-L. Winnacker, Institute of Genetics, University of Cologne,
of Germany: Strand-specific initiation and termination of adenovirus-type-2 DNA repliCc
Feder
ation
I
J. Pan, M. Celma, and S.M. Weissman,
Department of Human Genetics, Yale University School
of Medicin
New Haven, Connecticut: Nucleotide
sequences at the ends of VA RNA.
R.E. Gelinas and R.J. Roberts, Cold
Spring Harbor Laboratory, New York: 5:Terminal oligonucleotides
fro
adenovirus-2-infected cells.
N.W. Fraser and E. Ziff, Department of Molecular Cell Biology, The Rockefeller University, New Yor
Analysis of 3:terminal regions of late Ad2 mRNAs.
S.G. Zimmer, E.A. Craig, M. Sayavedra,
and H.J. Raskas, Department of Pathology, Washington Universi
School of Medicine, St. Louis, Missouri: In vivo and in vitro studies of adenovirus-2 nuclear RNAs
S.J. Flint, S.M. Berget, and P.A. Sharp, Center
for Cancer Research, MIT, Cambridge, Massachusetts:
The si
of adenovirus-2 early and transformed cell mRNA species.
P. Neuwald, J. Meyer, J.V. Maizel, and H. Westphal, Laboratory of Molecular Genetics, NICHHD Nation
Institutes of Health, Bethesda, Maryland: Mapping of R loops generated by adenovirus-type-2 messeng
RNA. it
W. BOttner, Z. Veres-Molnar, and M. Green, Institute for Molecular Virology, St. Louis University School 01
Medicine, Missouri: Preparative isolation and mapping of adenovirus-2 early messenger RNA species.
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hodPHYCOMYCES
arranged by
RICHARD SUTTER, West Virginia University
MAX DELBRUCK, California Institute of Technology
33 participants
SATURDAY AFTERNOON, August 21
!,)ig
Session 1 biosi
E
deve
H.I. Yaxan, Departamento de Genetica, Facultad de Ciencias, Universidad de Sevilla, Spain: ProtelA
variability in Phycomyces wild types. Icof
A.P. Eslava and M.I. Alvarez, Max-Planck-Institut fi.ir Molekulare Genetik, West Berlin, Germarvu'l
Mutagenesis in Phycomyces. 41P
C. Pueyo and E. Cerda-Olmedo, Departamento de Genetica, Facultad de Ciencias, Universidad de Sevin:in
Spain: Genetic classification of lethality induced by several fungicides, ICR-170, and heat. uoi
F.J. Murillo and S. Torres-Martinez, Departamento de Genetica, Facultad de Ciencias, Universidad dHp
Sevilla, Spain: Mutational analysis of the carotene pathway. Ito
M. DelbrOck, Division of Biology, California Institute of Technology, Pasadena: The dar paradox.
K. Brunke and R. Mercurio, Department of Microbiology, University of Pennsylvania, Philadelphia: Procklual
dure for isolation of auxotrophic mutants in Phycomyces. uaugE
K. Bergman and W. Pieciak, Department of Biology, Northeastern University, Boston, Massachusett*le,
Biochemical genetics of a g-glucosidase from Phycomyces.
Chairperson: E. Cercla-Olmedo, Universidad de Sevilla, Sevilla, Spain
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SUNDAY MORNING, August 22
'Session 2
hairperson: E. D. Lipson, California Institute of Technology, Pasadena, California
T. Ootaki, Biology Department, Yamagata University, Yamagata, Japan: Complementation tests between (+)
Phycomyces mutants with abnormal phototropisms.
i3A.P. Es lava, M.I. Alvarez, E.D. Lipson, D.E. Presti, and K. Kong, Division of Biology, California Institute of
Technology, Pasadena: Recombination between Phycomyces photomutants.
.D. Lipson and S.M. Block, Division of Biology, California Institute of Technology, Pasadena: Kinetics of
adaptation in Phycomyces light responses.
. Reissig and M. Delbruck, Division of Biology, California Institute of Technology, Pasadena: Riboflavin
analog effects on Phycomyces.
.D. Lipson and D.E. Presti, Division of Biology, California Institute of Technology, Pasadena: Light-induced
absorbance changes in Phycomyces photomutants.
. Delbrdck, A. Katzir, and D. Presti, Divisions of Biology and Engineering, California Institute of Technolo-
gy, Pasadena: Responses of Phycomyces indicating optical excitation of the lowest triplet state of
riboflavin.
J. Cohen, Department of Biochemistry and Molecular Biology, University of Florida, Gainesville: Cyclic
em nucleotide responses of Phycomyces.
. La Pointe and Robert J. Cohen, Department of Biochemistry and Molecular Biology, University of Florida,
Gainesville: Polyamine levels during the light growth response of Phycomyces.
P. Fischer, H. Lyle, and K.S. Thomson*, Division of Biology, California Institute of Technology, Pasadena;
*Fachbereich Biologie, Universitat Kaiserslautern, Federal Republic of Germany: The chitin synthetase
system in Phycomyces.
.W. Foster, M. Pene, and H.C. Berg, Department of Molecular, Cellular, and Developmental Biology,
University of Colorado, Boulder: The technology and photophysiology of Halobacterium halobium.
I. Delbriick and D. Presti, Division of Biology, California Institute of Technology, Pasadena: Tropic
behavior of carB, carR, and carBcarR mutants.
Lafay and J. Matricon, Laboratoire Biologie Experimentale, Orsay, France: Reconsidering avoidance and
house response.
MONDAY MORNING, August 23
.ssion 3
iairperson: R. P. Sutter, West Virginia Urfiversity, Morgantown, West Virginia
P. Whitaker and R.P. Sutter, Department of Biology, West Virginia University, Morgantown: Trisporic acid
biosynthesis in Phycomyces blakesleeanus.
I.E. Nelson and R.P. Sutter, Department of Biology, West Virginia University, Morgantown: Zygophore
development in select mucoraceous fungi.
pd. Jockusch and T. Wurtz, Biocenter, Basel, Switzerland and Max-Planck-Institut, Tithingen, Federal Repub-
lic of Germany: Mutants of Muco mucedo affected in their gamone responses.
errlb. Bu'lock and B.E. Jones, Microbial Chemistry Laboratory, The University, Manchester, England: Cyclic
AMP in Mucor spp.
e
O'Donnell, G.R. Hooper, and W.G. Fields, Northern Regional Research Center, ARS, USDA, Peoria,
Illinois: Zygosporogenesis in Phycomyces blakesleeanus Burgeff.
,(0/.H. Schroeder and D. Tsongas, Division of Biology, California Institute of Technology, Pasadena: Some
new observations during the sexual differentiation of Phycomyces.
Cerda-Olmedo, Departamento de Genetica, Universidad de Sevilla, Spain: Nuclear interaction in the
1, sexual cycle.
a
Gauger, School of Life Sciences, University of Nebraska, Lincoln: Recombinant progeny from immature
10
zygotes of Rhizopus stolonifer.
Cercla-Olmedo, Departamento de Genetica, Universidad de Sevilla, Spain: Germspore formation.
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BACTERIOPHAGE
arranged by
AHMAD I. BUKNGHARI, Cold Spring Harbor Laboratory
ELISABETH LJUQUIST, Cold Spring Harbor Laboratory
136 participants
TUESDAY EVENING, August 24
Session 1: P2-P4 interaction; Focus on the life cycles of P22, P1, and Mu
L. Tinelli, G. Deho, and R. Goldstein, Department of Microbiology and Molecular Genetics, Harvard
Medical School, Boston, Massachusetts: Studies on the interference exerted by satellite phage P4 on
helper phage P2.
G. Deli& L. Tinelli, and R. Goldstein, Department of Microbiology and
a
 Molecular Genetics, Harvard
Medical School, Boston, Massachusetts: Satellite phage P4-Characterization of a mutant affected in thr
ability to derepress helper prophage P2.
e
S. Valla and B.H. Lindqvist, Institute of Medical Biology, University of Tromso, Norway: P4-induced
activation of P2 transcription in vitro.
D. Botstein and P. Grisafi, Department of Biology, Massachusetts Institute of Technology, cambrid,e)
Overproduction of c2 repressor by c/y mutants of phage P22. °
M.M. Susskind, Department of Microbiology, University of Massachusetts Medical School, Worcester)
Mechanism of action and control of P22 antirepressor. C
J.R. Scott, M.M. Kropf, and R.H. Chesney, Department of Microbiology, Emory University, Atlanta, Georgia: ii
A gene affecting maintenance of the plasmid state of P1 and P7 (Amp).
R.H. Chesney and J.R. Scott, Department of Microbiology, Emory University, Atlanta, Georgia: Suppressior
of dnaA- by P1 and P7.
H. Khatoon and A.I. Bukhari, Cold Spring Harbor Laboratory, New York: A mutant of bacteriophage Mu tha. C
is temperature sensitive for establishment but not for maintenance of lysogeny.
H. Khatoon and A.I. Bukhari, Cold Spring Harbor Laboratory, New York: Excision of the X mutants o,CI
prophage Mu.
E. Ljungquist and A.I. Bukhari, Cold Spring Harbor Laboratory, New York: Most of the parental Mu DNA
retains its free ends after infection of host cells.
WEDNESDAY MORNING, August 25
fa
Session 2: The X life cycle-N gene function; Promotion and termination Be
M. Rosenberg and D. Court, Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Marlir SU
land: A nucleotide sequence common to pi, and transcripts-A possible N recognition site. SJ(
C. Dambly, L. Desmet, and F. Salomon, Laboratory of Genetics, Department of Molecular Biolog)
Universite libre de Bruxelles, Rhode St. Genese, Belgium: The so-called paradox of Ximm21. ma
J.S. Salstrom, M. Fiandt, and W. Szybalski, McArdle Laboratory, University of Wisconsin, Madison: I solatio
Re,of XN"imm434nin5 recombinants.
e,DiJ.S. Salstrom and W. Szybalski, McArdle Laboratory, University of Wisconsin, Madison: Revertants of phag
Bellambda nutL mutants.
J. Greenblatt and P. Malnoe, Department of Molecular Biology, University of Geneva, Switzerland: Studie
Ore
on the gene N protein of bacteriophage X.
G. Cesareni, S. Nasi, and E. Calef, Centro degli Acidi Nucleici, Consiglio Nazionale delle Ricerche, Rorn(G,oll
ue
Italy: Ambers in the Ai gene.
g
R. Maurer and M. Ptashne, Department of Biochemistry and Molecular Biology, Harvard UniversitDds
Cambridge, Massachusetts: Function and control of the PRm promoter of phage X in vivo.
M. Rosenberg and D.L. Wulff,* National Cancer Institute, Bethesda, Maryland; *Department of Moleculz1.li
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Biology and Biochemistry, University of California, Irvine: Termination of rightward transcription in the
lambda y region.
D. Court, M. Rosenberg, B. de Crombrugghe, C. Brady, and D. Wulff,* Laboratory of Molecular Biology,
National Cancer Institute, Bethesda, Maryland; *Department of Molecular Biology and Biochemistry,
University of California, Irvine: Transcription termination at a Rho-dependent signal in vivo and in vitro.
P.). Anevski, D.A. Wilder, H.A. Lozeron, and D. Apirion,* Department of Biochemistry, St. Louis University,
Missouri; *Department of Microbiology, Washington University, St. Louis, Missouri: Supression of
bacteriophage lambda gene N mutations in a polar suppressor host deficient in ribonuclease III activity.
WEDNESDAY EVENING, August 25
m( id
Session 3: The X life cycle-Immunity establishment; Integration-excision
Cis M. Jones and I. Herskowitz, Institute of Molecular Biology and Department of Biology, University of Oregon,
Eugene: c111-independent mutants of X.
S. Hayes and C. Hayes, Department of Molecular Biology and Biochemistry, University of California, Irvine:
de Control of repressor establishment transcription.
A. Honigman, S.L. Hu, and W. Szybalski, McArdle Laboratory, University of Wisconsin, Madison: Anti-
bad termination of RNA leader sequences as the regulatory mechanism for the establishment of lysogeny by
coliphage X.
ir A.B. Oppenheim, A. Oppenheim, N. Katzir, and M. Belfort, Department of Microbiological Chemistry, The
Hebrew UniversityHadassah Medical School, Jerusalem, Israel: Regulation of the Int gene bac-
teriophage X.
vc S. Chung and H. Echols, Department of Molecular Biology, University of California, Berkeley: Activation of
integrative but not excisive recombination by the cll gene of phage A.
S. Adhya,* D. Court,* H.A. Nash,t and L. Enquist,** *NCI, tNIMH, **NICHHD, National Institutes of
ko, Health, Bethesda, Maryland: Regulation of the genes for X integration and excision.
M. Kotewicz, S. Chung, Y. Takeda, and H. Echols, Department of Molecular Biology, University of
muip California, Berkeley: Int protein of phage A-Purification and regulation.
K. Mizuuchi, M. Gellert, R. Weisberg, and H. Nash, National Institutes of Health, Bethesda, Maryland:
tang)
Characterization of integrative recombination of phage X DNA in vitro.
THURSDAY MORNING, August 26
Session 4: X Proteins; Various X and host functions
A. Folkmanis, Y. Takeda, and H. Echols, Department of Molecular Biology, University of California,
Berkeley: In vitro studies of the Xcro product.
G. Sutcliffe, Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Mas-
sachusetts: Purified virions may contain a control protein bound to an operator.
C. Epp and M. Pearson, Department of Medical Genetics, University of Toronto, Canada: Identification of
i'3° more X early gene products.
,
P. Toothman and I. Herskowitz, Institute of Molecular Biology, University of Oregon, Eugene: The effect of
,
Rex on X development.
L. Debrouwere, M. Zabeau, J. Schell and M. Van Montagu, Laboratory of Genetics, State University of Gent,
Belgium: Ral mutations in X.
R.E. Malone, M.M. Stahl, D.K. Chattoraj, and F.W. Stahl, Institute of Molecular Biology, University of
Oregon, Eugene: Chi recombination hot spot sites.
S. Gottesman, Department of Biology, Massachusetts Institute of Technology, Cambridge: Effects of E. coli
deg- mutants on lambda growth.
A. Das, B. Citron, D. Court, and S. Adhya, Laboratory of Molecular Biology, National Cancer Institute,
p Bethesda, Maryland: Pleiotropic properties of rho mutants of Escherichia coli.
1 sigma mutant of RNA polymerase.
aH.H. Liebke, A. Pao, and J. Speyer, Department of Biological Sciences, University of Connecticut, Storrs: A
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THURSDAY EVENING, August 26
Session 5: A. Functional mRNA; X DNA replication
B. Morphogenesis I
K.K. Mark, L.C. Tsui, Y.P. Yu, K.C.
Luk, C.K. Lau, C.L. Choi, K.C. Li, and K.S. Ho, Department of Biology
New Asia College, The Chinese
University of Hong Kong: Effect of multiplicity of infection
on gene
y, The Hebrew 01.
, Indiana:
I
expression.
Y lambda m
West Lafayette
A. Oppenheim and A.B. Oppenheim,
Department of Microbiological Chemistry,
, Univer
sity-Hadassah Medical School, Jerusalem, Israel:
Functional analysis of earl I L
ent of
degradation.
T.J. Pollock and I. Tessman, Department of Biological Sciences, Purdue University,
Decayons-Functional decay units of phage S13 messenger RNA.
M.E. Furth,* C. McLeester,* and J. Yates, t *McArdle Laboratory and
±Enzyme Institute
Wisconsin, Madison: Recombinants of phages X
and c680 or 82 with hybrid replication proteins.
say of
aBcot :ton,
M.E. Furth,* W.F. Dove,* B. Williams,t and F.R. Blattner,± *McArdle Laboratory and tDepartm
Genetics, University of Wisconsin, Madison: Mapping the origin of DNA replication of phage X.
L.C. Gosule and D.K. Chattoraj, Institute of Molecular Biology,
Cancer
of DNA induced by polyamines.
M. Syvanen, Department of Microbiology and Molecular Genetics,
Massachusetts: DNA packaging steps with bacteriophage lambda.
N. Sternberg and R. Weisberg,* NICHHD, National Institutes of Health, Bethesda; *Frederick
Research Center, Frederick, Maryland: A model for the packaging of X DNA.
FRIDAY MORNING, August 27
Session 6: Morphogenesis II
o.
A.R. Poteete and D. Botstein, Department of Biology, Massachusetts Institute of Technology, Cambridge:
I
P22 proheads in in vitro DNA packaging.
P. Youderian and J. King, Massachusetts Institute of Technology, Cambridge: X Tail length determination. i
D. Shore, L. Tinelli, G. DehO, J. Tsipis, and R. Goldstein, Department of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachusetts: Head size determination by satellite bac- [
teriophage P4-Characterization of a P4 sid (size direction) mutant which makes large capsids equal in q,
size to that of its helper P2.
M.K. Showe, E. Isobe, and L. Onorato, Department of Microbiology, Biozentrum der Universitat Basel,
1(1
Switzerland: T4 prehead proteinase-Identification and characterization of the purified enzyme and its i
cleavage from the T4 gene 21 protein.
AWE
J.R. Paulson and U.K. Laemmli, Department of Biochemical Sciences, Princeton University, New Jersey: The 18i
structure of the morphogenetic core of the T4 head.
of
S.C. Kayman and J. King, Massachusetts Institute of Technology, Cambridge: Distribution of suppressors
Ts phenotypes in the T4 baseplate.
VI
P.B. Berget and J.A. King, Massachusetts Institute of Technology, Cambridge: Characterization of T4
baseplate assembly intermediates.
Y. Yamada, J. Silnutzer, and D. Nakada, Department of Biochemistry, University of Pittsburgh School of
Medicine, Pennsylvania: A host mutation which blocks T7 phage assembly.
T. Isobe, L. W. Black, and A. Tsugita, Abteilung Microbiologie, Biozentrum der Universitat Basel, Switzer-
land: Specificity of the assembly-dependent cleavage in bacteriophage T4.
'.0
FRIDAY EVENING, August 27
'LS(
ofC
Session 7: DNA recombination-replication
P.J. Vlachopoulou and P.D. Sadowski, Department of Medical Genetics, University of Toronto, Canada: A Cm
physical assay for bacteriophage T7 recombination in vitro. ,cli
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ref-
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Re'
W.K. Holloman and C.M. Radding, Department of Medicine, Yale University School of Medicine, New
Haven, Connecticut: Promotion of a common step in genetic recombination by superhelical DNA and
the recA gene.
H. Fujisawa and M. Hayashi, Department of Biology, University of California, San Diego: Functions of gene
C and gene D products of bacteriophage 4X174.
E.S. Tessman and P.K. Peterson, Department of Biological Sciences, Purdue University, West Lafayette,
Indiana: Evidence for a complex composed of rep protein and OX174 F and A proteins which acts late in
infection.
P.D. Baas, W. Keegstra, and H.S. Jansz, Institute of Molecular Biology and Laboratory for Physiological
Chemistry, State University, Utrecht, The Netherlands: Mechanism of bacteriophage OX174 RF DNA
replication.
E.S. Tessman and P.K. Peterson, Department of Biological Sciences, Purdue University, West Lafayette,
Indiana: Gene A protein is required for single-stranded DNA synthesis of phage S13.
D.K. Chattoraj, Microbial Genetics Laboratory, Karolinska Institutet, Stockholm, Sweden: A strand-specific
break near the origin of bacteriophage P2 DNA replication.
J. Glassberg and C.R. Stewart, Department of Biology, Rice University, Houston, Texas: Initiation and
termination of SPO1 DNA replication.
K. Denniston-Thompson and W. Ginoza, Department of Microbiology and Cell Biology, The Pennsylvania
State University, University Park: Multiple sites of initiation of T4 DNA synthesis.
SATURDAY MORNING, August 28
Session 8: T4
D. Belin and R.H. Epstein, Departement de Biologie Moleculaire, University de Geneve, Switzerland: A
temperature-sensitive mutation which affects the synthesis of the mutant gene product.
J.D. Childs, Biology and Health Physics Division, Atomic Energy of Canada Limited, Chalk River Nuclear
idge Laboratories, Ontario: T4 mutants unable to grow on streptomycin resistant hosts.
College, Pennsylvania: T4-induced ADP-ribosylation of E. coil
i. RNA polymerase.
cuI3I 0. Skold and C. Linder, Department of Microbiology, Faculty of Pharmacy, University of Uppsala, Sweden:
bac. Evidence for a diffusible T4 phage protein governing the initiation of delayed early RNA synthesis.
jalin M.F. Mowrey and J.S. Wiberg, Department of Radiation Biology and Biophysics, University of Rochester,
New York: Basis for decreased production of T4D regA- mutants at high temperature.
E. Kutter, L. Snyder,* B. Guttman, and R. Bestwick, The Evergreen State College, Olympia, Washington;
its *Michigan State University, East Larising: Mutants permitting the production of viable phage in which C
replaces HMC.
,111e D. Bradley, E. Kutter, B. Guttman, and N. Mesta, The Evergreen State College, Olympia, Washington: Effects
of cytosin in T4 DNA on T4 early-enzyme synthesis.
Hof K.E. Abremski and L.W. Black, Department of Biological Chemistry, University of Maryland, School of
Medicine, Baltimore: A possible role for bacteriophage T4 internal protein I in the infection of E. coli
004 CT596.
001°1
SATURDAY AFTERNOON, August 28
ession 9: Manipulations of phage genomes; Physical mapping
D.K. Chattoraj, Y.K. Oberoi, and G. Bertani, Microbial Genetics Laboratory, Karolinska Institutet, Stockholm,
Sweden: Eco RI cleavage of bacteriophage P2 DNA in vivo and in vitro.
.W. Schumm,* D.D. Moore, F.R. Blattner, and M.M. Howe,* *Department of Bacteriology and Department
of Genetics, University of Wisconsin, Madison: In vitro construction of X-Mu hybrids.
1. Sternberg, D. Tiemeier, and L. Enquist, NICHHD, National Institutes of Health, Bethesda, and Frederick
\ Cancer Research Center, Frederick, Maryland: In vitro packaging of EcoRl DNA fragments in a X Dam
dd3. vector.
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N. Sternberg, D. Tiemeier, and L. Enquist, LMG, NICHHD, N
and
ational Institutes of Health
, Bethesda
and
Frederick Cancer Research Center, Frederick, Maryland: The in vitro construction of AP] hybrids. ' -
R.I. Mural, T. Yun, and D. Vapnek, Program in Genetics and Departments of Zoology, gioch_emistr
Microbiology, University of Georgia, Athens: Physical and genetic mapping of cloned P1 DNA fragY' °-
generated by restriction endonucleases. ents
F. DeBruijn and A.I. Bukhari, Cold Spring Harbor Laboratory, New York: Insertion elements in mutant
bacteriophages Mu and Pl.
utants
of
L.T. Chow and A.I. Bukhari, Cold Spring Harbr Laboratory, New York: The invertible G sequence of phage
Mu DNA is identical to the invertible sequeonce of phage P1 DNA.
L.T. Chow, R. Kahmann, and D. Kamp, Cold Spring Harbor Laboratory, New York: Electron- microscopic
studies of nondefective Mu phage containing deletions or substitutions in the G and /or /3 regions
SUNDAY MORNING, August 29
Session 10: PRR1; T1, P22, T7 mutants; Nucleotide reactions; EM techniques
P. Dhaese, J. Vandekerckhove, and M. Van Montagu, Laboratorium voor Histologie en Genetika, Rij ksuni
versiteit Gent, Belgium: Studies on PRR1, an RNA phage specific for broad-host-range P-group plasmids
M.D. Roberts and H. Drexler, Department of Microbiology and Immunology, Bowman Gray School Of
Medicine of Wake Forest University, Winston-Salem, North Carolina: Transducing mutants of Ti.
M. Ruddel and V. Israel, Medical College of Georgia, Augusta: Isolation of a bacteriophage P22 mutation
reversibly temperature sensitive in both an early and a late step.
J.E. Mott and J. Speyer, Department of Biological Sciences, University of Connecticut, Storrs: The growth
inhibition and release of inhibition of T7 and lambda on P2 lysogens.
J. Davison and F. Brunel, MRC Virology Unit and Beatson Institute for Cancer Research, Glasgow, Scotland:
Restriction insensitivity in bacteriophage T5.
H.R. Warner, T.J. Mozer, and S. Rakow, Department of Biochemistry, University of Minnesota, St. Paul:
Metabolism of deoxyribonucleotides after infection of Escherichia coli with bacteriophage T5.
A.R. Shaw and D.J. McCorquodale, Department of Biochemistry, Medical College of Ohio, Toledo: De-
creased levels of nucleoside triphosphates after BF23-infection of Escherichia coli carrying Col lb
plasmids.
I. Tessman, Department of Biological Sciences, Purdue University, West Lafayette, Indiana: A mechanism of
UV reactivation.
T.R. Broker and L.T. Chow, Cold Spring Harbor Laboratory, New York: Visualization of the terminal proteins
of B. subtilis phage (1)29 DNA with ferritin-biotin:avidin labels.
K. Calame and G. Ihler, Department of Biochemistry, University of Pittsburgh School of Medicine, Pennsyl-
vania: EM visualization of DNA-ribosome initiation complexes.
HERPESVIRUSES
arranged by
JOSEPH S. PAGANO, University of North Carolina
JOHN SU BAK-SHARPE, University of Glasgow
173 participants
TUESDAY EVENING, August 31
Session 1: DNA structure I
Chairpersons: P. Sheldrick, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France
P. Wildy, University of Cambridge, Cambridge, England
P. Sheldrick, N. Berthelot, and S. Chousterman, I.R.S.C., Villejuif, France: Channel catfish virus-A
"minimal" herpesvirus?
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;1(
Cc
Pd D. Hayward, W. King, and E. Kieff, Department of Medicine, University of Chicago, Illinois: The DNA of
Epstein-Barr viruses-Restriction-enzyme analysis.
Sod J.E. Shaw and J.S. Pagano, Cancer Center Program and Departments of Medicine and Bacteriology, School
of Medicine, University of North Carolina, Chapel Hill: Analysis of the Epstein-Barr-virus DNA
synthesized in superinfected Raji cells.
sot Y. Yajima, Y.-S. Lee, and M. Nonoyama, Departments of Microbiology. Rush-PresbyterianSt. Luke's
Medical Center and University of Illinois Medical Center, Chicago, Illinois: Characterization of Epstein-
age ; Barr-virus DNA obtained after superinfection of Raji cells with HRI EB virus.
G.W. Bornkamm,* H. Delius,t B. Fleckenstein,* C. Mulder,** and H. zur Hausen,* *Institute fdr Klinische
)Pic Virologie, Universitat Erlangen, Federal Republic of Germany; tEMBO Laboratorium, Heidelberg,
Federal Republic of Germany; **University of Massachusetts Medical School, Worcester: Characteriza-
tion of Epstein-Barr-virus DNA from P3HR-1 and B 95-8 cells.
A. Adams, G. Bjursell, C. Kaschka-Dierich, L. Falk, and T. Lindahl, Departments of Tumor Biology,
Biochemistry, and Chemistry, Karolinska Institute, Stockholm, Sweden: Strain differences in Epstein-Barr
virus.
M. Andersson, A. Adams, and T. Lindahl, Departments of Chemistry and Tumor Biology, Karolinska
uni- Institute, Stockholm, Sweden: Integrated sequences of Epstein-Barr-virus DNA in human lymphoid cell
ds. lines.
'lot C. Mulder, B. Fleckenstein, G.W. Bornkamm, F.J. Werner, H. Delius, and J. Simonds, University of
Massachusetts Medical School, Worcester; Institut fdr Klinische Virologie, Universitat Erlangen, Max-
on Planck-Institut fur Biochemie, Munich, and EMBO Laboratorium, Heidelberg, Federal Republic of Ger-
many; National Cancer Institute, Bethesda, Maryland: Structural analysis of Herpesvirus saimiri and
Alb Herpesvirus ateles DNA.
and:
WEDNESDAY MORNING, September 1
)01
Session 2A: DNA structure II
)1I
Deb Chairpersons: H. zur Hausen, Institut fdr Klinische Virologie, Erlangen, Federal Republic of Germany
P. Schaffer, Baylor College of Medicine, Houston, Texas
01 B.A. Kilpatrick and E.-S. Huang, Department of Bacteriology and Medicine, and Cancer Research Center,
University of North Carolina, Chapel Hill: Structural analysis of cytomegalovirus genomes.
tem
"G.S. Hayward, T.G. Buchman, and B. Roizman, Department of Microbiology, University of Chicago,
Illinois: Cleavage maps of HSV-1 and HSV-2 DNA molecules.
N.M. Wilkie, R. Cortini, D. Powell, and J.B. Clements, Institute of Virology, Glasgow, Scotland: Sequence
arrangement and physical maps for herpesvirus DNAs.
J. Skare and W.C. Summers, Yale University School of Medicine, New Haven, Connecticut: Restriction-
endonuclease cleavage maps of the DNA of the KOS strain of HSV-1.
N. Frenkel and H. Locker, Department of Biology, University of Chicago, Illinois: Origin and coding
capacity of defective herpes simplex virus DNA.
H.C. Kaerner, C.H. Schroder, A. Ott, B. Stegmann, K. Munk, and G. Darai, Institute of Virus Research,
German Cancer Research Center, Heidelberg, and Institute of Medical Virology, University of Heidel-
berg, Federal Republic of Germany: A defective genotype of HSV ANG.
Session 28: Genetics
I.T. Jofre, V.C. Carter, M.C. Timbury,* and P.A. Schaffer, Department of Virology and Epidemiology, Baylor
College of Medicine, Houston, Texas; *Institute of Virology, University of Glasgow, Scotland: Genetic
studies with temperature-sensitive mutants of herpes simplex virus.
N.D. Stow, J.H. Subak-Sharpe, and N.M. Wilkie, Institue of Virology, University of Glasgow, Scotland:
Rescue of selected genetic markers from restriction-endonuclease-produced fragments of herpes simplex
virus type 1 DNA.
111
mutants
W.P. Summers, WC Summers,
and K.J. Cremer, Yale University School of Medicine, New
y, Glasgow,
aracteriza-
Connecticut: The thymidine
kinase gene of HSV-1.
J. Bookout, D.J.M Purifoy,
P.A. Schaffer, and N. Biswal, Department of Virology and Epiderniolo
College of Medicine, Houston,
Texas: Rescue of genetic information by temperature-sensitivgY' Baylor
from purified defective DNA
of HSV-1.
A.T. Jamieson, and J.H. Subak-Sharpe,
n Ind
S. Moira Brown, D.A. Ritchie,
Scotland: The effect of
5-fluorodeoxyuridine on partial "HETS" and on recombination.
M.K. Howett and F. Rapp,
The Pennsylvania State University College of Medicine
tion of host-range temperature-sensitive mutants
of herpes simplex virus type 2.
G.S. Read, S. Person, and
P.M. Keller, Laboratory of Biophysics, Department of Biochemist
Biophysics, Penn State University, University
Park, Pennsylvania: Genetic analysis of cell fusion Ty and
by syncytia-producing
mutants of herpes simplex virus type 1.
i uced
WEDNESDAY EVENING, September 1
Session 3: Replication
Chairpersons: B. Hirt, Swiss Institute for Experimental Cancer
Research, Lausanne, Switzerland
T. Ben-Porat, Vanderbilt University
School of Medicine, Nashville, Tennessee
T. Ben-Porat and J.-H. Jean,
Department of Microbiology, Vanderbilt University School of Medicine
Nashville, Tennessee: Studies on the replication
of parental pseudorabies (Pr) viral DNA.
D.J. O'Callaghan, J.C. Cohen, G.P.
Allen, and C.C. Randall, Department of Microbiology, University
01
Mississippi Medical Center, Jackson: Studies of the replication and transcription of equine herpesvirus
type 1.
R.J. Jacob and B. Roizman, Departments of Microbiology and Biophysics/Theoretical Biology, University 01
Chicago, Illinois: The structure of replicating herpes simplex DNA molecules. ssi
I. Hirsch, N. Biswal, J. Roubal,* and V. Vonka,* Department of Virology and Epidemiology, Baylor Colle
gof Medicine, Houston, Texas; *Institute of Sera and Vaccines, Prague, Czechoslovakia: Replicating DNAiaii
of herpes simplex virus type 1.
J. Shlomai, A. Friedmann, and Y. Becker, Laboratory for Molecular Virology, Hebrew University-Hadassal.
Medical School, and Department of Genetics, Hebrew University, Jerusalem, Israel: Replicative interHa'
mediates of herpes simplex virus DNA. prc
T. Seebeck and J.S. Pagano, Cancer Research Center, University of North Carolina, Chapel Hill: In vitr(1.8'
synthesis of Epstein-Barr-virus DNA. arc
Y. Becker, Y. Asher, and J. Shlomai, Laboratory for Molecular Virology, Hebrew University-HadassaIDN
Medical School, Jerusalem, Israel: In vitro synthesis of viral DNA in nuclei isolated from cells infectetS.KI
with wild-type and a phosphonoacetic-acid-resistant mutant of herpes simplex virus.
M.L. Fenwick, Department of Microbiology and Biophysics/Theoretical Biology, University of ChicagcPti°r1!
Illinois: Synthesis of virus-specific proteins in enucleated cells. . ha
Ang
THURSDAY MORNING, September 2
Mr
meg
Session 4: Protein I
StatE
iniecti
Chairpersons: P. Spear, University of Chicago, Chicago, Illinois
Stec
S. Klein, Karolinska Institute, Stockholm, Sweden Immu
D. Baron and J.L. Strominger, Sidney Farber Cancer Center, Harvard Medical School, Boston,
sachusetts: Heat stability of the Epstein-Barr nuclear antigen.
H. zur Hausen, K.O. Fresen, and B. Merkt, Institut fiir Klinische Virologie, Erlangen, Federal Republic ( Che
Durhd,
Germany: Heterogeneity of EBNA induction by P3HR-1 virus.
G. Klein, Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden: EBV-cycle and surfac,Pillrin
marker studies on somatic-cell hybrids and on EBV-converted sublines of virus-DNA negative lyricaPPati
phomas.
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M.F. Stinski, D.R. Thomsen, and E.S. Mocarski, Department of Microbiology, University of Iowa, Iowa City:
riorl Membrane glycoproteins of human cytomegalovirus.
Velicer and R.L. Witter,* Michigan State University and *USDA Regional Poultry Research Laboratory,
East Lansing, Michigan: Physical, chemical, and immunological characterization of antigens from
Marek's disease herpesvirus infected cells.
.F. Naegele and A. Granoff, Laboratories of Virology, St. Jude Children's Research Hospital, Memphis,
Tennessee: The detection of LHV-associated membrane antigen(s) on Lucke tumor cells.
.A. Killington, R.E. Randall, and D.H. Watson, Department of Microbiology, School of Medicine, The
and
University of Leeds, England: Studies on the type-specific antigens of herps simplex virus types 1 and 2.
. Ludwig, G. Pauli, and M.D. Daniel,* Institute of Virology, Justus Liebig University, Giessen, Federal
Republic of Germany; *New England Regional Primate Research Center, Harvard Medical School,
Southborough, Massachusetts: Common antigenic components of different herpesviruses.
.W. Knowles, S. Person, G.S. Read, T. Holland, and P.M. Keller, Biophysics Laboratory, Department of
Biochemistry and Biophysics, Penn State University, University Park, Pennsylvania: A correlation be-
tween the inhibition of cell fusion and the appearance of surface glycoproteins in HSV-1-infected cells.
.J. Courtney, J.W. Burek, and R. Eberle, Department of Virology and Epidemiology, Baylor College of
Medicine, Houston, Texas: Biochemical and immunological studies of herpes simplex virus type 1 and
type 2 glycoproteins resolved by sodium dodecyl sulfate-hydroxylapatite chromatography.
C. Glorioso and J.W. Smith, Department of Microbiology, Louisiana State University Medical Center, New
Orleans: Expression of cell-surface antigens in HSV-1 and HSV-2 infected BHK-21 cells.
.S. Marsden, R.G. Hope, J. Hay, and M.C. Timbury, M.R.C. Virology Unit and Department of Virology,
University of Glasgow, Scotland: The polypeptide profiles of temperature-sensitive mutants of HSV-2.
THURSDAY EVENING, September 2
ssion 5A: Protein II
airpersons: D. Watson, University of Leeds, Leeds, England
J. Stevens, University of California Medical Center, Los Angeles, California
Hay, H.S. Marsden, and R.T. Hay, Institute of Virology, University of Glasgow, Scotland: DNA-binding
proteins in herpesvirus-infected cells.
J. Bayliss and M. Nonoyama, Departments of Microbiology, Rush-Presbyterian-St. Luke's Medical Center
and University of Illinois, Chicago: Superinfection of Raji cells with Epstein-Barr virus: The induction of
DNA-binding proteins.
S. Kim, V. Sapienza, R.I. Carp, and H.M. Moon, Department of Microbiology and Animal Experimenta-
tion, New York State Institute for Research in Mental Retardation, Staten Island: Analysis of structural
polypeptides of purified human cytomegalovirus.
Fiala,* W. Gibsont, R.W. Honess,** and L.B. Guzett *Martin Luther King Jr. General Hospital, Los
Angeles, California; 1-The Salk Institute, La Jolla, California; **University of Leeds, England; t*Veterans
Administration (Wadsworth) and UCLA, Los Angeles, California: Structural polypeptides of cyto
megalovirus virions, dense bodies, and nucleocapsids.
sion 5B: Latency
. Stevens,* K.L. Lofgren,* H.S. Marsden,t and J.H. Subak-Sharpe,1 *Department of Microbiology and
Immunology, University of California, Los Angles; 1-Institute of Virology, University of Glasgow, Scot-
land: Temperature-sensitive mutants of herpes simplex virus differ in the capacity to establish latent
Bosh infections.
' . Cheung, D.J. Lang, and E.S. Huang, Department of Pediatrics, Duke University Medical Center,
,algo Durham, and Department of Medicine, University of North Carolina, Chapel Hill: Detection of latent
murine cytomegalovirus genome in tissues of commercially supplied laboratory mice.
ciegicliapp and C. Reed, Department of Microbiology, The Milton S. Hershey Medical Center, The Pennsylva-
i
A
.negiia
State University College of Medicine, Hershey: Interaction between superinfecting herpesviruses and
ndogenous type-C viruses.
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Chicago, Illinois.
University
A.S. Rubenstein and R.G. Duff, Department
of Virology, Abbott Laboratories, North
of disodium phosphonoacetate on
latent herpesvirus.
J.H. Joncas, J. Menezes, and E.S. Huang, Pediatric
Research Center, Ste.-Justine Hospital,
Montreal, Canada; Virology Center, Institut
Armand-Frappier, University of Quebec, Montreal, Canada;. E fl
Effects
Cancer Research Center, University
of North Carolina, Chapel Hill: Persistence of less than one
copy per
cell of the CMV genome in a human
lymphoblastoid cell line.
I.T. Magrath, P.A. Pizzo, and A.S. Levine, Pediatric Oncology Branch, National Cancer Institute, Beth
esdaMaryland: Increased yield of Epstein-Barr virus and EBV DNA from P3HR1 cells stimulated with
corticosteroid at 32°C.
FRIDAY MORNING, September 3
Session 6: Transformation
Chairpersons: A. Nahmias, Emory University School of Medicine, Atlanta, Georgia
F. Rapp, Pennsylvania State University, College of Medicine, Hershey, Pennsylvania
V.L. Flannery, R.J. Courtney, and P.A. Schaffer, Department of Virology and Epidemiology, Baylor College of
Medicine, Houston, Texas: Expression of a herpes simplex virus-specific antigen in HSV-transformed
cells.
C.D. Copple, L.B. Chen, and J.K. McDougall, Cold Spring Harbor Laboratory, New York: Properties of
HSV-2-transformed hamster cells.
R. Buttyan, J. Leiden, and P.G. Spear, Department of Microbiology, University of Chicago, Illinois: Regula-
tion of herpes simplex virus gene expression in transformed cells.
S. Bachetti and F.L. Graham, Departments of Pathology and Biology, McMaster University, Hamilton,
Ontario, Canada: Transfer of the gene for thymidine kinase to human cells by means of purified herpes
simplex viral DNA.
L. Geder, R. Lausch, and F. Rapp, Department of Microbiology, The Milton S. Hershey Medical Center, The
Pennsylvania State University College of Medicine, Hershey: Properties of human embryo lung fibro-
blasts transformed in vitro by human cytomegalovirus.
J.M. DeMarchi and A.S. Kaplan, Department of Microbiology, Vanderbilt University School of Medicine,
Nashville, Tennessee: Nonproductive infection in human embryonic lung cells stimulated by CMV to
synthesize cellular DNA.
K. Nazerian, E.A. Stephens, J.M. Sharma, L.F. Lee, M. Gailitis, and R.L. Witter, Regional Poultry Research
Laboratory, USDA, East Lansing, Michigan: A non-producer, transplantable lymphoblastoid cell line from
Marek's disease tumor.
A.A. Newton, Department of Biochemistry, University of Cambridge, England: Growth stimulation of duck
fibroblasts infected with Marek's disease virus.
E. Henderson, L. Heston, and G. Miller, Department of Pediatrics and Epidemiology and Public Health, Yale
University School of Medicine, New Haven, Connecticut: Biologic activities of transforming strains of
EBV differ in their sensitivity to UV inactivation.
J. Menezes, H. Dussault, and P. Patel, Department of Microbiology and Immunology and Pediatric Research
Center, University of Montreal, Quebec, Canada: Epstein-Barr virus (EBV) strains-Further differences'`
between lymphocyte-transforming (B95-8) and nontransforming (P3HR-1) EBV strains in regard to their(
ability to induce nuclear antigen (EBNA) and early antigen (EA).
G. Lenoir, A. Voller,* M.C. Berthelon, M.F. Lavoue, and G. de The, International Agency for Research on
I
Cancer, Lyon, France; *The Zoological Society of London, England: Studies on the characterization o
Epstein-Barr virus early antigens.
D.A. Thorley-Lawson, Sidney Farber Cancer Center, Harvard Medical School, Boston, Massachusetts:I
Studies on the early behavior of cellular DNA after infection of human lymphocytes by Epstein-Barr virus.
F. Deinhardt, L.A. Falk, M. Nonoyama, L. Wolfe, C. Bergholz, B. Lapin, L. Yakovleva, V. Agrba, G. Henle
and W. Henle, Department of Microbiology, Rush-PresbyterianSt. Luke's Medical Center, Chicago
Illinois; Institute of Experimental Pathology and Therapy, Sukhumi, USSR; The Children's Hospital o
Philadelphia, Pennsylvania: Baboon lymphotropic herpesvirus related to Epstein-Barr virus.
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F. Colbere-Garapin and F. Horodniceanu, Department of Virology, Pasteur Institute, Paris, France: On-
cogenic transformation of hamster cells by herpes simplex virus DNA.
sib i L.S. Kucera and J.P. Gusdon, Departments of Microbiology and Immunology and Obstetrics and Gynecol-
iac ogy, Bowman Gray School of Medicine, Winston-Salem, North Carolina: Oncogenic transformation of
rat embryo fibroblasts with photoinactivated herpes simplex virus type 2.
J.C.M. Macnab, B. Visser, J. Hay, and A.T. Jamieson, Institute of Virology, University of Glasgow, Scotland:
Iiesd Tumorigenicity of HSV-2-transformed cells in immunosuppressed and immunocompetent rats.
i wit
FRIDAY AFTERNOON, September 3
Session 7: Enzymes and PAA
Chairperson: A. Weissbach, Roche Institute of Molecular Biology, Nutley, New Jersey
J.A. Boezi, S.S. Leinbach, and L.F. Lee, Department of Biochemistry, Michigan State University, and USDA,
ARS Regional Poultry Research Laboratory, East Lansing, Michigan: Mechanism of phosphonoacetate
inhibition of herpesvirus-induced DNA polymerase: Alternate product or dead-end inhibitor?
liege f E.-S. Huang, S.-M. Huong, S.-T Chen, C.-H. Huang, and J. S. Pagano, Department of Medicine and Cancer
;lord Research Center, University of North Carolina, Chapel Hill: DNA polymerases of various EBV-producing,
nonproducing, and superinfected lymphoblastoid cells and their sensitivities to phosphonoacetic acid.
die; l D.J.M. Purifoy and K.L. Powell, Department of Virology and Epidemiology, Baylor College of Medicine,
Houston, Texas: Herpes simplex virus DNA polymerase associated with a virus-induced polypeptide.
Rer R.W. Honess, Department of Microbiology, School of Medicine, The University of Leeds, England: Physiol-
ogy and genetics of herpes simplex virus resistance and sensitivity to phosphonoacetic acid.
rdr, S. Kit and D.R. Dubbs, Division of Biochemical Virology, Baylor College of Medicine, Houston, Texas:
Iher:6 Regulation of herpesvirus thymidine kinase in cells [LM (TK)/HSV-1] transformed by UV-irradiated herpes
simplex virus.
itece I.E. Estes and E.-S. Huang, Department of Medicine and Cancer Research Center, University of North
ng 10" Carolina, Chapel Hill: Thymidine kinase activity in WI3 8 cells infected with human CMV.
Y.-C. Cheng, Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park
ied1( Memorial Institute, Buffalo, New York: Deoxythymidine kinase induced in HeLa TK cells by herpes
0.110 simplex virus type I and type II. Substrate specificity and kinetic behavior.
T.-S. Chan, Department of Physiology, University of Connecticut Health Center, Farmington: Induction of
Res6h deoxycytidine deaminase activity in a mouse cell line by infection with herpes simplex virus.
linen Y. Langelier and G. Buttin, Unite de Genetique Cellulaire, I.R.B.M., Paris, France: Deoxycytidylate
(dCMP)-deaminase activity in hamster cells infected by herpes simplex virus-Lack of evidence for a viral
lofdi< isozyme.
e SATURDAY MORNING, September 4
;train)ISession 8: Transcription, translation, and regulation of host function
Resed
h
Chairperson: B. Roizman, University of Chicago, Chicago, Illinois
rdtolP.C. Jones, G.S. Hayward, and B. Roizman, Departments of Microbiology and Biophysics/Theoretical
Biology, University of Chicago, Illinois: Templates for early functions (alpha mRNA) in HSV-1 DNA are
,sedre located within both the L and S segments.
,rizooDt W. Bodemer, M. Bodemer, and E.E. Petersen, Institute of Virology, Zentrum Hygiene der Universitat
Freiburg, Federal Republic of Germany: Characterization of viral mRNA from cells lytically infected with
55achris herpes simplex virus type 2 and hybridization of mRNA to Ecol fragmented viral DNA.
oroi,51.B. Clements, B. Perbal, and N.M. Wilkie, Institute of Virology, University of Glasgow, Scotland: Herpes
simplex virus-specific transcripts in infected BHK cells.
!,
(
4o,
or .R. Stringer, L.E. Holland, M.K. Rice, R.I. Swanstrom, and E.K. Wagner, Department of Molecular Biology
1,1100°` and Biochemistry, University of California, Irvine: Metabolism of HSV-specific mRNA in infected HeLa
cells.
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Y. Nishioka and S.J. Silverstein, Department
of Microbiology, Columbia University, New York, New
Fate of host mRNA sequences following productive
infection with HSV-1. York:
L.I. Pizer and P. Beard,* Department of Microbiology, University
of Pennsylvania, Philadelphia;
*s
Institute for Experimental Cancer Research, Lausanne:
The effect of herpesvirus infection on
polyoma-transformed cells.
mRNAwlisn
L. Pereira, M. Wolff, and B. Roizman, Departments
of Microbiology and Biophysics/Theoretical Biology
University of Chicago, Illinois: a-Infected polypeptides
of HSV-1 and HSV-2-A comparative
study
of their synthesis, processing, and transport.
I.W. Halliburton, Department of Microbiology, School of Medicine, University of Leeds, England: Studies on
the control of protein synthesis using is mutants and recombinants of HSV.
ORIGINS OF HUMAN CANCER
arranged by
J.D. WATSON, Cold Spring Harbor Laboratory
H. H. HIATT, Harvard University School of Public Health
J.A. WINSTEN, Harvard University School of Public Health
237 participants
TUESDAY EVENING, September 7
Welcoming remarks: J.D. Watson, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
H. H. Hiatt, Harvard University School of Public Health, Boston, Mass.
Opening address: R. Doll, University of Oxford, Oxford, England
I. INCIDENCE OF CANCER IN HUMANS
Session 1: Effects of geography and genetic background
Chairperson: J. Clemmesen, Danish Cancer Registry, Copenhagen, Denmark
J.W. Berg, Department of Preventive Medicine, University of Iowa, Iowa City: Worldwide variations in
cancer incidence-Known, presumptive, and possible causes.
W.J. Blot, T.J. Mason, R. Hoover, and J.F. Fraumeni, Jr., Environmental Epidemiology Branch, National
Cancer Institute, Bethesda, Maryland: Cancer by county-Etiologic implications.
L. Chiazze, Jr., D.L. Levin, and D.T. Silverman, Georgetown University School of Medicine, Washington,
D.C., and Biometry Branch, National Cancer Institute, Bethesda, Maryland: Recent changes in estimated
cancer mortality.
A.G. Knudson, University of Texas Health Science Center, Houston: Genetic predisposition to cancer.
WEDNESDAY MORNING, September 8
Session 2A: Changing patterns
Chairperson: J. Berg, University of Iowa, Iowa City, Iowa
T. Hirayama, Epidemiology Division, National Cancer Center Research Institute, Tokyo: Changing patterns
of cancer in Japan with special reference to the decrease in stomach cancer mortality.
B. Henderson and M. Pike, University of Southern California School of Medicine, Los Angeles: Hormonal
basis of breast cancer.
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4.1A'
J. Clemmesen, Danish Cancer Registry and Department of Pathology, Finsen Institute, Copenhagen:
Correlation of sites.
Session 2B: Effects of occupation
Chairperson: N. Nelson, New York University Medical Center, New York, New York
N. Nelson, Institute of Environmental Medicine, New York University Medical Center, New York: The
carcinogenicity of chloro ethers and related compounds.
C. Maltoni, Institute of Oncology and Tumor Center, Bologna, Italy: Vinyl chloride carcinogenicity-An
experimental model for carcinogenesis studies.
I.J. Selikoff, Environmental Sciences Laboratory, Mount Sinai School of Medicine, City University of New
York: Cancer risk of asbestos exposure.
S. Hernberg, Department of Epidemiology and Biometry, Institute of Occupational Health, Helsinki, Finland:
Incidence of cancer in populations with exceptional exposure to metals.
T. Norseth, Institute of Occupational Health, Oslo, Norway: Industrial viewpoints on the effects of occupa-
tion on cancer caused by metals.
WEDNESDAY AFTERNOON, September 8
Public policy panel I: Influence of the media
Judith Crighton, CBS News
Judy Randal, New York Daily News
Jonathan Spivak, The Wall Street Journal
Morton Mintz, The Washington Post
WEDNESDAY EVENING, September 8
Session 3: Effects of drugs
Chairperson: J. Fraumeni, National Cancer Institute, Bethesda, Maryland
R. Hoover, Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland: Effects of
riar drugs-Immunosuppression.
R.W. Miller, Clinical Epidemiology Branch, National Cancer Institute, Bethesda, Maryland: Prenatal factors.
H. Jick, Department of Medicine, Boston University Medical Center, Massachusetts: The magnitude of the
problem of drug-induced cancer.
A.L. Herbst,* R.E. Scully, S.J. Robboy, and W.R. Welch, *Department of Obstetrics and Gynecology,
esir University of Chicago, Illinois; Department of Pathology, Massachusetts General Hospital, Boston:
Abnormal development of the human genital tract following prenatal exposure to diethylstilbestrol.
!Ice( N.S. Weiss, Department of Epidemiology, School of Public Health and Community Medicine, University of
Washington, Seattle: Exogenous estrogens and the incidence of cancer in tissues of Mdllerian origin.
M. Pike and B. Henderson, University of Southern California School of Medicine, Los Angeles: Liver
adenoma and oral contraceptives.
R.H. Adamson and S.M. Sieber, Laboratory of Chemical Pharmacology, National Cancer Institute, Bethesda,
Maryland: Antineoplastic agents as potential carcinogens.
E. Bueding and R. Batzinger, Johns Hopkins University, Baltimore, Maryland: Hycanthone and other
antischistosomal drugs-Lack of obligatory association between chemotherapeutic effects and mutagenic
activity.
P. Goldman, J.A. Ingelfinger, and P.A. Friedman, Clinical Pharmacology Division, Department of Phar-
macology, Harvard Medical School, Boston, Massachusetts: Metronidazole, isoniazid, and the threat of
human cancer.
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THURSDAY MORNING, September 9
Massachusetts:'
Session 4A: Effects of radiation
power.
A. Upton, State University of New
York, Stony Brook, New York
, Boston, Mo
A.C. Upton, Department of Pathology, State
University of New York, Stony Brook: Carcinogenic
effects of
radiation.
En.,
G.B. Hutchison, Department of
Epidemiology, Harvard School of Public Health
Carcinogenic effects of medical irradiation.
W.H. Ellet and A.C.B. Richardson, Criteria and
Standards Division, Office of Radiation Programs,
mental Protection Agency, Washington, D.C.: Estimates
of the cancer risk due to nuclear electric
r
generation.
E.L. Scott and M.L. Straf, Statistical Laboratory, University
of California, Berkeley; Committee
on Statistics
National Academy of Sciences, Washington, D.C.: Ultraviolet radiation as a cause of cancer.
Session 4B: Effects of diet
Chairperson: T. Sugimura, National Cancer Center, Tokyo, Japan
C.A. Linsell, International Agency for Research on Cancer, Lyon, France: Field studies to evaluate a dietary'
carcinogen.
B.K. Armstrong, Department of Medicine, University of Western Australia, Nedlands: Epidemiologic ap-
proaches to the role of diet in carcinogenesis as exemplified by endometrial cancer.
M.J. Hill, Central Public Health Laboratory, Colindale, London: The role of unsaturated bile acids in the
etiology of large-bowel cancer.
J.H. Weisburger and E.L. Wynder, American Health Foundation, Naylor Dana Institute for Disease
Prevention, Valhalla, New York: On the etiology and metabolic epidemiology of the main human
cancers.
THURSDAY AFTERNOON, September 9
Public policy panel II: FDA -Diethylstilbestrol
Peter Hutt, Covington and Burling, Washington, D.C.
Thomas Jukes, University of California, Berkeley
Roy Hertz, George Washington Medical School, Washington, D.C.
II. MECHANISM OF CARCINOGENESIS
THURSDAY EVENING, September 9
Session 5A: Electrophilicity I
Chairperson: E. Miller, University of Wisconsin, Madison, Wisconsin
J.A. Miller and E.C. Miller, McArdle Laboratory for Cancer Research, University of Wisconsin Medical
Center, Madison: Ultimate chemical carcinogens as reactive mutagenic electrophiles.
P.H. Magee, Fels Research Institute, Temple University School of Medicine, Philadelphia, Pennsylvania:
Evidence for the formation of electrophilic metabolites from N-nitroso compounds.
D.M. Jerina, H. Yagi, M. Schaefer-Ridder, R. Lehr, D.R. Thakker, A.W. Wood,* A.Y.H. LU,* D. Ryan,* S
West,* W. Levin,* and A.H. Conney,* NIAMDD, National Institutes of Health, Bethesda, Maryland
*Department of Biochemistry and Drug Metabolism, Hoffman-LaRoche, Inc., Nutley, New Jersey: Bay-
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region epoxides of dihydrodiols-A unifying concept which explains the mutagenic and carcinogenic
activity of polycyclic aromatic hydrocarbon metabolites.
Session 58: Genetics and cancer
Chairperson: A. Hollaender, Associated Universities, Inc., Washington, D.C.
B.N. Ames and J. McCann, Department of Biochemistry, University of California, Berkeley: Do chemical
t and physical carcinogens cause cancer through damage to DNA?
R. Peto, University of Oxford, England: Rate-determining causes of human cancer which are not caused by
la. "Ames-type" mutagens.
ow
R.B. Setlow, Biology Department, Brookhaven National Laboratory, Upton, New York: Xeroderma
pigmentosum-Damage to DNA is involved in carcinogenesis.
Jtic J.B. Little, Department of Physiology, Harvard University School of Public Health, Boston, Massachusetts:
Radiation carcinogenesis in vitro-Implications for mechanisms.
A.M. Sincock, The Galton Laboratory, University College London, England: In vitro chromosomal effects of
asbestos and other materials.
FRIDAY MORNING, September 10
0.Session 6A: Viruses I
it Chairperson: J.D. Watson, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
H.E. Varmus, D. Spector, D. Stehelin, T. Padgett, C.T. Deng, and J.M. Bishop, Department of Microbiology,
University of California Medical School, San Francisco: Function and origin of the transforming gene of
avian sarcoma virus.
G.J. Todaro, Laboratory of Viral Carcinogenesis, National Cancer Institute, Bethesda, Maryland: RNA tumor
virus genes (virogenes) and the transforming genes (oncogenes)-Genetic transmission, infectious spread,
and modes of
P. Tegtmeyer, Department of Microbiology, State University of New York, Stony Brook: Gene function of
tumor virus SV40.
McDougall, Cold Spring Harbor Laboratory, New York: Tumorigenicity of cell lines transformed in vitro
by adenoviruses.
11 B. Roizman, N. Frenkel, E. Kieff, and P. Spear, University of Chicago, Illinois: Herpesviruses and human
cancer-The relevance of the association.
. Session 68: Modifying factors
I.Chairperson: E. Reich, The Rockefeller University, New York, New York
0. Stutman, Department of Cellular Immunobiology, Memorial Sloan-Kettering Cancer Center, New York,
= New York: Immune surveillance.
I.B. Weinstein, M. Wigler, and C. Pietropaolo, Institute of Cancer Research and Departments of Medicine
and Microbiology, Columbia University, New York, New York: The action of tumor-promoting agents in
cell culture.
i R.K. Boutwell, McArdle Laboratory, University of Wisconsin, Madison: On the role of the induction of
ornithine decarboxylase in tumor promotion.
M.B. Sporn, Lung Cancer Branch, National Cancer Institute, Bethesda, Maryland: Prevention of epithelial
pl cancer by vitamin A and its synthetic analogs (retinoids).
FRIDAY AFTERNOON, September 10
Pt
445Public policy panel III: FDA-Cyclamates
{Arnold Brown, Mayo Clinic, Rochester, Minnesota
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George R. Thompson, International Flavors and
Fragrances, Union Beach, New Jersey
Richard Bates, Food and Drug Administration,
Rockville, Maryland
FRIDAY EVENING, September 10
Inc.
Session 7A: Electrophilicity II
Chairperson: I.B. Weinstein, Columbia
University, New York, New York
D. Ryan, S. West, A.W. Wood, J. Kapitulnik, D.R. Thakker,* H. Yagi,*W. Levin, A.Y.H. Lu, D.m, j
muta-
genicity
and A.H. Conney, Department of Biochemistry and Drug Metabolism, Hoffmann-La Roche,
New Jersey; *NIAMDD, National Institutes of Health, Bethesda, Maryland: Properties of theult'ey
1
y Medicine
microsomal monoxygenase system and epoxide hydrase-Factors influencing the metabolism and
metabo-
lism
of benzo(a)pyrene.
L.W. Wattenberg, L.K.T. Lam, J.L. Speier, W.D. Loub, and P. Borchert, Department of Laboratory .
and Pathology, University of Minnesota, Minneapolis: Inhibitors of chemical carcinogenesis.
D.J. Brusick, K. Bakshi, D.R. Jagannath, and U. Weekes, Department of Genetics, Litton Bionetics,
Kensington, Maryland: Organ specificity and the effects of microsomal enzyme modifiers on the
'
Inc.,
of chemical carcinogens to active mutagens in mice and rats. I
D.P.H. Hsieh, J.J. Wong, and Z.A. Wong, Department of Environmental Toxicology, University of California
,Davis: Hepatic biotransformation of aflatoxin and its carcinogenic activity.
M.F. Rajewsky, L.H. Augenlicht, H. Biessmann, R. Goth, D.F. Hdlser, O.D. Laerum, and L.Ya. Lomakina,
Institut fdr Zellbiologie (Tumorforschung), Universitat Essen, Federal Republic of Germany: Nervous
system- specific carcinogenesis by ethylnitrosourea in the rat-Molecular and cellular aspects.
Session 7B: Aryl hydroxylase genetics
Chairperson: D. Jerina, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes
of Health, Bethesda, Maryland
R.E. Kouri and D.W. Nebert, Department of Biochemical Oncology, Microbiological Associates,. Inc., and
Developmental Pharmacology Branch, NICHHD, National Institutes of Health, Bethesda, Maryland:
Genetic regulation of susceptibility to polycyclic hydrocarbon-induced tumors in the mouse.
G.H. Kellermann, Department of Human Oncology, University of Wisconsin Medical School, Madison:
Hereditary factors in human cancer.
A. Poland and A. Kende, Departments of Pharmacology and Chemistry, University of Rochester, New York:
The regulation of aryl hydrocarbon hydroxylase activity-Evidence for an induction receptor.
S.S. Thorgeirsson, A.R. Boobis, P.J. Wirth, and C.E. Reinhold, Development Pharmacology Branch,
NICHHD, National Institutes of Health, Bethesda, Maryland: Genetic regulation of metabolism,
mutagenicity, and carcinogenicity of 2-acetylaminofluorene and related compounds in mice.
III. HUMAN RISK ASSESSMENT
SATURDAY MORNING, September 11
Session 8: Animal cancer tests
Chairperson: S. Weinhouse, Temple University School of Medicine, Philadelphia, Pennsylvania
S. Weinhouse, Fels Research Institute and Department of Biochemistry, Temple University School of
Medicine, Philadelphia, Pennsylvania: Problems in the assessment of human risk of carcinogenesis byi
chemicals.
U. Saffiotti, Experimental Pathology Branch, Carcinogenesis, DCCP, National Cancer Institute, Bethesda
Maryland: Identifying and defining chemical carcinogens.
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W.G. Flamm, Division of Cancer Cause and Prevention, National Cancer Institute, Bethesda, Maryland:
Animal tests and human hazards.
L. Tomatis, International Agency for Research on Cancer, Lyon, France: Value of long-term testing for the
implementation of primary prevention.
, H. Popper, C. Maltoni, I.J. Selikoff, R.A. Squire, and L.B. Thomas, Mount Sinai School of Medicine, New
York; Institute of Oncology, Bologna, Italy; National Cancer Institute, Bethesda, Maryland: Comparison
of neoplastic hepatic lesions in man and experimental animals.
D.P. Rall, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina:
Species differences in carcinogenesis testing.
D.G. Hoel, National Institutes of Environmental Health Sciences, Research Triangle Park, North Carolina:
Some problems in low-dose extrapolations.
N. Mantel, Biostatistics Center, George Washington University, Washington, D.C.: Aspects of the Hartley-
Sielken approach for setting "safe doses" of carcinogens.
SATURDAY AFTERNOON, September 11
:"Sess ion 9: Short-term assays-Predictive value
t.). Chairperson: B. Ames, University of California, Berkeley, California
P. 1. McCann, C. Sawyer, and B.N. Ames, Department of Biochemistry, University of California, Berkeley: The
Salmonella/microsome test-Predictive value for animal carcinogenicity.
' P. Moreau, A. Bailone, and R. Devoret, Section de Radiobiologie, Laboratoire d'Enzymologie du CNRS,
Gif-sur-Yvette, France: A new test for potential carcinogens-Prophage Y induction in E. coli K12 envA
uvrB
K. Russell and M. Meselson, The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Quantitative measures of carcinogenic and mutagenic potency.
0 E. Vogel, Department of Radiation, Genetic and Chemical Mutation, University of Leiden, The Netherlands:
Identification of carcinogens by mutagenicity testing in Drosophila.
H .F
. Stich, R.H.C. San, P. Lam, J. Koropatnick, and L. Lo, Cancer Research Centre and Department of
111:10: Medical Genetics, The University of British Columbia, Vancouver, Canada: Unscheduled DNA synthesis
as a short-term assay for chemical carcinogens.
C. Heidelberger, Cancer Center, University of Southern California, Los Angeles: Oncogenic transformation
by chemical carcinogens of rodent cell lines.
E. Huberman, Biology Division, Oak Ridge National Laboratory, Tennessee: Mutability of different genetic
loci in mammalian cells by metabolically activated chemical carcinogens.
T. Kakunaga, National Cancer Institute, Bethesda, Maryland: Chemical transformation of rodent and human
11/v" cells.
1°11'W.R. Bruce and J.A. Heddle, Ontario Cancer Institute, Toronto, Canada: The comparison of the mi-
cronucleus and sperm abnormality assays for the mutagenic activity of 61 different agents.
SUNDAY MORNING, September 12
Session 10: Industrial and agricultural chemicals
Chairperson: L. Golberg, Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina
R. Allen and D.H. Norback, Department of Pathology and Regional Primate Research Center, University of
Wisconsin, Madison: Carcinogenic potential of the polychlorinated bi phenyls.
.j. Gehring, P.G. Watanabe, and J.D. Young, Toxicology Research Laboratory, Health and Environmental
L Research, Dow Chemical, Midland, Michigan: The relevance of dose-dependent pharmacokinetics and
biochemical alterations in the assessment of carcinogenic hazard by chemicals.
Infante and J.K. Wagoner, National Institute for Occupational Safety and Health, Cincinnati, Ohio:
Chloroprene-Observations of carcinogenesis and mutagenesis.
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J.R. Withey, Bureau of Chemical Safety,
Health Protection Bran( II, I lealth and Welfare, Ottawa, c ,i1,
odaira-shi,Y.
S.S. Epstein, Department of Occupational and
Environmental Medicine, School of Public Health,
B. Ames, Biochemistry Department, University of California, Berkeley: Other
Tokyo: Mutagenicity screening on pesticides.
of Illinois, Chicago: Halogenated hydrocarbons-Pesticides.
Shirasu, M. Moriya, H. Tezuka,
Mutagenic, carcinogenic, and terratogenic hazards
arising from human exposure to plastics additivanada:
and S. Teramoto, Institute of
chemicals from in
U !vs. , Eniers., ,l.
C
vitro experiments. 0
N
A
el
Public Policy Panel IV: EPA-Dieldrin If.
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SUNDAY AFTERNOON, September 12
Walter Appleby, Shell Chemical Company, San Ramon, California
John Kolojeski, Environmental Protection Agency, Washington, D.C.
SUNDAY EVENING, September 12
Session 11: Air and water pollutants (additives)
Chairperson: R. Doll, Oxford University, Oxford, England "41
T. Mack, M. Pike, and B. Henderson, University of Southern California School of Medicine, Los Angeles:,K
Epidemiological methods for human risk assessment.
P.J. Lawther and R.E. Waller, MRC Environmental Hazards Unit, St. Bartholomew's Hospital Medical.0
College, London, England: Air pollutants and lung cancer-Recent trends in England and Wales.
R.E. Albert, Institute of Environmental Medicine, New York University Medical Center, New York: Car_ A
cinogenic atmospheric pollutants.
D.H. Fine, D.P. Rounbehler, R. Ross, and T. Fan, Cancer Research Department, Thermo Electron Research
Center, Waltham, Massachusetts: Human exposure to preformed N-nitroso compounds.
essi
R.H. Harris, T. Page, and N. Reiches, Environmental Defense Fund, Resources for the Future, Inc., Washing-
ton, D.C., and Department of Preventive Medicine, Ohio State University, Columbus: Drinking-waterM
contamination and its relations to human cancers.
T.A. DeRouen and J.E. Diem,* University of Washington, Seattle; *Tulane University, New Orleans,'
Louisiana: Relationships between cancer mortality in Louisiana, drinking-water source, and other possi-
ble causative agents.
C.R. Buncher, Division of Epidemiology and Biostatistics, Department of Environmental Health, University"
of Cincinnati, College of Medicine, Ohio: Drinking water as an epidemiologic risk factor for cancer. In
D.R. Taves, Department of Pharmacology and Toxicology, University of Rochester, New York: Fluoridation'1E
and cancer mortality. la
MONDAY MORNING, September 13
of
Session 12: Viruses II
Chairperson: G. Todaro, National Cancer Institute, Bethesda, Maryland
M. Essex,* J.R. Stephenson,t W.D. Hardy, Jr.,** S.M. Cotter,* and S. A. Aronson,t *Harvard School of Public
Health, Boston, Massachusetts; 1-National Cancer Institute, Bethesda, Maryland; **Memorial Sloan-
Kettering Cancer Center, New York, New York: Leukemia, lymphoma, and fibrosarcoma of cats as
models for similar diseases of man.
W.H.F. Jarrett, Department of Veterinary Pathology, University of Glasgow Veterinary School, Scotlan&m,
Development of vaccines against feline leukemia.
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M.J. Van Der Maaten and J.M. Miller, U.S. Department of Agriculture, National Animal Disease Center,
tit Ames, Iowa: Current assessment of human health hazards associated with bovine leukemia virus.
M.B. Gardner, R.M. McAllister, V. Klement, S. Rasheed, R.W. Rongey, B.E. Henderson, and H.P. Charman,
Departments of Pathology, Pediatrics, and Microbiology, University of Southern California School of
4 Medicine and Children's Hospital, Los Angeles; Frederick Cancer Research Center, Frederick, Maryland:
Search for type-C virus in humans.
R.C. Gallo, National Cancer Institute, Bethesda, Maryland: Some ideas on the origin of leukemia in man and
recent evidence for the presence of acquired and endogenous type-C-viral-related sequences.
) C. McGrath, H.D. Soule, E.J. Marianeau, L.J. Larson, and M.A. Rich, Michigan Cancer Foundation, Detroit:
A biological rationale for isolation of endogenous viruses from human breast carcinoma.
G. de The, International Agency for Research on Cancer, Lyon, France: Origins of human cancers-Can
epidemiology help in searching for a viral etiology?
W.E. Rawls, Department of Pathology, McMaster University, Hamilton, Ontario, Canada: Herpes simplex
viruses and human malignancies.
MONDAY AFTERNOON, September 13
Session 13A: Viruses Ill
Chairperson: B. Hirt, Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland
kito G. Khoury, M. Brown, C.-J. Lai, P. Howley, M. Israel, and M. Martin, National Cancer Institute and NIAID,
National Institutes of Health, Bethesda, Maryland: Human papovaviruses and their relationship to SV40.
031,G. Orth, Institute Gustave Roussy, Villejuif, France: Papillomaviruses-Possible role in human cancer.
0 M. Green and J. Mackey, Institute for Molecular Virology, St. Louis University School of Medicine, Missouri:
0 Are oncogenic human adenoviruses associated with human cancer? Analysis of human tumors for
adenovirus-transforming gene sequences.
011
Session 13B: Possible dietary carcinogens
Chairperson: P. Magee, Temple University Medical School, Philadelphia, Pennsylvania
T. Sugimura, T. Matsushima, H. Matsumoto, T. Kawachi, M. Nagao, S. Sato, T. Yahagi, Y. Seino, M.
Sawamura, and A. Shirai, National Cancer Center Resarch Institute and Institute of Medical Science,
!fiF Tokyo University, Japan: Mutagen-carcinogen and food.
N W. Lijinsky, Chemical Carcinogenesis, Frederick Cancer Research Center, Frederick, Maryland: Ni-
trosamines and their precursors in food.
!jori H. Endo, Division of Chemistry, Cancer Research Institute, Kyushu University Medical School, Fukuoka,
Japan: Survey of mutagens formed from environmental materials under physiological conditions.
S.R. Tannenbaum, M.C. Archer, and J.S. Wishnok, Department of Nutrition and Food Science, MIT,
Cambridge, Massachusetts: Nitrates, nitrites, N-nitroso compounds, and human cancer.
W.R. Bruce, A.J. Varghese, and R. Furrer, Ontario Cancer Institute, Toronto, Canada: A mutagen in the feces
of normal humans.
ro
MONDAY EVENING, September 13
tond;Remarks: Theodore W. Cooper, Assistant Secretary for Health, Department of Health,
Education, and
Welfare, Washington, D.C.
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TUESDAY MORNING, September 14
Session 14: Further strategies and standard setting
Chairperson: S. M. Wolfe, Public Citizen's Health Research Group, Washington, D.C.
S.M. Wolfe, Public Citizen's Health Research Group, Washington, D.C.: Standard setting-Preventiv
after the fact?
W. N i ch o I so n , Mount Sinai School of Medicine, City University of New York, New York: Standards forr
carcinogens dtheir effectiveness.
J.K. Wagoner and P.F. Infante, National Institute for Occupational Safety and Health, Cincinnati 0
Vinyl chloride-The use of laboratory assay for regulatory control. , hid:
W. Lijinsky, Frederick Cancer Research Center, Frederick, Maryland: Standard setting for nitrates
an
nitrosamines.
E.C. Hammond, American Cancer Society, New York, New York: Smoking.
Summary: J. Cairns, Imperial Cancer Research Fund, London, England
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IN- HOUSE SEMINARS
'old Spring Harbor in-house seminars were initiated to provide a
emiformal avenue for communication between the various research
roups at the laboratory. They are particularly useful for research
iersonnel who have joined the laboratory during the summer. The
nminars also afford a necessary opportunity for the graduate students
Ind postgraduate staff to develop their skills in defending, organizing,
hd presenting their research. In addition to those listed below, sem i-
ars were given by many others involved in research at this laboratory.
)ctober
4th. Drs. Ada L. and Donald E. 01 ins, Oak Ridge National Laboratory, Tennessee:
ovember
5th. Dr. James Lake, New York University Medical Center, New York: Ribosome structure-Localization of specific
proteins by electron microscopy of antibody labels.
4th. Dr. John Carbon, University of California, Santa Barbara: Biochemical construction of hybrid ColE1 plasmids -Making
and using an E. coli gene bank.
9th. Dr. Marshall Hurwitz, Albert Einstein College of Medicine, Bronx, New York: Adenovirus DNA synthesis.
4th. Dr. George Fey, Cold Spring Harbor Laboratory, New York: Peptide analysis of structural proteins from SV40 is
mutants.
1st. Dr. Jerry Both, Roche Institute of Molecular Biology, Nutley, New Jersey: Factors influencing the efficiency of
mRNA-ribosome interactions.
4th. Dr. Ah mad Bukhari, Cold Spring Harbor Laboratory, New York: Mutants of E. coli unable to survive in animals-Safe
hosts
in
DNA recombinant molecules.
4th. Dr. Victor Ling, Ontario Cancer Institute, Toronto, Canada: A cell-surface glycoprotein in modulating drug permeabil-
ity  Chinese hamster ovary cell mutants.
ecember
rd. Dr. Masayori Inouye, State University of New York at Stony Brook: Biosynthesis and assembly of a lipoprotein of the E.
coli outer membrane.
lb. Dr. Timothy Hall, University of Wisconsin, Madison: Studies on the aminoacylation property of RNA from several
plant viruses.
M. Dr. Vivian Mautner, The Cancer Center, Massachusetts Institute of Technology, Cambridge: Immunological studies of
cell-surface components in normal and transformed cells.
111. Dr. Yung Chi Cheng, Roswell Park Memorial Institute, Buffalo, New York: Comparisons of purified thymidine kinases
from herpesvirus-infected and noninfected human cells.
'th. Dr. Tim Hunt, Cambridge University, England: The control of protein synthesis by reversible phosphorylation of an
initiation factor.
)th. Dr. Gerry Rubin, Stanford School of Medicine, California: Arrangement of sequences in cloned segments of Drosophila
DNA.
luary
st. Dr. Joan Kaplan, Massachusetts General Hospital, Boston: The induction of SV40 virus from transformed hamster cells.
$. Dr. A. Mirzabekov Molecular Biology Institute, Moscow, USSR: Chromatin structure and DNA-protein interaction as
studied by the biochemical approach.
th: Dr. Ronald H. Cohn, Stanford University, California: The organization of histone genes.
M. Dr. Suzanne Emerson, University of Virginia, Charlottesville: Identification of the proteins involved in transcribing the
RNA genome of vesicular stomatitis virus.
The "nu" structure of chromatin.
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February
3rd. Dr. Jane Flint, Massachusetts Institute of Technology,
Cambridge: Ordered transcription of RNA tumor virus
g e n o
in vitro.
11
protein
12th. Dr. Warren Maltzman, University of California, Berkeley:
Regulation of phage lambda DNA synthesis.
13th. Dr. Beatrice Mintz, The Institute of Cancer Research,
Philadelphia, Pennsylvania: Normalized gene expression
teratocarcinoma cell differentiation.
18th. Dr. George Miller, Yale Medical School, New Haven,
Connecticut: Host-cell factors and transformation by Epstein_
Barr virus.
25th. Dr. S. Muthukrishnan, Roche Institute of Molecular
Biology, Nutley, New Jersey: mRNA methylation and iiti
i
synthesis in eukaryotes. Ve
27th. Dr. William Haseltine, Massachusetts
Institute of Technology, Cambridge: Ordered transcription of RNA tumor virus
0
genomes in vitro. lok
March Ff
1st. Dr. Ernest Winocour, Weizmann Institute, Rehovot, Israel: Recombination between SV40 and the host genome ,")(
2nd. Dr. Eiichi Ohtsubo, State University of New York at Stony Brook: Structure and function of E. coli sex and resistance fe
factors as determined by EM heteroduplex analysis and restriction-enzyme mapping.
5th. Dr. Philip Serwer, California Institute of Technology, Pasadena: Phage T7 DNA packaging-Biophysical analysis using
ow
iothalimate density gradients. 1dt
9th. Dr. Fred Blattner, University of Wisconsin, Madison: Efforts to construct "safe" lambda vectors for cloning DNA. A,
12th. Dr. John Bridgen, University of Alabama, Birmingham: New microsequencing technique-Application to membrane
proteins.
16th. Dr. Maxine Singer, National Institutes of Health, Bethesda, Maryland: Interaction of histone with superhelical DNA
19th. Dr. Nicholas Maroudas, Imperial Cancer Research Institute, London, England: Physical chemistry of nonspecific cell
adhesion and spreading on synthetic solid substrata.
25th. Dr. Wayne Barnes, Medical Research Council at Cambridge, England: Manipulating a DNA plasmid to study the
histidine operon.
26th. Dr. J.P. Trinkhaus, Yale University, New Haven, Connecticut: Modes of cell locomotion in vivo.
30th. Dr. David Denhardt, McGill University, Montreal, Quebec, Canada: DNA replication, with special emphasis on
(IDX174.
April
1st. Dr. Guenter Albrecht-Buehler, Cold Spring Harbor Laboratory, New York: A quantitative description of locomotory
surface activities in spreading 3T3 cells.
8th. Dr. James Manley, Cold Spring Harbor Laboratory, New York: Metabolism of abnormal polypeptides by the lacZ gene
of E. coli.
13th. Dr. Dick Fine, Boston University, Massachusetts: Coated vesicles-What they tell us about Ca++ regulation in
nonmuscle cells.
15th. Dr. James McDougall, Cold Spring Harbor Laboratory, New York: Clonal derivatives of a herpes-type-2-transformed
hamster cell line (333-8-9)-Cytogenic analysis and virus messenger-RNA detection.
20th. Dr. Vincenzo Enea, The Rockefeller University, New York: Deletion mutants of phage F1-Mutants with no genes.
23rd. Dr. Bob Wayland, Institute Pasteur, Paris, France: Protein synthesis and actin heterogeneity in cultured muscle cells.
May
7th. Dr. Robert Tjian, Harvard University, Boston, Massachusetts: Regulatory proteins of phage SP01.
11th. Dr. Gunther Blobel, The Rockefeller University, New York: Early events in the secretory pathway.
14th. Dr. David Ward, Yale University, New Haven, Connecticut: Structure and replication of nondefective parvoviruses
Antineoplastic agents (?).
17th. Dr. Robert Goldman, Carnegie-Mellon Institute, Pittsburgh, Pennsylvania: Actomyosinlike contractile structures and
the control of normal and virus-transformed cell behavior.
18th. Dr. Douglas Berg, University of Wisconsin, Madison: A transposable segment of prokaryotic DNA which encodes
resistance to kanamycin.
25th. Dr. M.V. Nermut, Medical Reseach Council, London, England: Structural elements in adenovirus cores.
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UNDERGRADUATE SUMMER
RESEARCH PROGRAM
Another aspect of the summer program at the Laboratory is the participation of college undergraduate students
Y,!g in active research projects under the supervision of full-time laboratory staff members. The program was
id initiated in 1959. Since that year 175 students have completed the course, and many have gone on to creative
careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental principles of
'biology, (2) an increased awareness of major problem areas under investigation, (3) an increased awareness of
the physical and intellectual tools for modern research and the pertinence of this information to future training,
ve, and (4) a personal acquaintance with research, research workers, and centers for study.
Ten college undergraduates, selected from a large number of applicants, take part in the program, which is
now mainly supported by Laboratory funds. This year's students are listed below, with their laboratory sponsors
P9 and topics of research. We gratefully acknowledge the generosity of Central General Hospital, Plainview, New
,v( York, which provided fellowships to support the work of Mark Glen, Franklin Moser, and Beth Weinstein.
Mark Dulaney Glen, University of The nucleotide sequence of the gene for
Pennsylvania adenovirus-2 virus-associated RNA
Supervisor: M. Mathews
Marion Gold, University of California, In vitro studies of protein degradation
Berkeley in Escherichia coli
Supervisor: C.G. Miller
Robert Craig Gudor, University of
California, Berkeley
Supervisor: A. I. Bukhari
Francine Bryanne Hanberg, Yale
University
Supervisor: R. J. Roberts
Nancy Harris, Yale University
Supervisor: J. Manley
Franklin G. Moser, Yale University
Supervisor: L.B. Chen
Phyllis Barbara Moses, The Johns Hopkins
University
Supervisor: R. Kahmann
James Albert Rhodes, Harvard College
Supervisor: K. Burridge
James M. Roberts, Amherst College
Supervisors: T. Broker and L. Chow
Beth Weinstein, Cornell University
Supervisor: J. Broach
Interaction of the genomes of bacterio-
phages Mu and P1 in Escherichia coli
Screening bacterial strains for new
restriction endonucleases
Transcription of adenovirus-2 DNA by
wheat-germ RNA polymerases
Distribution of cell-surface LETS
protein in cocultures of normal and
transformed cells
Structure and biological properties of
hybrids made in vitro between pMB9 and
the c-terminal Hind III fragment of
bacteriophage Mu
Direct gel analysis of glycoproteins
from cultured fibroblasts and
epithelial cells
A cytoplasmic RNA transcript map of
adenovirus 2 determined by electron
microscopy of RNA:DNA hybrids
Search for operon for mutants in the
galactose system of yeast
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NATURE STUDY PROGRAM
The Nature Study Program is designed for elementary and high school students who wish to achieve a greater
understanding of their environment. In summer and fall of 1976, 376 students participated in this program.
When weather permitted, most of the courses were held outdoors on the laboratory grounds or at the Uplands
,r'arm Nature Preserve of the Nature Conservancy. The Laboratory has built and equipped classroom-
aboratories at Uplands Farm for the study of field specimens collected by students.
This fall a Marine Environmental Science course was conducted as a joint project with the Marine Sciences
esearch Center at the State University at Stony Brook. The instructors were advanced graduate students and
L : ell-known specialists holding university appointments and actively engaged in research in their specific
1 subject areas. An all-day trip to Stony Brook and a cruise on the center's research vessel Onrust were included.
* :(4e
11, director: Sanford Kaufman, M.S., M.P.A., biology teacher, Hewlett High School.i.
EACHERS
Linda Bovich, M.S., science teacher, Rocky Point High School
Donn Dunn, M.S., art and photography teacher, Hewlett High School
Steven Englebright, M.S., curator of geology, SUNY at Stony Brook
George Hechtel, Ph.D., Department of Biology, SUNY at Stony Brook
Barbarajean Kaufman M.S., Ph.D. candidate, SUNY at Stony Brook
I.L. McHugh, Ph.D., Marine Sciences Research Center, SUNY at Stony Brook
Fred Maasch, M.Ed., biology teacher, Islip High School
Harold O'Connors, Ph.D., Marine Sciences Research Center, SUNY at Stony Brook
C. Donald Powers, Ph.D., Marine Sciences Research Center, SUNY at Stony Brook
lames Romansky, M.S., biology teacher, Bay Shore High School
Anthony Taormina, New York State Department of Conservation
Edward Tronolone, M.S., science teacher, Lynbrook High School
Robert Wilson, Ph.D., Marine Sciences Research Center, SUNY at Stony Brook
Charles Wurster, Ph.D., Marine Sciences Research Center, SUNY at Stony Brook
OURSES
General Nature Study
Advanced Nature Study
,...1 Elementary Geology
Advanced Geology
Bird Study
Seashore Life
Vertebrate Biology
Reptiles and Amphibians
Aquatic Biology
Marine Biology
Nature Photography I and II
Fresh Water Life I and II
12!
LABORATORY STAFF
NOVEMBER 1976
DIRECTOR
J. D. Watson
ADMINISTRATIVE DIRECTOR
William R. Udry
ASSISTANT DIRECTOR
FOR RESEARCH
Raymond Geste land
RESEARCH SCIENTISTS
Guenter Albrecht-Buehler
Michael Botchan
Thomas Broker
Ahmad Bukhari
Louise Chow
Richard Gelinas
George Fey
Terri Grodzicker
Walter Keller
James Lewis
Thomas Maniatis
Michael Mathews
James McDougall
Richard Roberts
Joseph Sambrook
William Topp
Sayeeda Zain
David Zips&
POSTDOCTORAL FELLOWS
Ramunas Bigelis
James Broach
Keith Burridge
Lan Bo Chen
Yih-Shyun Edmund Cheng
Denise Galloway
Thomas Gingeras
Marian Harter
John Hassell
Regine Kahmann
Dietmar Kamp
Hajra Khatoon
Elisabeth Ljungquist
Merilyn Sleigh
Robert Tjian
Marcus Zabeau
GRADUATE STUDENTS
Ashley Dunn
William E. Gordon III
Daniel Klessig
Norman Maitland
James Manley
Gek-Kee Sim
RESEARCH ASSISTANTS
Linda Ambrosio
Joseph Bonventre
Frans DeBruijn
Barbara Doretsky
Geraldine Gavin
Ronni Greene
Robert Gudor
Randi Kelch
Robert Lancaster
Marjorie Lazarus
Sheila Levings
Anita Lewis
Bernice Lieberman
Robert McGuirk
Phyllis Myers
Rosemary Oliveros
Diana O'Loane
Rebecca Pashley
Elaine Paul
Patricia Reichel
John Scott
Susanne Weirich
Ingrid Wendel
Norma Wills
Steven Young
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SUPPORTING STAFF
Robert Borruso
Sallie Chait
Bruce DeTroy
Agnes Fisher
Maria Hedges
Marie Moschitta
Carilyn Mutt
Joyce Schneider
Madeline Szadkowski
Deborah Whitfield
Robert Yaffe
PUBLICATIONS DEPARTMENT
Ndncy Ford
Roberta Salant
.\nnette Zaninovic
GENETICS RESEARCH UNIT,
CARNEGIE INSTITUTION
OF WASHINGTON
Alfred Hershey
Barbara McClintock
LIBRARY STAFF BUILDINGS AND GROUNDS
Susan Gensel
Laura Hyman
Elizabeth Roberts
ADMINISTRATIVE
AND GENERAL STAFF
Deon Baker
Steven'Cassaniti
Joan Cook
Guy Cozza
Barbara Eggers
Ellen Farrant
Maryalice Gladding
Martin Hen le
James Herb
Louis lammuno
William Keen
Gladys Kist
John Maroney
Susan Messina
Agnes Meyer
Dorothy Nilsson
Eileen Oates
Donna Walsh
DEPARTMENT
Robert Anderson
John Bach
Barry Becker
Karl Berg
Carol Caldarelli
Vincent Carey
Barbara Cuff
Carmen Dewan
Joseph Ellis
Stephen Fusaro
Robert Grundel
Douglas Haskett
Mary Hill
Robert Klipera
Julius Kulmayer
William Leyden
Thomas Lyden
Alfred Nickel
Alfred Pfeiffer
Jack Richards
Lane Smith
Jerry Sorrentino
James Stanley
Hans Trede
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FINANCIAL STATEMENT
BALANCE SHEET
year ended October 31, 1976
with comparative figures for 1975
ASSETS
CURRENT FUNDS
Unrestricted
1976 1975
Cash $ (49,845) $ 126,878
Marketable securities 93,148
Accounts receivable 66,739 70,059
Inventory of books 212,839 167,085
Prepaid expenses 33,921 8,796
Due from restricted fund 214,654 36,595
Total unrestricted 571,456 409,413
Restricted
Grants receivable 728,974 605,651
Total current funds 1,300,430 1,015,064
PLANT FUNDS
Investment 85,037 39,197
Due from unrestricted fund 293,468 176,156
Land and improvements 595,954 581,496
Buildings 2,315,592 1,980,099
Furniture, fixtures, and equipment 614,980 476,789
Books and periodicals 365,630 365,630
Construction in progress 17,211 276,993
4,287,872 3,896,360
Less allowance for depreciation
and amortization 867,187 686,331
Total plant funds 3,420,685 3,210,029
BANBURY EDUCATIONAL CENTER
Cash 200
Prepaid expenses 100
Due from unrestricted fund 42,951
43,251
Land 772,500
Buildings 245,000
Furniture, fixtures, and equipment 113,343
Construction in progress 3,954
1,134,797
Less allowance for depreciation 14,221
1,120,576
Total Banbury Educational Center 1,163,827
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LIABILITIES
CURRENT FUNDS
Unrestricted
AND FUND BALANCES
1976 1975
Accounts payable $ 49,097 $ 58,347
Due to plant funds 293,468 176,156
Due to Banbury Educational Center 42,951
Fund balance 185,940 174,910
Total unrestricted 571,456 409,413
Restricted
Due to unrestricted funds 214,654 36,595
Fund balance 514,320 569,056
Total restricted 728,974 605,651
Total current funds 1,300,430 1,015,064
PLANT FUNDS
Fund balance
BANBURY EDUCATIONAL CENTER
3,420,685 3,210,029
Fund balance 1,163,827
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CURRENT REVENUES, EXPENDITURES, AND TRANSFERS
year ended October 31, 1976
with comparative figures for 1975
COLD SPRING HARBOR LABORATORY
REVENUES
1976 1975
Grants $1,918,414 $1,661,421
Indirect cost allowance on grants 783,683 856,344
Contributions 170,799 62,072
Robertson Research Fund contribution 300,000 275,000
Summer programs 175,658 151,235
Laboratory rental 19,754 19,633
Marina rental 35,430 31,300
Investment income 10,363 19,990
Publications sales 289,698 382,221
Dining hall 220,783 160,021
Rooms and apartments 143,823 133,576
Other sources 11,762 24,747
Total revenues 4,080,167 3,777,560
EXPENDITURES
Research* 1,722,024 1,593,093
Summer programs* 371,888 179,861
Library 82,927 56,361
Operation and maintenance of plant 626,047 502,136
General and administrative 446,570 387,595
Publications sales* 225,863 224,145
Dining hall* 190,354 188,786
Total expenditures 3,665,673 3,131,977
TRANSFERS TO PLANT FUNDS 403,464 507,950
Total expenditures and transfers 4,069,137 3,639,927
Excess of revenues over expenditures and transfers 11,030 137,633
*Reported exclusive of an allocation for operation and maintenance of plant, general and
administrative, and library.
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BANBURY EDUCATIONAL CENTER
REVENUES
Contributions
1976 1975
(including land, buildings, and furnishings) $1,230,843
Rooms and Apartments 11,646
Total revenues 1,242,489
EXPENDITURES
Operation and maintenance of plant 65,361
General and administrative 13,301
Total expenditures 78,662
Excess of revenues over expenditures 1,163,827
NOTE: Copies of the complete financial statements, certified by our independent auditors, Peat,
Marwick, Mitchell & Co., are available upon request from the Comptroller, Cold Spring
Harbor Laboratory.
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FINANCIAL SUPPORT
OF THE LABORATORY
The Cold Spring Harbor Laboratory is a publicly supported educational institution chartered by the University of
the State of New York and may receive contributions which are tax exempt under the provisions of the Internal
Revenue Code, particularly Section 501 C. In addition, the Laboratory has been formally designated a "public
charity" by the Internal Revenue Service. Accordingly, it is an acceptable recipient of grants which would result
trom the termination of "private" foundations.
The Laboratory depends upon the generous contributions of its sponsors, participating institutions, and friends
for central institutional needs and capital improvements. In addition, the development of any new programs,
such as year-round research in neurobiology and the marine sciences, can only be undertaken with substantial
support from private sources.
Methods of contributing to Cold Spring Harbor Laboratory
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities
(1) Your broker or bank may sell the securities and remit the proceeds directly to the Laboratory.
(2) If you wish to send stock directly to the Laboratory, either (a) endorse the certificate(s) by signing your
name on the back, leave the space for the transferee's name blank, have your signature guaranteed on the
certificate(s) by your bank or broker, and send the certificate(s) by registered mail to the Laboratory, or (b)
send unsigned certificate(s) with a covering letter and send under separate cover a stock power executed
in blank, with signature guarantee, for each certificate, and also a copy of the covering letter (use first-class
mail). Depreciated securities should be sold to establish a tax loss, then the contribution to the Laboratory
should be made by check.
Bequests
Probably most wills need to be updated. Designating the Cold Spring Harbor Laboratory as a beneficiary
ensures that a bequest will be utilized as specified for continuing good.
Appreciated real estate or personal property
Sizable tax benefits can result from such donations; the Laboratory can use some in its program and can sell
others
Lite insurance and charitable remainder trusts can he structured to suit the donor's specific desires as to extent,
timing, and tax needs.
Conversion of private foundation to "public" status on termination
This may be done by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of the
private foundation could be accounted for as a separate fund and used for the purposes specified by the
donor. Alternatively, the private foundation can be established as a "supporting organization of the Cold
Spring Harbor Laboratory."
For additional information, please contact the Administrative Director, Cold Spring Harbor Laboratory, P.O.
Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-692-6660.
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GRANTS
November 1, 1975-October 31, 1976
NEW GRANTS
Grantor
Principal investigator
and program Total award
Duration of
grant
National Institutes of Health Dr. Watson - general research
support $ 46,495 4/1/76
- 3/31/77Contract - advanced bacterial
genetics workshop 25,325 7/1/76
- 6/30/77Dr. Watson - herpesvirus workshop 22,000 6/30/76
- 6/29/77Dr. Watson - conference on origins
of human cancer 60,000 6/30/76
- 6/29/77
Dr. Maniatis - research subcontract
from Harvard 26,850 7/1/76
- 12/31/76
National Science Foundation Dr. Bukhari - research 120,000 8/1/76 - 7/31/78
Dr. Albrecht-Buehler - research 10,000 6/1/76
- 11/30/77
Dr. Bukhari - conference on
DNA insertions 3,000 3/15/76 - 2/28/77
Dr. Zain - research 12,100 3/1/76 - 5/31/77
Dr. Watson - herpesvirus workshop 5,000 5/15/76
- 4/30/77
Dr. Geste land - workshop on
Dictyostelium 4,600 4/15/76 - 9/30/76
Rita Allen Foundation Dr. Lewis - research 150,000 8/1/76 - 7/31/81
Anna Fuller Fund Dr. Manley - fellowship 10,000 9/1/76 - 8/31/77
Interboro Leukemia Organization Dr. Watson - equipment support 4,000 4/1/76 - 6/30/76
Muscular Dystrophy Association Dr. Chen - fellowship 13,500 1/1/76 - 12/31/76
Merck, Sharp & Dohme
Research Laboratories Dr. Watson - Symposium support 5,000 6/1/76 - 6/8/76
Hoffman-La Roche, Inc. Dr. Watson - Symposium support 6,000 6/1/76 - 6/8/76
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:ONTINUING GRANTS
7,rantor
\lational Institutes of Health
National Science Foundation
-Helen Hay Whitney Foundation
yolkswagen Foundation
nergy Research and
Development Administration
7163rass Foundation
American Cancer Society
,oley Foundation
hti as Fuller Fund
:_ystic Fibrosis Foundation
klfred P. Sloan Foundation
4 1ne Coffin Childs Memorial
Fund for Cancer Research
Principal investigator
and program
Dr. Watson - general research
support
Dr. Bukhari - career development
Dr. Hassell - fellowship
Dr. Gelinas - fellowship
Dr. Watson - Cancer Research
Center
Dr. Watson - Symposium support
Dr. Zipser - research
Dr. Gesteland - summer workshops
Dr. Watson - neurobiology training
Dr. Albrecht-Buehler - research
Dr. Gesteland - research
Dr. Bukhari - research
Dr. Roberts - research
Dr. Zipser - research
Dr. Gesteland - research
W. Udry - Symposium support
Dr. Daniell - fellowship
Dr. Watson - training support
Dr. Watson - Symposium support
Dr. Watson - neurobiology training
Dr. Endow - fellowship
Dr. Lewis - research
Dr. Watson - neurobiology
Dr. Burridge - fellowship
Dr. Bukhari - research
Dr. Watson - neurobiology
Total award
Duration of
grant
$ 145,638 1/1/75 - 3/31/76
110,000 5/1/75 - 4/30/80
26,000 10/1/75 - 9/30/77
26,000 7/3/74 - 7/2/76
7,789,000 1/1/72 - 12/31/76
96,000 4/1/74 - 3/31/79
350,000 5/1/74 - 4/30/79
194,895 4/1/74 - 3/31/77
152,172 5/1/74 - 4/30/77
76,300 7/1/75 - 6/30/77
45,000 1/1/75 - 12/31/77
60,000 8/1/74 - 1/31/77
50,000 6/15/74 - 11/30/76
160,000 1/1/74 - 2/28/78
41,400 9/1/74 - 2/29/76
5,000 5/15/76 - 4/30/77
17,583 3/1/74 - 12/31/75
73,085 1/1/71 - 12/31/76
8,000 6/1/76 - 6/8/76
5,000 6/1/76 - 9/30/76
10,333 1/1/75 - 2/29/76
74,100 7/1/75 - 6/30/77
10,000 1/1/76 - 12/31/76
18,100 6/1/75 - 5/31/77
29,000 1/1/75 - 12/31/76
165,000 1/1/75 - 12/31/78
Dr. Bothwell - fellowship 10,500 7/1/75 - 6/30/76
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Dr. Stefan G. Belman
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Mr. & Mrs. Donald Deming
Mr. & Mrs. Charles W. Dow
Rose Finnegan
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Mrs. William J. Galione
Mr. & Mrs. Harold L. Gardner
Mr. & Mrs. Robert A. Gay
Mrs. Paul Grant
A. Guha
Ann Hammond
Mollie Harnden
Dr. & Mrs. C. Hartenstein
Ira Herskowitz
Mrs. Joseph Hearst
Mr. & Mrs. Rudolf Hunermund
Gladys Kist
James F. Langton
Mr. & Mrs. Thomas Losee, Jr.
Leila L. McKnight
Dr. W. Reichardt
Mr. & Mrs. John Ricks
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Dr. Robert F. Schleif
Dr. Carl Schildkraut
Dr. & Mrs. W. Shropshire,
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Dr. Gunther S. Stent
S. G. and D. L. Stephens pl
Uppsala University
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Eugene J. Smith
Carol E. Snow
Dr. & Mrs. Samuel Teich
J. Thorner
Mr. & Mrs. Robert Yaffe
_JONG ISLAND
3IOLOGICAL ASSOCIATION
lie new Williams House, built with LIBA contributions, nears completion in spring 1977.
e Laboratory was founded in 1890 by several local philanthropists and the Brooklyn Institute of Arts and
iences. The first chairman of the Board of Managers of the Laboratory was Eugene G. Blackford, who served
m 1890 until his death in 1904. William J. Matheson succeeded him, serving until 1923.
In that year when the Brooklyn Institute of Arts and Sciences withdrew from Cold Spring Harbor, the local
Y10,0porters of the research formalized their efforts by incorporating as the Long Island Biological Association.
done! T. S. Williams became the first Chairman of the new group. Jointly with the Carnegie Institution of
Washington, LIBA continued to support and direct the research at Cold Spring Harbor Laboratory.
In 1962 the Laboratory was reorganized as an operating organization and LIBA relinquished its management
sponsibilities. During the past 14 years, LIBA's chief function has been to widen the interest of the community
ithe Laboratory and to help support it financially.
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